data_1t2m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1t2m _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.903 0.382 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.456 ' CG2' ' HG2' ' A' ' 87' ' ' GLU . 21.4 mt -95.45 127.31 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.006 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.42 139.27 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.502 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 86.2 m -89.11 113.79 24.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.851 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -105.84 149.27 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.384 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -120.66 112.66 19.16 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.733 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.67 163.02 27.02 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.188 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -103.73 174.31 5.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.219 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -107.58 115.88 30.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.398 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.37 -41.3 10.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.615 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -163.4 47.08 0.13 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.689 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.44 -146.73 18.29 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.481 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 30.4 mtt -138.97 95.46 2.96 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.682 0.277 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.41 74.09 2.13 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.548 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.61 143.68 13.26 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.616 0.246 . . . . 0.0 111.012 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -87.64 147.25 25.35 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.187 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.2 pp -138.77 164.32 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.699 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.491 ' CG1' ' HB2' ' A' ' 35' ' ' TYR . 7.3 p -151.48 144.12 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.388 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.46 91.97 3.86 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.999 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.03 179.84 6.11 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.249 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 -179.99 4.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.716 0.293 . . . . 0.0 110.945 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.41 -138.82 2.56 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.708 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.57 149.79 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.866 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.53 18.22 36.48 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.489 -0.862 . . . . 0.0 110.986 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.34 105.66 3.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.729 0.299 . . . . 0.0 110.859 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.08 26.77 2.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.987 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -122.1 -158.81 0.79 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.8 100.22 5.41 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.826 0.346 . . . . 0.0 110.703 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.18 155.36 28.53 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.763 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.2 mm -88.31 93.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 CA-C-O 120.951 0.405 . . . . 0.0 110.473 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.491 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 91.8 m-85 -83.65 145.88 28.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.759 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.54 107.89 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.211 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -68.06 -42.97 79.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.941 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.6 t -168.03 171.76 9.38 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.139 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.7 t -128.99 120.94 53.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.578 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.35 130.47 34.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.85 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.13 126.55 27.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.55 -20.77 22.43 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.726 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.88 157.02 48.96 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.712 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.48 -39.9 64.91 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.54 -36.68 68.35 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.469 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -70.39 -49.19 51.66 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.28 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.48 -40.99 88.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.269 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.96 -50.85 69.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.164 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.13 46.57 3.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.442 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.26 -67.82 0.91 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.638 0.256 . . . . 0.0 110.91 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.78 158.4 18.78 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.811 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.35 176.06 8.44 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.58 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.35 147.69 44.15 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.473 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.99 45.36 57.33 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.412 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.39 179.64 3.99 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.478 0.18 . . . . 0.0 110.974 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 65.3 tt0 -123.46 147.97 46.65 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.208 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.76 127.76 48.6 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.304 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -109.07 -62.71 1.44 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.027 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.0 m -102.75 143.01 32.94 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.39 110.21 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.56 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.3 40.4 24.58 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.273 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.69 -26.46 12.38 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.11 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.75 175.39 10.72 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.963 0.382 . . . . 0.0 110.846 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.21 121.51 24.95 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.781 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.9 mt -96.86 51.19 1.13 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.798 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.3 t -95.98 90.94 2.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.77 31.56 2.91 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.526 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.7 mt -118.41 157.56 26.94 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.854 0.359 . . . . 0.0 110.97 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.8 p -79.71 166.29 21.95 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.976 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -58.49 -37.96 76.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.719 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -64.66 -48.98 72.77 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.945 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -56.22 -47.57 78.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.356 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.98 -53.3 32.86 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.313 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.44 -42.78 83.09 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.052 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.4 -35.96 81.65 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.084 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.3 mt -71.93 -38.57 69.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.781 -0.19 . . . . 0.0 110.909 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 56.5 mtt -62.37 -37.26 85.03 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.235 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.1 t -74.86 -32.51 61.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.585 0.231 . . . . 0.0 110.769 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -88.74 50.98 2.06 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.413 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 40.2 p -120.03 170.89 8.87 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.812 0.339 . . . . 0.0 111.194 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.22 -169.62 2.35 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.755 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.0 m -54.9 -48.0 73.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.592 0.234 . . . . 0.0 110.994 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.66 138.74 20.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.796 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.6 t -133.91 114.33 19.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.18 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.25 132.36 36.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.538 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.5 mp -138.95 132.75 30.81 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.62 0.247 . . . . 0.0 111.141 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 28.0 tt0 -100.86 101.72 12.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.681 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.85 149.86 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.767 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.18 119.36 36.1 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.231 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? . . . . . 0 N--CA 1.463 0.223 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.767 179.731 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 C--O 1.235 0.315 0 CA-C-O 121.276 0.56 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.403 HG22 HD12 ' A' ' 6' ' ' ILE . 19.4 mm -92.05 125.2 44.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.919 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.63 139.72 47.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.141 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.489 ' HB ' ' HG3' ' A' ' 87' ' ' GLU . 2.4 t -95.39 140.88 29.64 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.077 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -118.78 124.93 73.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.083 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.04 116.06 22.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.8 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.76 143.08 36.78 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.401 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -101.93 170.34 8.2 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.171 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -101.18 119.72 39.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.366 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.43 -40.54 5.33 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -152.87 32.26 0.49 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.974 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.12 177.59 22.75 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.235 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.1 mmm -115.27 96.61 5.75 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.749 0.309 . . . . 0.0 110.75 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.09 72.14 2.85 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.555 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mp -139.8 115.95 10.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.634 0.254 . . . . 0.0 110.646 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 m -85.99 100.07 11.88 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.956 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 pt -81.31 174.79 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.574 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG11 ' HB2' ' A' ' 35' ' ' TYR . 3.5 p -158.85 144.55 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.34 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.59 124.3 49.07 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.835 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.6 -179.54 8.26 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.966 0.412 . . . . 0.0 111.62 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -101.87 164.84 11.51 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.91 -143.55 3.88 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.1 153.65 26.63 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.022 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.45 19.15 39.74 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.169 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.46 111.01 5.62 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.71 0.291 . . . . 0.0 110.898 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -94.37 24.84 4.2 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.888 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -123.66 -147.44 0.38 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tp -136.29 112.41 9.72 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.752 0.311 . . . . 0.0 110.555 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.38 176.89 24.63 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.816 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.4 mm -97.11 151.5 4.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.715 0.293 . . . . 0.0 110.765 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.47 ' HB2' HG11 ' A' ' 22' ' ' VAL . 85.1 m-85 -140.38 156.41 46.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.157 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.68 100.59 11.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.713 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -74.53 -39.0 62.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.541 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.44 162.14 8.18 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.205 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.81 109.53 20.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.558 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.3 t -65.95 127.4 27.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.307 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -60.85 143.03 55.61 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.007 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.81 -14.76 62.62 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.921 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.05 -173.84 33.01 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.312 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.15 -51.1 26.88 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.75 -37.74 85.38 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -64.07 -49.2 73.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.456 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.46 -36.1 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.374 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.49 -54.25 11.2 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.75 69.86 1.36 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.719 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -139.74 27.44 2.23 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.549 0.214 . . . . 0.0 111.51 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -175.63 179.48 1.41 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.596 0.236 . . . . 0.0 111.036 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.11 -176.97 6.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.603 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.36 146.99 38.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.161 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.53 47.64 15.58 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.375 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -116.98 177.76 4.59 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.672 0.272 . . . . 0.0 111.1 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 9.3 tm0? -112.45 165.15 12.48 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.125 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.16 126.3 12.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.782 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.25 -63.12 1.36 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.318 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.7 m -115.73 152.48 33.15 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 111.666 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.406 HG13 ' HG2' ' A' ' 77' ' ' MET . 39.0 t -133.14 113.81 20.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.875 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.2 36.44 23.85 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.208 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.55 -14.25 60.26 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.209 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -80.53 143.87 32.93 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 117.158 0.479 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.3 p -92.56 137.41 32.39 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.046 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mp -137.91 87.54 2.26 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.267 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.6 t -135.87 87.11 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.752 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.73 -24.01 3.35 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.644 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.4 mt -72.71 175.12 6.71 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.198 0.523 . . . . 0.0 111.814 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -101.51 176.25 5.3 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.999 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -61.38 -39.16 89.65 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.091 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.23 -53.16 61.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.164 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -58.62 -48.36 81.27 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.137 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.44 -50.77 72.64 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.652 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.14 -40.5 96.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.777 0.322 . . . . 0.0 110.806 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.86 -31.39 72.6 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.116 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.6 mt -79.35 -30.47 42.67 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.007 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.406 ' HG2' HG13 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -66.37 -29.8 70.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.391 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.0 t -77.2 -31.24 55.17 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 121.156 -0.218 . . . . 0.0 110.787 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -95.35 56.81 1.9 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.816 0.341 . . . . 0.0 111.52 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.3 p -116.64 179.33 4.04 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.087 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.19 -174.13 4.08 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.797 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -53.56 -52.62 59.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.973 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.2 t -92.79 146.34 6.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.83 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.7 t -135.0 133.62 53.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.27 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.88 101.6 8.42 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.512 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mt -99.95 113.28 25.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.578 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.489 ' HG3' ' HB ' ' A' ' 8' ' ' THR . 3.1 tt0 -81.37 95.53 7.05 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.994 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 31.9 m -101.28 166.32 2.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.142 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.457 ' CB ' ' HB3' ' A' ' 56' ' ' GLN . . . -119.98 142.53 48.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.656 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.237 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.701 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.821 0.343 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mt -85.59 128.95 38.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.03 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 pt -146.01 149.63 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.972 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 6.4 t -106.72 142.61 36.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 110.825 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -131.3 137.14 56.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.532 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.2 m -87.1 112.34 21.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.761 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.28 164.39 17.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.738 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -122.58 148.69 44.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.73 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -85.08 107.28 17.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.706 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.82 56.8 2.7 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.619 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 57.31 39.52 28.42 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.167 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.73 171.41 39.6 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.66 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -138.71 -68.34 0.45 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.536 0.208 . . . . 0.0 111.069 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.76 65.5 3.5 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.106 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.48 108.94 4.85 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.594 0.235 . . . . 0.0 111.053 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.3 m -81.02 97.06 7.33 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.709 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pt -98.23 175.44 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.692 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.5 p -159.53 138.79 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.274 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.73 107.46 18.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.028 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -148.63 179.84 7.52 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.926 0.393 . . . . 0.0 111.583 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -97.12 168.47 10.43 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.27 -142.28 3.46 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.79 149.91 27.63 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.844 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.19 17.57 31.48 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.287 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.34 108.24 4.36 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.714 0.292 . . . . 0.0 110.786 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.69 25.38 3.12 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.765 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.9 mmtm -121.47 -155.43 0.64 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.239 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.6 99.02 4.51 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.845 0.355 . . . . 0.0 110.631 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.43 154.91 25.53 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.928 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 35.2 mm -88.95 100.14 10.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.882 0.372 . . . . 0.0 110.662 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -89.84 153.89 20.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.605 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -99.97 113.61 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.758 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -82.52 -40.94 20.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.627 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 m -164.06 173.23 12.77 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.284 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.4 t -137.44 152.02 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.199 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.8 t -101.71 140.96 19.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.085 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.32 109.96 1.75 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.772 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.82 -24.83 4.78 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.0 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.63 159.94 33.92 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.813 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.9 -55.59 25.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.515 0.198 . . . . 0.0 111.475 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.74 -32.24 69.05 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.332 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.74 -55.28 8.99 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.018 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 t -63.69 -46.69 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.283 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.56 -33.31 75.3 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.284 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.29 36.9 92.35 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.825 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -85.01 -32.21 23.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.525 0.202 . . . . 0.0 111.094 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.05 175.44 9.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.867 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.81 -171.08 3.17 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.01 149.76 47.37 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.152 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.06 50.94 25.77 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.418 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -120.51 176.2 5.62 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.631 0.253 . . . . 0.0 111.091 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -128.69 139.06 52.42 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 6.4 mp -119.51 135.45 54.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.981 0.42 . . . . 0.0 111.206 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.66 -59.52 1.69 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.466 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.7 m -117.68 163.21 16.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.898 0.38 . . . . 0.0 111.864 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.8 t -145.85 136.4 18.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.96 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 44.17 37.05 1.7 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.952 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.26 40.69 40.6 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.746 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -140.97 156.29 46.08 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.721 0.261 . . . . 0.0 110.679 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 m -86.49 128.33 34.95 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.831 0.348 . . . . 0.0 111.001 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -137.88 37.01 2.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.437 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 p -114.07 45.5 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.66 0.743 . . . . 0.0 110.665 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.51 36.27 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.174 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 pp -144.82 169.99 16.97 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.671 0.272 . . . . 0.0 110.926 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.55 177.42 8.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.199 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -63.34 -34.06 76.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.289 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -50.93 71.9 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.652 0.263 . . . . 0.0 110.92 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -62.62 -42.74 99.76 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.458 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB3' HG13 ' A' ' 34' ' ' ILE . . . -67.0 -54.14 24.64 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.509 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.35 -35.69 74.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.826 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.424 ' O ' HG21 ' A' ' 78' ' ' THR . 3.8 tp10 -69.86 -29.41 66.64 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.133 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.3 mt -79.48 -37.62 36.38 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.77 -0.196 . . . . 0.0 111.028 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.9 mtm -68.76 -32.38 72.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.405 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 75' ' ' GLU . 15.1 t -73.79 -30.29 62.66 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.491 0.186 . . . . 0.0 111.217 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -92.71 44.3 1.15 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.448 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.2 p -102.89 161.04 14.07 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.831 0.348 . . . . 0.0 111.434 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.2 p -95.86 -166.49 1.44 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -39.17 68.87 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.868 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 t -103.46 142.06 18.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.087 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 t -145.74 142.14 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.271 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.16 112.62 17.92 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.457 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -110.39 119.56 39.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.239 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 3.5 tt0 -81.44 85.44 6.47 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.335 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.6 m -80.31 173.08 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.417 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.66 125.92 15.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.633 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.827 -179.911 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.234 0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.46 ' CG2' ' HG2' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -110.58 123.78 66.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.633 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -126.3 138.58 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.388 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 1.6 m -94.03 120.4 34.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.875 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -124.45 142.64 40.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.891 0.377 . . . . 0.0 111.224 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 p -80.3 147.34 31.19 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.96 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.2 mt -144.49 128.82 17.85 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.831 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -91.34 146.53 23.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.939 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -69.42 110.71 4.85 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.04 68.69 1.27 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.567 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.5 t30 57.98 40.13 25.85 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.145 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.3 177.7 14.99 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.79 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.9 mmm -129.94 103.32 6.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.626 0.25 . . . . 0.0 110.693 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.59 79.85 0.57 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.865 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mp -146.63 124.26 11.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.585 0.231 . . . . 0.0 110.853 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.1 m -89.5 138.56 31.35 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.031 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 1.2 pp -136.85 169.08 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.755 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -157.79 141.42 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.294 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.07 94.74 7.33 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.636 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.71 179.17 5.99 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.462 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -123.38 -179.82 4.46 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.289 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.29 -141.77 3.22 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.01 153.52 19.82 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.735 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.41 22.59 38.63 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.094 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.21 102.06 7.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.541 -0.329 . . . . 0.0 111.133 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.38 16.6 8.48 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 -168.95 2.94 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.109 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tp -119.68 133.58 55.57 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.56 0.219 . . . . 0.0 110.689 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.06 147.68 18.88 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.662 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.3 mm -80.89 92.03 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.876 0.369 . . . . 0.0 110.223 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 20.2 m-85 -75.18 155.24 37.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.488 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.5 t -102.36 109.07 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.585 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.12 -42.85 75.5 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.804 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.77 179.44 0.71 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.183 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.44 146.93 28.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.019 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.3 t -95.96 131.07 43.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.364 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.6 139.01 58.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.864 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.5 -17.24 59.64 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.082 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.31 -164.83 7.61 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.716 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.37 -43.44 12.12 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.64 -42.59 77.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.783 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -59.12 -45.86 89.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.404 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.1 t -73.39 -33.71 41.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.41 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -55.38 34.17 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.292 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.74 61.12 1.63 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.608 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -121.49 -44.49 2.35 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.527 0.203 . . . . 0.0 111.189 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.412 ' HB3' HG12 ' A' ' 88' ' ' VAL . 1.3 pp -130.32 174.2 10.07 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.865 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.95 -168.06 2.83 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.3 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.11 142.91 50.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.192 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.07 49.53 4.97 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.325 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.21 -179.85 5.08 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.458 0.17 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -130.84 134.0 46.43 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.723 0.297 . . . . 0.0 111.354 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.7 mt -110.85 131.27 55.19 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.486 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.21 -56.77 2.16 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.687 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -117.9 147.27 43.27 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.003 0.43 . . . . 0.0 111.987 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -126.94 103.92 11.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.318 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.478 ' HB2' HG23 ' A' ' 84' ' ' VAL . 4.4 t0 60.78 39.39 17.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.992 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.67 -23.29 29.05 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.299 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -74.31 132.45 42.08 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 117.227 0.513 . . . . 0.0 110.934 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.0 p -91.2 120.5 32.17 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.673 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 mp -110.09 43.41 1.37 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.851 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.99 86.55 2.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.66 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.0 27.47 3.99 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.584 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.0 mt -109.02 176.01 5.25 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.883 0.373 . . . . 0.0 110.934 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.5 m -107.36 168.44 9.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.024 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -57.52 -35.46 70.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.118 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -58.76 -54.61 45.16 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.907 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.2 mmt-85 -61.7 -46.11 91.07 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.985 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.07 -55.37 35.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.392 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.26 81.39 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.154 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -60.62 -33.06 72.21 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.315 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.2 mt -81.19 -40.73 23.44 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.019 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 11.7 mtp -66.84 -41.48 87.33 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.191 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.2 t -61.64 -33.29 73.68 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.173 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -101.72 65.1 1.0 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.803 0.335 . . . . 0.0 111.126 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.88 159.99 15.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.873 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 t -76.7 -172.23 2.17 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.835 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.9 p -53.0 -33.51 52.01 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.128 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.9 t -131.28 127.68 60.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.191 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 61' ' ' ASP . 9.3 p -113.1 129.37 68.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.538 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.45 85.73 3.7 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.874 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.13 119.03 26.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.335 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 27.2 tt0 -88.76 102.6 15.16 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.859 0.361 . . . . 0.0 110.227 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.412 HG12 ' HB3' ' A' ' 51' ' ' LEU . 12.5 p -96.19 147.99 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.963 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.52 129.88 56.46 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.544 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.246 0 O-C-N 123.375 0.422 . . . . 0.0 110.852 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.095 0.474 . . . . 0.0 111.376 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.54 128.01 43.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.532 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -139.44 143.62 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.82 0.343 . . . . 0.0 111.583 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -98.28 111.75 23.98 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.84 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 m -107.42 144.03 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.441 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.3 m -99.4 143.41 29.68 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.998 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.429 HD23 ' CB ' ' A' ' 44' ' ' ALA . 0.4 OUTLIER -145.53 167.72 22.32 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.222 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.1 137.81 53.32 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.525 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -64.1 100.69 0.34 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.922 0.391 . . . . 0.0 111.049 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.21 73.59 2.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.433 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.58 36.78 28.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.097 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 130.24 -159.43 22.73 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.306 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.2 mmt -127.32 -59.11 1.25 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.654 0.264 . . . . 0.0 110.988 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.11 55.52 4.77 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.505 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mp -145.58 118.46 8.73 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.555 0.217 . . . . 0.0 110.774 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -80.76 100.77 8.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.862 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 pt -100.69 174.69 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.65 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 35' ' ' TYR . 2.8 p -157.77 135.91 2.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.257 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.05 89.75 3.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.499 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.52 178.52 6.41 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.738 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.35 168.11 11.8 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.869 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -151.43 -143.28 3.68 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.86 152.1 26.2 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.93 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.56 19.26 33.8 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.183 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.41 109.18 4.74 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.737 0.303 . . . . 0.0 110.957 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -92.75 25.02 3.29 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.713 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -124.01 -151.54 0.48 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.66 109.46 8.64 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.672 0.273 . . . . 0.0 110.443 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.53 164.42 15.52 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.748 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.1 mm -91.85 138.39 19.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.661 0.267 . . . . 0.0 110.667 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.473 ' HB2' HG11 ' A' ' 22' ' ' VAL . 97.8 m-85 -130.13 138.41 50.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.183 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.22 99.83 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.929 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -73.21 -38.84 65.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.472 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 t -161.02 160.03 30.09 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.203 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.7 119.24 54.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.698 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.97 135.75 27.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.419 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -72.44 145.29 47.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.899 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.74 -15.08 63.29 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.181 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.61 -167.16 8.34 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.538 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.429 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -87.19 -38.18 16.61 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.413 ' N ' HD22 ' A' ' 11' ' ' LEU . . . -72.36 -43.73 63.59 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.27 -34.87 78.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.682 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.7 t -81.7 -39.71 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 120.567 0.222 . . . . 0.0 111.119 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.2 -35.04 77.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.24 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.27 31.16 43.08 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.656 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -86.76 -41.29 14.23 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.609 0.242 . . . . 0.0 110.925 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 pp -141.77 169.36 17.74 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.945 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.13 -170.83 3.35 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.483 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.83 154.6 41.68 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.533 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.44 25.05 73.73 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.753 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.24 173.11 6.45 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.814 0.307 . . . . 0.0 111.35 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -109.25 162.37 14.36 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.988 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 mt -141.46 125.47 17.22 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.965 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.48 -63.54 1.43 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.556 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.2 p -113.91 146.98 39.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.948 0.404 . . . . 0.0 111.84 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.1 t -139.87 125.86 21.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.475 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 t70 58.24 37.53 26.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.575 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.84 28.66 72.9 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.057 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -123.6 153.27 40.92 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.939 0.369 . . . . 0.0 110.845 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.6 p -95.19 135.65 36.5 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.138 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 73' ' ' ALA . 10.0 mt -126.9 38.82 4.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.045 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.4 t -99.16 94.72 3.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.976 0.417 . . . . 0.0 110.405 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.86 33.81 2.33 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.462 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.8 mt -123.66 176.57 6.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.72 0.295 . . . . 0.0 110.685 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.7 m -98.86 165.31 11.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.153 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -58.53 -29.1 66.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.193 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -68.67 -34.77 76.26 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.611 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -67.45 -54.39 20.63 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.146 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.406 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -60.46 -41.23 93.72 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.649 0.262 . . . . 0.0 111.272 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.61 -40.1 92.25 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.99 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -77.72 -30.56 51.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.518 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.91 -41.41 78.25 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.313 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 54.8 mtt -60.45 -45.37 93.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.014 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.7 t -67.02 -29.74 69.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.677 0.275 . . . . 0.0 110.53 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -87.42 50.35 1.99 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.349 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.7 p -125.99 172.18 10.16 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.769 0.319 . . . . 0.0 110.917 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.6 p -86.88 -171.26 3.44 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.182 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 m -55.36 -36.7 66.61 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.018 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.3 t -108.01 139.91 28.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.165 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 t -139.27 137.9 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.13 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.72 109.71 19.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.79 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mp -105.32 122.56 46.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 29.4 tt0 -92.92 106.75 18.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.408 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.7 m -109.67 171.38 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.654 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.75 128.89 49.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.808 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.249 0 CA-C-O 121.117 0.484 . . . . 0.0 110.943 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.304 0 CA-C-O 120.996 0.427 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.1 mm -80.42 128.44 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.959 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 pt -147.53 144.83 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.18 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 1.3 m -103.44 105.47 15.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.414 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.1 m -93.66 145.03 8.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.993 0.425 . . . . 0.0 111.596 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.4 m -95.71 101.96 13.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.524 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.24 141.79 34.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -109.65 115.43 29.86 Favored 'General case' 0 CA--C 1.526 0.054 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.767 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.63 122.8 12.9 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.252 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -115.06 73.16 0.82 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.351 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 60.34 38.2 19.75 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.017 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.81 153.81 6.4 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.591 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.4 mtp -100.72 -65.21 0.98 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.615 0.245 . . . . 0.0 110.778 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.96 65.28 2.23 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.125 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mp -142.2 111.8 6.68 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.777 0.322 . . . . 0.0 110.815 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 m -80.21 112.97 18.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.699 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 pt -114.68 173.71 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.594 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.43 ' CG1' ' HB2' ' A' ' 35' ' ' TYR . 4.3 p -148.17 137.65 16.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.232 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.404 ' HB1' ' N ' ' A' ' 70' ' ' GLN . . . -97.98 108.6 21.34 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.51 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -153.07 176.42 11.92 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.331 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.91 172.66 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.01 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.57 -143.31 3.63 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.33 157.74 16.94 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.79 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.45 25.1 40.64 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.79 104.84 8.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.92 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -86.55 10.46 15.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.466 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -144.53 -162.65 1.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.02 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.3 134.55 46.5 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.672 0.272 . . . . 0.0 110.308 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.61 152.23 17.75 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.663 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.8 mm -93.52 132.27 38.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 120.679 0.276 . . . . 0.0 110.498 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.43 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 69.5 m-85 -121.94 163.47 19.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.224 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.83 135.46 55.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.099 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.29 -33.78 5.52 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.581 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.5 165.5 35.47 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.746 0.307 . . . . 0.0 111.325 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.7 t -140.31 126.14 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.576 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.1 t -62.34 131.58 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.427 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -80.51 98.18 7.47 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.607 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.83 -39.37 0.64 Allowed Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.697 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.83 160.15 52.26 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.538 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.15 -38.82 54.28 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.69 -43.39 76.38 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.708 0.289 . . . . 0.0 111.166 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -76.53 -35.65 58.16 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.111 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.2 t -68.64 -42.57 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.057 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.13 -44.5 87.84 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.247 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.47 27.56 65.32 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.667 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -82.72 -33.84 27.44 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.744 0.272 . . . . 0.0 110.884 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 pp -130.39 -178.98 5.0 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.78 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.91 -162.48 1.53 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.255 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.3 151.0 20.06 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.009 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.47 50.56 9.55 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.425 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -132.54 179.19 6.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.741 0.305 . . . . 0.0 111.105 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.405 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 7.2 tm0? -116.34 161.1 19.55 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.681 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 pp -164.93 155.61 14.26 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.927 0.394 . . . . 0.0 111.776 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.18 -54.76 0.31 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.513 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -76.4 132.91 39.98 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.843 0.354 . . . . 0.0 111.558 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.2 t -145.34 117.17 2.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.515 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.421 ' HB2' HG13 ' A' ' 84' ' ' VAL . 5.0 t0 58.53 40.3 23.94 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.039 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.26 23.14 78.42 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.984 -0.626 . . . . 0.0 112.984 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.0 mtt-85 -128.68 128.14 43.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.711 0.256 . . . . 0.0 110.324 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m -83.98 116.8 23.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.3 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.7 mt -98.77 76.98 2.21 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.594 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.54 96.64 4.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.6 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.25 37.77 0.91 Allowed Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.532 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 mp -135.03 179.31 6.4 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.785 0.326 . . . . 0.0 110.928 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.4 m -107.81 176.74 5.04 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.95 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.404 ' N ' ' HB1' ' A' ' 23' ' ' ALA . 34.6 tt0 -58.21 -39.88 80.16 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.679 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -51.12 70.7 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.907 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 47.1 mmt-85 -59.2 -50.87 72.36 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.17 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.94 -52.6 64.71 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.329 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.11 -45.64 92.3 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.051 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.47 -36.28 77.91 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.901 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.11 -39.45 49.42 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.728 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.2 mtt -65.78 -32.82 74.56 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.04 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.2 t -78.9 -32.43 45.75 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.559 0.219 . . . . 0.0 110.905 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 43.6 mtp85 -89.63 50.54 1.92 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.703 0.287 . . . . 0.0 111.563 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.5 p -120.68 -179.86 4.12 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.936 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -89.0 -173.02 3.91 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.08 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.6 p -56.6 -49.77 73.93 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.505 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.89 133.32 36.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.737 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 61' ' ' ASP . 21.3 t -139.46 125.68 23.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.22 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.84 111.92 23.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.708 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 59' ' ' SER . 2.7 mp -109.98 123.01 48.88 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.985 0.422 . . . . 0.0 111.421 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 19.2 tt0 -91.42 98.45 11.69 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.16 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 m -102.26 171.49 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.928 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -125.67 131.55 52.59 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.586 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp . . . . . 0 C--O 1.234 0.256 0 O-C-N 123.345 0.403 . . . . 0.0 110.602 179.775 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 . . . . . 0 C--O 1.234 0.262 0 CA-C-O 121.165 0.507 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.2 mm -92.81 94.64 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.888 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.89 137.06 34.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.265 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 m -89.01 130.68 35.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.002 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.41 111.31 35.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.114 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.41 101.55 13.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.39 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.6 mt -122.5 161.98 22.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.939 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 150.95 24.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.774 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.25 114.42 26.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.007 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.95 -38.1 6.74 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.192 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -160.32 42.54 0.19 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.047 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.29 -170.71 30.28 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.3 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.2 mmm -107.09 -48.03 3.56 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.508 0.194 . . . . 0.0 111.131 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.13 78.49 0.18 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.734 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.23 144.56 17.35 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.815 0.34 . . . . 0.0 111.179 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -94.41 90.87 6.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.628 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 pt -96.38 163.42 2.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.614 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.7 p -141.04 138.54 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.147 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.34 89.99 3.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.675 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.82 176.06 7.56 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.515 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -96.88 168.76 10.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.28 -143.14 3.59 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.06 153.92 22.42 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.023 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.29 18.84 30.26 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.243 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.58 108.42 4.71 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -95.22 37.26 1.18 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.568 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 38.7 mmtm -140.21 -148.5 0.25 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.648 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.77 103.19 5.98 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 110.517 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.9 145.94 21.89 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.888 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.6 mm -87.47 99.32 8.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.805 0.336 . . . . 0.0 110.701 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -90.59 147.53 23.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.531 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.53 120.83 51.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.845 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -96.27 -35.36 11.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.972 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 t -162.51 158.96 24.3 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.054 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.1 t -123.71 128.38 74.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.621 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.4 t -68.37 120.89 16.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.056 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -59.58 109.01 0.81 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.742 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.39 -21.27 5.16 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.626 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.52 158.17 51.37 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.147 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.66 -41.1 21.59 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.13 -52.9 52.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.367 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -39.29 85.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.5 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.9 t -71.82 -40.86 69.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.537 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.82 -54.72 30.62 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.588 0.232 . . . . 0.0 111.304 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.18 79.43 1.39 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.764 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.0 mmt-85 -144.1 -51.39 0.31 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.719 0.295 . . . . 0.0 110.943 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 pp -113.39 167.79 10.28 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.912 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.08 -166.8 2.17 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.241 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.02 150.04 26.59 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.271 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.22 40.99 8.77 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.721 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -131.62 177.04 7.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.791 0.329 . . . . 0.0 111.246 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -122.13 150.32 42.36 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.002 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.6 mt -128.44 123.9 34.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.476 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.18 -63.63 1.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.424 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.7 m -111.37 151.77 28.07 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.929 0.395 . . . . 0.0 111.703 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.493 HG12 ' HG2' ' A' ' 77' ' ' MET . 42.9 t -141.45 132.33 26.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.654 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 t70 56.9 27.72 13.49 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.451 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.32 -7.78 81.28 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.862 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -111.23 135.35 51.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 117.427 0.613 . . . . 0.0 110.926 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.5 m -71.63 130.44 41.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.327 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.7 mt -112.78 33.61 4.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.893 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.56 90.26 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.236 0.541 . . . . 0.0 110.382 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 31' ' ' LYS . . . 151.14 -30.26 0.98 Allowed Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.425 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.04 -169.64 2.62 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.684 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -98.51 169.66 9.37 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.665 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -55.6 -31.41 62.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.864 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.89 -48.08 60.09 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.242 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -38.69 71.58 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.533 0.206 . . . . 0.0 111.018 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.26 -53.37 12.69 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.176 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.76 -37.93 74.51 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.408 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.67 -33.59 64.52 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.599 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.0 mt -79.71 -39.11 31.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.475 0.178 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.493 ' HG2' HG12 ' A' ' 60' ' ' VAL . 12.2 mtp -66.45 -34.43 77.92 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.051 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.6 t -71.67 -38.14 70.69 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.87 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -91.21 58.02 3.57 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.925 0.393 . . . . 0.0 110.75 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 p -109.85 160.84 16.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.006 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.7 m -75.25 -179.23 4.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.943 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.4 m -53.5 -38.83 64.06 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.304 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.7 t -106.1 136.22 41.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.728 0.299 . . . . 0.0 110.707 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 t -124.71 142.66 40.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.474 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.39 100.19 6.56 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.728 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.26 139.24 50.13 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.073 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -107.3 101.23 10.62 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.035 0.445 . . . . 0.0 110.292 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.3 p -89.0 137.61 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.751 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.85 119.31 34.12 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.264 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.646 179.611 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 1.5 tt0 . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.941 0.4 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.6 mm -90.83 108.19 19.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.839 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -135.69 138.63 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.418 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.423 ' HB ' ' HG3' ' A' ' 87' ' ' GLU . 6.1 t -104.38 143.17 33.36 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.238 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 p -128.93 137.33 57.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.304 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.21 96.64 7.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.899 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 44' ' ' ALA . 8.7 tp -85.48 132.45 34.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.21 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -108.46 115.78 30.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.376 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -67.36 120.7 14.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.374 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.08 -41.79 7.0 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.711 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -164.91 38.57 0.07 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.877 0.37 . . . . 0.0 111.187 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.73 -168.64 23.5 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.567 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.5 mtp -129.6 -66.47 0.8 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.543 0.211 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.446 ' HA3' ' HB ' ' A' ' 40' ' ' VAL . . . 65.81 74.17 0.54 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.174 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.1 mt -142.2 108.32 5.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.744 0.306 . . . . 0.0 111.046 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.7 91.05 5.83 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.554 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 pp -97.12 177.59 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.608 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.2 p -156.67 135.91 3.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.262 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.7 87.48 3.16 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.541 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.75 176.79 6.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.619 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 176.26 5.59 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.117 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.82 -143.45 3.68 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.95 150.31 27.91 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.899 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.76 18.03 37.3 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.342 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.77 108.83 5.2 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.642 0.258 . . . . 0.0 111.008 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.97 25.56 3.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.802 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.99 -154.38 0.58 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 tp -136.49 106.73 6.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.614 0.245 . . . . 0.0 110.576 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.84 152.26 20.93 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.93 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.428 ' CG1' HD11 ' A' ' 65' ' ' LEU . 40.5 mm -91.25 96.84 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.874 0.368 . . . . 0.0 110.673 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -89.04 150.83 22.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.612 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.7 t -106.85 131.04 57.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.704 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 pttp -116.89 -30.18 5.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.901 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.69 155.13 42.79 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.956 0.408 . . . . 0.0 111.777 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.8 t -138.18 120.86 19.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.171 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.446 ' HB ' ' HA3' ' A' ' 18' ' ' GLY . 32.3 t -64.43 127.89 25.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.811 0.338 . . . . 0.0 111.477 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 103.7 1.64 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.337 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.5 -10.66 4.34 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.419 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.55 -158.14 4.95 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.413 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.449 ' HB2' HD23 ' A' ' 11' ' ' LEU . . . -91.17 -38.79 12.5 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.7 70.86 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -66.96 -35.31 79.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.482 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.1 t -80.75 -42.21 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.607 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -53.79 54.29 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.63 0.252 . . . . 0.0 111.427 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.38 51.81 2.65 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.579 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.57 -51.03 2.18 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.621 0.248 . . . . 0.0 110.626 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 pp -109.13 139.03 44.57 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.536 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.0 177.35 5.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.26 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.53 150.8 46.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.796 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.53 40.62 18.2 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.102 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -126.16 177.71 6.23 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.739 0.304 . . . . 0.0 111.306 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -124.47 149.02 47.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.3 mt -123.76 121.69 36.13 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.706 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.66 -53.21 3.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.785 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.87 157.17 40.04 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.171 0.51 . . . . 0.0 112.338 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.444 HG23 ' CD1' ' A' ' 65' ' ' LEU . 21.8 t -141.17 109.67 2.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.757 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.27 35.89 26.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.13 17.73 60.51 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.457 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.44 123.04 39.28 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.222 0.511 . . . . 0.0 110.408 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 m -82.63 135.4 35.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.205 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.444 ' CD1' HG23 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -110.31 -3.1 16.38 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.591 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.58 87.07 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.418 0.627 . . . . 0.0 110.911 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.79 -18.61 2.77 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 113.008 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.65 -170.99 2.75 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.917 0.359 . . . . 0.0 111.105 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.18 176.99 4.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.368 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -59.38 -31.02 68.84 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.267 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -68.02 -38.77 82.97 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.515 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -67.06 -40.11 87.02 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.457 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.62 -52.93 21.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.518 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.12 -37.84 84.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.913 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -71.24 -32.01 68.25 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.262 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.9 mt -78.01 -35.23 50.16 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.435 0.159 . . . . 0.0 111.358 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 12.4 mtt -70.67 -31.72 68.73 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.342 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.1 t -74.43 -30.6 61.97 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.46 0.17 . . . . 0.0 111.46 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -89.17 49.18 1.73 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.745 0.307 . . . . 0.0 111.415 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.406 ' HB ' HG23 ' A' ' 84' ' ' VAL . 67.7 p -121.53 171.37 8.85 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.724 0.297 . . . . 0.0 111.351 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.4 p -90.01 -165.7 1.41 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.467 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 80.0 p -59.61 -34.37 72.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.156 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.2 t -111.9 139.34 36.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.741 0.305 . . . . 0.0 110.982 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.406 HG23 ' HB ' ' A' ' 80' ' ' THR . 15.5 t -142.73 130.38 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.286 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.21 116.3 28.83 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 8' ' ' THR . 4.0 mm? -111.37 114.03 26.9 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.113 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG3' ' HB ' ' A' ' 8' ' ' THR . 2.1 tt0 -81.22 101.36 9.66 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.5 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.0 p -94.06 147.63 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.811 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -119.04 126.08 50.86 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.122 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.246 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.1 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 . . . . . 0 C--O 1.234 0.282 0 CA-C-O 121.104 0.478 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.8 mm -85.23 111.03 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.839 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.52 141.56 46.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.14 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 8.0 t -106.63 141.6 37.64 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.834 0.349 . . . . 0.0 111.299 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.9 p -119.5 128.45 75.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.349 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.0 m -82.95 94.5 7.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 mt -93.44 155.39 17.38 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.135 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -117.1 110.51 18.29 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.075 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -57.08 116.78 3.44 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.266 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -86.34 -47.73 9.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.556 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -166.21 42.54 0.06 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.46 -167.69 19.75 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.527 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.1 mmm -133.52 100.83 4.92 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.643 0.258 . . . . 0.0 110.791 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.22 79.98 0.6 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.547 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 mp -145.96 127.25 14.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.62 0.248 . . . . 0.0 110.749 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.32 99.27 11.04 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.882 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pt -96.61 175.4 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.472 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 35' ' ' TYR . 3.4 p -159.81 148.3 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.598 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.78 124.76 46.88 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.464 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.36 -179.14 7.45 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.79 164.82 13.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.792 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.33 -144.17 3.85 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.59 164.03 13.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.811 0.339 . . . . 0.0 111.148 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.44 19.98 49.51 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.455 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.65 -165.8 1.34 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.137 0.494 . . . . 0.0 110.187 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.459 ' C ' ' HG2' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -169.84 20.39 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.36 178.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.459 ' HG2' ' C ' ' A' ' 30' ' ' ASP . 6.0 mmmt -156.08 -164.17 1.64 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.01 106.32 14.27 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.838 0.352 . . . . 0.0 110.523 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.79 -173.05 27.94 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.212 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.2 mm -99.33 152.91 4.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.603 0.239 . . . . 0.0 110.725 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.432 ' HB2' HG12 ' A' ' 22' ' ' VAL . 18.9 m-85 -135.37 164.22 28.24 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.351 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.62 115.78 44.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -101.58 -33.11 10.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.946 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.2 161.13 21.96 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.926 0.393 . . . . 0.0 111.386 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.4 t -135.7 115.72 17.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.683 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.46 136.48 26.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.416 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 145.09 53.39 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.022 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.08 -22.67 39.45 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.959 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.04 174.62 36.71 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.775 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.94 -37.57 75.91 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.6 -37.76 68.02 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -67.75 -49.05 64.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.502 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.86 -31.15 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.632 0.253 . . . . 0.0 111.314 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.78 -55.97 16.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.404 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.2 31.69 16.25 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.889 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -111.27 27.38 9.73 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.753 0.311 . . . . 0.0 110.933 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 pp -172.82 171.91 4.23 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.966 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.64 171.52 16.77 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.468 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.32 136.85 57.54 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.024 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.06 49.27 3.13 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.091 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -130.83 179.18 6.12 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.744 0.307 . . . . 0.0 111.243 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.445 ' HB3' ' HB2' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -118.45 173.14 7.0 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.918 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.0 mt -151.67 119.23 6.06 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.668 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.443 ' CD1' HG11 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -90.35 -64.02 1.19 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.196 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.8 m -126.08 151.5 47.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.569 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 52.6 t -135.78 118.16 21.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.773 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 t0 58.33 40.31 24.59 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.965 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.24 29.13 68.9 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.834 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.9 mtt-85 -123.84 144.25 49.85 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 m -91.16 120.78 32.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.788 0.328 . . . . 0.0 111.39 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mp -111.54 -5.74 14.5 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.821 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.443 HG11 ' CD1' ' A' ' 58' ' ' LEU . 12.0 p -81.99 71.38 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.857 0.837 . . . . 0.0 110.181 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 155.07 40.23 0.02 OUTLIER Glycine 0 CA--C 1.523 0.571 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.275 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.54 177.79 10.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.741 0.305 . . . . 0.0 111.048 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.55 179.29 5.19 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.268 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -61.6 -35.54 78.15 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.322 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -54.6 -52.5 61.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.72 0.295 . . . . 0.0 110.798 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -62.65 -41.78 99.24 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.812 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.25 -56.21 23.79 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.499 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.38 93.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.022 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -66.68 -28.4 68.42 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.24 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.3 mt -75.49 -34.39 60.86 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.676 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 mtt -77.99 -39.2 43.12 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.321 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.7 t -63.34 -32.8 74.31 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.778 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -90.9 57.65 3.58 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.192 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 51.7 p -122.79 178.47 5.02 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.096 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 m -108.43 -167.2 1.2 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.783 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.7 p -57.26 -30.32 64.55 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.478 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.44 137.7 50.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 120.652 0.263 . . . . 0.0 111.209 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.0 t -143.79 134.65 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.414 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.46 120.37 42.21 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.692 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mp -114.67 117.13 29.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.283 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 1.6 mt-10 -81.28 93.04 6.45 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.646 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 10.9 p -87.61 141.22 14.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.541 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . . . -106.94 139.74 40.85 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.146 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.731 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.015 0.436 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 4.0 mt -90.21 127.31 42.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.052 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 pt -141.67 146.79 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.264 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.493 ' HB ' ' HG2' ' A' ' 87' ' ' GLU . 2.7 t -101.49 147.16 26.7 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.156 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' A' ' 50' ' ' ARG . 26.9 m -124.99 128.86 73.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.462 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.0 m -87.78 102.5 14.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.487 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mp -125.04 167.38 14.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.366 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -126.0 170.82 11.34 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.044 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -69.09 94.01 0.63 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.888 0.375 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.98 81.95 2.18 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.512 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 57.54 36.18 26.6 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.088 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.08 173.4 30.19 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.629 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.6 mmt -87.27 -73.02 0.49 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.559 0.219 . . . . 0.0 110.749 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.83 66.74 1.82 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.651 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.9 mp -145.74 117.89 8.35 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.646 0.26 . . . . 0.0 110.658 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.5 m -80.62 96.33 6.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.741 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 pt -105.11 175.99 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.59 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -156.32 141.24 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.241 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.28 92.82 6.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.639 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.44 178.39 5.42 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.281 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.79 179.97 3.82 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.288 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.81 -143.7 3.74 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.676 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.49 161.82 18.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.702 0.286 . . . . 0.0 111.075 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.81 19.92 45.62 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.853 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.68 -163.01 0.9 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.231 0.539 . . . . 0.0 110.173 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -170.29 20.64 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.227 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -159.92 -168.81 2.33 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.48 0.312 . . . . 0.0 110.268 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 tp -105.44 127.44 53.0 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.798 0.332 . . . . 0.0 110.994 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.88 147.55 16.27 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.518 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 73' ' ' ALA . 1.6 mp -81.41 97.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.976 0.417 . . . . 0.0 109.981 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -87.86 143.96 26.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.28 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.9 t -103.52 122.8 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.847 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -92.09 -40.61 10.96 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.885 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 m -165.02 175.82 9.13 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.727 0.298 . . . . 0.0 111.168 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.39 145.37 34.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.154 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.9 t -84.49 146.55 6.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.529 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.39 140.97 52.21 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.062 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.19 18.12 80.12 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.506 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.38 176.22 32.53 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.234 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.42 -62.18 2.06 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.64 -33.24 68.08 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.694 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -67.89 -56.81 7.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.109 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.6 t -66.07 -35.25 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.75 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.13 -48.84 49.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.616 0.246 . . . . 0.0 110.896 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.46 87.59 0.72 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.627 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.424 ' HB3' HG12 ' A' ' 9' ' ' VAL . 8.3 mmt180 -146.27 -67.13 0.28 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.59 0.233 . . . . 0.0 110.857 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.37 152.2 21.86 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.067 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.81 -162.2 1.18 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.181 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.36 144.08 53.54 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.516 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.71 50.58 6.42 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.248 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.62 131.95 45.21 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.449 0.166 . . . . 0.0 110.966 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -92.73 145.85 24.1 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.745 0.307 . . . . 0.0 111.182 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.78 121.8 42.61 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.723 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -96.9 -47.16 5.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.209 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.5 m -138.94 152.83 48.04 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.099 0.476 . . . . 0.0 111.542 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.0 t -136.03 114.23 15.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.157 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 62.07 35.93 15.62 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.443 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.38 -18.72 35.75 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.583 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -75.72 147.77 39.1 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 117.436 0.618 . . . . 0.0 111.038 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 p -95.83 116.26 28.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.818 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 mp -101.47 37.59 1.77 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.964 0.412 . . . . 0.0 110.7 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.46 100.72 11.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.16 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.16 4.48 18.33 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.18 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 pp -113.29 163.32 14.97 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 117.184 0.492 . . . . 0.0 110.867 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 p -85.04 168.5 14.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.871 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -57.08 -28.43 62.6 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.494 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.59 -49.58 76.95 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.75 0.31 . . . . 0.0 110.269 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -38.75 81.34 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.042 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.402 ' HB3' HG12 ' A' ' 34' ' ' ILE . . . -61.38 -55.77 27.78 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.434 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.15 94.43 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.136 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -62.75 -37.08 85.19 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.83 -35.0 72.26 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.013 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 4.8 mtt -68.91 -40.99 78.79 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.096 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.5 t -67.53 -36.69 81.49 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.596 0.236 . . . . 0.0 110.614 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -88.59 56.24 3.7 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.888 0.375 . . . . 0.0 111.115 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.5 p -112.52 -175.14 2.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.635 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.9 m -102.0 -169.76 1.72 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -34.0 67.08 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.594 0.235 . . . . 0.0 110.968 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.56 143.94 29.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.0 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 t -142.76 137.75 27.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.448 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.22 102.5 11.17 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.011 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 8' ' ' THR . 7.0 mp -94.56 117.22 29.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.074 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.493 ' HG2' ' HB ' ' A' ' 8' ' ' THR . 3.8 mm-40 -80.42 95.98 6.58 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.632 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 35.8 m -86.98 170.39 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.35 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.38 125.95 22.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.094 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt . . . . . 0 C--O 1.234 0.265 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.674 179.813 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 89' ' ' ALA . 28.0 tt0 . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.937 0.398 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.2 mm -79.33 121.87 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.339 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 pt -145.35 146.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.373 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.1 t -121.18 124.77 45.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 110.961 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.413 HG13 ' HD2' ' A' ' 50' ' ' ARG . 16.6 t -120.89 145.94 26.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.197 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.91 112.24 24.01 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.677 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.1 152.69 29.27 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.254 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -110.1 158.81 17.91 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.496 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -99.97 133.7 43.96 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.206 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.2 -42.3 3.06 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.135 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -154.13 42.66 0.53 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.838 0.351 . . . . 0.0 110.983 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.44 -156.36 15.8 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.453 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.96 -58.66 2.04 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.492 0.187 . . . . 0.0 110.91 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.78 53.16 39.82 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.746 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.5 mt -142.88 116.71 9.31 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.66 0.266 . . . . 0.0 111.218 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.04 126.58 40.48 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.646 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 pt -115.54 176.01 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.624 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 35' ' ' TYR . 2.4 p -153.28 137.24 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.451 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.08 101.29 12.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.483 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -134.1 -179.66 5.69 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.411 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -114.04 169.11 9.25 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.19 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.06 -143.35 3.65 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.23 157.42 16.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.85 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.72 23.91 46.21 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.52 104.42 7.88 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.108 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.67 11.16 13.58 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.583 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -146.06 -167.3 2.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.835 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 tp -103.39 119.2 38.43 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.686 0.279 . . . . 0.0 110.593 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.63 177.73 25.87 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.739 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.6 mm -103.77 150.93 6.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 120.733 0.302 . . . . 0.0 110.825 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.44 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 92.7 m-85 -137.92 150.26 46.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.03 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.7 t -80.72 95.39 2.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.628 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -42.19 98.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.965 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.1 t -175.33 166.52 3.36 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.417 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.2 t -126.77 137.9 56.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.837 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -82.48 119.92 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.374 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -63.56 110.04 1.86 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.838 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.1 -3.2 14.31 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.518 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.12 -139.2 1.69 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.433 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.08 -62.2 1.27 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.487 0.184 . . . . 0.0 111.436 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.0 -33.79 76.17 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.411 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.67 -39.91 90.16 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.223 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -67.25 -39.98 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.636 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -59.32 -55.33 36.14 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.6 0.238 . . . . 0.0 111.29 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.62 19.53 37.46 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.312 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.413 ' HD2' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -83.06 -33.65 26.37 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.147 0.474 . . . . 0.0 110.862 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -123.99 163.68 20.88 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.17 175.64 9.92 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.276 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.23 145.13 56.63 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.196 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.68 47.04 8.17 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.97 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.26 -176.99 3.41 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.612 0.244 . . . . 0.0 110.844 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -118.83 153.77 33.97 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.151 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.1 tt -137.77 135.75 36.63 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.809 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.07 -59.03 2.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.793 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.2 p -116.65 158.02 24.45 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.137 0.494 . . . . 0.0 112.097 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 t -140.11 119.36 12.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.53 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t0 60.31 35.13 20.76 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.023 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.43 -5.91 71.09 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.581 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.3 mtt-85 -91.95 148.83 21.91 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 117.484 0.642 . . . . 0.0 111.187 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.5 m -89.12 139.81 30.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.237 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.39 79.4 1.76 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.962 0.41 . . . . 0.0 111.377 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.6 t -130.45 95.37 2.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.363 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.97 -26.48 4.23 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.891 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 mt -73.13 176.11 6.14 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.836 0.351 . . . . 0.0 111.449 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 m -109.45 -178.25 3.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.039 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -59.04 -35.09 72.71 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.347 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -58.2 -59.04 5.92 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.624 0.249 . . . . 0.0 110.966 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.6 mmt-85 -61.88 -44.72 96.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.93 -54.92 41.63 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.104 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.48 -48.31 82.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.092 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.76 -38.64 78.89 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.982 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.6 mt -76.07 -35.88 59.23 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.097 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -76.43 -35.19 58.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.3 t -71.13 -39.06 72.22 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.538 0.208 . . . . 0.0 110.956 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -93.77 59.96 2.89 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.882 0.373 . . . . 0.0 111.016 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.7 p -117.06 169.41 9.44 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.995 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.99 -169.17 0.45 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.754 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.3 p -79.83 -52.49 7.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.808 0.337 . . . . 0.0 110.377 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.34 74.49 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.581 0.705 . . . . 0.0 110.795 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.452 HG12 HD21 ' A' ' 86' ' ' LEU . 13.1 t -89.18 148.4 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.972 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 p -110.61 117.04 32.42 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.661 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.452 HD21 HG12 ' A' ' 84' ' ' VAL . 4.2 mm? -111.73 122.22 47.22 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.296 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -87.65 83.17 7.23 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.035 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t -89.3 145.9 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.536 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 5' ' ' GLU . . . -110.2 117.12 32.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.166 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt . . . . . 0 C--O 1.233 0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 179.662 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 57.7 tt0 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.888 0.375 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.2 mm -82.04 126.41 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.196 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 pt -148.49 149.57 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.363 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 14.5 m -113.61 123.95 51.17 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.629 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.13 138.28 52.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.375 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.69 135.5 51.21 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.657 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -147.97 176.03 10.5 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.031 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -119.61 144.57 47.05 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.147 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -79.74 146.47 32.35 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.354 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -50.32 4.26 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.365 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -161.39 43.19 0.16 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.999 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.79 -160.54 19.41 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.53 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 90.4 mtp -142.61 101.75 3.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.92 80.63 0.63 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.369 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 mp -147.17 117.16 7.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.647 0.261 . . . . 0.0 110.494 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 p -82.0 131.55 35.25 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.949 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 pp -124.37 174.12 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.089 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.6 p -157.67 140.84 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.138 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.27 104.01 16.0 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.996 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.28 176.4 8.75 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.819 0.342 . . . . 0.0 111.691 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -101.93 175.1 5.66 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.311 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.33 -142.66 3.47 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.56 151.17 27.14 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.034 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.85 19.35 36.28 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.401 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.83 108.85 5.72 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.769 0.318 . . . . 0.0 111.185 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -95.15 30.8 2.06 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.322 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.96 -148.2 0.35 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tp -143.14 113.79 7.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.73 0.3 . . . . 0.0 110.753 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.75 152.97 19.16 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.564 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.471 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 31.4 mm -80.63 100.19 4.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.854 0.359 . . . . 0.0 110.444 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -84.53 156.38 21.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.039 0.447 . . . . 0.0 111.258 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -105.68 112.94 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.763 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.36 -36.78 22.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.129 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -164.85 165.39 20.53 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.831 0.348 . . . . 0.0 111.224 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.9 t -130.39 112.78 23.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.859 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -60.95 130.49 25.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.092 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.7 149.52 46.48 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.07 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.24 -31.09 8.89 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.545 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.31 142.87 46.49 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.521 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.3 -38.57 53.6 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.82 -53.72 44.46 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.683 0.277 . . . . 0.0 111.4 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.84 -44.59 85.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.048 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.5 t -61.82 -37.3 77.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.469 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.14 -53.32 59.09 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.083 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.88 44.49 1.51 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.159 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -142.79 31.89 1.43 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.736 0.268 . . . . 0.0 110.983 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.5 mt -149.87 168.62 23.23 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.447 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -171.12 151.97 3.34 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.125 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.23 152.18 45.41 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.886 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.11 52.68 26.38 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.782 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.11 171.36 11.97 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.72 0.295 . . . . 0.0 111.187 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 89' ' ' ALA . 1.9 tm0? -110.18 154.54 23.21 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.825 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.471 ' HB3' ' HB ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -137.57 119.8 15.68 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.573 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tt -107.79 -55.99 2.29 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.024 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.8 t -103.42 145.69 29.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.05 0.452 . . . . 0.0 112.176 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.97 119.81 10.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.763 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 56.65 44.41 23.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.133 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.82 27.39 73.31 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.083 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -130.74 138.07 49.8 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.677 0.275 . . . . 0.0 110.33 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.7 m -92.85 124.61 36.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.53 83.18 2.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.266 0.555 . . . . 0.0 111.084 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.2 t -110.12 94.94 3.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.803 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.78 36.85 1.02 Allowed Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.488 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.6 mt -116.05 157.55 24.51 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.727 0.299 . . . . 0.0 110.792 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -77.11 160.58 28.92 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -54.36 -35.24 62.56 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.954 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.37 -43.44 81.39 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.459 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -61.12 -53.34 58.23 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.492 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB3' HG13 ' A' ' 34' ' ' ILE . . . -62.57 -43.45 98.79 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.316 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.75 80.77 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.603 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -65.6 -35.7 81.59 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.248 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.2 mt -74.84 -35.87 62.38 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.095 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.467 ' O ' HG23 ' A' ' 80' ' ' THR . 5.9 mtt -69.15 -29.1 67.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.365 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.7 t -79.7 -30.62 41.07 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 121.297 -0.161 . . . . 0.0 111.24 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -93.44 40.33 1.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.714 0.292 . . . . 0.0 111.216 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 77' ' ' MET . 68.8 p -93.11 170.08 9.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 111.515 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.6 m -103.57 -165.02 1.12 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.46 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.78 -35.89 71.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.135 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.6 t -93.17 149.66 4.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.799 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 t -134.43 91.69 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.109 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.8 m -89.25 88.68 7.61 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.767 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.0 mt -106.36 139.89 40.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.511 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 12.1 tt0 -113.97 105.74 13.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.087 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.8 m -102.53 172.61 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.045 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.418 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . . . -136.17 131.56 34.8 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.526 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 48.8 mmtt . . . . . 0 C--O 1.234 0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.802 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.068 0.461 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.66 121.87 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.759 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 pp -141.97 137.06 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.315 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 3.7 t -99.04 138.89 35.49 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.069 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.55 136.06 46.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.421 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.15 95.9 6.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.869 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.97 134.31 34.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -90.98 176.7 6.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.059 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.28 130.75 54.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.148 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.02 -45.26 4.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.587 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -161.73 43.21 0.15 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.26 -164.25 14.52 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.794 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 16.3 mtp -119.05 99.99 7.07 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.731 0.301 . . . . 0.0 110.464 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.603 ' HA3' ' CG2' ' A' ' 40' ' ' VAL . . . -90.65 75.72 1.63 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.093 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.0 mp -147.93 108.41 4.13 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.571 0.224 . . . . 0.0 110.871 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -85.62 82.41 8.25 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.055 0.455 . . . . 0.0 110.27 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 1.2 pp -82.86 175.88 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.049 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.16 145.75 14.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.415 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -98.55 100.04 11.25 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.83 176.09 9.01 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.805 0.336 . . . . 0.0 111.566 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 178.47 4.55 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.19 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.81 -142.3 3.45 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.0 147.5 32.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.967 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.47 16.91 30.74 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.377 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.55 108.54 5.44 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.733 -0.234 . . . . 0.0 110.852 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -93.34 23.58 4.4 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.862 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.06 -158.51 0.72 Allowed 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.9 106.81 7.92 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.737 0.303 . . . . 0.0 110.943 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.22 153.38 24.37 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.699 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' A' ' 57' ' ' LEU . 33.5 mm -80.97 90.7 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-O 120.817 0.341 . . . . 0.0 110.523 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 20.2 m-85 -81.25 161.43 23.94 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.525 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.6 t -122.93 126.01 73.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.639 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.21 -29.68 6.19 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.1 t -136.65 156.57 48.36 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.032 0.444 . . . . 0.0 111.852 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.02 133.48 26.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.481 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.603 ' CG2' ' HA3' ' A' ' 18' ' ' GLY . 30.0 m -61.07 134.02 26.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.885 0.374 . . . . 0.0 111.366 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.63 93.44 6.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.429 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.26 30.04 4.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.297 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.65 -139.39 10.26 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.688 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.86 -33.56 10.49 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.812 0.306 . . . . 0.0 111.76 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.22 -47.25 11.01 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.374 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -58.58 -38.82 78.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.345 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 t -76.63 -33.73 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.089 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -46.34 90.08 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.978 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.27 29.53 24.82 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.623 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -100.68 -41.63 6.84 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.703 0.287 . . . . 0.0 110.867 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 pp -129.44 162.11 28.84 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.781 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.91 -175.14 5.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.25 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.61 135.38 52.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.258 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.0 46.28 3.39 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.347 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -133.36 173.02 11.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.711 0.291 . . . . 0.0 111.296 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -131.11 143.87 50.98 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.883 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 34' ' ' ILE . 1.9 mp -112.97 122.26 47.09 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.252 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tt -94.34 -58.41 2.22 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.743 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 m -138.99 156.25 47.37 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.955 0.407 . . . . 0.0 111.524 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.43 HG12 ' HG ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -102.9 -167.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.141 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -67.22 68.81 0.08 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.09 0.471 . . . . 0.0 110.83 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.99 25.37 9.67 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.559 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -135.61 147.67 48.73 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.653 0.227 . . . . 0.0 110.633 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 m -113.43 110.9 21.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.924 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.1 mt -102.02 68.6 1.13 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.672 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.18 97.55 3.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.34 -32.11 5.0 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.589 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.29 168.72 11.85 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.004 0.431 . . . . 0.0 111.477 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.5 p -91.23 167.15 12.53 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.073 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -55.42 -26.06 39.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.562 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.52 -46.92 71.42 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.804 0.335 . . . . 0.0 110.609 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -49.04 79.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.252 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.38 -51.7 68.7 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.111 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.98 -43.8 82.05 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -34.7 78.94 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.204 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.0 mt -74.82 -35.61 62.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.642 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 9.3 mtt -72.67 -38.31 67.66 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.063 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.0 t -68.06 -31.15 70.59 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 121.233 -0.187 . . . . 0.0 111.002 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -89.32 53.18 2.56 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.761 0.315 . . . . 0.0 111.423 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.7 p -127.06 166.77 16.97 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.228 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.31 -170.23 3.03 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.381 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 m -54.11 -43.9 70.82 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.253 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.5 t -103.2 135.73 39.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.938 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.5 t -139.92 121.99 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.537 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.02 123.89 35.72 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.588 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.43 ' HG ' HG12 ' A' ' 60' ' ' VAL . 6.3 mt -131.47 134.08 45.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.707 0.289 . . . . 0.0 111.148 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 1.5 mt-10 -81.43 112.11 18.39 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.883 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.0 t -99.72 132.41 45.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.557 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.23 142.17 40.45 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.934 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp . . . . . 0 C--O 1.234 0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.899 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--O 1.234 0.275 0 CA-C-O 120.811 0.339 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -80.1 98.05 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.961 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 pt -106.26 157.78 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.324 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.1 m -124.46 128.79 49.53 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.871 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.451 HG11 ' HG3' ' A' ' 50' ' ' ARG . 20.3 t -137.4 151.73 26.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.406 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.93 106.31 18.33 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.717 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.07 154.9 17.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -117.84 137.82 52.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.057 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -72.44 111.44 7.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 110.924 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.53 86.37 2.4 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.599 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 56.61 38.14 29.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.134 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.92 -159.55 14.41 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 mmt -136.67 99.59 4.1 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.758 0.313 . . . . 0.0 110.96 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.28 72.34 1.34 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.657 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mp -142.19 128.44 19.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.632 0.253 . . . . 0.0 110.676 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.95 132.29 33.84 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.163 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 pt -133.84 171.08 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.973 0.416 . . . . 0.0 111.933 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -157.24 138.72 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.002 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.87 97.47 9.31 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.74 -179.82 5.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.511 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.25 -179.59 3.99 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.289 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.25 -142.36 3.41 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.97 155.86 17.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.795 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.55 23.6 43.65 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.408 -0.901 . . . . 0.0 110.955 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.26 103.39 7.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.534 -0.333 . . . . 0.0 111.272 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.456 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 10.5 t70 -87.22 9.21 20.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.435 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.456 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 4.3 mttt -142.59 -167.46 2.51 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.192 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tp -112.01 132.74 54.61 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.635 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.55 153.16 17.74 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.567 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 57' ' ' LEU . 47.3 mm -83.5 101.32 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.892 0.377 . . . . 0.0 110.63 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -87.96 136.75 32.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.551 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.81 115.66 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.104 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -73.73 -44.75 55.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.785 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.35 172.22 3.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 111.501 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.8 t -124.77 136.88 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.19 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.61 142.64 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.407 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -72.11 138.97 48.14 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.814 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.49 -14.2 65.36 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.25 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.93 -168.19 16.81 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.558 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.04 -54.5 6.46 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.96 81.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.299 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -58.99 -44.83 91.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.083 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.4 t -75.56 -34.2 28.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.096 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.88 -38.99 70.89 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.114 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.19 27.03 71.88 Favored Glycine 0 CA--C 1.521 0.469 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.897 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.451 ' HG3' HG11 ' A' ' 9' ' ' VAL . 7.6 mmt180 -102.51 -34.37 9.15 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.553 0.216 . . . . 0.0 111.015 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 pp -122.38 175.98 6.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.05 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.96 -171.03 3.49 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.287 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.15 153.55 42.43 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.188 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.31 53.15 14.37 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.085 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.13 160.22 24.18 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.743 0.306 . . . . 0.0 111.135 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -113.44 109.88 19.4 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.443 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 34' ' ' ILE . 2.2 mt -85.76 119.31 25.95 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.364 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.64 -61.38 1.47 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.57 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 m -120.61 156.99 30.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 111.705 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.5 t -135.54 113.87 15.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.559 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t0 64.47 20.69 12.24 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.311 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.36 -23.46 26.75 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.642 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.06 142.71 27.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.494 0.647 . . . . 0.0 111.148 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.76 122.84 36.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.95 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.8 mt -102.79 39.94 1.46 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.04 97.08 6.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.267 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.04 38.19 0.76 Allowed Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.305 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.5 mt -138.5 174.89 10.06 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.704 0.288 . . . . 0.0 110.757 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.6 m -94.8 165.81 12.29 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -55.65 -31.84 62.69 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.968 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -57.72 8.88 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.335 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -53.72 -48.23 69.82 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.664 -0.243 . . . . 0.0 111.621 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.01 -48.59 73.37 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.714 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.34 90.31 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.025 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -59.73 -26.9 66.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.361 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.3 mt -87.66 -48.27 8.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.593 0.235 . . . . 0.0 111.115 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -31.36 69.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.076 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.2 t -74.25 -31.22 62.49 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.629 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -87.1 49.67 1.86 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.734 0.302 . . . . 0.0 111.377 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.426 ' HB ' ' CG2' ' A' ' 84' ' ' VAL . 1.5 p -103.63 169.09 8.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.841 0.353 . . . . 0.0 111.234 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.87 -168.1 1.5 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.57 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 96.9 p -55.38 -36.84 66.82 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.271 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.8 t -122.96 138.33 53.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.621 0.248 . . . . 0.0 111.256 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.426 ' CG2' ' HB ' ' A' ' 80' ' ' THR . 3.6 t -141.37 147.76 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.504 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.4 m -102.7 99.26 9.22 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.856 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -106.55 136.47 46.27 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.259 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -117.29 101.0 8.06 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.661 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 m -104.05 166.56 2.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.254 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.18 113.57 19.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.769 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? . . . . . 0 C--O 1.234 0.283 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.912 -179.884 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 C--O 1.233 0.209 0 CA-C-O 120.862 0.363 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.88 122.43 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.867 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 pt -127.17 150.37 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.508 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 m -88.92 120.63 30.5 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.093 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.18 138.81 37.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.113 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.33 107.13 14.83 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.821 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.1 mt -100.7 164.97 11.62 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.139 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.62 111.08 7.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.131 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.25 103.76 0.12 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.325 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -53.11 5.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.738 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -149.54 38.81 0.78 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.985 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.34 -171.32 15.86 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.5 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.3 mtp -136.01 80.19 1.81 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.851 0.357 . . . . 0.0 111.027 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.55 80.87 1.76 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.727 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.36 139.09 17.92 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.85 0.357 . . . . 0.0 110.914 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.4 m -100.61 135.59 41.81 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 pp -126.73 178.18 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.798 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -131.96 167.01 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.975 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -145.41 80.9 1.61 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.546 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.44 -179.34 7.0 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.673 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.86 172.08 14.26 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.755 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -151.16 -143.95 3.82 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.666 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.76 151.52 27.67 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.855 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.56 18.88 39.4 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.086 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.31 112.77 5.61 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.657 -0.271 . . . . 0.0 110.877 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.52 23.9 4.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.96 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -124.21 -149.58 0.43 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 tp -129.5 119.14 23.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.691 0.281 . . . . 0.0 110.788 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.82 164.74 12.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.102 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 28.3 mm -99.55 133.06 43.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.437 ' HB2' ' CG2' ' A' ' 22' ' ' VAL . 54.8 m-85 -117.0 168.6 10.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.666 0.269 . . . . 0.0 111.178 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.22 108.99 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.855 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -73.41 -41.96 62.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.76 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.35 166.04 2.77 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.178 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.1 t -123.45 128.55 74.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.47 146.36 7.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.414 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.6 tptt -65.73 143.38 57.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.833 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.32 -32.62 6.95 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.598 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.19 150.35 46.7 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.62 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.54 -36.78 56.34 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.73 -46.85 74.13 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.56 0.219 . . . . 0.0 111.143 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.85 -40.35 88.27 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.027 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 37.8 t -74.0 -31.94 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.253 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.71 -55.97 26.86 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.336 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.2 29.3 31.22 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.922 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -99.2 -45.87 5.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.887 0.343 . . . . 0.0 110.731 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.37 177.95 4.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.914 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.81 177.54 10.89 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.6 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.74 152.43 45.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.271 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.33 49.08 41.27 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.978 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.56 173.71 7.01 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.761 0.315 . . . . 0.0 111.541 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.2 tm0? -115.85 161.29 18.99 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.979 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.91 129.13 18.77 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.897 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.99 -60.56 1.62 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.461 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 m -119.29 152.69 36.27 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.445 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.43 HG22 HD22 ' A' ' 65' ' ' LEU . 44.0 t -136.01 131.64 49.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.815 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t70 54.92 36.86 27.71 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.779 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.52 28.69 73.05 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.083 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.08 145.49 48.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.922 0.361 . . . . 0.0 110.856 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.9 m -90.94 111.56 23.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.774 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.43 HD22 HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -123.58 76.71 1.44 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.156 0.503 . . . . 0.0 110.995 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 t -121.1 96.25 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.542 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.73 -30.75 2.93 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.743 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.27 168.86 9.72 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.048 0.451 . . . . 0.0 111.86 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 m -91.39 172.3 8.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.527 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -54.94 -28.63 52.57 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.054 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -61.81 -48.87 78.66 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-O 120.717 0.294 . . . . 0.0 110.77 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -63.78 -49.77 71.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.292 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.89 -54.32 47.5 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.511 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.84 94.36 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.882 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HA ' HG21 ' A' ' 78' ' ' THR . 0.5 OUTLIER -65.52 -35.35 80.61 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 179.472 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 mt -67.12 -30.06 69.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.148 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.4 mtt -73.81 -39.7 63.9 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.247 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.424 HG21 ' HA ' ' A' ' 75' ' ' GLU . 11.6 t -68.93 -30.99 69.56 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.554 0.216 . . . . 0.0 111.194 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -89.79 49.54 1.74 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.84 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.2 p -123.92 172.16 9.14 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.912 0.387 . . . . 0.0 111.381 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.28 -171.42 3.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.637 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 p -51.71 -46.62 64.01 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.5 t -97.96 137.97 24.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.096 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -128.54 130.93 69.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.92 98.43 8.28 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.271 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.03 115.02 26.94 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.737 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.88 104.89 15.23 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.978 0.418 . . . . 0.0 110.773 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 32.5 m -92.01 168.31 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.803 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.64 133.52 49.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.659 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt . . . . . 0 C--O 1.232 0.18 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.319 -179.745 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 N--CA 1.463 0.218 0 CA-C-O 121.126 0.489 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.98 133.79 29.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.303 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.24 138.16 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.392 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -104.23 120.02 40.23 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.474 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -118.67 170.72 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.646 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.17 116.34 15.27 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.857 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 mp -126.07 165.91 17.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.142 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -107.95 135.67 48.94 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.088 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 125.06 22.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.115 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.59 66.1 0.95 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.677 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 56.99 38.49 29.39 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.3 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.13 -152.81 24.59 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.374 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.7 mtt -147.61 -72.99 0.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.709 0.254 . . . . 0.0 111.484 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.17 63.87 2.43 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.604 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 mp -143.82 123.8 13.57 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.499 0.19 . . . . 0.0 110.607 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -85.1 125.31 32.67 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.697 0.284 . . . . 0.0 110.989 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 pt -127.88 171.46 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.607 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -159.6 138.5 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.302 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -99.2 97.26 8.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.817 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -131.15 -179.76 5.53 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.633 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -119.72 -179.91 4.04 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.84 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.13 -144.14 3.91 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.789 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.02 163.41 14.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.666 0.269 . . . . 0.0 110.918 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.44 20.93 52.97 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.564 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.94 -164.65 1.26 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.023 0.439 . . . . 0.0 110.092 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.555 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -173.39 21.24 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.254 178.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -154.35 -168.92 3.08 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.741 0.416 . . . . 0.0 110.221 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.24 116.94 30.55 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.873 0.368 . . . . 0.0 110.575 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.23 144.62 16.03 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.699 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.5 mm -77.55 99.59 2.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 120.955 0.407 . . . . 0.0 110.606 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -86.89 144.84 26.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.404 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.4 t -93.95 118.73 40.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.985 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -80.21 -42.54 23.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.854 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.8 172.08 4.98 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.437 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.8 t -124.53 132.13 71.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.022 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.73 142.77 14.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.0 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 155.44 39.23 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.344 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.91 16.66 70.68 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.003 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -99.2 153.55 19.74 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.349 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.0 -35.78 62.25 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.1 -32.64 56.76 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.344 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -76.43 -44.32 36.34 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.21 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.6 t -65.47 -48.42 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.233 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.85 -31.97 61.79 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.33 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.9 54.98 2.91 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.935 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -62.94 1.52 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.701 0.286 . . . . 0.0 111.08 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.07 161.11 32.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.907 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.35 -177.06 3.67 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.08 144.32 57.33 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.412 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.01 44.08 46.87 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.546 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -112.71 179.84 3.86 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.648 0.261 . . . . 0.0 111.143 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 13.2 tm0? -127.31 158.53 36.97 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.082 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.0 mt -143.81 130.61 20.33 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.55 0.215 . . . . 0.0 111.18 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.8 -59.59 1.73 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.787 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.5 m -90.48 139.66 30.48 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.024 0.44 . . . . 0.0 112.152 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.3 t -141.54 110.68 2.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.742 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 56.74 37.13 28.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.119 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.62 28.63 60.95 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.004 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -118.99 148.08 43.38 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.808 0.304 . . . . 0.0 110.68 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.4 91.81 7.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.774 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.9 mt -96.61 93.29 6.67 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.995 0.426 . . . . 0.0 110.945 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.2 t -138.86 94.74 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.137 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.9 37.25 0.97 Allowed Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.815 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.32 157.51 42.35 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.887 0.375 . . . . 0.0 111.057 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 p -74.29 168.13 20.24 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.374 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -58.57 -40.58 83.51 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.9 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -55.04 -40.32 70.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.945 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -66.54 -48.31 70.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.215 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.61 -49.1 67.41 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.235 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.75 -43.63 90.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.803 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -64.98 -37.4 87.53 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.5 mt -73.27 -36.71 66.39 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.235 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.4 mtp -76.37 -34.52 58.91 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.801 -0.182 . . . . 0.0 111.429 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 t -73.37 -39.89 64.78 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 121.216 -0.193 . . . . 0.0 110.851 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 73.2 mtp85 -90.68 59.03 4.08 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.0 0.429 . . . . 0.0 110.57 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.4 p -114.29 164.29 14.11 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.289 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.1 p -79.4 -165.69 0.83 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.573 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.5 -51.98 67.27 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.538 0.208 . . . . 0.0 110.902 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.3 t -100.61 138.47 24.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.018 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.4 t -132.82 127.55 55.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.563 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.59 107.31 19.79 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.472 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.4 mt -116.35 136.91 52.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.96 0.41 . . . . 0.0 111.452 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 38.4 tt0 -106.66 97.3 7.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.109 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 19.7 t -98.8 139.05 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.785 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.84 118.28 36.59 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.677 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.258 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.866 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 . . . . . 0 C--O 1.233 0.22 0 CA-C-O 121.255 0.55 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.6 mm -91.6 128.43 43.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.83 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 pt -147.84 149.15 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.516 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -118.91 130.96 56.0 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.848 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 t -125.89 141.09 46.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.74 92.61 7.76 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.632 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.89 131.64 34.48 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.27 138.86 31.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -68.81 155.33 40.37 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.918 0.39 . . . . 0.0 111.356 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.31 66.6 1.27 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.531 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 57.49 35.95 26.42 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.127 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.58 -172.54 27.1 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.508 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 11.7 mmm -112.31 -73.48 0.67 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.616 0.246 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.82 49.44 7.1 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.836 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mp -148.54 110.15 4.47 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.604 0.24 . . . . 0.0 110.744 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 t -80.59 130.47 35.14 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.15 178.32 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.658 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.2 p -148.52 145.19 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.409 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.14 84.92 2.41 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.329 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.76 179.21 4.21 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.531 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.84 176.97 9.24 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.745 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.33 145.14 13.28 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.16 155.56 40.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.873 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.39 19.87 48.83 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.49 -159.8 0.99 Allowed 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 123.421 0.689 . . . . 0.0 109.737 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -173.78 31.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.923 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.78 -171.57 3.72 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.624 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.62 106.01 15.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.72 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.66 174.81 33.62 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.801 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.7 mm -102.27 111.49 32.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.657 0.265 . . . . 0.0 110.711 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.427 ' CE1' ' HG2' ' A' ' 56' ' ' GLN . 81.7 m-85 -104.35 153.82 20.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.36 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.05 125.45 53.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.128 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.38 -34.81 8.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.337 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 m -164.87 168.32 17.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.763 0.316 . . . . 0.0 111.417 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.7 t -135.74 138.44 47.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.991 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.09 133.99 29.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.33 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.65 140.36 49.66 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.074 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.6 -14.46 64.87 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.304 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.22 -161.66 5.53 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.405 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.77 -36.71 14.12 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.16 -51.37 68.13 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.87 -38.99 83.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.447 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.6 t -73.45 -31.88 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.031 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.7 -44.05 85.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.099 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.8 51.78 14.22 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.681 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.71 -45.93 2.26 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.611 0.244 . . . . 0.0 111.294 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 pp -135.58 172.51 12.91 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.006 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.9 -160.12 1.09 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.381 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.8 152.96 43.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.574 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.03 48.1 21.67 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.159 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -121.31 170.61 9.44 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.736 0.303 . . . . 0.0 111.422 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.427 ' HG2' ' CE1' ' A' ' 35' ' ' TYR . 7.5 tm0? -119.45 135.01 54.94 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.916 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.97 129.32 53.38 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.804 0.335 . . . . 0.0 111.014 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.47 -61.4 1.6 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.459 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.3 p -111.45 146.63 36.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.061 0.458 . . . . 0.0 111.867 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.11 119.19 39.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.479 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t70 59.95 35.26 21.64 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.04 -16.04 56.53 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.678 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -92.1 138.29 31.66 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 117.381 0.59 . . . . 0.0 111.096 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.15 114.44 25.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.825 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.2 mt -100.74 76.89 1.83 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.711 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 t -122.25 91.5 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.034 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.11 32.6 1.98 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.574 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.4 mt -123.15 155.67 36.57 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.744 0.307 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.1 m -74.03 158.75 33.74 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -55.06 -35.79 64.9 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.956 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.02 -44.21 97.2 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.919 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.31 -52.89 56.28 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.224 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.28 -52.04 66.37 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.569 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.64 -46.85 86.21 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.018 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HA ' HG21 ' A' ' 78' ' ' THR . 1.8 tp10 -62.54 -36.96 84.26 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.677 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.1 mt -69.39 -34.05 73.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.961 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.0 mtt -71.99 -39.53 69.2 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.114 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.418 HG21 ' HA ' ' A' ' 75' ' ' GLU . 11.1 t -68.53 -32.35 72.23 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.564 0.221 . . . . 0.0 110.983 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -91.52 48.24 1.45 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.542 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.8 p -109.38 174.3 5.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.764 0.316 . . . . 0.0 111.207 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -84.9 -170.25 3.04 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.67 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -56.14 -37.83 70.02 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.684 0.278 . . . . 0.0 111.094 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -113.47 139.23 39.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.097 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.1 t -130.37 119.62 46.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.082 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.91 98.31 11.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.826 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.0 mp -103.17 127.15 50.55 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.12 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -91.94 96.29 10.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.543 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.4 p -93.32 147.58 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.874 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.72 135.01 54.41 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.101 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.191 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.062 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--O 1.234 0.267 0 CA-C-O 120.991 0.424 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.494 ' CG2' ' HG2' ' A' ' 87' ' ' GLU . 1.4 mp -94.49 126.01 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.815 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.5 pt -138.41 143.21 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.403 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 25.3 m -96.4 134.49 39.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.828 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -117.92 127.08 75.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.24 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.07 99.78 11.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.797 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.8 mt -107.79 157.58 18.02 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.965 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -118.93 138.61 52.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.828 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -72.21 114.67 10.58 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.304 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.49 -41.1 7.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.611 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -160.39 44.12 0.2 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.49 -177.6 29.66 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.576 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.0 mtt -120.19 93.57 4.1 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.819 0.342 . . . . 0.0 110.895 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.8 71.38 3.0 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.486 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mp -146.09 115.56 7.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.571 0.224 . . . . 0.0 110.466 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m -80.07 129.52 34.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.906 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 2.9 pp -124.22 176.16 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.017 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.89 151.47 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.617 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.13 115.2 29.76 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.785 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.65 -179.58 8.21 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.896 0.379 . . . . 0.0 111.909 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -94.43 167.11 11.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.861 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.05 -141.76 3.45 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.25 147.74 30.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.986 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.63 16.42 37.31 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.267 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.99 107.9 4.34 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.573 0.225 . . . . 0.0 110.951 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -93.37 25.15 3.52 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.946 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.29 -157.77 0.72 Allowed 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.68 108.53 9.1 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.808 0.337 . . . . 0.0 110.677 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.31 -178.23 22.58 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.768 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.3 mm -97.48 129.04 48.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.617 0.246 . . . . 0.0 110.759 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.5 ' CE2' ' HG3' ' A' ' 56' ' ' GLN . 15.3 m-85 -114.2 166.03 12.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.139 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.21 109.55 28.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.844 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.05 -34.95 22.17 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.201 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.7 t -169.58 170.88 7.89 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.707 0.289 . . . . 0.0 111.518 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.0 t -130.7 151.41 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.213 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 t -101.53 139.86 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.147 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -58.74 136.29 57.69 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.043 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.28 -22.48 37.64 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.01 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.29 135.08 45.41 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.468 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.22 -36.34 19.83 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.25 -50.53 73.27 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 111.361 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -70.93 -45.56 64.01 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.88 -36.42 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.396 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.62 -49.84 29.34 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.657 0.265 . . . . 0.0 110.914 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.04 60.56 1.06 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.809 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -123.37 -50.9 1.87 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.681 0.277 . . . . 0.0 110.936 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 pp -122.57 175.99 6.17 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.28 -174.89 5.14 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.305 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.75 165.81 20.59 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.356 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.59 45.72 88.14 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.34 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.22 172.98 11.94 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.799 0.333 . . . . 0.0 111.423 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.5 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -112.64 173.29 6.44 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.706 179.5 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.406 HD22 ' CD2' ' A' ' 86' ' ' LEU . 3.1 tp -155.84 133.05 10.77 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.066 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.4 -60.52 1.87 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.34 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 5.7 t -97.43 146.15 25.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.189 0.519 . . . . 0.0 112.14 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.4 t -140.41 126.66 21.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.596 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.8 t0 54.99 38.37 30.42 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.05 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.81 -12.92 45.93 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.707 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -90.73 158.78 16.69 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 117.399 0.6 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.57 108.04 16.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.43 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.83 96.76 6.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 110.988 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.2 t -125.03 92.61 2.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.814 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.16 36.24 0.88 Allowed Glycine 0 CA--C 1.518 0.271 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.313 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.4 mt -120.08 174.78 6.27 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.773 0.32 . . . . 0.0 110.728 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -98.23 163.71 12.61 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -57.09 -28.42 62.61 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.454 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -66.2 -49.2 68.11 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.739 0.304 . . . . 0.0 110.695 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.7 -45.5 82.58 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.365 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.81 -51.45 62.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.593 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.17 -37.04 78.96 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.749 0.309 . . . . 0.0 110.695 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -67.9 -37.49 81.79 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.818 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mt -73.47 -40.81 63.85 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.163 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -32.66 74.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.172 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.4 t -79.63 -33.5 41.33 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.881 -0.145 . . . . 0.0 111.388 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.81 46.04 1.35 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.688 0.28 . . . . 0.0 111.499 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 71.5 p -106.39 168.78 8.92 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.812 0.339 . . . . 0.0 111.026 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -80.62 -167.01 1.21 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.536 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.2 p -59.88 -39.8 86.52 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.674 0.273 . . . . 0.0 110.693 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.6 t -105.03 142.73 17.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.804 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.7 t -135.98 143.73 35.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.229 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.421 ' HB ' HG23 ' A' ' 8' ' ' THR . 0.0 OUTLIER -122.3 118.89 29.57 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.695 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.406 ' CD2' HD22 ' A' ' 57' ' ' LEU . 4.8 mp -120.2 120.81 37.22 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.415 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.494 ' HG2' ' CG2' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -81.68 93.19 6.72 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.476 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 p -88.18 137.31 21.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.641 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . . . -105.62 126.57 52.29 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.038 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp . . . . . 0 C--O 1.233 0.208 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.445 179.859 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 41.1 tt0 . . . . . 0 C--O 1.234 0.279 0 CA-C-O 121.039 0.447 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -84.12 126.72 40.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.657 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 pt -145.86 146.65 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 13.2 t -115.42 141.69 47.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.775 0.321 . . . . 0.0 111.107 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.73 148.78 20.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.502 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.83 128.53 33.55 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.998 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.4 121.93 39.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.712 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -101.04 99.13 9.53 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.701 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.3 130.28 43.89 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.176 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -78.95 -59.34 2.82 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.503 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -158.01 37.4 0.25 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.077 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.05 -163.96 28.62 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.359 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.1 mmt -139.4 101.46 4.24 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.674 0.273 . . . . 0.0 111.047 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.7 77.36 0.71 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.729 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.14 137.41 12.81 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 111.058 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -105.45 109.0 20.82 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.776 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 pt -102.91 178.29 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.473 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 35' ' ' TYR . 2.5 p -155.42 134.42 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.228 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.29 104.24 16.13 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.63 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -143.74 -179.72 6.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.186 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -101.46 179.36 4.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.53 -145.4 4.23 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.83 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.33 163.19 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.652 0.263 . . . . 0.0 110.921 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.49 20.13 44.14 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.555 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.81 -163.11 0.94 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.203 0.525 . . . . 0.0 109.962 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.446 ' C ' ' HG2' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -168.13 18.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.62 178.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HG2' ' C ' ' A' ' 30' ' ' ASP . 0.1 OUTLIER -156.97 -170.79 3.41 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 tp -99.54 123.96 44.29 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.607 0.241 . . . . 0.0 110.864 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.16 175.03 15.54 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.806 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.405 ' N ' ' CD1' ' A' ' 34' ' ' ILE . 1.6 mp -103.46 154.0 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 O-C-N 122.774 -0.25 . . . . 0.0 110.456 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.421 ' HB2' HG12 ' A' ' 22' ' ' VAL . 68.2 m-85 -136.14 158.46 44.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.249 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.4 t -102.94 108.84 25.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -81.71 -38.92 25.02 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.821 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.0 t -175.23 158.39 2.38 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.094 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.418 ' CG1' ' HB2' ' A' ' 46' ' ' ASP . 10.9 t -128.07 146.13 34.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.901 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.68 140.32 16.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.968 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -68.28 91.08 0.37 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.434 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.63 -32.35 0.48 Allowed Glycine 0 CA--C 1.519 0.342 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.493 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.56 148.15 41.91 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.049 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -55.09 -21.08 11.49 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.94 -33.73 19.58 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.504 0.192 . . . . 0.0 111.442 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.418 ' HB2' ' CG1' ' A' ' 39' ' ' VAL . 0.7 OUTLIER -86.21 -49.13 7.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.264 -179.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.83 -29.88 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.829 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 11.6 m-20 -86.83 -50.04 7.0 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.554 0.216 . . . . 0.0 110.552 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.52 93.14 2.28 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.389 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -143.18 -50.62 0.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.442 0.163 . . . . 0.0 111.056 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 pp -135.37 138.86 43.75 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.752 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.14 -170.52 1.67 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.304 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.28 153.66 42.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 111.121 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.83 37.29 65.91 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.284 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.46 173.88 6.12 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.769 0.318 . . . . 0.0 111.062 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.63 156.6 33.96 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.795 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 mt -133.95 135.13 43.32 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.152 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.41 -55.93 2.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.555 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.3 m -115.0 156.06 25.79 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.1 t -140.14 139.25 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.138 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 43.47 41.75 3.48 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.167 0.587 . . . . 0.0 111.793 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.8 32.55 74.13 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.807 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -132.75 145.37 50.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.932 0.366 . . . . 0.0 110.7 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.8 m -92.55 126.15 37.51 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.48 61.43 1.64 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.334 0.588 . . . . 0.0 111.022 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.5 t -102.74 98.44 6.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.676 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.6 -26.21 2.67 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.068 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 mt -76.54 174.09 10.75 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.802 0.334 . . . . 0.0 111.083 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.5 t -96.94 -176.57 3.6 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.972 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -60.1 -32.81 71.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -58.54 -58.85 6.73 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.958 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -63.38 -42.78 98.85 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.267 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.08 -48.41 81.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.272 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.21 -44.85 71.24 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.749 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.46 -31.88 70.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.05 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mt -71.17 -36.54 72.03 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.727 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.2 mtt -67.62 -46.36 72.74 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.133 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.8 t -64.4 -27.92 69.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 121.213 -0.195 . . . . 0.0 111.043 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.4 mtm-85 -91.19 51.68 1.97 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.407 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.3 p -130.48 -177.29 4.27 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.865 0.364 . . . . 0.0 110.998 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 t -110.58 -165.5 1.0 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.562 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 t -54.73 -49.93 69.6 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.117 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.2 t -86.95 126.15 40.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.217 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.4 t -145.9 110.2 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.231 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.35 120.14 25.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.658 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.8 mt -110.44 115.15 29.14 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.719 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 2.2 tt0 -87.2 92.16 8.97 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.353 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.8 m -94.39 173.55 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.354 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.88 120.67 26.63 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.076 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 8.9 mmtt . . . . . 0 C--O 1.234 0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.6 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 C--O 1.233 0.195 0 CA-C-O 121.215 0.531 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.2 mt -93.52 138.75 19.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.57 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 pp -145.35 141.99 22.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.438 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 2.2 m -101.9 114.41 28.48 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.816 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -127.97 162.34 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.642 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.36 142.36 29.33 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.188 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.13 129.3 56.62 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.832 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 82' ' ' SER . 6.8 mmtt -94.63 107.89 19.87 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.72 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -66.7 124.81 23.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.248 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -97.48 -53.57 3.41 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.857 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -154.46 36.3 0.42 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.32 -149.91 17.96 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.273 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.4 mmt -141.9 105.5 4.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.854 0.359 . . . . 0.0 111.055 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.12 36.2 4.2 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.475 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mp -111.71 106.97 15.92 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 p -79.67 128.45 33.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.007 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.34 172.58 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.964 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.76 143.19 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.453 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.16 112.83 25.65 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.524 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -154.16 172.24 17.88 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.924 0.392 . . . . 0.0 111.779 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -113.83 161.2 17.86 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.063 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.79 -140.3 3.56 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.2 158.98 16.22 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.863 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.53 25.57 42.74 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.404 -0.903 . . . . 0.0 110.902 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.65 104.19 7.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.396 -0.402 . . . . 0.0 111.088 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -88.08 14.04 9.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.478 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -145.85 -162.01 1.43 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.03 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.99 141.76 40.63 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.688 0.28 . . . . 0.0 110.672 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -123.41 144.49 15.64 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.658 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.8 mm -94.04 108.93 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -96.28 168.71 10.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 0.0 111.778 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.35 108.57 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.674 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -40.13 77.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.944 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.28 170.25 4.32 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.887 0.375 . . . . 0.0 111.552 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.1 t -134.84 127.67 49.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.597 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.96 137.81 23.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.136 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -65.27 152.92 42.53 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.36 20.34 69.42 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.928 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.39 -147.68 8.59 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.371 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.15 -43.41 6.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.658 0.266 . . . . 0.0 111.443 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.91 -34.03 30.13 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.239 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.74 -39.49 94.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.107 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.09 -35.89 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.847 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -42.06 72.56 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.272 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.03 76.56 1.13 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.478 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -133.88 -49.58 0.82 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.535 0.168 . . . . 0.0 111.264 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 pp -135.03 148.17 49.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 111.212 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -126.73 -169.47 2.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.161 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.37 145.37 56.16 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.933 0.397 . . . . 0.0 111.931 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.28 30.14 54.97 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.068 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -101.72 176.05 5.35 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.973 0.387 . . . . 0.0 111.655 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -116.74 169.91 9.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.835 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.69 139.09 15.8 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.705 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mt -121.05 -58.49 1.8 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.1 m -121.82 153.85 37.79 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.51 122.06 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.847 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 t0 57.67 33.8 23.69 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.207 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.54 -8.49 71.66 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.341 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -84.81 155.24 21.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.133 0.466 . . . . 0.0 111.177 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.9 t -99.29 139.95 34.18 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.036 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mp -136.02 36.49 2.81 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.984 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 t -97.85 92.6 2.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.48 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.93 -25.47 4.14 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.644 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 mt -74.4 -177.32 3.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.866 0.365 . . . . 0.0 111.254 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.7 t -115.82 -171.81 2.04 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.008 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -62.57 -30.3 71.22 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.465 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.75 -50.73 69.89 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.775 0.321 . . . . 0.0 110.817 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -69.73 -42.49 73.91 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.987 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.43 -47.71 75.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.376 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.99 -69.18 0.29 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.263 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -37.88 -39.93 0.41 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.7 mt -70.73 -40.1 72.97 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.528 0.204 . . . . 0.0 111.384 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.21 -7.17 59.16 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.14 -29.13 28.89 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 122.376 -0.203 . . . . 0.0 110.97 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -90.85 31.93 1.03 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.432 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 54.0 p -79.89 176.01 10.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.821 0.343 . . . . 0.0 110.811 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.35 -160.68 1.05 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.587 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 19.6 m -56.12 -27.65 54.76 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.34 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 t -132.97 142.73 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.945 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.0 p -158.3 127.09 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.341 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.49 106.22 15.91 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.068 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.6 115.25 29.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.824 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 36.3 tt0 -88.7 109.15 19.9 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.508 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.0 m -117.02 169.91 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.708 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -120.33 131.16 54.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.698 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.812 0.339 . . . . 0.0 110.412 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptm . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.684 0.278 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.54 132.7 42.06 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.88 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -128.1 89.5 50.03 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.29 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.6 -174.19 1.2 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.858 2.372 . . . . 0.0 112.817 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -126.0 105.38 8.85 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.194 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.456 ' CG2' ' HG2' ' A' ' 87' ' ' GLU . 21.4 mt -95.45 127.31 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.006 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.42 139.27 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.502 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 86.2 m -89.11 113.79 24.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.851 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -105.84 149.27 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.384 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -120.66 112.66 19.16 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.733 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.67 163.02 27.02 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.188 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -103.73 174.31 5.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.219 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -107.58 115.88 30.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.398 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.37 -41.3 10.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.615 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -163.4 47.08 0.13 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.689 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.44 -146.73 18.29 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.481 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 30.4 mtt -138.97 95.46 2.96 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.682 0.277 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.41 74.09 2.13 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.548 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.61 143.68 13.26 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.616 0.246 . . . . 0.0 111.012 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -87.64 147.25 25.35 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.187 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.2 pp -138.77 164.32 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.699 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.491 ' CG1' ' HB2' ' A' ' 35' ' ' TYR . 7.3 p -151.48 144.12 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.388 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.46 91.97 3.86 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.999 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.03 179.84 6.11 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.249 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 -179.99 4.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.716 0.293 . . . . 0.0 110.945 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.41 -138.82 2.56 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.708 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.57 149.79 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.866 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.53 18.22 36.48 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.489 -0.862 . . . . 0.0 110.986 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.34 105.66 3.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.729 0.299 . . . . 0.0 110.859 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.08 26.77 2.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.987 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -122.1 -158.81 0.79 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.8 100.22 5.41 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.826 0.346 . . . . 0.0 110.703 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.18 155.36 28.53 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.763 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.2 mm -88.31 93.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 CA-C-O 120.951 0.405 . . . . 0.0 110.473 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.491 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 91.8 m-85 -83.65 145.88 28.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.759 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.54 107.89 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.211 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -68.06 -42.97 79.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.941 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.6 t -168.03 171.76 9.38 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.139 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.7 t -128.99 120.94 53.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.578 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.35 130.47 34.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.85 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.13 126.55 27.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.55 -20.77 22.43 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.726 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.88 157.02 48.96 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.712 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.48 -39.9 64.91 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.54 -36.68 68.35 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.469 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -70.39 -49.19 51.66 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.28 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.48 -40.99 88.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.269 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.96 -50.85 69.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.164 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.13 46.57 3.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.442 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.26 -67.82 0.91 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.638 0.256 . . . . 0.0 110.91 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.78 158.4 18.78 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.811 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.35 176.06 8.44 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.58 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.35 147.69 44.15 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.473 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.99 45.36 57.33 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.412 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.39 179.64 3.99 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.478 0.18 . . . . 0.0 110.974 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 65.3 tt0 -123.46 147.97 46.65 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.208 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.76 127.76 48.6 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.304 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -109.07 -62.71 1.44 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.027 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.0 m -102.75 143.01 32.94 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.39 110.21 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.56 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.3 40.4 24.58 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.273 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.69 -26.46 12.38 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.11 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.75 175.39 10.72 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.963 0.382 . . . . 0.0 110.846 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.21 121.51 24.95 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.781 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.9 mt -96.86 51.19 1.13 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.798 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.3 t -95.98 90.94 2.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.77 31.56 2.91 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.526 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.7 mt -118.41 157.56 26.94 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.854 0.359 . . . . 0.0 110.97 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.8 p -79.71 166.29 21.95 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.976 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -58.49 -37.96 76.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.719 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -64.66 -48.98 72.77 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.945 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -56.22 -47.57 78.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.356 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.98 -53.3 32.86 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.313 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.44 -42.78 83.09 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.052 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.4 -35.96 81.65 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.084 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.3 mt -71.93 -38.57 69.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.781 -0.19 . . . . 0.0 110.909 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 56.5 mtt -62.37 -37.26 85.03 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.235 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.1 t -74.86 -32.51 61.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.585 0.231 . . . . 0.0 110.769 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -88.74 50.98 2.06 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.413 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 40.2 p -120.03 170.89 8.87 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.812 0.339 . . . . 0.0 111.194 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.22 -169.62 2.35 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.755 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.0 m -54.9 -48.0 73.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.592 0.234 . . . . 0.0 110.994 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.66 138.74 20.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.796 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.6 t -133.91 114.33 19.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.18 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.25 132.36 36.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.538 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.5 mp -138.95 132.75 30.81 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.62 0.247 . . . . 0.0 111.141 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 28.0 tt0 -100.86 101.72 12.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.681 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.85 149.86 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.767 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.18 119.36 36.1 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.231 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -71.39 102.34 2.61 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.767 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -156.19 -161.98 1.21 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.958 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.47 139.12 2.58 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.489 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.432 179.846 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.1 mtm . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 120.492 0.187 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.11 112.49 24.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.852 0.358 . . . . 0.0 110.8 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -104.53 148.87 36.72 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.965 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.86 -166.2 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.814 2.342 . . . . 0.0 112.327 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -72.04 83.42 0.98 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.276 0.56 . . . . 0.0 111.029 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.403 HG22 HD12 ' A' ' 6' ' ' ILE . 19.4 mm -92.05 125.2 44.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.919 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.63 139.72 47.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.141 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.489 ' HB ' ' HG3' ' A' ' 87' ' ' GLU . 2.4 t -95.39 140.88 29.64 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.077 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -118.78 124.93 73.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.083 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.04 116.06 22.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.8 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.76 143.08 36.78 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.401 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -101.93 170.34 8.2 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.171 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -101.18 119.72 39.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.366 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.43 -40.54 5.33 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -152.87 32.26 0.49 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.974 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.12 177.59 22.75 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.235 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.1 mmm -115.27 96.61 5.75 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.749 0.309 . . . . 0.0 110.75 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.09 72.14 2.85 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.555 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mp -139.8 115.95 10.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.634 0.254 . . . . 0.0 110.646 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 m -85.99 100.07 11.88 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.956 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 pt -81.31 174.79 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.574 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG11 ' HB2' ' A' ' 35' ' ' TYR . 3.5 p -158.85 144.55 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.34 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.59 124.3 49.07 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.835 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.6 -179.54 8.26 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.966 0.412 . . . . 0.0 111.62 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -101.87 164.84 11.51 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.91 -143.55 3.88 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.1 153.65 26.63 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.022 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.45 19.15 39.74 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.169 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.46 111.01 5.62 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.71 0.291 . . . . 0.0 110.898 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -94.37 24.84 4.2 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.888 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -123.66 -147.44 0.38 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tp -136.29 112.41 9.72 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.752 0.311 . . . . 0.0 110.555 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.38 176.89 24.63 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.816 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.4 mm -97.11 151.5 4.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.715 0.293 . . . . 0.0 110.765 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.47 ' HB2' HG11 ' A' ' 22' ' ' VAL . 85.1 m-85 -140.38 156.41 46.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.157 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.68 100.59 11.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.713 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -74.53 -39.0 62.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.541 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.44 162.14 8.18 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.205 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.81 109.53 20.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.558 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.3 t -65.95 127.4 27.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.307 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -60.85 143.03 55.61 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.007 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.81 -14.76 62.62 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.921 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.05 -173.84 33.01 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.312 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.15 -51.1 26.88 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.75 -37.74 85.38 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -64.07 -49.2 73.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.456 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.46 -36.1 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.374 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.49 -54.25 11.2 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.75 69.86 1.36 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.719 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -139.74 27.44 2.23 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.549 0.214 . . . . 0.0 111.51 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -175.63 179.48 1.41 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.596 0.236 . . . . 0.0 111.036 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.11 -176.97 6.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.603 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.36 146.99 38.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.161 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.53 47.64 15.58 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.375 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -116.98 177.76 4.59 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.672 0.272 . . . . 0.0 111.1 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 9.3 tm0? -112.45 165.15 12.48 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.125 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.16 126.3 12.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.782 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.25 -63.12 1.36 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.318 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.7 m -115.73 152.48 33.15 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 111.666 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.406 HG13 ' HG2' ' A' ' 77' ' ' MET . 39.0 t -133.14 113.81 20.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.875 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.2 36.44 23.85 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.208 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.55 -14.25 60.26 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.209 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -80.53 143.87 32.93 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 117.158 0.479 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.3 p -92.56 137.41 32.39 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.046 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mp -137.91 87.54 2.26 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.267 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.6 t -135.87 87.11 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.752 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.73 -24.01 3.35 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.644 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.4 mt -72.71 175.12 6.71 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.198 0.523 . . . . 0.0 111.814 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -101.51 176.25 5.3 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.999 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -61.38 -39.16 89.65 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.091 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.23 -53.16 61.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.164 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -58.62 -48.36 81.27 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.137 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.44 -50.77 72.64 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.652 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.14 -40.5 96.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.777 0.322 . . . . 0.0 110.806 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.86 -31.39 72.6 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.116 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.6 mt -79.35 -30.47 42.67 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.007 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.406 ' HG2' HG13 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -66.37 -29.8 70.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.391 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.0 t -77.2 -31.24 55.17 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 121.156 -0.218 . . . . 0.0 110.787 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -95.35 56.81 1.9 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.816 0.341 . . . . 0.0 111.52 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.3 p -116.64 179.33 4.04 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.087 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.19 -174.13 4.08 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.797 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -53.56 -52.62 59.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.973 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.2 t -92.79 146.34 6.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.83 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.7 t -135.0 133.62 53.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.27 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.88 101.6 8.42 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.512 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mt -99.95 113.28 25.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.578 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.489 ' HG3' ' HB ' ' A' ' 8' ' ' THR . 3.1 tt0 -81.37 95.53 7.05 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.994 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 31.9 m -101.28 166.32 2.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.142 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.457 ' CB ' ' HB3' ' A' ' 56' ' ' GLN . . . -119.98 142.53 48.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.656 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.86 70.83 2.65 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.701 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -101.28 -165.78 1.24 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.219 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.25 138.44 2.42 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.514 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.989 179.853 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mmt . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.655 0.265 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.0 96.58 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.042 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 59.11 78.82 0.33 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.224 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.76 167.39 27.33 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.816 2.344 . . . . 0.0 112.838 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -112.91 97.25 6.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.018 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mt -85.59 128.95 38.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.03 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 pt -146.01 149.63 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.972 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 6.4 t -106.72 142.61 36.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 110.825 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -131.3 137.14 56.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.532 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.2 m -87.1 112.34 21.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.761 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.28 164.39 17.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.738 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -122.58 148.69 44.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.73 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -85.08 107.28 17.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.706 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.82 56.8 2.7 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.619 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 57.31 39.52 28.42 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.167 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.73 171.41 39.6 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.66 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -138.71 -68.34 0.45 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.536 0.208 . . . . 0.0 111.069 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.76 65.5 3.5 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.106 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.48 108.94 4.85 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.594 0.235 . . . . 0.0 111.053 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.3 m -81.02 97.06 7.33 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.709 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pt -98.23 175.44 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.692 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.5 p -159.53 138.79 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.274 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.73 107.46 18.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.028 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -148.63 179.84 7.52 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.926 0.393 . . . . 0.0 111.583 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -97.12 168.47 10.43 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.27 -142.28 3.46 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.79 149.91 27.63 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.844 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.19 17.57 31.48 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.287 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.34 108.24 4.36 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.714 0.292 . . . . 0.0 110.786 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.69 25.38 3.12 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.765 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.9 mmtm -121.47 -155.43 0.64 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.239 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.6 99.02 4.51 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.845 0.355 . . . . 0.0 110.631 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.43 154.91 25.53 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.928 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 35.2 mm -88.95 100.14 10.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.882 0.372 . . . . 0.0 110.662 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -89.84 153.89 20.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.605 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -99.97 113.61 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.758 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -82.52 -40.94 20.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.627 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 m -164.06 173.23 12.77 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.284 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.4 t -137.44 152.02 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.199 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.8 t -101.71 140.96 19.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.085 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.32 109.96 1.75 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.772 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.82 -24.83 4.78 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.0 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.63 159.94 33.92 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.813 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.9 -55.59 25.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.515 0.198 . . . . 0.0 111.475 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.74 -32.24 69.05 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.332 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.74 -55.28 8.99 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.018 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 t -63.69 -46.69 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.283 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.56 -33.31 75.3 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.284 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.29 36.9 92.35 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.825 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -85.01 -32.21 23.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.525 0.202 . . . . 0.0 111.094 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.05 175.44 9.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.867 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.81 -171.08 3.17 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.01 149.76 47.37 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.152 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.06 50.94 25.77 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.418 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -120.51 176.2 5.62 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.631 0.253 . . . . 0.0 111.091 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -128.69 139.06 52.42 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 6.4 mp -119.51 135.45 54.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.981 0.42 . . . . 0.0 111.206 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.66 -59.52 1.69 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.466 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.7 m -117.68 163.21 16.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.898 0.38 . . . . 0.0 111.864 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.8 t -145.85 136.4 18.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.96 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 44.17 37.05 1.7 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.952 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.26 40.69 40.6 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.746 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -140.97 156.29 46.08 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.721 0.261 . . . . 0.0 110.679 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 m -86.49 128.33 34.95 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.831 0.348 . . . . 0.0 111.001 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -137.88 37.01 2.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.437 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 p -114.07 45.5 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.66 0.743 . . . . 0.0 110.665 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.51 36.27 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.174 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 pp -144.82 169.99 16.97 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.671 0.272 . . . . 0.0 110.926 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.55 177.42 8.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.199 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -63.34 -34.06 76.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.289 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -50.93 71.9 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.652 0.263 . . . . 0.0 110.92 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -62.62 -42.74 99.76 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.458 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB3' HG13 ' A' ' 34' ' ' ILE . . . -67.0 -54.14 24.64 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.509 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.35 -35.69 74.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.826 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' O ' HG21 ' A' ' 78' ' ' THR . 3.8 tp10 -69.86 -29.41 66.64 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.133 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.3 mt -79.48 -37.62 36.38 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.77 -0.196 . . . . 0.0 111.028 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.9 mtm -68.76 -32.38 72.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.405 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 75' ' ' GLU . 15.1 t -73.79 -30.29 62.66 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.491 0.186 . . . . 0.0 111.217 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -92.71 44.3 1.15 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.448 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.2 p -102.89 161.04 14.07 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.831 0.348 . . . . 0.0 111.434 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.2 p -95.86 -166.49 1.44 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -39.17 68.87 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.868 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 t -103.46 142.06 18.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.087 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 t -145.74 142.14 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.271 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.16 112.62 17.92 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.457 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -110.39 119.56 39.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.239 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 3.5 tt0 -81.44 85.44 6.47 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.335 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.6 m -80.31 173.08 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.417 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.66 125.92 15.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.633 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -66.45 87.95 0.13 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.827 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -110.55 -168.16 1.28 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.039 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 145.62 140.13 3.48 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.348 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.047 -0.977 . . . . 0.0 111.468 -179.861 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ptm . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.445 0.164 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? 64.27 75.42 0.38 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.452 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 68.45 146.29 0.11 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.768 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.86 177.93 7.89 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.514 2.143 . . . . 0.0 112.569 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -100.66 92.17 4.98 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.882 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.46 ' CG2' ' HG2' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -110.58 123.78 66.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.633 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -126.3 138.58 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.388 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 1.6 m -94.03 120.4 34.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.875 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -124.45 142.64 40.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.891 0.377 . . . . 0.0 111.224 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 p -80.3 147.34 31.19 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.96 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.2 mt -144.49 128.82 17.85 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.831 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -91.34 146.53 23.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.939 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -69.42 110.71 4.85 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.04 68.69 1.27 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.567 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.5 t30 57.98 40.13 25.85 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.145 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.3 177.7 14.99 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.79 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.9 mmm -129.94 103.32 6.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.626 0.25 . . . . 0.0 110.693 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.59 79.85 0.57 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.865 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mp -146.63 124.26 11.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.585 0.231 . . . . 0.0 110.853 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.1 m -89.5 138.56 31.35 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.031 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 1.2 pp -136.85 169.08 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.755 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -157.79 141.42 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.294 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.07 94.74 7.33 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.636 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.71 179.17 5.99 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.462 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -123.38 -179.82 4.46 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.289 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.29 -141.77 3.22 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.01 153.52 19.82 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.735 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.41 22.59 38.63 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.094 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.21 102.06 7.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.541 -0.329 . . . . 0.0 111.133 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.38 16.6 8.48 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 -168.95 2.94 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.109 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tp -119.68 133.58 55.57 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.56 0.219 . . . . 0.0 110.689 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.06 147.68 18.88 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.662 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.3 mm -80.89 92.03 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.876 0.369 . . . . 0.0 110.223 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 20.2 m-85 -75.18 155.24 37.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.488 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.5 t -102.36 109.07 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.585 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.12 -42.85 75.5 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.804 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.77 179.44 0.71 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.183 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.44 146.93 28.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.019 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.3 t -95.96 131.07 43.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.364 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.6 139.01 58.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.864 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.5 -17.24 59.64 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.082 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.31 -164.83 7.61 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.716 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.37 -43.44 12.12 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.64 -42.59 77.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.783 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -59.12 -45.86 89.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.404 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.1 t -73.39 -33.71 41.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.41 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -55.38 34.17 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.292 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.74 61.12 1.63 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.608 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -121.49 -44.49 2.35 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.527 0.203 . . . . 0.0 111.189 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.412 ' HB3' HG12 ' A' ' 88' ' ' VAL . 1.3 pp -130.32 174.2 10.07 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.865 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.95 -168.06 2.83 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.3 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.11 142.91 50.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.192 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.07 49.53 4.97 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.325 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.21 -179.85 5.08 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.458 0.17 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -130.84 134.0 46.43 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.723 0.297 . . . . 0.0 111.354 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.7 mt -110.85 131.27 55.19 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.486 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.21 -56.77 2.16 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.687 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -117.9 147.27 43.27 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.003 0.43 . . . . 0.0 111.987 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.7 t -126.94 103.92 11.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.318 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.478 ' HB2' HG23 ' A' ' 84' ' ' VAL . 4.4 t0 60.78 39.39 17.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.992 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.67 -23.29 29.05 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.299 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -74.31 132.45 42.08 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 117.227 0.513 . . . . 0.0 110.934 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.0 p -91.2 120.5 32.17 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.673 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 mp -110.09 43.41 1.37 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.851 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.99 86.55 2.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.66 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.0 27.47 3.99 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.584 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.0 mt -109.02 176.01 5.25 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.883 0.373 . . . . 0.0 110.934 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.5 m -107.36 168.44 9.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.024 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -57.52 -35.46 70.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.118 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -58.76 -54.61 45.16 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.907 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.2 mmt-85 -61.7 -46.11 91.07 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.985 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.07 -55.37 35.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.392 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.26 81.39 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.154 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -60.62 -33.06 72.21 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.315 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.2 mt -81.19 -40.73 23.44 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.019 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 11.7 mtp -66.84 -41.48 87.33 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.191 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.2 t -61.64 -33.29 73.68 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.173 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -101.72 65.1 1.0 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.803 0.335 . . . . 0.0 111.126 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.88 159.99 15.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.873 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 t -76.7 -172.23 2.17 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.835 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.9 p -53.0 -33.51 52.01 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.128 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.9 t -131.28 127.68 60.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.191 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 61' ' ' ASP . 9.3 p -113.1 129.37 68.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.538 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.45 85.73 3.7 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.874 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.13 119.03 26.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.335 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 27.2 tt0 -88.76 102.6 15.16 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.859 0.361 . . . . 0.0 110.227 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.412 HG12 ' HB3' ' A' ' 51' ' ' LEU . 12.5 p -96.19 147.99 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.963 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.52 129.88 56.46 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.544 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.83 83.57 0.11 Allowed 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.375 0.422 . . . . 0.0 110.852 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -108.02 -168.49 1.38 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.047 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.53 139.92 4.73 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.409 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.616 179.845 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.71 0.291 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.98 129.17 11.91 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.706 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 61.94 98.05 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.71 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.93 -178.19 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.093 2.529 . . . . 0.0 113.121 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.34 92.81 6.51 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.376 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.54 128.01 43.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.532 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -139.44 143.62 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.82 0.343 . . . . 0.0 111.583 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -98.28 111.75 23.98 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.84 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 m -107.42 144.03 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.441 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.3 m -99.4 143.41 29.68 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.998 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.429 HD23 ' CB ' ' A' ' 44' ' ' ALA . 0.4 OUTLIER -145.53 167.72 22.32 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.222 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.1 137.81 53.32 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.525 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -64.1 100.69 0.34 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.922 0.391 . . . . 0.0 111.049 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.21 73.59 2.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.433 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.58 36.78 28.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.097 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 130.24 -159.43 22.73 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.306 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.2 mmt -127.32 -59.11 1.25 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.654 0.264 . . . . 0.0 110.988 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.11 55.52 4.77 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.505 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mp -145.58 118.46 8.73 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.555 0.217 . . . . 0.0 110.774 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -80.76 100.77 8.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.862 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 pt -100.69 174.69 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.65 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 35' ' ' TYR . 2.8 p -157.77 135.91 2.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.257 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.05 89.75 3.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.499 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.52 178.52 6.41 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.738 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.35 168.11 11.8 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.869 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -151.43 -143.28 3.68 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.86 152.1 26.2 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.93 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.56 19.26 33.8 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.183 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.41 109.18 4.74 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.737 0.303 . . . . 0.0 110.957 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -92.75 25.02 3.29 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.713 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -124.01 -151.54 0.48 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.66 109.46 8.64 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.672 0.273 . . . . 0.0 110.443 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.53 164.42 15.52 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.748 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.1 mm -91.85 138.39 19.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.661 0.267 . . . . 0.0 110.667 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.473 ' HB2' HG11 ' A' ' 22' ' ' VAL . 97.8 m-85 -130.13 138.41 50.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.183 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.22 99.83 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.929 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -73.21 -38.84 65.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.472 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 t -161.02 160.03 30.09 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.203 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.7 119.24 54.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.698 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.97 135.75 27.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.419 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -72.44 145.29 47.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.899 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.74 -15.08 63.29 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.181 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.61 -167.16 8.34 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.538 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.429 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -87.19 -38.18 16.61 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.413 ' N ' HD22 ' A' ' 11' ' ' LEU . . . -72.36 -43.73 63.59 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.27 -34.87 78.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.682 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.7 t -81.7 -39.71 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 120.567 0.222 . . . . 0.0 111.119 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.2 -35.04 77.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.24 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.27 31.16 43.08 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.656 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -86.76 -41.29 14.23 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.609 0.242 . . . . 0.0 110.925 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 pp -141.77 169.36 17.74 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.945 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.13 -170.83 3.35 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.483 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.83 154.6 41.68 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.533 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.44 25.05 73.73 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.753 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.24 173.11 6.45 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.814 0.307 . . . . 0.0 111.35 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -109.25 162.37 14.36 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.988 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 mt -141.46 125.47 17.22 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.965 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.48 -63.54 1.43 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.556 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.2 p -113.91 146.98 39.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.948 0.404 . . . . 0.0 111.84 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.1 t -139.87 125.86 21.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.475 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 t70 58.24 37.53 26.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.575 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.84 28.66 72.9 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.057 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -123.6 153.27 40.92 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.939 0.369 . . . . 0.0 110.845 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.6 p -95.19 135.65 36.5 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.138 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 73' ' ' ALA . 10.0 mt -126.9 38.82 4.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.045 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.4 t -99.16 94.72 3.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.976 0.417 . . . . 0.0 110.405 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.86 33.81 2.33 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.462 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.8 mt -123.66 176.57 6.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.72 0.295 . . . . 0.0 110.685 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.7 m -98.86 165.31 11.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.153 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -58.53 -29.1 66.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.193 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -68.67 -34.77 76.26 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.611 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -67.45 -54.39 20.63 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.146 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.406 ' HA ' HD21 ' A' ' 65' ' ' LEU . . . -60.46 -41.23 93.72 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.649 0.262 . . . . 0.0 111.272 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.61 -40.1 92.25 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.99 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -77.72 -30.56 51.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.518 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.91 -41.41 78.25 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.313 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 54.8 mtt -60.45 -45.37 93.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.014 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.7 t -67.02 -29.74 69.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.677 0.275 . . . . 0.0 110.53 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -87.42 50.35 1.99 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.349 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.7 p -125.99 172.18 10.16 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.769 0.319 . . . . 0.0 110.917 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.6 p -86.88 -171.26 3.44 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.182 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 m -55.36 -36.7 66.61 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.018 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.3 t -108.01 139.91 28.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.165 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.0 t -139.27 137.9 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.13 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.72 109.71 19.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.79 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mp -105.32 122.56 46.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 29.4 tt0 -92.92 106.75 18.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.408 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.7 m -109.67 171.38 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.654 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.75 128.89 49.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.808 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.2 83.97 0.09 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.117 0.484 . . . . 0.0 110.943 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -118.34 162.95 17.45 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.754 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.42 136.06 2.08 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.56 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.443 179.741 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.773 0.32 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.85 142.67 49.43 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.782 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.92 105.08 16.93 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.954 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.47 -173.26 0.78 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.646 2.231 . . . . 0.0 112.578 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.59 105.95 10.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.996 0.427 . . . . 0.0 111.008 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.1 mm -80.42 128.44 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.959 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 pt -147.53 144.83 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.18 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 1.3 m -103.44 105.47 15.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.414 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.1 m -93.66 145.03 8.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.993 0.425 . . . . 0.0 111.596 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.4 m -95.71 101.96 13.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.524 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.24 141.79 34.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -109.65 115.43 29.86 Favored 'General case' 0 CA--C 1.526 0.054 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.767 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.63 122.8 12.9 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.252 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -115.06 73.16 0.82 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.351 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 60.34 38.2 19.75 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.017 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.81 153.81 6.4 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.591 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.4 mtp -100.72 -65.21 0.98 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.615 0.245 . . . . 0.0 110.778 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.96 65.28 2.23 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.125 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mp -142.2 111.8 6.68 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.777 0.322 . . . . 0.0 110.815 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 m -80.21 112.97 18.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.699 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 pt -114.68 173.71 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.594 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.43 ' CG1' ' HB2' ' A' ' 35' ' ' TYR . 4.3 p -148.17 137.65 16.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.232 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.404 ' HB1' ' N ' ' A' ' 70' ' ' GLN . . . -97.98 108.6 21.34 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.51 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -153.07 176.42 11.92 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.331 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.91 172.66 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.01 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.57 -143.31 3.63 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.33 157.74 16.94 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.79 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.45 25.1 40.64 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.79 104.84 8.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.92 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -86.55 10.46 15.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.466 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -144.53 -162.65 1.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.02 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.3 134.55 46.5 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.672 0.272 . . . . 0.0 110.308 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.61 152.23 17.75 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.663 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.8 mm -93.52 132.27 38.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 120.679 0.276 . . . . 0.0 110.498 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.43 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 69.5 m-85 -121.94 163.47 19.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.224 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.83 135.46 55.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.099 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.29 -33.78 5.52 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.581 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.5 165.5 35.47 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.746 0.307 . . . . 0.0 111.325 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.7 t -140.31 126.14 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.576 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.1 t -62.34 131.58 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.427 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -80.51 98.18 7.47 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.607 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.83 -39.37 0.64 Allowed Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.697 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.83 160.15 52.26 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.538 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.15 -38.82 54.28 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.69 -43.39 76.38 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.708 0.289 . . . . 0.0 111.166 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -76.53 -35.65 58.16 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.111 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.2 t -68.64 -42.57 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.057 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.13 -44.5 87.84 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.247 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.47 27.56 65.32 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.667 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -82.72 -33.84 27.44 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.744 0.272 . . . . 0.0 110.884 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 pp -130.39 -178.98 5.0 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.78 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.91 -162.48 1.53 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.255 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.3 151.0 20.06 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.009 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.47 50.56 9.55 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.425 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -132.54 179.19 6.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.741 0.305 . . . . 0.0 111.105 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.405 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 7.2 tm0? -116.34 161.1 19.55 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.681 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 pp -164.93 155.61 14.26 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.927 0.394 . . . . 0.0 111.776 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.18 -54.76 0.31 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.513 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -76.4 132.91 39.98 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.843 0.354 . . . . 0.0 111.558 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.2 t -145.34 117.17 2.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.515 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.421 ' HB2' HG13 ' A' ' 84' ' ' VAL . 5.0 t0 58.53 40.3 23.94 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.039 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.26 23.14 78.42 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.984 -0.626 . . . . 0.0 112.984 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.0 mtt-85 -128.68 128.14 43.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.711 0.256 . . . . 0.0 110.324 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m -83.98 116.8 23.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.3 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.7 mt -98.77 76.98 2.21 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.594 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.54 96.64 4.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.6 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.25 37.77 0.91 Allowed Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.532 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 mp -135.03 179.31 6.4 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.785 0.326 . . . . 0.0 110.928 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.4 m -107.81 176.74 5.04 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.95 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.404 ' N ' ' HB1' ' A' ' 23' ' ' ALA . 34.6 tt0 -58.21 -39.88 80.16 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.679 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -51.12 70.7 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.907 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 47.1 mmt-85 -59.2 -50.87 72.36 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.17 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.94 -52.6 64.71 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.329 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.11 -45.64 92.3 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.051 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.47 -36.28 77.91 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.901 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.11 -39.45 49.42 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.728 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.2 mtt -65.78 -32.82 74.56 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.04 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.2 t -78.9 -32.43 45.75 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.559 0.219 . . . . 0.0 110.905 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 43.6 mtp85 -89.63 50.54 1.92 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.703 0.287 . . . . 0.0 111.563 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.5 p -120.68 -179.86 4.12 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.936 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -89.0 -173.02 3.91 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.08 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.6 p -56.6 -49.77 73.93 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.505 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.89 133.32 36.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.737 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 61' ' ' ASP . 21.3 t -139.46 125.68 23.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.22 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.84 111.92 23.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.708 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 59' ' ' SER . 2.7 mp -109.98 123.01 48.88 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.985 0.422 . . . . 0.0 111.421 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 19.2 tt0 -91.42 98.45 11.69 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.16 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.4 m -102.26 171.49 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.928 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -125.67 131.55 52.59 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.586 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -66.28 91.56 0.17 Allowed 'General case' 0 C--O 1.234 0.256 0 O-C-N 123.345 0.403 . . . . 0.0 110.602 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -113.07 -165.87 1.03 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.138 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.97 137.51 2.21 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.485 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.585 -0.722 . . . . 0.0 111.9 -179.917 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mmt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -99.92 165.16 11.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.719 0.295 . . . . 0.0 111.252 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -128.8 148.04 67.02 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.977 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.63 165.45 30.76 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.813 2.342 . . . . 0.0 112.595 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -75.67 82.88 2.66 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.165 0.507 . . . . 0.0 110.959 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.2 mm -92.81 94.64 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.888 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.89 137.06 34.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.265 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 m -89.01 130.68 35.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.002 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.41 111.31 35.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.114 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.41 101.55 13.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.39 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.6 mt -122.5 161.98 22.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.939 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 150.95 24.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.774 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.25 114.42 26.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.007 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.95 -38.1 6.74 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.192 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -160.32 42.54 0.19 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.047 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.29 -170.71 30.28 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.3 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.2 mmm -107.09 -48.03 3.56 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.508 0.194 . . . . 0.0 111.131 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.13 78.49 0.18 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.734 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.23 144.56 17.35 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.815 0.34 . . . . 0.0 111.179 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -94.41 90.87 6.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.628 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 pt -96.38 163.42 2.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.614 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.7 p -141.04 138.54 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.147 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.34 89.99 3.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.675 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.82 176.06 7.56 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.515 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -96.88 168.76 10.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.28 -143.14 3.59 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.06 153.92 22.42 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.023 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.29 18.84 30.26 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.243 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.58 108.42 4.71 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -95.22 37.26 1.18 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.568 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 38.7 mmtm -140.21 -148.5 0.25 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.648 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.77 103.19 5.98 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 110.517 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.9 145.94 21.89 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.888 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.6 mm -87.47 99.32 8.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.805 0.336 . . . . 0.0 110.701 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -90.59 147.53 23.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.531 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.53 120.83 51.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.845 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -96.27 -35.36 11.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.972 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 t -162.51 158.96 24.3 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.054 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.1 t -123.71 128.38 74.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.621 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.4 t -68.37 120.89 16.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.056 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -59.58 109.01 0.81 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.742 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.39 -21.27 5.16 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.626 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.52 158.17 51.37 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.147 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.66 -41.1 21.59 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.13 -52.9 52.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.367 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -39.29 85.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.5 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.9 t -71.82 -40.86 69.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.537 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.82 -54.72 30.62 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.588 0.232 . . . . 0.0 111.304 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.18 79.43 1.39 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.764 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.0 mmt-85 -144.1 -51.39 0.31 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.719 0.295 . . . . 0.0 110.943 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 pp -113.39 167.79 10.28 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.912 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.08 -166.8 2.17 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.241 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.02 150.04 26.59 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.271 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.22 40.99 8.77 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.721 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -131.62 177.04 7.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.791 0.329 . . . . 0.0 111.246 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -122.13 150.32 42.36 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.002 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.6 mt -128.44 123.9 34.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.476 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.18 -63.63 1.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.424 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.7 m -111.37 151.77 28.07 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.929 0.395 . . . . 0.0 111.703 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.493 HG12 ' HG2' ' A' ' 77' ' ' MET . 42.9 t -141.45 132.33 26.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.654 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 t70 56.9 27.72 13.49 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.451 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.32 -7.78 81.28 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.862 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -111.23 135.35 51.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 117.427 0.613 . . . . 0.0 110.926 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.5 m -71.63 130.44 41.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.327 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.7 mt -112.78 33.61 4.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.893 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.56 90.26 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.236 0.541 . . . . 0.0 110.382 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 31' ' ' LYS . . . 151.14 -30.26 0.98 Allowed Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.425 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.04 -169.64 2.62 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.684 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -98.51 169.66 9.37 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.665 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -55.6 -31.41 62.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.864 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.89 -48.08 60.09 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.242 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -38.69 71.58 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.533 0.206 . . . . 0.0 111.018 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.26 -53.37 12.69 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.176 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.76 -37.93 74.51 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.408 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.67 -33.59 64.52 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.599 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.0 mt -79.71 -39.11 31.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.475 0.178 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.493 ' HG2' HG12 ' A' ' 60' ' ' VAL . 12.2 mtp -66.45 -34.43 77.92 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.051 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.6 t -71.67 -38.14 70.69 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.87 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -91.21 58.02 3.57 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.925 0.393 . . . . 0.0 110.75 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 p -109.85 160.84 16.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.006 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.7 m -75.25 -179.23 4.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.943 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.4 m -53.5 -38.83 64.06 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.304 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.7 t -106.1 136.22 41.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.728 0.299 . . . . 0.0 110.707 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 t -124.71 142.66 40.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.474 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.39 100.19 6.56 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.728 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.26 139.24 50.13 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.073 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -107.3 101.23 10.62 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.035 0.445 . . . . 0.0 110.292 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.3 p -89.0 137.61 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.751 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.85 119.31 34.12 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.264 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -99.79 115.64 30.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.646 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -140.92 -169.13 2.75 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.681 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.08 -138.83 1.61 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.548 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.439 -0.791 . . . . 0.0 111.167 -179.947 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.2 mtt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.529 0.204 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? 59.01 39.15 23.82 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.894 0.378 . . . . 0.0 110.951 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.5 145.92 98.3 Favored Pre-proline 0 CA--C 1.529 0.171 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.039 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.22 175.28 10.16 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.749 2.299 . . . . 0.0 112.871 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 1.5 tt0 -102.81 92.54 4.64 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.057 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.6 mm -90.83 108.19 19.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.839 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -135.69 138.63 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.418 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.423 ' HB ' ' HG3' ' A' ' 87' ' ' GLU . 6.1 t -104.38 143.17 33.36 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.238 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 p -128.93 137.33 57.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.304 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.21 96.64 7.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.899 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 44' ' ' ALA . 8.7 tp -85.48 132.45 34.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.21 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -108.46 115.78 30.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.376 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -67.36 120.7 14.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.374 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.08 -41.79 7.0 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.711 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -164.91 38.57 0.07 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.877 0.37 . . . . 0.0 111.187 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.73 -168.64 23.5 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.567 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.5 mtp -129.6 -66.47 0.8 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.543 0.211 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.446 ' HA3' ' HB ' ' A' ' 40' ' ' VAL . . . 65.81 74.17 0.54 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.174 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.1 mt -142.2 108.32 5.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.744 0.306 . . . . 0.0 111.046 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.7 91.05 5.83 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.554 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 pp -97.12 177.59 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.608 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.2 p -156.67 135.91 3.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.262 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.7 87.48 3.16 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.541 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.75 176.79 6.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.619 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 176.26 5.59 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.117 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.82 -143.45 3.68 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.95 150.31 27.91 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.899 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.76 18.03 37.3 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.342 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.77 108.83 5.2 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.642 0.258 . . . . 0.0 111.008 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.97 25.56 3.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.802 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.99 -154.38 0.58 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 tp -136.49 106.73 6.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.614 0.245 . . . . 0.0 110.576 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.84 152.26 20.93 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.93 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.428 ' CG1' HD11 ' A' ' 65' ' ' LEU . 40.5 mm -91.25 96.84 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.874 0.368 . . . . 0.0 110.673 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -89.04 150.83 22.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.612 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.7 t -106.85 131.04 57.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.704 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 pttp -116.89 -30.18 5.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.901 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.69 155.13 42.79 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.956 0.408 . . . . 0.0 111.777 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.8 t -138.18 120.86 19.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.171 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.446 ' HB ' ' HA3' ' A' ' 18' ' ' GLY . 32.3 t -64.43 127.89 25.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.811 0.338 . . . . 0.0 111.477 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 103.7 1.64 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.337 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.5 -10.66 4.34 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.419 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.55 -158.14 4.95 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.413 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.449 ' HB2' HD23 ' A' ' 11' ' ' LEU . . . -91.17 -38.79 12.5 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.7 70.86 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -66.96 -35.31 79.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.482 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.1 t -80.75 -42.21 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.607 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -53.79 54.29 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.63 0.252 . . . . 0.0 111.427 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.38 51.81 2.65 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.579 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.57 -51.03 2.18 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.621 0.248 . . . . 0.0 110.626 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 pp -109.13 139.03 44.57 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.536 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.0 177.35 5.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.26 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.53 150.8 46.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.796 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.53 40.62 18.2 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.102 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -126.16 177.71 6.23 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.739 0.304 . . . . 0.0 111.306 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -124.47 149.02 47.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 29.3 mt -123.76 121.69 36.13 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.706 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.66 -53.21 3.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.785 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.87 157.17 40.04 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.171 0.51 . . . . 0.0 112.338 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.444 HG23 ' CD1' ' A' ' 65' ' ' LEU . 21.8 t -141.17 109.67 2.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.757 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.27 35.89 26.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.13 17.73 60.51 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.457 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.44 123.04 39.28 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.222 0.511 . . . . 0.0 110.408 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 m -82.63 135.4 35.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.205 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.444 ' CD1' HG23 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -110.31 -3.1 16.38 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.591 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.58 87.07 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.418 0.627 . . . . 0.0 110.911 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.79 -18.61 2.77 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 113.008 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.65 -170.99 2.75 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.917 0.359 . . . . 0.0 111.105 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.18 176.99 4.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.368 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -59.38 -31.02 68.84 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.267 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -68.02 -38.77 82.97 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.515 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -67.06 -40.11 87.02 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.457 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.62 -52.93 21.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.518 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.12 -37.84 84.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.913 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -71.24 -32.01 68.25 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.262 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.9 mt -78.01 -35.23 50.16 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.435 0.159 . . . . 0.0 111.358 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 12.4 mtt -70.67 -31.72 68.73 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.342 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.1 t -74.43 -30.6 61.97 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.46 0.17 . . . . 0.0 111.46 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -89.17 49.18 1.73 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.745 0.307 . . . . 0.0 111.415 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.406 ' HB ' HG23 ' A' ' 84' ' ' VAL . 67.7 p -121.53 171.37 8.85 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.724 0.297 . . . . 0.0 111.351 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.4 p -90.01 -165.7 1.41 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.467 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 80.0 p -59.61 -34.37 72.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.156 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.2 t -111.9 139.34 36.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.741 0.305 . . . . 0.0 110.982 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.406 HG23 ' HB ' ' A' ' 80' ' ' THR . 15.5 t -142.73 130.38 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.286 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.21 116.3 28.83 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 8' ' ' THR . 4.0 mm? -111.37 114.03 26.9 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.113 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG3' ' HB ' ' A' ' 8' ' ' THR . 2.1 tt0 -81.22 101.36 9.66 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.5 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.0 p -94.06 147.63 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.811 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -119.04 126.08 50.86 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.122 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -96.05 131.27 42.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.1 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -161.3 -169.9 2.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.976 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 170.42 136.85 2.16 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.519 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.137 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.685 0.279 . . . . 0.0 111.503 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.29 33.93 23.15 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.795 0.331 . . . . 0.0 111.034 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -128.28 152.46 78.0 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.945 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.43 173.45 6.43 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.985 2.457 . . . . 0.0 112.866 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -89.41 89.59 7.94 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.223 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.8 mm -85.23 111.03 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.839 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.52 141.56 46.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.14 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 8.0 t -106.63 141.6 37.64 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.834 0.349 . . . . 0.0 111.299 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.9 p -119.5 128.45 75.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.349 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.0 m -82.95 94.5 7.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 mt -93.44 155.39 17.38 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.135 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -117.1 110.51 18.29 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.075 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -57.08 116.78 3.44 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.266 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -86.34 -47.73 9.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.556 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -166.21 42.54 0.06 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.46 -167.69 19.75 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.527 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.1 mmm -133.52 100.83 4.92 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.643 0.258 . . . . 0.0 110.791 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.22 79.98 0.6 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.547 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 mp -145.96 127.25 14.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.62 0.248 . . . . 0.0 110.749 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.32 99.27 11.04 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.882 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pt -96.61 175.4 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.472 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 35' ' ' TYR . 3.4 p -159.81 148.3 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.598 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.78 124.76 46.88 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.464 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.36 -179.14 7.45 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.79 164.82 13.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.792 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.33 -144.17 3.85 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.59 164.03 13.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.811 0.339 . . . . 0.0 111.148 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.44 19.98 49.51 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.455 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.65 -165.8 1.34 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.137 0.494 . . . . 0.0 110.187 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.459 ' C ' ' HG2' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -169.84 20.39 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.36 178.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.459 ' HG2' ' C ' ' A' ' 30' ' ' ASP . 6.0 mmmt -156.08 -164.17 1.64 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.01 106.32 14.27 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.838 0.352 . . . . 0.0 110.523 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.79 -173.05 27.94 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.212 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.2 mm -99.33 152.91 4.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.603 0.239 . . . . 0.0 110.725 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.432 ' HB2' HG12 ' A' ' 22' ' ' VAL . 18.9 m-85 -135.37 164.22 28.24 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.351 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.62 115.78 44.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -101.58 -33.11 10.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.946 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.2 161.13 21.96 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.926 0.393 . . . . 0.0 111.386 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.4 t -135.7 115.72 17.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.683 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.46 136.48 26.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.416 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 145.09 53.39 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.022 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.08 -22.67 39.45 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.959 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.04 174.62 36.71 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.775 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.94 -37.57 75.91 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.6 -37.76 68.02 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -67.75 -49.05 64.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.502 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.86 -31.15 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.632 0.253 . . . . 0.0 111.314 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.78 -55.97 16.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.404 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.2 31.69 16.25 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.889 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -111.27 27.38 9.73 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.753 0.311 . . . . 0.0 110.933 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 pp -172.82 171.91 4.23 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.966 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.64 171.52 16.77 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.468 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.32 136.85 57.54 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.024 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.06 49.27 3.13 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.091 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -130.83 179.18 6.12 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.744 0.307 . . . . 0.0 111.243 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.445 ' HB3' ' HB2' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -118.45 173.14 7.0 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.918 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.0 mt -151.67 119.23 6.06 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.668 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.443 ' CD1' HG11 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -90.35 -64.02 1.19 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.196 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.8 m -126.08 151.5 47.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.569 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 52.6 t -135.78 118.16 21.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.773 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 t0 58.33 40.31 24.59 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.965 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.24 29.13 68.9 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.834 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.9 mtt-85 -123.84 144.25 49.85 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 m -91.16 120.78 32.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.788 0.328 . . . . 0.0 111.39 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mp -111.54 -5.74 14.5 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.821 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.443 HG11 ' CD1' ' A' ' 58' ' ' LEU . 12.0 p -81.99 71.38 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.857 0.837 . . . . 0.0 110.181 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 155.07 40.23 0.02 OUTLIER Glycine 0 CA--C 1.523 0.571 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.275 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.54 177.79 10.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.741 0.305 . . . . 0.0 111.048 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.55 179.29 5.19 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.268 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -61.6 -35.54 78.15 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.322 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -54.6 -52.5 61.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.72 0.295 . . . . 0.0 110.798 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -62.65 -41.78 99.24 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.812 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.25 -56.21 23.79 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.499 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.38 93.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.022 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -66.68 -28.4 68.42 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.24 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.3 mt -75.49 -34.39 60.86 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.676 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 mtt -77.99 -39.2 43.12 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.321 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.7 t -63.34 -32.8 74.31 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.778 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -90.9 57.65 3.58 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.192 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 51.7 p -122.79 178.47 5.02 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.096 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 m -108.43 -167.2 1.2 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.783 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.7 p -57.26 -30.32 64.55 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.478 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.44 137.7 50.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 120.652 0.263 . . . . 0.0 111.209 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.0 t -143.79 134.65 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.414 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.46 120.37 42.21 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.692 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mp -114.67 117.13 29.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.283 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 1.6 mt-10 -81.28 93.04 6.45 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.646 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 10.9 p -87.61 141.22 14.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.541 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . . . -106.94 139.74 40.85 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.146 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.81 109.26 20.78 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.731 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -146.61 -173.89 4.33 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.894 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 157.92 139.26 2.67 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.488 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.156 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.368 0.128 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.75 111.28 19.46 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.699 0.285 . . . . 0.0 110.966 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -114.05 94.37 34.07 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.948 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.62 162.44 10.49 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.023 2.482 . . . . 0.0 112.982 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -99.51 93.88 6.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.92 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 4.0 mt -90.21 127.31 42.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.052 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 pt -141.67 146.79 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.264 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.493 ' HB ' ' HG2' ' A' ' 87' ' ' GLU . 2.7 t -101.49 147.16 26.7 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.156 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' A' ' 50' ' ' ARG . 26.9 m -124.99 128.86 73.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.462 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.0 m -87.78 102.5 14.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.487 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mp -125.04 167.38 14.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.366 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -126.0 170.82 11.34 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.044 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -69.09 94.01 0.63 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.888 0.375 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.98 81.95 2.18 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.512 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 57.54 36.18 26.6 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.088 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.08 173.4 30.19 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.629 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.6 mmt -87.27 -73.02 0.49 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.559 0.219 . . . . 0.0 110.749 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.83 66.74 1.82 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.651 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.9 mp -145.74 117.89 8.35 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.646 0.26 . . . . 0.0 110.658 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.5 m -80.62 96.33 6.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.741 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 pt -105.11 175.99 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.59 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -156.32 141.24 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.241 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.28 92.82 6.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.639 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.44 178.39 5.42 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.281 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.79 179.97 3.82 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.288 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.81 -143.7 3.74 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.676 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.49 161.82 18.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.702 0.286 . . . . 0.0 111.075 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.81 19.92 45.62 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.853 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.68 -163.01 0.9 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.231 0.539 . . . . 0.0 110.173 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -170.29 20.64 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.227 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -159.92 -168.81 2.33 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.48 0.312 . . . . 0.0 110.268 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 tp -105.44 127.44 53.0 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.798 0.332 . . . . 0.0 110.994 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.88 147.55 16.27 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.518 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 73' ' ' ALA . 1.6 mp -81.41 97.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.976 0.417 . . . . 0.0 109.981 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -87.86 143.96 26.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.28 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.9 t -103.52 122.8 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.847 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -92.09 -40.61 10.96 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.885 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 m -165.02 175.82 9.13 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.727 0.298 . . . . 0.0 111.168 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.39 145.37 34.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.154 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.9 t -84.49 146.55 6.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.529 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.39 140.97 52.21 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.062 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.19 18.12 80.12 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.506 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.38 176.22 32.53 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.234 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.42 -62.18 2.06 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.64 -33.24 68.08 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.694 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -67.89 -56.81 7.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.109 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.6 t -66.07 -35.25 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.75 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.13 -48.84 49.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.616 0.246 . . . . 0.0 110.896 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.46 87.59 0.72 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.627 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.424 ' HB3' HG12 ' A' ' 9' ' ' VAL . 8.3 mmt180 -146.27 -67.13 0.28 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.59 0.233 . . . . 0.0 110.857 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.37 152.2 21.86 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.067 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.81 -162.2 1.18 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.181 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.36 144.08 53.54 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.516 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.71 50.58 6.42 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.248 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.62 131.95 45.21 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.449 0.166 . . . . 0.0 110.966 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -92.73 145.85 24.1 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.745 0.307 . . . . 0.0 111.182 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.78 121.8 42.61 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.723 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -96.9 -47.16 5.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.209 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.5 m -138.94 152.83 48.04 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.099 0.476 . . . . 0.0 111.542 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.0 t -136.03 114.23 15.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.157 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 62.07 35.93 15.62 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.443 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.38 -18.72 35.75 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.583 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -75.72 147.77 39.1 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 117.436 0.618 . . . . 0.0 111.038 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 p -95.83 116.26 28.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.818 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 mp -101.47 37.59 1.77 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.964 0.412 . . . . 0.0 110.7 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.46 100.72 11.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.16 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.16 4.48 18.33 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.18 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 pp -113.29 163.32 14.97 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 117.184 0.492 . . . . 0.0 110.867 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 p -85.04 168.5 14.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.871 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -57.08 -28.43 62.6 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.494 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.59 -49.58 76.95 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.75 0.31 . . . . 0.0 110.269 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -38.75 81.34 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.042 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.402 ' HB3' HG12 ' A' ' 34' ' ' ILE . . . -61.38 -55.77 27.78 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.434 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.15 94.43 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.136 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -62.75 -37.08 85.19 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.83 -35.0 72.26 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.013 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 4.8 mtt -68.91 -40.99 78.79 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.096 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.5 t -67.53 -36.69 81.49 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.596 0.236 . . . . 0.0 110.614 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -88.59 56.24 3.7 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.888 0.375 . . . . 0.0 111.115 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.5 p -112.52 -175.14 2.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.635 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.9 m -102.0 -169.76 1.72 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -34.0 67.08 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.594 0.235 . . . . 0.0 110.968 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.56 143.94 29.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.0 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 t -142.76 137.75 27.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.448 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.22 102.5 11.17 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.011 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 8' ' ' THR . 7.0 mp -94.56 117.22 29.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.074 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.493 ' HG2' ' HB ' ' A' ' 8' ' ' THR . 3.8 mm-40 -80.42 95.98 6.58 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.632 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 35.8 m -86.98 170.39 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.35 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.38 125.95 22.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.094 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -85.18 116.26 23.43 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.674 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -152.58 -167.93 2.9 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.077 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.13 137.03 2.15 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.507 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.953 179.914 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mtm . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -127.06 33.45 4.91 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.653 0.263 . . . . 0.0 110.864 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -115.77 97.24 48.59 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.777 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.0 170.61 2.04 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.172 2.581 . . . . 0.0 113.305 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 89' ' ' ALA . 28.0 tt0 -103.52 96.99 7.1 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.104 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.2 mm -79.33 121.87 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.339 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 pt -145.35 146.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.373 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.1 t -121.18 124.77 45.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 110.961 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.413 HG13 ' HD2' ' A' ' 50' ' ' ARG . 16.6 t -120.89 145.94 26.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.197 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.91 112.24 24.01 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.677 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.1 152.69 29.27 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.254 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -110.1 158.81 17.91 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.496 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -99.97 133.7 43.96 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.206 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.2 -42.3 3.06 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.135 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -154.13 42.66 0.53 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.838 0.351 . . . . 0.0 110.983 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.44 -156.36 15.8 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.453 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.96 -58.66 2.04 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.492 0.187 . . . . 0.0 110.91 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.78 53.16 39.82 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.746 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.5 mt -142.88 116.71 9.31 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.66 0.266 . . . . 0.0 111.218 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.04 126.58 40.48 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.646 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 pt -115.54 176.01 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.624 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 35' ' ' TYR . 2.4 p -153.28 137.24 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.451 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.08 101.29 12.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.483 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -134.1 -179.66 5.69 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.411 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -114.04 169.11 9.25 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.19 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.06 -143.35 3.65 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.23 157.42 16.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.85 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.72 23.91 46.21 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.52 104.42 7.88 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.108 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.67 11.16 13.58 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.583 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -146.06 -167.3 2.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.835 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 tp -103.39 119.2 38.43 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.686 0.279 . . . . 0.0 110.593 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.63 177.73 25.87 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.739 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.6 mm -103.77 150.93 6.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 120.733 0.302 . . . . 0.0 110.825 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.44 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 92.7 m-85 -137.92 150.26 46.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.03 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.7 t -80.72 95.39 2.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.628 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -42.19 98.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.965 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.1 t -175.33 166.52 3.36 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.417 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.2 t -126.77 137.9 56.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.837 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -82.48 119.92 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.374 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -63.56 110.04 1.86 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.838 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.1 -3.2 14.31 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.518 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.12 -139.2 1.69 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.433 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.08 -62.2 1.27 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.487 0.184 . . . . 0.0 111.436 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.0 -33.79 76.17 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.411 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.67 -39.91 90.16 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.223 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -67.25 -39.98 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.636 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -59.32 -55.33 36.14 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.6 0.238 . . . . 0.0 111.29 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.62 19.53 37.46 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.312 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.413 ' HD2' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -83.06 -33.65 26.37 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.147 0.474 . . . . 0.0 110.862 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -123.99 163.68 20.88 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.17 175.64 9.92 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.276 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.23 145.13 56.63 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.196 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.68 47.04 8.17 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.97 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.26 -176.99 3.41 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.612 0.244 . . . . 0.0 110.844 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -118.83 153.77 33.97 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.151 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.1 tt -137.77 135.75 36.63 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.809 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.07 -59.03 2.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.793 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.2 p -116.65 158.02 24.45 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.137 0.494 . . . . 0.0 112.097 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 t -140.11 119.36 12.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.53 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t0 60.31 35.13 20.76 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.023 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.43 -5.91 71.09 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.581 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.3 mtt-85 -91.95 148.83 21.91 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 117.484 0.642 . . . . 0.0 111.187 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.5 m -89.12 139.81 30.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.237 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.39 79.4 1.76 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.962 0.41 . . . . 0.0 111.377 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.6 t -130.45 95.37 2.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.363 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.97 -26.48 4.23 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.891 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 mt -73.13 176.11 6.14 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.836 0.351 . . . . 0.0 111.449 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 m -109.45 -178.25 3.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.039 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -59.04 -35.09 72.71 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.347 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -58.2 -59.04 5.92 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.624 0.249 . . . . 0.0 110.966 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.6 mmt-85 -61.88 -44.72 96.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.93 -54.92 41.63 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.104 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.48 -48.31 82.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.092 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.76 -38.64 78.89 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.982 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.6 mt -76.07 -35.88 59.23 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.097 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -76.43 -35.19 58.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.3 t -71.13 -39.06 72.22 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.538 0.208 . . . . 0.0 110.956 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -93.77 59.96 2.89 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.882 0.373 . . . . 0.0 111.016 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.7 p -117.06 169.41 9.44 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.995 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.99 -169.17 0.45 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.754 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.3 p -79.83 -52.49 7.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.808 0.337 . . . . 0.0 110.377 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.34 74.49 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.581 0.705 . . . . 0.0 110.795 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.452 HG12 HD21 ' A' ' 86' ' ' LEU . 13.1 t -89.18 148.4 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.972 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.1 p -110.61 117.04 32.42 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.661 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.452 HD21 HG12 ' A' ' 84' ' ' VAL . 4.2 mm? -111.73 122.22 47.22 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.296 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -87.65 83.17 7.23 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.035 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t -89.3 145.9 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.536 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 5' ' ' GLU . . . -110.2 117.12 32.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.166 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -83.7 122.65 28.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.54 -159.41 0.92 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.73 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.83 -137.44 1.05 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.119 -0.563 . . . . 0.0 112.491 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.119 179.915 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmm . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.644 0.259 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.18 167.1 16.91 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.972 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -99.9 139.85 21.1 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.346 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -76.77 172.64 15.83 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.847 2.364 . . . . 0.0 112.804 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 57.7 tt0 -111.66 96.54 6.15 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.2 mm -82.04 126.41 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.196 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 pt -148.49 149.57 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.363 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 14.5 m -113.61 123.95 51.17 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.629 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.13 138.28 52.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.375 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.69 135.5 51.21 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.657 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -147.97 176.03 10.5 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.031 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -119.61 144.57 47.05 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.147 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -79.74 146.47 32.35 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.354 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -50.32 4.26 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.365 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -161.39 43.19 0.16 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.999 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.79 -160.54 19.41 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.53 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 90.4 mtp -142.61 101.75 3.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.92 80.63 0.63 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.369 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 mp -147.17 117.16 7.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.647 0.261 . . . . 0.0 110.494 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 p -82.0 131.55 35.25 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.949 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 pp -124.37 174.12 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.089 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.6 p -157.67 140.84 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.138 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.27 104.01 16.0 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.996 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.28 176.4 8.75 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.819 0.342 . . . . 0.0 111.691 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -101.93 175.1 5.66 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.311 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.33 -142.66 3.47 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.56 151.17 27.14 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.034 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.85 19.35 36.28 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.401 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.83 108.85 5.72 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.769 0.318 . . . . 0.0 111.185 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -95.15 30.8 2.06 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.322 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.96 -148.2 0.35 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tp -143.14 113.79 7.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.73 0.3 . . . . 0.0 110.753 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.75 152.97 19.16 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.564 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.471 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 31.4 mm -80.63 100.19 4.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.854 0.359 . . . . 0.0 110.444 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -84.53 156.38 21.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.039 0.447 . . . . 0.0 111.258 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -105.68 112.94 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.763 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.36 -36.78 22.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.129 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -164.85 165.39 20.53 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.831 0.348 . . . . 0.0 111.224 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.9 t -130.39 112.78 23.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.859 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -60.95 130.49 25.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.092 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.7 149.52 46.48 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.07 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.24 -31.09 8.89 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.545 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.31 142.87 46.49 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.521 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.3 -38.57 53.6 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.82 -53.72 44.46 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.683 0.277 . . . . 0.0 111.4 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.84 -44.59 85.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.048 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.5 t -61.82 -37.3 77.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.469 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.14 -53.32 59.09 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.083 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.88 44.49 1.51 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.159 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -142.79 31.89 1.43 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.736 0.268 . . . . 0.0 110.983 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.5 mt -149.87 168.62 23.23 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.447 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -171.12 151.97 3.34 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.125 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.23 152.18 45.41 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.886 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.11 52.68 26.38 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.782 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.11 171.36 11.97 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.72 0.295 . . . . 0.0 111.187 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 89' ' ' ALA . 1.9 tm0? -110.18 154.54 23.21 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.825 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.471 ' HB3' ' HB ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -137.57 119.8 15.68 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.573 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tt -107.79 -55.99 2.29 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.024 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.8 t -103.42 145.69 29.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.05 0.452 . . . . 0.0 112.176 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.97 119.81 10.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.763 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 56.65 44.41 23.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.133 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.82 27.39 73.31 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.083 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -130.74 138.07 49.8 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.677 0.275 . . . . 0.0 110.33 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.7 m -92.85 124.61 36.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.53 83.18 2.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.266 0.555 . . . . 0.0 111.084 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.2 t -110.12 94.94 3.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.803 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.78 36.85 1.02 Allowed Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.488 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.6 mt -116.05 157.55 24.51 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.727 0.299 . . . . 0.0 110.792 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -77.11 160.58 28.92 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -54.36 -35.24 62.56 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.954 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.37 -43.44 81.39 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.459 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -61.12 -53.34 58.23 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.492 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB3' HG13 ' A' ' 34' ' ' ILE . . . -62.57 -43.45 98.79 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.316 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.75 80.77 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.603 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -65.6 -35.7 81.59 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.248 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.2 mt -74.84 -35.87 62.38 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.095 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.467 ' O ' HG23 ' A' ' 80' ' ' THR . 5.9 mtt -69.15 -29.1 67.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.365 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.7 t -79.7 -30.62 41.07 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 121.297 -0.161 . . . . 0.0 111.24 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -93.44 40.33 1.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.714 0.292 . . . . 0.0 111.216 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 77' ' ' MET . 68.8 p -93.11 170.08 9.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 111.515 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.6 m -103.57 -165.02 1.12 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.46 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.78 -35.89 71.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.135 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.6 t -93.17 149.66 4.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.799 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 t -134.43 91.69 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.109 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.8 m -89.25 88.68 7.61 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.767 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.0 mt -106.36 139.89 40.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.511 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 12.1 tt0 -113.97 105.74 13.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.087 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.8 m -102.53 172.61 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.045 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.418 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . . . -136.17 131.56 34.8 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.526 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 48.8 mmtt -76.3 118.87 19.45 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.802 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -148.01 -159.28 1.01 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.77 -135.66 0.53 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.408 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.364 -0.827 . . . . 0.0 111.203 179.951 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptt? . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.677 0.275 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -115.26 165.69 12.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.757 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 67.29 114.19 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.052 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.506 ' O ' HD13 ' A' ' 6' ' ' ILE . 53.2 Cg_exo -55.7 176.35 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.882 2.388 . . . . 0.0 112.84 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -90.54 86.09 6.31 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.068 0.461 . . . . 0.0 111.242 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.506 HD13 ' O ' ' A' ' 4' ' ' PRO . 3.4 mp -99.66 121.87 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.759 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 pp -141.97 137.06 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.315 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 3.7 t -99.04 138.89 35.49 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.069 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.55 136.06 46.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.421 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.15 95.9 6.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.869 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.97 134.31 34.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -90.98 176.7 6.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.059 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.28 130.75 54.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.148 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.02 -45.26 4.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.587 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -161.73 43.21 0.15 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.26 -164.25 14.52 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.794 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 16.3 mtp -119.05 99.99 7.07 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.731 0.301 . . . . 0.0 110.464 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.603 ' HA3' ' CG2' ' A' ' 40' ' ' VAL . . . -90.65 75.72 1.63 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.093 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.0 mp -147.93 108.41 4.13 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.571 0.224 . . . . 0.0 110.871 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -85.62 82.41 8.25 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.055 0.455 . . . . 0.0 110.27 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 1.2 pp -82.86 175.88 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.049 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.16 145.75 14.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.415 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -98.55 100.04 11.25 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.83 176.09 9.01 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.805 0.336 . . . . 0.0 111.566 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 178.47 4.55 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.19 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.81 -142.3 3.45 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.0 147.5 32.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.967 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.47 16.91 30.74 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.377 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.55 108.54 5.44 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.733 -0.234 . . . . 0.0 110.852 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -93.34 23.58 4.4 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.862 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.06 -158.51 0.72 Allowed 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.9 106.81 7.92 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.737 0.303 . . . . 0.0 110.943 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.22 153.38 24.37 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.699 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' A' ' 57' ' ' LEU . 33.5 mm -80.97 90.7 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-O 120.817 0.341 . . . . 0.0 110.523 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 20.2 m-85 -81.25 161.43 23.94 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.525 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.6 t -122.93 126.01 73.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.639 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.21 -29.68 6.19 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.1 t -136.65 156.57 48.36 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.032 0.444 . . . . 0.0 111.852 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.02 133.48 26.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.481 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.603 ' CG2' ' HA3' ' A' ' 18' ' ' GLY . 30.0 m -61.07 134.02 26.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.885 0.374 . . . . 0.0 111.366 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.63 93.44 6.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.429 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.26 30.04 4.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.297 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.65 -139.39 10.26 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.688 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.86 -33.56 10.49 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.812 0.306 . . . . 0.0 111.76 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.22 -47.25 11.01 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.374 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -58.58 -38.82 78.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.345 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 t -76.63 -33.73 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.089 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -46.34 90.08 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.978 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.27 29.53 24.82 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.623 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -100.68 -41.63 6.84 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.703 0.287 . . . . 0.0 110.867 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 pp -129.44 162.11 28.84 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.781 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.91 -175.14 5.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.25 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.61 135.38 52.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.258 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.0 46.28 3.39 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.347 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -133.36 173.02 11.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.711 0.291 . . . . 0.0 111.296 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -131.11 143.87 50.98 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.883 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 34' ' ' ILE . 1.9 mp -112.97 122.26 47.09 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.252 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tt -94.34 -58.41 2.22 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.743 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 m -138.99 156.25 47.37 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.955 0.407 . . . . 0.0 111.524 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.43 HG12 ' HG ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -102.9 -167.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.141 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -67.22 68.81 0.08 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.09 0.471 . . . . 0.0 110.83 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.99 25.37 9.67 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.559 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -135.61 147.67 48.73 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.653 0.227 . . . . 0.0 110.633 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 m -113.43 110.9 21.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.924 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.1 mt -102.02 68.6 1.13 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.672 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.18 97.55 3.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.34 -32.11 5.0 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.589 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.29 168.72 11.85 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.004 0.431 . . . . 0.0 111.477 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.5 p -91.23 167.15 12.53 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.073 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -55.42 -26.06 39.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.562 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.52 -46.92 71.42 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.804 0.335 . . . . 0.0 110.609 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -49.04 79.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.252 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.38 -51.7 68.7 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.111 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.98 -43.8 82.05 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -34.7 78.94 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.204 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.0 mt -74.82 -35.61 62.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.642 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 9.3 mtt -72.67 -38.31 67.66 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.063 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.0 t -68.06 -31.15 70.59 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 121.233 -0.187 . . . . 0.0 111.002 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -89.32 53.18 2.56 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.761 0.315 . . . . 0.0 111.423 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.7 p -127.06 166.77 16.97 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.228 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.31 -170.23 3.03 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.381 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 m -54.11 -43.9 70.82 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.253 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.5 t -103.2 135.73 39.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.938 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.5 t -139.92 121.99 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.537 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.02 123.89 35.72 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.588 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.43 ' HG ' HG12 ' A' ' 60' ' ' VAL . 6.3 mt -131.47 134.08 45.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.707 0.289 . . . . 0.0 111.148 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 1.5 mt-10 -81.43 112.11 18.39 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.883 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.0 t -99.72 132.41 45.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.557 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.23 142.17 40.45 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.934 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -102.44 122.31 44.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -159.93 -171.38 3.22 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.088 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.78 138.0 2.32 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.462 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.416 -0.802 . . . . 0.0 111.048 179.902 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.469 0.176 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -98.65 172.45 7.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.776 0.322 . . . . 0.0 110.941 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -127.67 116.27 20.99 Favored Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.095 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.61 144.12 53.78 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.624 2.216 . . . . 0.0 112.622 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -116.52 99.35 7.1 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.856 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mp -80.1 98.05 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.961 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 pt -106.26 157.78 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.324 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.1 m -124.46 128.79 49.53 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.871 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.451 HG11 ' HG3' ' A' ' 50' ' ' ARG . 20.3 t -137.4 151.73 26.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.406 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.93 106.31 18.33 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.717 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.07 154.9 17.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -117.84 137.82 52.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.057 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -72.44 111.44 7.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 110.924 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.53 86.37 2.4 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.599 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 56.61 38.14 29.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.134 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.92 -159.55 14.41 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 mmt -136.67 99.59 4.1 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.758 0.313 . . . . 0.0 110.96 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.28 72.34 1.34 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.657 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mp -142.19 128.44 19.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.632 0.253 . . . . 0.0 110.676 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.95 132.29 33.84 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.163 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 pt -133.84 171.08 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.973 0.416 . . . . 0.0 111.933 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -157.24 138.72 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.002 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.87 97.47 9.31 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.74 -179.82 5.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.511 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.25 -179.59 3.99 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.289 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.25 -142.36 3.41 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.97 155.86 17.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.795 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.55 23.6 43.65 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.408 -0.901 . . . . 0.0 110.955 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.26 103.39 7.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.534 -0.333 . . . . 0.0 111.272 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.456 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 10.5 t70 -87.22 9.21 20.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.435 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.456 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 4.3 mttt -142.59 -167.46 2.51 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.192 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tp -112.01 132.74 54.61 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.635 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.55 153.16 17.74 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.567 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 57' ' ' LEU . 47.3 mm -83.5 101.32 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.892 0.377 . . . . 0.0 110.63 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -87.96 136.75 32.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.551 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.81 115.66 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.104 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -73.73 -44.75 55.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.785 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.35 172.22 3.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 111.501 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.8 t -124.77 136.88 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.19 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.61 142.64 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.407 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -72.11 138.97 48.14 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.814 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.49 -14.2 65.36 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.25 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.93 -168.19 16.81 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.558 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.04 -54.5 6.46 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.96 81.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.299 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -58.99 -44.83 91.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.083 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.4 t -75.56 -34.2 28.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.096 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.88 -38.99 70.89 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.114 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.19 27.03 71.88 Favored Glycine 0 CA--C 1.521 0.469 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.897 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.451 ' HG3' HG11 ' A' ' 9' ' ' VAL . 7.6 mmt180 -102.51 -34.37 9.15 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.553 0.216 . . . . 0.0 111.015 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 pp -122.38 175.98 6.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.05 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.96 -171.03 3.49 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.287 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.15 153.55 42.43 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.188 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.31 53.15 14.37 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.085 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.13 160.22 24.18 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.743 0.306 . . . . 0.0 111.135 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -113.44 109.88 19.4 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.443 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 34' ' ' ILE . 2.2 mt -85.76 119.31 25.95 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.364 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.64 -61.38 1.47 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.57 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 m -120.61 156.99 30.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 111.705 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.5 t -135.54 113.87 15.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.559 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t0 64.47 20.69 12.24 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.311 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.36 -23.46 26.75 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.642 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.06 142.71 27.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.494 0.647 . . . . 0.0 111.148 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.76 122.84 36.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.95 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.8 mt -102.79 39.94 1.46 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.04 97.08 6.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.267 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.04 38.19 0.76 Allowed Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.305 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.5 mt -138.5 174.89 10.06 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.704 0.288 . . . . 0.0 110.757 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.6 m -94.8 165.81 12.29 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -55.65 -31.84 62.69 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.968 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -57.72 8.88 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.335 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -53.72 -48.23 69.82 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.664 -0.243 . . . . 0.0 111.621 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.01 -48.59 73.37 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.714 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.34 90.31 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.025 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -59.73 -26.9 66.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.361 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.3 mt -87.66 -48.27 8.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.593 0.235 . . . . 0.0 111.115 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -31.36 69.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.076 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.2 t -74.25 -31.22 62.49 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.629 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -87.1 49.67 1.86 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.734 0.302 . . . . 0.0 111.377 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.426 ' HB ' ' CG2' ' A' ' 84' ' ' VAL . 1.5 p -103.63 169.09 8.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.841 0.353 . . . . 0.0 111.234 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.87 -168.1 1.5 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.57 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 96.9 p -55.38 -36.84 66.82 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.271 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.8 t -122.96 138.33 53.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.621 0.248 . . . . 0.0 111.256 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.426 ' CG2' ' HB ' ' A' ' 80' ' ' THR . 3.6 t -141.37 147.76 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.504 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.4 m -102.7 99.26 9.22 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.856 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -106.55 136.47 46.27 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.259 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -117.29 101.0 8.06 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.661 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 m -104.05 166.56 2.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.254 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.18 113.57 19.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.769 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -78.57 131.22 36.68 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.912 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.19 -165.8 1.42 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.005 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.36 135.99 2.21 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.558 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.096 179.898 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mtm . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.677 0.275 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -158.62 29.85 0.23 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.655 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -148.85 83.26 6.88 Favored Pre-proline 0 N--CA 1.465 0.307 0 CA-C-O 120.664 0.269 . . . . 0.0 111.1 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.44 169.46 19.73 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.806 2.337 . . . . 0.0 112.952 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -105.86 94.0 4.94 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.123 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.88 122.43 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.867 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 pt -127.17 150.37 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.508 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 m -88.92 120.63 30.5 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.093 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.18 138.81 37.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.113 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.33 107.13 14.83 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.821 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.1 mt -100.7 164.97 11.62 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.139 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.62 111.08 7.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.131 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.25 103.76 0.12 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.325 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -53.11 5.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.738 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -149.54 38.81 0.78 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.985 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.34 -171.32 15.86 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.5 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.3 mtp -136.01 80.19 1.81 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.851 0.357 . . . . 0.0 111.027 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.55 80.87 1.76 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.727 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.36 139.09 17.92 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.85 0.357 . . . . 0.0 110.914 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.4 m -100.61 135.59 41.81 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 pp -126.73 178.18 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.798 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -131.96 167.01 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.975 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -145.41 80.9 1.61 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.546 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.44 -179.34 7.0 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.673 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.86 172.08 14.26 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.755 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -151.16 -143.95 3.82 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.666 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.76 151.52 27.67 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.855 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.56 18.88 39.4 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.086 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.31 112.77 5.61 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.657 -0.271 . . . . 0.0 110.877 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.52 23.9 4.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.96 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -124.21 -149.58 0.43 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 tp -129.5 119.14 23.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.691 0.281 . . . . 0.0 110.788 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.82 164.74 12.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.102 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 28.3 mm -99.55 133.06 43.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.437 ' HB2' ' CG2' ' A' ' 22' ' ' VAL . 54.8 m-85 -117.0 168.6 10.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.666 0.269 . . . . 0.0 111.178 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.22 108.99 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.855 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -73.41 -41.96 62.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.76 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.35 166.04 2.77 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.178 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.1 t -123.45 128.55 74.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.47 146.36 7.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.414 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.6 tptt -65.73 143.38 57.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.833 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.32 -32.62 6.95 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.598 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.19 150.35 46.7 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.62 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.54 -36.78 56.34 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.73 -46.85 74.13 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.56 0.219 . . . . 0.0 111.143 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.85 -40.35 88.27 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.027 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 37.8 t -74.0 -31.94 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.253 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.71 -55.97 26.86 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.336 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.2 29.3 31.22 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.922 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -99.2 -45.87 5.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.887 0.343 . . . . 0.0 110.731 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.37 177.95 4.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.914 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.81 177.54 10.89 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.6 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.74 152.43 45.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.271 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.33 49.08 41.27 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.978 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.56 173.71 7.01 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.761 0.315 . . . . 0.0 111.541 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.2 tm0? -115.85 161.29 18.99 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.979 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.91 129.13 18.77 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.897 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.99 -60.56 1.62 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.461 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 m -119.29 152.69 36.27 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.445 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.43 HG22 HD22 ' A' ' 65' ' ' LEU . 44.0 t -136.01 131.64 49.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.815 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t70 54.92 36.86 27.71 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.779 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.52 28.69 73.05 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.083 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.08 145.49 48.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.922 0.361 . . . . 0.0 110.856 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.9 m -90.94 111.56 23.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.774 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.43 HD22 HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -123.58 76.71 1.44 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.156 0.503 . . . . 0.0 110.995 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 t -121.1 96.25 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.542 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.73 -30.75 2.93 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.743 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.27 168.86 9.72 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.048 0.451 . . . . 0.0 111.86 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 m -91.39 172.3 8.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.527 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -54.94 -28.63 52.57 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.054 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -61.81 -48.87 78.66 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-O 120.717 0.294 . . . . 0.0 110.77 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -63.78 -49.77 71.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.292 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.89 -54.32 47.5 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.511 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.84 94.36 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.882 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HA ' HG21 ' A' ' 78' ' ' THR . 0.5 OUTLIER -65.52 -35.35 80.61 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 179.472 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 mt -67.12 -30.06 69.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.148 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.4 mtt -73.81 -39.7 63.9 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.247 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.424 HG21 ' HA ' ' A' ' 75' ' ' GLU . 11.6 t -68.93 -30.99 69.56 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.554 0.216 . . . . 0.0 111.194 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -89.79 49.54 1.74 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.84 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.2 p -123.92 172.16 9.14 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.912 0.387 . . . . 0.0 111.381 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.28 -171.42 3.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.637 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 p -51.71 -46.62 64.01 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.5 t -97.96 137.97 24.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.096 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -128.54 130.93 69.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.92 98.43 8.28 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.271 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.03 115.02 26.94 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.737 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.88 104.89 15.23 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.978 0.418 . . . . 0.0 110.773 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 32.5 m -92.01 168.31 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.803 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.64 133.52 49.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.659 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -94.56 123.1 37.79 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.319 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -163.12 -167.01 1.37 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.13 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.78 138.17 2.49 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.304 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.346 -179.961 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mtp . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 111.475 0.176 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -90.14 52.9 2.36 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.912 0.387 . . . . 0.0 110.924 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -69.64 146.45 95.91 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.02 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.08 169.67 2.65 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.965 2.443 . . . . 0.0 112.9 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -79.86 84.62 5.61 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.087 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.98 133.79 29.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.303 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.24 138.16 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.392 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -104.23 120.02 40.23 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.474 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -118.67 170.72 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.646 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.17 116.34 15.27 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.857 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 mp -126.07 165.91 17.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.142 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -107.95 135.67 48.94 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.088 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 125.06 22.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.115 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.59 66.1 0.95 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.677 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 56.99 38.49 29.39 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.3 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.13 -152.81 24.59 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.374 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.7 mtt -147.61 -72.99 0.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.709 0.254 . . . . 0.0 111.484 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.17 63.87 2.43 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.604 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 mp -143.82 123.8 13.57 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.499 0.19 . . . . 0.0 110.607 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -85.1 125.31 32.67 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.697 0.284 . . . . 0.0 110.989 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 pt -127.88 171.46 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.607 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -159.6 138.5 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.302 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -99.2 97.26 8.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.817 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -131.15 -179.76 5.53 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.633 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -119.72 -179.91 4.04 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.84 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.13 -144.14 3.91 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.789 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.02 163.41 14.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.666 0.269 . . . . 0.0 110.918 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.44 20.93 52.97 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.564 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.94 -164.65 1.26 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.023 0.439 . . . . 0.0 110.092 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.555 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -173.39 21.24 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.254 178.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -154.35 -168.92 3.08 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.741 0.416 . . . . 0.0 110.221 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.24 116.94 30.55 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.873 0.368 . . . . 0.0 110.575 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.23 144.62 16.03 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.699 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.5 mm -77.55 99.59 2.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 120.955 0.407 . . . . 0.0 110.606 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -86.89 144.84 26.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.404 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.4 t -93.95 118.73 40.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.985 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -80.21 -42.54 23.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.854 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.8 172.08 4.98 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.437 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.8 t -124.53 132.13 71.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.022 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.73 142.77 14.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.0 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 155.44 39.23 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.344 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.91 16.66 70.68 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.003 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -99.2 153.55 19.74 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.349 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.0 -35.78 62.25 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.1 -32.64 56.76 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.344 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -76.43 -44.32 36.34 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.21 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.6 t -65.47 -48.42 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.233 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.85 -31.97 61.79 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.33 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.9 54.98 2.91 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.935 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -62.94 1.52 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.701 0.286 . . . . 0.0 111.08 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.07 161.11 32.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.907 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.35 -177.06 3.67 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.08 144.32 57.33 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.412 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.01 44.08 46.87 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.546 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -112.71 179.84 3.86 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.648 0.261 . . . . 0.0 111.143 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 13.2 tm0? -127.31 158.53 36.97 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.082 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.0 mt -143.81 130.61 20.33 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.55 0.215 . . . . 0.0 111.18 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.8 -59.59 1.73 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.787 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.5 m -90.48 139.66 30.48 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.024 0.44 . . . . 0.0 112.152 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.3 t -141.54 110.68 2.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.742 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 56.74 37.13 28.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.119 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.62 28.63 60.95 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.004 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -118.99 148.08 43.38 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.808 0.304 . . . . 0.0 110.68 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.4 91.81 7.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.774 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.9 mt -96.61 93.29 6.67 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.995 0.426 . . . . 0.0 110.945 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.2 t -138.86 94.74 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.137 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.9 37.25 0.97 Allowed Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.815 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.32 157.51 42.35 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.887 0.375 . . . . 0.0 111.057 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 p -74.29 168.13 20.24 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.374 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -58.57 -40.58 83.51 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.9 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -55.04 -40.32 70.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.945 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -66.54 -48.31 70.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.215 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.61 -49.1 67.41 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.235 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.75 -43.63 90.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.803 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -64.98 -37.4 87.53 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.5 mt -73.27 -36.71 66.39 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.235 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.4 mtp -76.37 -34.52 58.91 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.801 -0.182 . . . . 0.0 111.429 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 t -73.37 -39.89 64.78 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 121.216 -0.193 . . . . 0.0 110.851 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 73.2 mtp85 -90.68 59.03 4.08 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.0 0.429 . . . . 0.0 110.57 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.4 p -114.29 164.29 14.11 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.289 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.1 p -79.4 -165.69 0.83 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.573 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.5 -51.98 67.27 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.538 0.208 . . . . 0.0 110.902 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.3 t -100.61 138.47 24.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.018 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.4 t -132.82 127.55 55.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.563 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.59 107.31 19.79 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.472 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.4 mt -116.35 136.91 52.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.96 0.41 . . . . 0.0 111.452 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 38.4 tt0 -106.66 97.3 7.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.109 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 19.7 t -98.8 139.05 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.785 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.84 118.28 36.59 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.677 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.57 123.76 22.16 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.866 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -169.92 -177.89 2.75 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.228 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.85 135.99 1.98 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.507 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.769 -0.634 . . . . 0.0 112.185 179.922 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ptt? . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.523 0.201 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.08 136.45 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.231 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -99.45 107.79 47.09 Favored Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.046 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.83 170.36 1.03 Allowed 'Trans proline' 0 C--N 1.351 0.711 0 C-N-CA 123.072 2.515 . . . . 0.0 112.956 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -75.7 86.14 2.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.006 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.6 mm -91.6 128.43 43.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.83 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 pt -147.84 149.15 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.516 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -118.91 130.96 56.0 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.848 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 t -125.89 141.09 46.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.74 92.61 7.76 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.632 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.89 131.64 34.48 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.27 138.86 31.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -68.81 155.33 40.37 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.918 0.39 . . . . 0.0 111.356 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.31 66.6 1.27 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.531 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 57.49 35.95 26.42 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.127 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.58 -172.54 27.1 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.508 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 11.7 mmm -112.31 -73.48 0.67 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.616 0.246 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.82 49.44 7.1 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.836 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mp -148.54 110.15 4.47 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.604 0.24 . . . . 0.0 110.744 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 t -80.59 130.47 35.14 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.15 178.32 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.658 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.2 p -148.52 145.19 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.409 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.14 84.92 2.41 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.329 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.76 179.21 4.21 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.531 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.84 176.97 9.24 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.745 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.33 145.14 13.28 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.16 155.56 40.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.873 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.39 19.87 48.83 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.49 -159.8 0.99 Allowed 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 123.421 0.689 . . . . 0.0 109.737 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -173.78 31.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.923 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.78 -171.57 3.72 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.624 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.62 106.01 15.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.72 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.66 174.81 33.62 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.801 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.7 mm -102.27 111.49 32.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.657 0.265 . . . . 0.0 110.711 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.427 ' CE1' ' HG2' ' A' ' 56' ' ' GLN . 81.7 m-85 -104.35 153.82 20.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.36 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.05 125.45 53.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.128 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.38 -34.81 8.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.337 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 m -164.87 168.32 17.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.763 0.316 . . . . 0.0 111.417 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.7 t -135.74 138.44 47.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.991 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.09 133.99 29.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.33 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.65 140.36 49.66 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.074 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.6 -14.46 64.87 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.304 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.22 -161.66 5.53 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.405 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.77 -36.71 14.12 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.16 -51.37 68.13 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.87 -38.99 83.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.447 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.6 t -73.45 -31.88 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.031 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.7 -44.05 85.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.099 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.8 51.78 14.22 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.681 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.71 -45.93 2.26 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.611 0.244 . . . . 0.0 111.294 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 pp -135.58 172.51 12.91 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.006 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.9 -160.12 1.09 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.381 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.8 152.96 43.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.574 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.03 48.1 21.67 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.159 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -121.31 170.61 9.44 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.736 0.303 . . . . 0.0 111.422 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.427 ' HG2' ' CE1' ' A' ' 35' ' ' TYR . 7.5 tm0? -119.45 135.01 54.94 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.916 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.97 129.32 53.38 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.804 0.335 . . . . 0.0 111.014 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.47 -61.4 1.6 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.459 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.3 p -111.45 146.63 36.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.061 0.458 . . . . 0.0 111.867 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.11 119.19 39.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.479 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t70 59.95 35.26 21.64 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.04 -16.04 56.53 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.678 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -92.1 138.29 31.66 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 117.381 0.59 . . . . 0.0 111.096 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.15 114.44 25.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.825 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.2 mt -100.74 76.89 1.83 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.711 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 t -122.25 91.5 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.034 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.11 32.6 1.98 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.574 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.4 mt -123.15 155.67 36.57 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.744 0.307 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.1 m -74.03 158.75 33.74 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -55.06 -35.79 64.9 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.956 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.02 -44.21 97.2 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.919 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.31 -52.89 56.28 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.224 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.28 -52.04 66.37 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.569 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.64 -46.85 86.21 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.018 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HA ' HG21 ' A' ' 78' ' ' THR . 1.8 tp10 -62.54 -36.96 84.26 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.677 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.1 mt -69.39 -34.05 73.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.961 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.0 mtt -71.99 -39.53 69.2 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.114 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.418 HG21 ' HA ' ' A' ' 75' ' ' GLU . 11.1 t -68.53 -32.35 72.23 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.564 0.221 . . . . 0.0 110.983 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -91.52 48.24 1.45 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.542 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.8 p -109.38 174.3 5.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.764 0.316 . . . . 0.0 111.207 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -84.9 -170.25 3.04 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.67 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -56.14 -37.83 70.02 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.684 0.278 . . . . 0.0 111.094 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -113.47 139.23 39.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.097 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.1 t -130.37 119.62 46.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.082 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.91 98.31 11.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.826 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.0 mp -103.17 127.15 50.55 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.12 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -91.94 96.29 10.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.543 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.4 p -93.32 147.58 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.874 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.72 135.01 54.41 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.101 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.98 126.93 42.47 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -160.96 -166.77 1.66 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.849 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 174.05 137.18 2.38 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.393 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.119 -0.943 . . . . 0.0 111.179 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.796 0.331 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -144.71 168.05 21.1 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.807 0.337 . . . . 0.0 111.088 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -117.99 116.23 36.18 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.172 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.47 -173.89 1.09 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.793 2.329 . . . . 0.0 112.762 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.56 103.07 9.1 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.991 0.424 . . . . 0.0 111.12 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.494 ' CG2' ' HG2' ' A' ' 87' ' ' GLU . 1.4 mp -94.49 126.01 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.815 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.5 pt -138.41 143.21 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.403 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 25.3 m -96.4 134.49 39.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.828 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -117.92 127.08 75.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.24 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.07 99.78 11.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.797 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.8 mt -107.79 157.58 18.02 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.965 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -118.93 138.61 52.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.828 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -72.21 114.67 10.58 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.304 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.49 -41.1 7.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.611 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -160.39 44.12 0.2 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.49 -177.6 29.66 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.576 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.0 mtt -120.19 93.57 4.1 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.819 0.342 . . . . 0.0 110.895 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.8 71.38 3.0 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.486 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mp -146.09 115.56 7.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.571 0.224 . . . . 0.0 110.466 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m -80.07 129.52 34.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.906 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 2.9 pp -124.22 176.16 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.017 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.89 151.47 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.617 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.13 115.2 29.76 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.785 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.65 -179.58 8.21 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.896 0.379 . . . . 0.0 111.909 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -94.43 167.11 11.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.861 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.05 -141.76 3.45 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.25 147.74 30.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.986 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.63 16.42 37.31 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.267 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.99 107.9 4.34 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.573 0.225 . . . . 0.0 110.951 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -93.37 25.15 3.52 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.946 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.29 -157.77 0.72 Allowed 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.68 108.53 9.1 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.808 0.337 . . . . 0.0 110.677 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.31 -178.23 22.58 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.768 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.3 mm -97.48 129.04 48.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.617 0.246 . . . . 0.0 110.759 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.5 ' CE2' ' HG3' ' A' ' 56' ' ' GLN . 15.3 m-85 -114.2 166.03 12.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.139 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.21 109.55 28.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.844 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.05 -34.95 22.17 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.201 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.7 t -169.58 170.88 7.89 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.707 0.289 . . . . 0.0 111.518 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.0 t -130.7 151.41 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.213 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 t -101.53 139.86 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.147 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -58.74 136.29 57.69 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.043 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.28 -22.48 37.64 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.01 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.29 135.08 45.41 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.468 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.22 -36.34 19.83 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.25 -50.53 73.27 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 111.361 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -70.93 -45.56 64.01 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.88 -36.42 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.396 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.62 -49.84 29.34 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.657 0.265 . . . . 0.0 110.914 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.04 60.56 1.06 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.809 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -123.37 -50.9 1.87 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.681 0.277 . . . . 0.0 110.936 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 pp -122.57 175.99 6.17 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.28 -174.89 5.14 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.305 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.75 165.81 20.59 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.356 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.59 45.72 88.14 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.34 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.22 172.98 11.94 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.799 0.333 . . . . 0.0 111.423 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.5 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -112.64 173.29 6.44 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.706 179.5 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.406 HD22 ' CD2' ' A' ' 86' ' ' LEU . 3.1 tp -155.84 133.05 10.77 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.066 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.4 -60.52 1.87 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.34 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 5.7 t -97.43 146.15 25.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.189 0.519 . . . . 0.0 112.14 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.4 t -140.41 126.66 21.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.596 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.8 t0 54.99 38.37 30.42 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.05 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.81 -12.92 45.93 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.707 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -90.73 158.78 16.69 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 117.399 0.6 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.57 108.04 16.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.43 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.83 96.76 6.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 110.988 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.2 t -125.03 92.61 2.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.814 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.16 36.24 0.88 Allowed Glycine 0 CA--C 1.518 0.271 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.313 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.4 mt -120.08 174.78 6.27 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.773 0.32 . . . . 0.0 110.728 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -98.23 163.71 12.61 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -57.09 -28.42 62.61 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.454 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -66.2 -49.2 68.11 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.739 0.304 . . . . 0.0 110.695 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.7 -45.5 82.58 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.365 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.81 -51.45 62.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.593 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.17 -37.04 78.96 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.749 0.309 . . . . 0.0 110.695 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -67.9 -37.49 81.79 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.818 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mt -73.47 -40.81 63.85 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.163 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -32.66 74.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.172 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.4 t -79.63 -33.5 41.33 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.881 -0.145 . . . . 0.0 111.388 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.81 46.04 1.35 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.688 0.28 . . . . 0.0 111.499 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 71.5 p -106.39 168.78 8.92 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.812 0.339 . . . . 0.0 111.026 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -80.62 -167.01 1.21 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.536 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.2 p -59.88 -39.8 86.52 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.674 0.273 . . . . 0.0 110.693 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.6 t -105.03 142.73 17.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.804 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.7 t -135.98 143.73 35.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.229 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.421 ' HB ' HG23 ' A' ' 8' ' ' THR . 0.0 OUTLIER -122.3 118.89 29.57 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.695 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.406 ' CD2' HD22 ' A' ' 57' ' ' LEU . 4.8 mp -120.2 120.81 37.22 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.415 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.494 ' HG2' ' CG2' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -81.68 93.19 6.72 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.476 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 p -88.18 137.31 21.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.641 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . . . -105.62 126.57 52.29 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.038 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -94.38 101.21 13.14 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.445 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -135.5 -172.9 3.2 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.16 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 157.07 140.83 3.03 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.356 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.634 179.953 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 111.323 0.12 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 mttp 67.08 156.85 0.11 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.949 0.404 . . . . 0.0 111.412 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -77.66 148.79 76.97 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.142 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.12 158.68 53.31 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.851 2.367 . . . . 0.0 112.726 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 41.1 tt0 -100.24 91.23 4.65 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.272 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -84.12 126.72 40.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.657 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 pt -145.86 146.65 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 13.2 t -115.42 141.69 47.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.775 0.321 . . . . 0.0 111.107 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.73 148.78 20.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.502 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.83 128.53 33.55 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.998 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.4 121.93 39.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.712 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -101.04 99.13 9.53 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.701 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.3 130.28 43.89 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.176 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -78.95 -59.34 2.82 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.503 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -158.01 37.4 0.25 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.077 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.05 -163.96 28.62 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.359 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.1 mmt -139.4 101.46 4.24 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.674 0.273 . . . . 0.0 111.047 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.7 77.36 0.71 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.729 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.14 137.41 12.81 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 111.058 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -105.45 109.0 20.82 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.776 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 pt -102.91 178.29 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.473 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 35' ' ' TYR . 2.5 p -155.42 134.42 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.228 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.29 104.24 16.13 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.63 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -143.74 -179.72 6.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.186 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -101.46 179.36 4.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.846 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.53 -145.4 4.23 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.83 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.33 163.19 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.652 0.263 . . . . 0.0 110.921 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.49 20.13 44.14 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.555 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.81 -163.11 0.94 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.203 0.525 . . . . 0.0 109.962 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.446 ' C ' ' HG2' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -168.13 18.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.62 178.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HG2' ' C ' ' A' ' 30' ' ' ASP . 0.1 OUTLIER -156.97 -170.79 3.41 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 tp -99.54 123.96 44.29 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.607 0.241 . . . . 0.0 110.864 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.16 175.03 15.54 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.806 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.405 ' N ' ' CD1' ' A' ' 34' ' ' ILE . 1.6 mp -103.46 154.0 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 O-C-N 122.774 -0.25 . . . . 0.0 110.456 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.421 ' HB2' HG12 ' A' ' 22' ' ' VAL . 68.2 m-85 -136.14 158.46 44.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.249 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.4 t -102.94 108.84 25.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -81.71 -38.92 25.02 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.821 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.0 t -175.23 158.39 2.38 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.094 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.418 ' CG1' ' HB2' ' A' ' 46' ' ' ASP . 10.9 t -128.07 146.13 34.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.901 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.68 140.32 16.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.968 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -68.28 91.08 0.37 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.434 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.63 -32.35 0.48 Allowed Glycine 0 CA--C 1.519 0.342 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.493 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.56 148.15 41.91 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.049 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -55.09 -21.08 11.49 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.94 -33.73 19.58 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.504 0.192 . . . . 0.0 111.442 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.418 ' HB2' ' CG1' ' A' ' 39' ' ' VAL . 0.7 OUTLIER -86.21 -49.13 7.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.264 -179.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.83 -29.88 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.829 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 11.6 m-20 -86.83 -50.04 7.0 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.554 0.216 . . . . 0.0 110.552 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.52 93.14 2.28 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.389 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -143.18 -50.62 0.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.442 0.163 . . . . 0.0 111.056 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 pp -135.37 138.86 43.75 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.752 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.14 -170.52 1.67 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.304 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.28 153.66 42.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 111.121 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.83 37.29 65.91 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.284 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.46 173.88 6.12 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.769 0.318 . . . . 0.0 111.062 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.63 156.6 33.96 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.795 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 mt -133.95 135.13 43.32 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.152 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.41 -55.93 2.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.555 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.3 m -115.0 156.06 25.79 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.1 t -140.14 139.25 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.138 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 43.47 41.75 3.48 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.167 0.587 . . . . 0.0 111.793 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.8 32.55 74.13 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.807 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -132.75 145.37 50.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.932 0.366 . . . . 0.0 110.7 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.8 m -92.55 126.15 37.51 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.48 61.43 1.64 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.334 0.588 . . . . 0.0 111.022 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.5 t -102.74 98.44 6.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.676 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.6 -26.21 2.67 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.068 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 mt -76.54 174.09 10.75 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.802 0.334 . . . . 0.0 111.083 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.5 t -96.94 -176.57 3.6 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.972 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -60.1 -32.81 71.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -58.54 -58.85 6.73 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.958 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -63.38 -42.78 98.85 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.267 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.08 -48.41 81.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.272 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.21 -44.85 71.24 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.749 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.46 -31.88 70.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.05 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mt -71.17 -36.54 72.03 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.727 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.2 mtt -67.62 -46.36 72.74 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.133 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.8 t -64.4 -27.92 69.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 121.213 -0.195 . . . . 0.0 111.043 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.4 mtm-85 -91.19 51.68 1.97 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.407 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.3 p -130.48 -177.29 4.27 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.865 0.364 . . . . 0.0 110.998 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 t -110.58 -165.5 1.0 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.562 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 t -54.73 -49.93 69.6 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.117 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.2 t -86.95 126.15 40.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.217 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.4 t -145.9 110.2 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.231 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.35 120.14 25.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.658 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.8 mt -110.44 115.15 29.14 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.719 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 2.2 tt0 -87.2 92.16 8.97 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.353 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.8 m -94.39 173.55 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.354 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.88 120.67 26.63 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.076 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 8.9 mmtt -84.59 94.26 8.56 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.6 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -162.89 -177.18 5.34 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.58 137.15 2.14 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.577 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.425 -0.797 . . . . 0.0 111.186 179.808 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.1 mmt . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.627 0.251 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.7 125.13 22.55 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 64.66 102.22 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.262 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.63 167.49 2.08 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.091 2.527 . . . . 0.0 113.151 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.89 88.88 7.63 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.469 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.2 mt -93.52 138.75 19.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.57 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 pp -145.35 141.99 22.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.438 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 2.2 m -101.9 114.41 28.48 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.816 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -127.97 162.34 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.642 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.36 142.36 29.33 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.188 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.13 129.3 56.62 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.832 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 82' ' ' SER . 6.8 mmtt -94.63 107.89 19.87 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.72 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -66.7 124.81 23.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.248 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -97.48 -53.57 3.41 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.857 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -154.46 36.3 0.42 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.32 -149.91 17.96 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.273 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.4 mmt -141.9 105.5 4.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.854 0.359 . . . . 0.0 111.055 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.12 36.2 4.2 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.475 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mp -111.71 106.97 15.92 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 p -79.67 128.45 33.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.007 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.34 172.58 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.964 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.76 143.19 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.453 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.16 112.83 25.65 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.524 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -154.16 172.24 17.88 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.924 0.392 . . . . 0.0 111.779 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -113.83 161.2 17.86 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.063 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.79 -140.3 3.56 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.2 158.98 16.22 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.863 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.53 25.57 42.74 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.404 -0.903 . . . . 0.0 110.902 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.65 104.19 7.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.396 -0.402 . . . . 0.0 111.088 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -88.08 14.04 9.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.478 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -145.85 -162.01 1.43 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.03 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.99 141.76 40.63 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.688 0.28 . . . . 0.0 110.672 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -123.41 144.49 15.64 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.658 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.8 mm -94.04 108.93 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -96.28 168.71 10.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 0.0 111.778 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.35 108.57 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.674 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -40.13 77.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.944 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.28 170.25 4.32 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.887 0.375 . . . . 0.0 111.552 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.1 t -134.84 127.67 49.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.597 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.96 137.81 23.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.136 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -65.27 152.92 42.53 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.36 20.34 69.42 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.928 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.39 -147.68 8.59 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.371 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.15 -43.41 6.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.658 0.266 . . . . 0.0 111.443 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.91 -34.03 30.13 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.239 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.74 -39.49 94.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.107 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.09 -35.89 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.847 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -42.06 72.56 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.272 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.03 76.56 1.13 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.478 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -133.88 -49.58 0.82 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.535 0.168 . . . . 0.0 111.264 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 pp -135.03 148.17 49.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 111.212 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -126.73 -169.47 2.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.161 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.37 145.37 56.16 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.933 0.397 . . . . 0.0 111.931 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.28 30.14 54.97 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.068 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -101.72 176.05 5.35 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.973 0.387 . . . . 0.0 111.655 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -116.74 169.91 9.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.835 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.69 139.09 15.8 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.705 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mt -121.05 -58.49 1.8 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.1 m -121.82 153.85 37.79 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.51 122.06 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.847 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 t0 57.67 33.8 23.69 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.207 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.54 -8.49 71.66 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.341 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -84.81 155.24 21.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.133 0.466 . . . . 0.0 111.177 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.9 t -99.29 139.95 34.18 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.036 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 mp -136.02 36.49 2.81 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.984 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 t -97.85 92.6 2.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.48 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.93 -25.47 4.14 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.644 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 mt -74.4 -177.32 3.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.866 0.365 . . . . 0.0 111.254 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.7 t -115.82 -171.81 2.04 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.008 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -62.57 -30.3 71.22 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.465 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.75 -50.73 69.89 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.775 0.321 . . . . 0.0 110.817 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -69.73 -42.49 73.91 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.987 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.43 -47.71 75.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.376 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.99 -69.18 0.29 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.263 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -37.88 -39.93 0.41 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.7 mt -70.73 -40.1 72.97 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.528 0.204 . . . . 0.0 111.384 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.21 -7.17 59.16 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.14 -29.13 28.89 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 122.376 -0.203 . . . . 0.0 110.97 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -90.85 31.93 1.03 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.432 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 54.0 p -79.89 176.01 10.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.821 0.343 . . . . 0.0 110.811 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.35 -160.68 1.05 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.587 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 19.6 m -56.12 -27.65 54.76 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.34 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 t -132.97 142.73 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.945 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.0 p -158.3 127.09 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.341 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.49 106.22 15.91 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.068 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.6 115.25 29.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.824 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 36.3 tt0 -88.7 109.15 19.9 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.508 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.0 m -117.02 169.91 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.708 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -120.33 131.16 54.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.698 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 75.14 3.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.812 0.339 . . . . 0.0 110.412 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -124.55 -165.71 1.42 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.994 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.81 142.4 3.85 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.474 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.537 -0.744 . . . . 0.0 111.33 179.73 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.903 0.382 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.667 HG22 ' HG2' ' A' ' 87' ' ' GLU . 21.4 mt -95.45 127.31 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.006 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.42 139.27 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.502 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 86.2 m -89.11 113.79 24.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.851 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 86' ' ' LEU . 14.4 p -105.84 149.27 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.384 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -120.66 112.66 19.16 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.733 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.67 163.02 27.02 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.188 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -103.73 174.31 5.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.219 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -107.58 115.88 30.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.398 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.37 -41.3 10.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.615 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -163.4 47.08 0.13 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.689 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.44 -146.73 18.29 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.481 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 30.4 mtt -138.97 95.46 2.96 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.682 0.277 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.41 74.09 2.13 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.548 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.61 143.68 13.26 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.616 0.246 . . . . 0.0 111.012 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -87.64 147.25 25.35 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.187 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.486 HD12 ' HG3' ' A' ' 70' ' ' GLN . 1.2 pp -138.77 164.32 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.699 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.506 ' CG1' ' HB2' ' A' ' 35' ' ' TYR . 7.3 p -151.48 144.12 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.388 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.46 91.97 3.86 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.999 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.03 179.84 6.11 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.249 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 -179.99 4.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.716 0.293 . . . . 0.0 110.945 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.41 -138.82 2.56 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.708 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.57 149.79 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.866 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.53 18.22 36.48 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.489 -0.862 . . . . 0.0 110.986 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.34 105.66 3.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.729 0.299 . . . . 0.0 110.859 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.08 26.77 2.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.987 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.442 ' HG3' HG12 ' A' ' 66' ' ' VAL . 8.4 mmtt -122.1 -158.81 0.79 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.8 100.22 5.41 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.826 0.346 . . . . 0.0 110.703 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.18 155.36 28.53 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.763 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.2 mm -88.31 93.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 CA-C-O 120.951 0.405 . . . . 0.0 110.473 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.506 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 91.8 m-85 -83.65 145.88 28.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.759 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.54 107.89 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.211 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -68.06 -42.97 79.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.941 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.6 t -168.03 171.76 9.38 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.139 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.7 t -128.99 120.94 53.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.578 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.35 130.47 34.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.85 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.13 126.55 27.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.55 -20.77 22.43 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.726 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.88 157.02 48.96 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.712 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.48 -39.9 64.91 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.438 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -72.54 -36.68 68.35 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.469 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -70.39 -49.19 51.66 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.28 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 43' ' ' GLY . 38.9 t -61.48 -40.99 88.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.269 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.96 -50.85 69.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.164 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.13 46.57 3.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.442 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.26 -67.82 0.91 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.638 0.256 . . . . 0.0 110.91 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.513 ' HB3' HG21 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -87.78 158.4 18.78 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.811 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.35 176.06 8.44 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.58 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.35 147.69 44.15 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.473 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.99 45.36 57.33 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.412 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.401 ' HB3' ' CG1' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -117.39 179.64 3.99 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.478 0.18 . . . . 0.0 110.974 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.691 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 65.3 tt0 -123.46 147.97 46.65 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.208 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.661 ' CD2' HG22 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -123.76 127.76 48.6 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.304 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.51 ' CD1' HG22 ' A' ' 66' ' ' VAL . 4.0 mm? -109.07 -62.71 1.44 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.027 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.0 m -102.75 143.01 32.94 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.52 HG21 HD11 ' A' ' 65' ' ' LEU . 22.0 t -137.39 110.21 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.56 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.3 40.4 24.58 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.273 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.69 -26.46 12.38 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.11 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.75 175.39 10.72 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.963 0.382 . . . . 0.0 110.846 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.21 121.51 24.95 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.781 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.52 HD11 HG21 ' A' ' 60' ' ' VAL . 36.9 mt -96.86 51.19 1.13 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.798 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.51 HG22 ' CD1' ' A' ' 58' ' ' LEU . 17.3 t -95.98 90.94 2.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.77 31.56 2.91 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.526 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.484 HD22 ' HG3' ' A' ' 72' ' ' ARG . 33.7 mt -118.41 157.56 26.94 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.854 0.359 . . . . 0.0 110.97 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.8 p -79.71 166.29 21.95 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.976 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.486 ' HG3' HD12 ' A' ' 21' ' ' ILE . 26.8 tt0 -58.49 -37.96 76.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.719 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -64.66 -48.98 72.77 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.945 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HG3' HD22 ' A' ' 68' ' ' LEU . 3.9 mmt180 -56.22 -47.57 78.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.356 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.98 -53.3 32.86 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.313 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' A' ' 21' ' ' ILE . . . -57.44 -42.78 83.09 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.052 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.446 ' O ' HG22 ' A' ' 78' ' ' THR . 0.5 OUTLIER -66.4 -35.96 81.65 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.084 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 80' ' ' THR . 13.3 mt -71.93 -38.57 69.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.781 -0.19 . . . . 0.0 110.909 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 56.5 mtt -62.37 -37.26 85.03 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.235 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 75' ' ' GLU . 10.1 t -74.86 -32.51 61.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.585 0.231 . . . . 0.0 110.769 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -88.74 50.98 2.06 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.413 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 76' ' ' LEU . 40.2 p -120.03 170.89 8.87 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.812 0.339 . . . . 0.0 111.194 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.22 -169.62 2.35 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.755 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.0 m -54.9 -48.0 73.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.592 0.234 . . . . 0.0 110.994 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.66 138.74 20.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.796 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.439 HG12 HD11 ' A' ' 86' ' ' LEU . 15.6 t -133.91 114.33 19.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.18 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.25 132.36 36.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.538 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.63 ' O ' HG12 ' A' ' 9' ' ' VAL . 4.5 mp -138.95 132.75 30.81 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.62 0.247 . . . . 0.0 111.141 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.667 ' HG2' HG22 ' A' ' 6' ' ' ILE . 28.0 tt0 -100.86 101.72 12.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.681 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.661 HG22 ' CD2' ' A' ' 57' ' ' LEU . 21.6 t -91.85 149.86 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.767 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -115.18 119.36 36.1 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.231 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? . . . . . 0 N--CA 1.463 0.223 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.767 179.731 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 C--O 1.235 0.315 0 CA-C-O 121.276 0.56 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.74 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 19.4 mm -92.05 125.2 44.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.919 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.63 139.72 47.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.141 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.537 ' HB ' ' HG3' ' A' ' 87' ' ' GLU . 2.4 t -95.39 140.88 29.64 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.077 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.534 HG11 ' HB3' ' A' ' 50' ' ' ARG . 31.3 m -118.78 124.93 73.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.083 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.564 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -84.04 116.06 22.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.8 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.628 HD22 ' HB1' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -139.76 143.08 36.78 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.401 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -101.93 170.34 8.2 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.171 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -101.18 119.72 39.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.366 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.43 -40.54 5.33 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -152.87 32.26 0.49 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.974 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.12 177.59 22.75 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.235 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.1 mmm -115.27 96.61 5.75 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.749 0.309 . . . . 0.0 110.75 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.09 72.14 2.85 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.555 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.563 HD21 ' CB ' ' A' ' 45' ' ' ALA . 4.6 mp -139.8 115.95 10.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.634 0.254 . . . . 0.0 110.646 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 m -85.99 100.07 11.88 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.956 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.706 HD11 ' HB2' ' A' ' 74' ' ' ALA . 1.9 pt -81.31 174.79 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.574 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.738 HG13 ' HB2' ' A' ' 35' ' ' TYR . 3.5 p -158.85 144.55 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.34 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.43 ' HB2' ' N ' ' A' ' 70' ' ' GLN . . . -104.59 124.3 49.07 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.835 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.6 -179.54 8.26 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.966 0.412 . . . . 0.0 111.62 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.439 ' HG3' HD12 ' A' ' 32' ' ' LEU . 4.4 mttt -101.87 164.84 11.51 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.91 -143.55 3.88 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.1 153.65 26.63 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.022 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.45 19.15 39.74 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.169 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.46 111.01 5.62 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.71 0.291 . . . . 0.0 110.898 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -94.37 24.84 4.2 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.888 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -123.66 -147.44 0.38 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.439 HD12 ' HG3' ' A' ' 25' ' ' LYS . 4.4 tp -136.29 112.41 9.72 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.752 0.311 . . . . 0.0 110.555 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.38 176.89 24.63 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.816 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 73' ' ' ALA . 26.4 mm -97.11 151.5 4.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.715 0.293 . . . . 0.0 110.765 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.738 ' HB2' HG13 ' A' ' 22' ' ' VAL . 85.1 m-85 -140.38 156.41 46.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.157 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.68 100.59 11.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.713 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -74.53 -39.0 62.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.541 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.44 162.14 8.18 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.205 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.81 109.53 20.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.558 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.3 t -65.95 127.4 27.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.307 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -60.85 143.03 55.61 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.007 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.81 -14.76 62.62 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.921 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -75.05 -173.84 33.01 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.312 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.628 ' HB1' HD22 ' A' ' 11' ' ' LEU . . . -71.15 -51.1 26.88 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.834 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -61.75 -37.74 85.38 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -64.07 -49.2 73.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.456 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 43' ' ' GLY . 44.9 t -64.46 -36.1 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.374 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.49 -54.25 11.2 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.75 69.86 1.36 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.719 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.534 ' HB3' HG11 ' A' ' 9' ' ' VAL . 2.4 mtt180 -139.74 27.44 2.23 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.549 0.214 . . . . 0.0 111.51 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.834 HD21 ' HB1' ' A' ' 45' ' ' ALA . 0.7 OUTLIER -175.63 179.48 1.41 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.596 0.236 . . . . 0.0 111.036 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.11 -176.97 6.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.603 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.36 146.99 38.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.161 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.53 47.64 15.58 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.375 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -116.98 177.76 4.59 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.672 0.272 . . . . 0.0 111.1 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.745 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 9.3 tm0? -112.45 165.15 12.48 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.125 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.655 ' HG ' HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -148.16 126.3 12.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.782 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.25 -63.12 1.36 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.318 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.7 m -115.73 152.48 33.15 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 111.666 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.692 HG11 ' HG2' ' A' ' 77' ' ' MET . 39.0 t -133.14 113.81 20.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.875 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.2 36.44 23.85 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.208 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.55 -14.25 60.26 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.209 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -80.53 143.87 32.93 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 117.158 0.479 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.3 p -92.56 137.41 32.39 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.046 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.514 HD13 HG23 ' A' ' 60' ' ' VAL . 4.4 mp -137.91 87.54 2.26 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.267 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.6 t -135.87 87.11 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.752 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.73 -24.01 3.35 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.644 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.4 mt -72.71 175.12 6.71 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.198 0.523 . . . . 0.0 111.814 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -101.51 176.25 5.3 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.999 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.43 ' N ' ' HB2' ' A' ' 23' ' ' ALA . 44.1 tt0 -61.38 -39.16 89.65 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.091 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.23 -53.16 61.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.164 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -58.62 -48.36 81.27 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.137 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -59.44 -50.77 72.64 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.652 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.706 ' HB2' HD11 ' A' ' 21' ' ' ILE . . . -62.14 -40.5 96.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.777 0.322 . . . . 0.0 110.806 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.562 ' O ' HG22 ' A' ' 78' ' ' THR . 3.8 tp10 -64.86 -31.39 72.6 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.116 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.6 mt -79.35 -30.47 42.67 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.007 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.692 ' HG2' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -66.37 -29.8 70.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.391 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 75' ' ' GLU . 11.0 t -77.2 -31.24 55.17 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 121.156 -0.218 . . . . 0.0 110.787 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -95.35 56.81 1.9 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.816 0.341 . . . . 0.0 111.52 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.3 p -116.64 179.33 4.04 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.087 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.19 -174.13 4.08 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.797 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -53.56 -52.62 59.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.973 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.564 ' CG1' HG22 ' A' ' 10' ' ' THR . 19.2 t -92.79 146.34 6.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.83 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.7 t -135.0 133.62 53.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.27 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.88 101.6 8.42 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.512 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.65 ' CD2' HG13 ' A' ' 60' ' ' VAL . 4.1 mt -99.95 113.28 25.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.578 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.669 ' HG2' HG22 ' A' ' 6' ' ' ILE . 3.1 tt0 -81.37 95.53 7.05 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.994 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.655 HG12 ' HG ' ' A' ' 57' ' ' LEU . 31.9 m -101.28 166.32 2.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.142 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.745 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -119.98 142.53 48.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.656 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.237 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.701 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.821 0.343 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.58 HG22 ' HG2' ' A' ' 87' ' ' GLU . 3.7 mt -85.59 128.95 38.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.03 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 pt -146.01 149.63 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.972 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.481 ' HB ' ' HG3' ' A' ' 87' ' ' GLU . 6.4 t -106.72 142.61 36.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 110.825 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.477 HG23 HD11 ' A' ' 11' ' ' LEU . 2.9 m -131.3 137.14 56.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.532 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.2 m -87.1 112.34 21.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.761 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.477 HD11 HG23 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -122.28 164.39 17.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.738 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -122.58 148.69 44.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.73 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -85.08 107.28 17.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.706 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.82 56.8 2.7 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.619 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 57.31 39.52 28.42 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.167 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.73 171.41 39.6 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.66 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -138.71 -68.34 0.45 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.536 0.208 . . . . 0.0 111.069 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.76 65.5 3.5 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.106 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.438 HD23 HG22 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -144.48 108.94 4.85 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.594 0.235 . . . . 0.0 111.053 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.3 m -81.02 97.06 7.33 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.709 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pt -98.23 175.44 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.692 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' A' ' 35' ' ' TYR . 6.5 p -159.53 138.79 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.274 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.73 107.46 18.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.028 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -148.63 179.84 7.52 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.926 0.393 . . . . 0.0 111.583 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -97.12 168.47 10.43 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.27 -142.28 3.46 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.79 149.91 27.63 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.844 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.19 17.57 31.48 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.287 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.34 108.24 4.36 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.714 0.292 . . . . 0.0 110.786 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.69 25.38 3.12 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.765 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.9 mmtm -121.47 -155.43 0.64 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.239 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.6 99.02 4.51 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.845 0.355 . . . . 0.0 110.631 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.43 154.91 25.53 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.928 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.527 HD11 ' HB2' ' A' ' 73' ' ' ALA . 35.2 mm -88.95 100.14 10.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.882 0.372 . . . . 0.0 110.662 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.465 ' HB2' HG13 ' A' ' 22' ' ' VAL . 82.7 m-85 -89.84 153.89 20.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.605 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -99.97 113.61 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.758 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -82.52 -40.94 20.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.627 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 m -164.06 173.23 12.77 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.284 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.438 HG22 HD23 ' A' ' 19' ' ' LEU . 19.4 t -137.44 152.02 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.199 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.8 t -101.71 140.96 19.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.085 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.32 109.96 1.75 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.772 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.82 -24.83 4.78 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.0 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -62.63 159.94 33.92 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.813 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.9 -55.59 25.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.515 0.198 . . . . 0.0 111.475 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.74 -32.24 69.05 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.332 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.74 -55.28 8.99 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.018 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 43' ' ' GLY . 26.9 t -63.69 -46.69 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.283 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.56 -33.31 75.3 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.284 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.29 36.9 92.35 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.825 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -85.01 -32.21 23.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.525 0.202 . . . . 0.0 111.094 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.471 HD22 HG11 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -137.05 175.44 9.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.867 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.81 -171.08 3.17 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.01 149.76 47.37 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.152 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.06 50.94 25.77 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.418 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -120.51 176.2 5.62 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.631 0.253 . . . . 0.0 111.091 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.74 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 24.4 tm0? -128.69 139.06 52.42 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.107 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.625 HD21 HD23 ' A' ' 86' ' ' LEU . 6.4 mp -119.51 135.45 54.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.981 0.42 . . . . 0.0 111.206 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.558 HD12 HE22 ' A' ' 56' ' ' GLN . 0.1 OUTLIER -101.66 -59.52 1.69 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.466 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.7 m -117.68 163.21 16.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.898 0.38 . . . . 0.0 111.864 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 86' ' ' LEU . 47.8 t -145.85 136.4 18.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.96 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.47 ' HB3' HG22 ' A' ' 80' ' ' THR . 5.4 p-10 44.17 37.05 1.7 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.952 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.26 40.69 40.6 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.746 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.424 ' O ' HD12 ' A' ' 65' ' ' LEU . 69.0 mtt-85 -140.97 156.29 46.08 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.721 0.261 . . . . 0.0 110.679 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 m -86.49 128.33 34.95 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.831 0.348 . . . . 0.0 111.001 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.62 HD23 ' HA ' ' A' ' 73' ' ' ALA . 5.4 mp -137.88 37.01 2.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.437 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.46 ' O ' HG22 ' A' ' 66' ' ' VAL . 13.2 p -114.07 45.5 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.66 0.743 . . . . 0.0 110.665 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.51 36.27 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.174 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.486 HD21 ' HA ' ' A' ' 65' ' ' LEU . 1.7 pp -144.82 169.99 16.97 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.671 0.272 . . . . 0.0 110.926 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.55 177.42 8.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.199 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -63.34 -34.06 76.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.289 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -50.93 71.9 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.652 0.263 . . . . 0.0 110.92 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -62.62 -42.74 99.76 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.458 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.62 ' HA ' HD23 ' A' ' 65' ' ' LEU . . . -67.0 -54.14 24.64 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.509 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.35 -35.69 74.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.826 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.404 ' O ' HG22 ' A' ' 78' ' ' THR . 3.8 tp10 -69.86 -29.41 66.64 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.133 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.57 HD23 ' HD2' ' A' ' 79' ' ' ARG . 24.3 mt -79.48 -37.62 36.38 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.77 -0.196 . . . . 0.0 111.028 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.484 ' CG ' HG11 ' A' ' 60' ' ' VAL . 5.9 mtm -68.76 -32.38 72.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.405 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 75' ' ' GLU . 15.1 t -73.79 -30.29 62.66 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.491 0.186 . . . . 0.0 111.217 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.57 ' HD2' HD23 ' A' ' 76' ' ' LEU . 17.6 ptp180 -92.71 44.3 1.15 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.448 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 61' ' ' ASP . 17.2 p -102.89 161.04 14.07 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.831 0.348 . . . . 0.0 111.434 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.2 p -95.86 -166.49 1.44 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -39.17 68.87 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.868 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 t -103.46 142.06 18.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.087 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.532 HG12 ' CD1' ' A' ' 86' ' ' LEU . 16.9 t -145.74 142.14 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.271 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.426 HG22 ' OG1' ' A' ' 8' ' ' THR . 0.1 OUTLIER -123.16 112.62 17.92 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.457 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.625 HD23 HD21 ' A' ' 57' ' ' LEU . 10.3 mp -110.39 119.56 39.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.239 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.58 ' HG2' HG22 ' A' ' 6' ' ' ILE . 3.5 tt0 -81.44 85.44 6.47 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.335 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.471 HG11 HD22 ' A' ' 51' ' ' LEU . 25.6 m -80.31 173.08 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.417 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.74 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -143.66 125.92 15.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.633 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.827 -179.911 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 89' ' ' ALA . 3.0 tt0 . . . . . 0 C--O 1.234 0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.935 HG22 ' HG2' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -110.58 123.78 66.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.633 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.663 HD12 ' CG2' ' A' ' 9' ' ' VAL . 1.1 pt -126.3 138.58 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.388 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 1.6 m -94.03 120.4 34.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.875 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.663 ' CG2' HD12 ' A' ' 7' ' ' ILE . 21.8 t -124.45 142.64 40.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.891 0.377 . . . . 0.0 111.224 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.404 HG22 HG23 ' A' ' 85' ' ' THR . 2.2 p -80.3 147.34 31.19 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.2 mt -144.49 128.82 17.85 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.831 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -91.34 146.53 23.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.939 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -69.42 110.71 4.85 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.601 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -101.04 68.69 1.27 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.567 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.5 t30 57.98 40.13 25.85 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.145 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.3 177.7 14.99 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.79 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.9 mmm -129.94 103.32 6.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.626 0.25 . . . . 0.0 110.693 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.409 ' HA3' ' HB ' ' A' ' 40' ' ' VAL . . . -98.59 79.85 0.57 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.865 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.541 HD21 ' CB ' ' A' ' 45' ' ' ALA . 4.5 mp -146.63 124.26 11.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.585 0.231 . . . . 0.0 110.853 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.1 m -89.5 138.56 31.35 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.031 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.459 HG21 ' HE3' ' A' ' 77' ' ' MET . 1.2 pp -136.85 169.08 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.755 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 35' ' ' TYR . 7.3 p -157.79 141.42 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.294 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.07 94.74 7.33 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.636 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.425 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -129.71 179.17 5.99 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.462 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -123.38 -179.82 4.46 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.289 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.29 -141.77 3.22 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.01 153.52 19.82 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.735 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.41 22.59 38.63 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.094 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.21 102.06 7.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.541 -0.329 . . . . 0.0 111.133 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.38 16.6 8.48 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 -168.95 2.94 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.109 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.461 HD12 ' HA ' ' A' ' 32' ' ' LEU . 3.2 tp -119.68 133.58 55.57 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.56 0.219 . . . . 0.0 110.689 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.06 147.68 18.88 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.662 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 57' ' ' LEU . 39.3 mm -80.89 92.03 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.876 0.369 . . . . 0.0 110.223 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.427 ' HB2' HG13 ' A' ' 22' ' ' VAL . 20.2 m-85 -75.18 155.24 37.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.488 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.5 t -102.36 109.07 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.585 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.12 -42.85 75.5 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.804 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.77 179.44 0.71 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.183 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.44 146.93 28.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.019 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.409 ' HB ' ' HA3' ' A' ' 18' ' ' GLY . 22.3 t -95.96 131.07 43.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.364 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.6 139.01 58.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.864 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.5 -17.24 59.64 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.082 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -72.31 -164.83 7.61 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.716 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.601 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . . . -87.37 -43.44 12.12 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.541 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -68.64 -42.59 77.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.783 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -59.12 -45.86 89.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.404 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 43' ' ' GLY . 29.1 t -73.39 -33.71 41.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.41 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -55.38 34.17 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.292 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.74 61.12 1.63 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.608 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.464 ' CD ' HG11 ' A' ' 9' ' ' VAL . 1.8 mmp_? -121.49 -44.49 2.35 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.527 0.203 . . . . 0.0 111.189 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.402 ' HB3' HG11 ' A' ' 88' ' ' VAL . 1.3 pp -130.32 174.2 10.07 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.865 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.95 -168.06 2.83 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.3 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.11 142.91 50.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.192 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.07 49.53 4.97 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.325 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.21 -179.85 5.08 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.458 0.17 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.67 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 46.6 tt0 -130.84 134.0 46.43 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.723 0.297 . . . . 0.0 111.354 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.61 HD22 HD12 ' A' ' 86' ' ' LEU . 87.7 mt -110.85 131.27 55.19 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.486 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.21 -56.77 2.16 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.687 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -117.9 147.27 43.27 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.003 0.43 . . . . 0.0 111.987 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.809 HG22 HD11 ' A' ' 86' ' ' LEU . 57.7 t -126.94 103.92 11.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.318 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.487 ' HB2' HG23 ' A' ' 84' ' ' VAL . 4.4 t0 60.78 39.39 17.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.992 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.67 -23.29 29.05 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.299 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -74.31 132.45 42.08 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 117.227 0.513 . . . . 0.0 110.934 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.0 p -91.2 120.5 32.17 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.673 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.741 ' HA ' HD12 ' A' ' 68' ' ' LEU . 3.1 mp -110.09 43.41 1.37 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.851 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.99 86.55 2.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.66 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.0 27.47 3.99 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.584 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 65' ' ' LEU . 29.0 mt -109.02 176.01 5.25 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.883 0.373 . . . . 0.0 110.934 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.5 m -107.36 168.44 9.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.024 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.419 ' HG3' HD12 ' A' ' 21' ' ' ILE . 35.3 tt0 -57.52 -35.46 70.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.118 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -58.76 -54.61 45.16 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.907 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.42 ' HG3' HD22 ' A' ' 68' ' ' LEU . 49.2 mmt-85 -61.7 -46.11 91.07 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.985 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.07 -55.37 35.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.392 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.26 81.39 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.154 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -60.62 -33.06 72.21 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.315 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.2 mt -81.19 -40.73 23.44 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.019 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.459 ' HE3' HG21 ' A' ' 21' ' ' ILE . 11.7 mtp -66.84 -41.48 87.33 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.191 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.675 HG23 ' HG3' ' A' ' 79' ' ' ARG . 13.2 t -61.64 -33.29 73.68 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.173 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.675 ' HG3' HG23 ' A' ' 78' ' ' THR . 84.5 mtm180 -101.72 65.1 1.0 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.803 0.335 . . . . 0.0 111.126 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.465 HG21 HG21 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -104.88 159.99 15.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.873 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 t -76.7 -172.23 2.17 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.835 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.9 p -53.0 -33.51 52.01 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.128 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.9 t -131.28 127.68 60.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.191 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 61' ' ' ASP . 9.3 p -113.1 129.37 68.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.538 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.404 HG23 HG22 ' A' ' 10' ' ' THR . 0.0 OUTLIER -97.45 85.73 3.7 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.874 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.809 HD11 HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -87.13 119.03 26.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.335 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.935 ' HG2' HG22 ' A' ' 6' ' ' ILE . 27.2 tt0 -88.76 102.6 15.16 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.859 0.361 . . . . 0.0 110.227 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.477 ' HA ' HD23 ' A' ' 57' ' ' LEU . 12.5 p -96.19 147.99 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.963 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.67 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -113.52 129.88 56.46 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.544 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.246 0 O-C-N 123.375 0.422 . . . . 0.0 110.852 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.095 0.474 . . . . 0.0 111.376 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.458 HG22 ' CG ' ' A' ' 87' ' ' GLU . 3.4 mp -91.54 128.01 43.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.532 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.832 HD12 HG13 ' A' ' 9' ' ' VAL . 1.1 pt -139.44 143.62 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.82 0.343 . . . . 0.0 111.583 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.68 HG23 ' HB2' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -98.28 111.75 23.98 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.84 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.832 HG13 HD12 ' A' ' 7' ' ' ILE . 14.6 m -107.42 144.03 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.441 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.3 m -99.4 143.41 29.68 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.998 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.509 HD21 ' N ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -145.53 167.72 22.32 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.222 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.61 ' CD ' HG22 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -119.1 137.81 53.32 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.525 179.617 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -64.1 100.69 0.34 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.922 0.391 . . . . 0.0 111.049 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.21 73.59 2.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.433 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.58 36.78 28.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.097 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 130.24 -159.43 22.73 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.306 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.2 mmt -127.32 -59.11 1.25 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.654 0.264 . . . . 0.0 110.988 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.11 55.52 4.77 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.505 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.714 ' HG ' HG13 ' A' ' 39' ' ' VAL . 4.1 mp -145.58 118.46 8.73 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.555 0.217 . . . . 0.0 110.774 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -80.76 100.77 8.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.862 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 pt -100.69 174.69 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.65 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 35' ' ' TYR . 2.8 p -157.77 135.91 2.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.257 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.05 89.75 3.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.499 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.52 178.52 6.41 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.738 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.35 168.11 11.8 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.869 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -151.43 -143.28 3.68 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.86 152.1 26.2 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.93 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.56 19.26 33.8 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.183 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.41 109.18 4.74 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.737 0.303 . . . . 0.0 110.957 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -92.75 25.02 3.29 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.713 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -124.01 -151.54 0.48 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.66 109.46 8.64 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.672 0.273 . . . . 0.0 110.443 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.53 164.42 15.52 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.748 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 73' ' ' ALA . 31.1 mm -91.85 138.39 19.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.661 0.267 . . . . 0.0 110.667 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.433 ' HB2' HG13 ' A' ' 22' ' ' VAL . 97.8 m-85 -130.13 138.41 50.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.183 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.22 99.83 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.929 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -73.21 -38.84 65.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.472 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 t -161.02 160.03 30.09 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.203 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.714 HG13 ' HG ' ' A' ' 19' ' ' LEU . 21.4 t -125.7 119.24 54.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.698 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.97 135.75 27.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.419 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -72.44 145.29 47.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.899 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.74 -15.08 63.29 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.181 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -71.61 -167.16 8.34 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.538 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.19 -38.18 16.61 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.509 ' N ' HD21 ' A' ' 11' ' ' LEU . . . -72.36 -43.73 63.59 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.27 -34.87 78.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.682 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 43' ' ' GLY . 39.7 t -81.7 -39.71 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 120.567 0.222 . . . . 0.0 111.119 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.2 -35.04 77.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.24 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.27 31.16 43.08 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.656 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -86.76 -41.29 14.23 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.609 0.242 . . . . 0.0 110.925 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.521 HD11 HD21 ' A' ' 19' ' ' LEU . 1.9 pp -141.77 169.36 17.74 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.945 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.13 -170.83 3.35 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.483 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.83 154.6 41.68 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.533 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.44 25.05 73.73 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.753 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.24 173.11 6.45 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.814 0.307 . . . . 0.0 111.35 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.586 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 9.8 tm0? -109.25 162.37 14.36 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.988 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.628 ' CD2' HD23 ' A' ' 86' ' ' LEU . 4.5 mt -141.46 125.47 17.22 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.965 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.458 HD12 HE22 ' A' ' 56' ' ' GLN . 0.0 OUTLIER -113.48 -63.54 1.43 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.556 -179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.2 p -113.91 146.98 39.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.948 0.404 . . . . 0.0 111.84 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.702 HG13 ' HG ' ' A' ' 86' ' ' LEU . 54.1 t -139.87 125.86 21.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.475 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.516 ' HB2' HG13 ' A' ' 84' ' ' VAL . 10.4 t70 58.24 37.53 26.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.575 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.84 28.66 72.9 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.057 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -123.6 153.27 40.92 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.939 0.369 . . . . 0.0 110.845 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.6 p -95.19 135.65 36.5 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.138 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.755 HD21 HD12 ' A' ' 76' ' ' LEU . 10.0 mt -126.9 38.82 4.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.045 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.4 t -99.16 94.72 3.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.976 0.417 . . . . 0.0 110.405 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.86 33.81 2.33 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.462 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.825 HD22 ' HG2' ' A' ' 72' ' ' ARG . 37.8 mt -123.66 176.57 6.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.72 0.295 . . . . 0.0 110.685 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.7 m -98.86 165.31 11.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.153 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -58.53 -29.1 66.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.193 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -68.67 -34.77 76.26 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.611 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.825 ' HG2' HD22 ' A' ' 68' ' ' LEU . 1.8 mpt_? -67.45 -54.39 20.63 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.146 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.412 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -60.46 -41.23 93.72 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.649 0.262 . . . . 0.0 111.272 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.61 -40.1 92.25 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.99 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -77.72 -30.56 51.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.518 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.755 HD12 HD21 ' A' ' 65' ' ' LEU . 10.2 mt -68.91 -41.41 78.25 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.313 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.445 ' HG2' HG11 ' A' ' 60' ' ' VAL . 54.8 mtt -60.45 -45.37 93.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.014 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.7 t -67.02 -29.74 69.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.677 0.275 . . . . 0.0 110.53 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -87.42 50.35 1.99 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.349 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.7 p -125.99 172.18 10.16 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.769 0.319 . . . . 0.0 110.917 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.6 p -86.88 -171.26 3.44 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.182 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 m -55.36 -36.7 66.61 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.018 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.61 HG22 ' CD ' ' A' ' 12' ' ' LYS . 29.3 t -108.01 139.91 28.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.165 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 61' ' ' ASP . 16.0 t -139.27 137.9 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.13 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.643 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -112.72 109.71 19.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.79 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.702 ' HG ' HG13 ' A' ' 60' ' ' VAL . 3.4 mp -105.32 122.56 46.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.179 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.68 ' HB2' HG23 ' A' ' 8' ' ' THR . 29.4 tt0 -92.92 106.75 18.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.408 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.613 HG12 ' HG ' ' A' ' 57' ' ' LEU . 20.7 m -109.67 171.38 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.654 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -124.75 128.89 49.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.808 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.249 0 CA-C-O 121.117 0.484 . . . . 0.0 110.943 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.304 0 CA-C-O 120.996 0.427 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 22.1 mm -80.42 128.44 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.959 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.712 HD12 HG13 ' A' ' 9' ' ' VAL . 1.7 pt -147.53 144.83 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.18 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 1.3 m -103.44 105.47 15.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.414 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.712 HG13 HD12 ' A' ' 7' ' ' ILE . 14.1 m -93.66 145.03 8.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.993 0.425 . . . . 0.0 111.596 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.4 m -95.71 101.96 13.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.524 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.683 HD11 ' HA ' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -102.24 141.79 34.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -109.65 115.43 29.86 Favored 'General case' 0 CA--C 1.526 0.054 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.767 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.63 122.8 12.9 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.252 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.835 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 0.4 OUTLIER -115.06 73.16 0.82 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.351 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 60.34 38.2 19.75 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.017 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.81 153.81 6.4 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.591 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.4 mtp -100.72 -65.21 0.98 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.615 0.245 . . . . 0.0 110.778 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.409 ' HA3' ' HB ' ' A' ' 40' ' ' VAL . . . 73.96 65.28 2.23 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.125 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.504 HD21 ' HB1' ' A' ' 45' ' ' ALA . 3.9 mp -142.2 111.8 6.68 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.777 0.322 . . . . 0.0 110.815 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 m -80.21 112.97 18.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.699 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 pt -114.68 173.71 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.594 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' A' ' 35' ' ' TYR . 4.3 p -148.17 137.65 16.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.232 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.98 108.6 21.34 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.51 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.446 ' N ' HD11 ' A' ' 32' ' ' LEU . . . -153.07 176.42 11.92 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.331 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HG3' HD22 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -108.91 172.66 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.01 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.57 -143.31 3.63 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.33 157.74 16.94 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.79 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.45 25.1 40.64 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -126.79 104.84 8.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.92 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -86.55 10.46 15.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.466 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.464 ' HB2' HG12 ' A' ' 66' ' ' VAL . 5.2 mmmt -144.53 -162.65 1.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.02 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.493 HD13 ' N ' ' A' ' 33' ' ' GLY . 0.4 OUTLIER -103.3 134.55 46.5 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.672 0.272 . . . . 0.0 110.308 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.493 ' N ' HD13 ' A' ' 32' ' ' LEU . . . -117.61 152.23 17.75 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.663 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.8 mm -93.52 132.27 38.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 120.679 0.276 . . . . 0.0 110.498 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.506 ' HB2' HG13 ' A' ' 22' ' ' VAL . 69.5 m-85 -121.94 163.47 19.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.224 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.42 ' CG2' HD23 ' A' ' 57' ' ' LEU . 22.0 t -115.83 135.46 55.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.099 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.29 -33.78 5.52 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.581 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.5 165.5 35.47 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.746 0.307 . . . . 0.0 111.325 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.4 HG13 ' HG ' ' A' ' 19' ' ' LEU . 23.7 t -140.31 126.14 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.576 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.409 ' HB ' ' HA3' ' A' ' 18' ' ' GLY . 34.1 t -62.34 131.58 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.427 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -80.51 98.18 7.47 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.607 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.83 -39.37 0.64 Allowed Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.697 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -68.83 160.15 52.26 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.538 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.835 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . . . -51.15 -38.82 54.28 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.683 ' HA ' HD11 ' A' ' 11' ' ' LEU . . . -55.69 -43.39 76.38 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.708 0.289 . . . . 0.0 111.166 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -76.53 -35.65 58.16 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.111 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 43' ' ' GLY . 38.2 t -68.64 -42.57 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.057 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.13 -44.5 87.84 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.247 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.47 27.56 65.32 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.667 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -82.72 -33.84 27.44 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.744 0.272 . . . . 0.0 110.884 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.46 ' C ' HD12 ' A' ' 51' ' ' LEU . 4.1 pp -130.39 -178.98 5.0 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.78 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.91 -162.48 1.53 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.255 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.3 151.0 20.06 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.009 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.47 50.56 9.55 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.425 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -132.54 179.19 6.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.741 0.305 . . . . 0.0 111.105 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 7.2 tm0? -116.34 161.1 19.55 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.681 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.649 ' HB3' HG12 ' A' ' 88' ' ' VAL . 2.3 pp -164.93 155.61 14.26 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.927 0.394 . . . . 0.0 111.776 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -145.18 -54.76 0.31 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.513 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -76.4 132.91 39.98 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.843 0.354 . . . . 0.0 111.558 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.739 HG11 ' HG2' ' A' ' 77' ' ' MET . 24.2 t -145.34 117.17 2.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.515 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.57 ' HB2' HG13 ' A' ' 84' ' ' VAL . 5.0 t0 58.53 40.3 23.94 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.039 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.26 23.14 78.42 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.984 -0.626 . . . . 0.0 112.984 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.0 mtt-85 -128.68 128.14 43.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.711 0.256 . . . . 0.0 110.324 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m -83.98 116.8 23.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.3 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.7 mt -98.77 76.98 2.21 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.594 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.464 HG12 ' HB2' ' A' ' 31' ' ' LYS . 25.5 t -122.54 96.64 4.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.6 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.25 37.77 0.91 Allowed Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.532 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 mp -135.03 179.31 6.4 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.785 0.326 . . . . 0.0 110.928 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.4 m -107.81 176.74 5.04 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.95 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -58.21 -39.88 80.16 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.679 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -51.12 70.7 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.907 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 47.1 mmt-85 -59.2 -50.87 72.36 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.17 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.94 -52.6 64.71 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.329 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.11 -45.64 92.3 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.051 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.47 -36.28 77.91 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.901 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 80' ' ' THR . 14.4 mt -77.11 -39.45 49.42 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.728 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.739 ' HG2' HG11 ' A' ' 60' ' ' VAL . 2.2 mtt -65.78 -32.82 74.56 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.04 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.2 t -78.9 -32.43 45.75 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.559 0.219 . . . . 0.0 110.905 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 43.6 mtp85 -89.63 50.54 1.92 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.703 0.287 . . . . 0.0 111.563 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 76' ' ' LEU . 13.5 p -120.68 -179.86 4.12 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.936 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -89.0 -173.02 3.91 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.08 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.6 p -56.6 -49.77 73.93 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.505 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.89 133.32 36.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.737 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 61' ' ' ASP . 21.3 t -139.46 125.68 23.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.22 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.84 111.92 23.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.708 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 59' ' ' SER . 2.7 mp -109.98 123.01 48.88 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.985 0.422 . . . . 0.0 111.421 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 19.2 tt0 -91.42 98.45 11.69 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.16 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.649 HG12 ' HB3' ' A' ' 57' ' ' LEU . 21.4 m -102.26 171.49 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.928 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.635 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -125.67 131.55 52.59 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.586 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp . . . . . 0 C--O 1.234 0.256 0 O-C-N 123.345 0.403 . . . . 0.0 110.602 179.775 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 . . . . . 0 C--O 1.234 0.262 0 CA-C-O 121.165 0.507 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.471 HG22 ' HB2' ' A' ' 87' ' ' GLU . 26.2 mm -92.81 94.64 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.89 137.06 34.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.265 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.442 ' CG2' HG22 ' A' ' 85' ' ' THR . 6.9 m -89.01 130.68 35.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.002 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 9' ' ' VAL . 27.4 m -113.41 111.31 35.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.114 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.41 101.55 13.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.39 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.562 HD22 ' CG ' ' A' ' 48' ' ' ASP . 81.6 mt -122.5 161.98 22.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.939 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 150.95 24.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.774 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.25 114.42 26.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.007 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.95 -38.1 6.74 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.192 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -160.32 42.54 0.19 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.047 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.29 -170.71 30.28 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.3 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.2 mmm -107.09 -48.03 3.56 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.508 0.194 . . . . 0.0 111.131 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.13 78.49 0.18 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.734 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.693 HD13 HG23 ' A' ' 21' ' ' ILE . 0.8 OUTLIER -158.23 144.56 17.35 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.815 0.34 . . . . 0.0 111.179 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -94.41 90.87 6.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.628 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.693 HG23 HD13 ' A' ' 19' ' ' LEU . 1.8 pt -96.38 163.42 2.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.614 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.7 p -141.04 138.54 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.147 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.34 89.99 3.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.675 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.82 176.06 7.56 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.515 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -96.88 168.76 10.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.28 -143.14 3.59 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.06 153.92 22.42 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.023 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.29 18.84 30.26 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.243 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.58 108.42 4.71 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -95.22 37.26 1.18 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.568 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.646 ' HB2' HG22 ' A' ' 66' ' ' VAL . 38.7 mmtm -140.21 -148.5 0.25 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.648 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -132.77 103.19 5.98 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 110.517 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.9 145.94 21.89 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.888 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.6 mm -87.47 99.32 8.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.805 0.336 . . . . 0.0 110.701 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -90.59 147.53 23.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.531 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.53 120.83 51.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.845 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -96.27 -35.36 11.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.972 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 t -162.51 158.96 24.3 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.054 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.1 t -123.71 128.38 74.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.621 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.4 t -68.37 120.89 16.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.056 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -59.58 109.01 0.81 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.742 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.39 -21.27 5.16 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.626 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.557 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.52 158.17 51.37 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.147 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.66 -41.1 21.59 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.13 -52.9 52.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.367 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -39.29 85.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.5 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 43' ' ' GLY . 40.9 t -71.82 -40.86 69.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.537 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.562 ' CG ' HD22 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -63.82 -54.72 30.62 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.588 0.232 . . . . 0.0 111.304 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.18 79.43 1.39 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.764 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.481 ' HG3' HD21 ' A' ' 11' ' ' LEU . 9.0 mmt-85 -144.1 -51.39 0.31 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.719 0.295 . . . . 0.0 110.943 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 pp -113.39 167.79 10.28 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.912 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.08 -166.8 2.17 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.241 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.02 150.04 26.59 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.271 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.22 40.99 8.77 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.721 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -131.62 177.04 7.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.791 0.329 . . . . 0.0 111.246 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.682 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 46.8 tt0 -122.13 150.32 42.36 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.002 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.6 mt -128.44 123.9 34.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.476 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.18 -63.63 1.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.424 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.7 m -111.37 151.77 28.07 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.929 0.395 . . . . 0.0 111.703 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.813 HG11 ' HG2' ' A' ' 77' ' ' MET . 42.9 t -141.45 132.33 26.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.654 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 t70 56.9 27.72 13.49 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.451 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.32 -7.78 81.28 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.862 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.453 ' NH1' HD22 ' A' ' 76' ' ' LEU . 12.2 ptp180 -111.23 135.35 51.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 117.427 0.613 . . . . 0.0 110.926 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.5 m -71.63 130.44 41.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.327 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.531 HD12 ' CG2' ' A' ' 60' ' ' VAL . 55.7 mt -112.78 33.61 4.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.893 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 31' ' ' LYS . 7.7 p -109.56 90.26 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.236 0.541 . . . . 0.0 110.382 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 31' ' ' LYS . . . 151.14 -30.26 0.98 Allowed Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.425 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.455 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -83.04 -169.64 2.62 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.684 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -98.51 169.66 9.37 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.665 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -55.6 -31.41 62.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.864 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.89 -48.08 60.09 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.242 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.455 ' HG3' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -56.29 -38.69 71.58 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.533 0.206 . . . . 0.0 111.018 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.26 -53.37 12.69 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.176 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.76 -37.93 74.51 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.408 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.67 -33.59 64.52 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.599 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.453 HD22 ' NH1' ' A' ' 63' ' ' ARG . 35.0 mt -79.71 -39.11 31.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.475 0.178 . . . . 0.0 111.123 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.813 ' HG2' HG11 ' A' ' 60' ' ' VAL . 12.2 mtp -66.45 -34.43 77.92 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.051 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.6 t -71.67 -38.14 70.69 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.87 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -91.21 58.02 3.57 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.925 0.393 . . . . 0.0 110.75 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 p -109.85 160.84 16.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.006 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.7 m -75.25 -179.23 4.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.943 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.4 m -53.5 -38.83 64.06 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.304 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.7 t -106.1 136.22 41.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.728 0.299 . . . . 0.0 110.707 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.419 ' CG1' HD11 ' A' ' 86' ' ' LEU . 16.3 t -124.71 142.66 40.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.474 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.442 HG22 ' CG2' ' A' ' 8' ' ' THR . 0.2 OUTLIER -124.39 100.19 6.56 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.728 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.669 ' CD2' HG13 ' A' ' 60' ' ' VAL . 2.1 mp -115.26 139.24 50.13 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.073 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.471 ' HB2' HG22 ' A' ' 6' ' ' ILE . 7.2 pt-20 -107.3 101.23 10.62 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.035 0.445 . . . . 0.0 110.292 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.3 p -89.0 137.61 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.751 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.682 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -95.85 119.31 34.12 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.264 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.646 179.611 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 1.5 tt0 . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.941 0.4 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.687 HG22 ' HG2' ' A' ' 87' ' ' GLU . 16.6 mm -90.83 108.19 19.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.839 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -135.69 138.63 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.418 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.474 ' HB ' ' HG3' ' A' ' 87' ' ' GLU . 6.1 t -104.38 143.17 33.36 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.238 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.768 HG21 ' HG3' ' A' ' 50' ' ' ARG . 13.6 p -128.93 137.33 57.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.304 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.456 HG23 HG23 ' A' ' 85' ' ' THR . 0.2 OUTLIER -81.21 96.64 7.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.899 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.611 HD21 ' HB3' ' A' ' 44' ' ' ALA . 8.7 tp -85.48 132.45 34.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.21 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.666 ' HG2' HG22 ' A' ' 83' ' ' VAL . 1.5 mmtt -108.46 115.78 30.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.376 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -67.36 120.7 14.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.374 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.08 -41.79 7.0 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.711 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -164.91 38.57 0.07 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.877 0.37 . . . . 0.0 111.187 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.73 -168.64 23.5 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.567 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.5 mtp -129.6 -66.47 0.8 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.543 0.211 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.475 ' HA3' ' HB ' ' A' ' 40' ' ' VAL . . . 65.81 74.17 0.54 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.174 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.1 mt -142.2 108.32 5.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.744 0.306 . . . . 0.0 111.046 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.7 91.05 5.83 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.554 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.685 HD13 HG23 ' A' ' 34' ' ' ILE . 1.6 pp -97.12 177.59 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.608 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.2 p -156.67 135.91 3.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.262 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.7 87.48 3.16 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.541 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.75 176.79 6.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.619 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 176.26 5.59 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.117 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.82 -143.45 3.68 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.95 150.31 27.91 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.899 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.76 18.03 37.3 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.342 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.77 108.83 5.2 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.642 0.258 . . . . 0.0 111.008 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.97 25.56 3.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.802 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.487 ' CB ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -120.99 -154.38 0.58 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 32' ' ' LEU . 1.5 tp -136.49 106.73 6.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.614 0.245 . . . . 0.0 110.576 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.84 152.26 20.93 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.93 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.685 HG23 HD13 ' A' ' 21' ' ' ILE . 40.5 mm -91.25 96.84 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.874 0.368 . . . . 0.0 110.673 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.418 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 77.3 m-85 -89.04 150.83 22.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.612 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 21' ' ' ILE . 30.7 t -106.85 131.04 57.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.704 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 pttp -116.89 -30.18 5.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.901 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.69 155.13 42.79 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.956 0.408 . . . . 0.0 111.777 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.8 t -138.18 120.86 19.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.171 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.475 ' HB ' ' HA3' ' A' ' 18' ' ' GLY . 32.3 t -64.43 127.89 25.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.811 0.338 . . . . 0.0 111.477 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 103.7 1.64 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.337 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.5 -10.66 4.34 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.419 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.535 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -73.55 -158.14 4.95 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.413 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.611 ' HB3' HD21 ' A' ' 11' ' ' LEU . . . -91.17 -38.79 12.5 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.435 ' N ' HD11 ' A' ' 11' ' ' LEU . . . -71.62 -37.7 70.86 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -66.96 -35.31 79.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.482 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 43' ' ' GLY . 24.1 t -80.75 -42.21 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.607 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -53.79 54.29 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.63 0.252 . . . . 0.0 111.427 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.38 51.81 2.65 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.579 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.768 ' HG3' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -120.57 -51.03 2.18 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.621 0.248 . . . . 0.0 110.626 179.655 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 pp -109.13 139.03 44.57 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.536 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.0 177.35 5.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.26 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.53 150.8 46.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.796 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.53 40.62 18.2 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.102 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -126.16 177.71 6.23 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.739 0.304 . . . . 0.0 111.306 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.794 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 20.0 tm0? -124.47 149.02 47.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.439 HD22 HD12 ' A' ' 86' ' ' LEU . 29.3 mt -123.76 121.69 36.13 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.706 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.66 -53.21 3.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.785 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.87 157.17 40.04 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.171 0.51 . . . . 0.0 112.338 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.785 ' CG2' HD11 ' A' ' 65' ' ' LEU . 21.8 t -141.17 109.67 2.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.757 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.27 35.89 26.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.13 17.73 60.51 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.457 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.498 ' HD2' HD22 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -124.44 123.04 39.28 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.222 0.511 . . . . 0.0 110.408 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 m -82.63 135.4 35.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.205 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.785 HD11 ' CG2' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -110.31 -3.1 16.38 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.591 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.55 ' O ' HG13 ' A' ' 66' ' ' VAL . 7.7 p -67.58 87.07 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.418 0.627 . . . . 0.0 110.911 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.79 -18.61 2.77 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 113.008 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -91.65 -170.99 2.75 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.917 0.359 . . . . 0.0 111.105 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.18 176.99 4.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.368 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -59.38 -31.02 68.84 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.267 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -68.02 -38.77 82.97 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.515 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -67.06 -40.11 87.02 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.457 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.544 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -69.62 -52.93 21.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.518 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.12 -37.84 84.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.913 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.464 ' O ' HG22 ' A' ' 78' ' ' THR . 29.4 tp10 -71.24 -32.01 68.25 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.262 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.498 HD22 ' HD2' ' A' ' 63' ' ' ARG . 11.9 mt -78.01 -35.23 50.16 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.435 0.159 . . . . 0.0 111.358 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 12.4 mtt -70.67 -31.72 68.73 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.342 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 75' ' ' GLU . 13.1 t -74.43 -30.6 61.97 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.46 0.17 . . . . 0.0 111.46 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.417 ' HD2' HD23 ' A' ' 76' ' ' LEU . 4.7 ptp180 -89.17 49.18 1.73 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.745 0.307 . . . . 0.0 111.415 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.502 ' HB ' HG22 ' A' ' 84' ' ' VAL . 67.7 p -121.53 171.37 8.85 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.724 0.297 . . . . 0.0 111.351 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.4 p -90.01 -165.7 1.41 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.467 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 80.0 p -59.61 -34.37 72.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.156 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.666 HG22 ' HG2' ' A' ' 12' ' ' LYS . 32.2 t -111.9 139.34 36.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.741 0.305 . . . . 0.0 110.982 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.502 HG22 ' HB ' ' A' ' 80' ' ' THR . 15.5 t -142.73 130.38 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.286 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.456 HG23 HG23 ' A' ' 10' ' ' THR . 0.1 OUTLIER -92.21 116.3 28.83 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.691 HD13 HG22 ' A' ' 60' ' ' VAL . 4.0 mm? -111.37 114.03 26.9 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.113 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.687 ' HG2' HG22 ' A' ' 6' ' ' ILE . 2.1 tt0 -81.22 101.36 9.66 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.5 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.0 p -94.06 147.63 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.811 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.794 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -119.04 126.08 50.86 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.122 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.246 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.1 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 . . . . . 0 C--O 1.234 0.282 0 CA-C-O 121.104 0.478 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 23.8 mm -85.23 111.03 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.839 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.52 141.56 46.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.14 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 8.0 t -106.63 141.6 37.64 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.834 0.349 . . . . 0.0 111.299 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.9 p -119.5 128.45 75.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.349 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.0 m -82.95 94.5 7.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 mt -93.44 155.39 17.38 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.135 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HD2' HG22 ' A' ' 83' ' ' VAL . 1.0 OUTLIER -117.1 110.51 18.29 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.075 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -57.08 116.78 3.44 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.266 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -86.34 -47.73 9.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.556 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -166.21 42.54 0.06 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.46 -167.69 19.75 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.527 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.1 mmm -133.52 100.83 4.92 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.643 0.258 . . . . 0.0 110.791 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.22 79.98 0.6 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.547 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 mp -145.96 127.25 14.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.62 0.248 . . . . 0.0 110.749 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.32 99.27 11.04 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.882 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pt -96.61 175.4 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.472 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.647 HG13 ' HB2' ' A' ' 35' ' ' TYR . 3.4 p -159.81 148.3 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.598 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.78 124.76 46.88 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.464 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.36 -179.14 7.45 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -114.79 164.82 13.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.792 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.33 -144.17 3.85 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.59 164.03 13.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.811 0.339 . . . . 0.0 111.148 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.44 19.98 49.51 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.455 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.415 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -122.65 -165.8 1.34 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.137 0.494 . . . . 0.0 110.187 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.45 ' C ' ' HG2' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -169.84 20.39 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.36 178.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.767 ' HB2' HG22 ' A' ' 66' ' ' VAL . 6.0 mmmt -156.08 -164.17 1.64 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 32' ' ' LEU . 0.9 OUTLIER -114.01 106.32 14.27 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.838 0.352 . . . . 0.0 110.523 179.175 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.79 -173.05 27.94 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.212 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.635 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 9.2 mm -99.33 152.91 4.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.603 0.239 . . . . 0.0 110.725 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.647 ' HB2' HG13 ' A' ' 22' ' ' VAL . 18.9 m-85 -135.37 164.22 28.24 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.351 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.62 115.78 44.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -101.58 -33.11 10.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.946 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.2 161.13 21.96 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.926 0.393 . . . . 0.0 111.386 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.4 t -135.7 115.72 17.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.683 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.46 136.48 26.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.416 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 145.09 53.39 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.022 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.08 -22.67 39.45 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.959 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.592 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.04 174.62 36.71 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.775 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.94 -37.57 75.91 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.701 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -72.6 -37.76 68.02 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -67.75 -49.05 64.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.502 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 43' ' ' GLY . 46.9 t -63.86 -31.15 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.632 0.253 . . . . 0.0 111.314 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.78 -55.97 16.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.404 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.2 31.69 16.25 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.889 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -111.27 27.38 9.73 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.753 0.311 . . . . 0.0 110.933 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.701 HD21 ' HB1' ' A' ' 45' ' ' ALA . 3.4 pp -172.82 171.91 4.23 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.966 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.64 171.52 16.77 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.468 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.32 136.85 57.54 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.024 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.06 49.27 3.13 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.091 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -130.83 179.18 6.12 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.744 0.307 . . . . 0.0 111.243 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.87 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -118.45 173.14 7.0 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.918 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 86' ' ' LEU . 6.0 mt -151.67 119.23 6.06 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.668 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.35 -64.02 1.19 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.196 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.8 m -126.08 151.5 47.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.569 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.777 HG13 ' HG ' ' A' ' 86' ' ' LEU . 52.6 t -135.78 118.16 21.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.773 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.517 ' HB2' HG13 ' A' ' 84' ' ' VAL . 3.2 t0 58.33 40.31 24.59 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.965 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.24 29.13 68.9 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.834 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.447 ' HD3' HD22 ' A' ' 76' ' ' LEU . 32.9 mtt-85 -123.84 144.25 49.85 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 m -91.16 120.78 32.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.788 0.328 . . . . 0.0 111.39 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.669 ' HA ' HD21 ' A' ' 68' ' ' LEU . 4.2 mp -111.54 -5.74 14.5 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.821 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.767 HG22 ' HB2' ' A' ' 31' ' ' LYS . 12.0 p -81.99 71.38 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.857 0.837 . . . . 0.0 110.181 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 155.07 40.23 0.02 OUTLIER Glycine 0 CA--C 1.523 0.571 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.275 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.669 HD21 ' HA ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -158.54 177.79 10.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.741 0.305 . . . . 0.0 111.048 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.55 179.29 5.19 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.268 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -61.6 -35.54 78.15 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.322 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -54.6 -52.5 61.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.72 0.295 . . . . 0.0 110.798 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -62.65 -41.78 99.24 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.812 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.635 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -56.25 -56.21 23.79 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.499 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.38 93.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.022 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.5 ' HA ' HG22 ' A' ' 78' ' ' THR . 7.6 tt0 -66.68 -28.4 68.42 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.24 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.447 HD22 ' HD3' ' A' ' 63' ' ' ARG . 25.3 mt -75.49 -34.39 60.86 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.676 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 mtt -77.99 -39.2 43.12 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.321 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 75' ' ' GLU . 12.7 t -63.34 -32.8 74.31 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.778 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -90.9 57.65 3.58 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.192 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.413 ' HB ' HG22 ' A' ' 84' ' ' VAL . 51.7 p -122.79 178.47 5.02 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.096 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 m -108.43 -167.2 1.2 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.783 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.7 p -57.26 -30.32 64.55 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.478 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.501 HG22 ' HD2' ' A' ' 12' ' ' LYS . 21.9 t -117.44 137.7 50.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 120.652 0.263 . . . . 0.0 111.209 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.517 HG13 ' HB2' ' A' ' 61' ' ' ASP . 19.0 t -143.79 134.65 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.414 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.46 120.37 42.21 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.692 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.777 ' HG ' HG13 ' A' ' 60' ' ' VAL . 3.4 mp -114.67 117.13 29.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.283 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 1.6 mt-10 -81.28 93.04 6.45 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.646 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.572 HG13 ' HE3' ' A' ' 90' ' ' LYS . 10.9 p -87.61 141.22 14.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.541 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.87 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -106.94 139.74 40.85 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.146 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.572 ' HE3' HG13 ' A' ' 88' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.731 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.015 0.436 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 88' ' ' VAL . 4.0 mt -90.21 127.31 42.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.052 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.488 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.8 pt -141.67 146.79 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.264 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.496 ' HB ' ' HG2' ' A' ' 87' ' ' GLU . 2.7 t -101.49 147.16 26.7 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.156 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.604 HG11 ' HB3' ' A' ' 50' ' ' ARG . 26.9 m -124.99 128.86 73.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.462 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.547 HG23 ' CG1' ' A' ' 83' ' ' VAL . 88.0 m -87.78 102.5 14.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.487 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.412 HD21 ' HA ' ' A' ' 45' ' ' ALA . 3.4 mp -125.04 167.38 14.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.366 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -126.0 170.82 11.34 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.044 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -69.09 94.01 0.63 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.888 0.375 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.402 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -101.98 81.95 2.18 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.512 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 57.54 36.18 26.6 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.088 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.08 173.4 30.19 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.629 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.6 mmt -87.27 -73.02 0.49 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.559 0.219 . . . . 0.0 110.749 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.83 66.74 1.82 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.651 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.43 ' CD2' HD11 ' A' ' 51' ' ' LEU . 4.9 mp -145.74 117.89 8.35 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.646 0.26 . . . . 0.0 110.658 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.5 m -80.62 96.33 6.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.741 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.547 HG22 HG22 ' A' ' 36' ' ' VAL . 2.1 pt -105.11 175.99 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.59 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -156.32 141.24 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.241 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.28 92.82 6.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.639 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.508 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . . . -124.44 178.39 5.42 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.281 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HG3' HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -112.79 179.97 3.82 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.288 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.81 -143.7 3.74 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.676 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.49 161.82 18.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.702 0.286 . . . . 0.0 111.075 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.81 19.92 45.62 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.853 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.68 -163.01 0.9 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.231 0.539 . . . . 0.0 110.173 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -170.29 20.64 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.227 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.888 ' HB2' HG12 ' A' ' 66' ' ' VAL . 5.1 mttp -159.92 -168.81 2.33 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.48 0.312 . . . . 0.0 110.268 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.447 HD12 ' HG3' ' A' ' 25' ' ' LYS . 1.5 tp -105.44 127.44 53.0 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.798 0.332 . . . . 0.0 110.994 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.88 147.55 16.27 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.518 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.505 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.6 mp -81.41 97.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.976 0.417 . . . . 0.0 109.981 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.508 ' CD2' ' HB3' ' A' ' 24' ' ' ALA . 22.7 m-85 -87.86 143.96 26.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.28 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 21' ' ' ILE . 38.9 t -103.52 122.8 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.847 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -92.09 -40.61 10.96 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.885 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 m -165.02 175.82 9.13 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.727 0.298 . . . . 0.0 111.168 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.412 HG13 ' HG ' ' A' ' 19' ' ' LEU . 21.3 t -126.39 145.37 34.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.154 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.9 t -84.49 146.55 6.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.529 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.39 140.97 52.21 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.062 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.19 18.12 80.12 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.506 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -96.38 176.22 32.53 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.234 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 14' ' ' GLN . . . -60.42 -62.18 2.06 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.412 ' HA ' HD21 ' A' ' 11' ' ' LEU . . . -57.64 -33.24 68.08 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.694 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -67.89 -56.81 7.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.109 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 43' ' ' GLY . 44.6 t -66.07 -35.25 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.75 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.13 -48.84 49.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.616 0.246 . . . . 0.0 110.896 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.46 87.59 0.72 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.627 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.604 ' HB3' HG11 ' A' ' 9' ' ' VAL . 8.3 mmt180 -146.27 -67.13 0.28 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.59 0.233 . . . . 0.0 110.857 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.43 HD11 ' CD2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -103.37 152.2 21.86 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.067 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.81 -162.2 1.18 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.181 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.36 144.08 53.54 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.516 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.71 50.58 6.42 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.248 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -130.62 131.95 45.21 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.449 0.166 . . . . 0.0 110.966 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.717 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 53.5 tt0 -92.73 145.85 24.1 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.745 0.307 . . . . 0.0 111.182 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -116.78 121.8 42.61 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.723 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -96.9 -47.16 5.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.209 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.5 m -138.94 152.83 48.04 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.099 0.476 . . . . 0.0 111.542 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.66 HG13 ' HG ' ' A' ' 86' ' ' LEU . 44.0 t -136.03 114.23 15.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.157 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.602 ' HB2' HG13 ' A' ' 84' ' ' VAL . 2.3 t70 62.07 35.93 15.62 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.443 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.38 -18.72 35.75 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.583 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.534 ' HD3' HD22 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -75.72 147.77 39.1 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 117.436 0.618 . . . . 0.0 111.038 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 p -95.83 116.26 28.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.818 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.595 ' HA ' HD21 ' A' ' 68' ' ' LEU . 5.1 mp -101.47 37.59 1.77 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.964 0.412 . . . . 0.0 110.7 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.888 HG12 ' HB2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -110.46 100.72 11.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.16 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.16 4.48 18.33 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.18 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.595 HD21 ' HA ' ' A' ' 65' ' ' LEU . 1.2 pp -113.29 163.32 14.97 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 117.184 0.492 . . . . 0.0 110.867 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 p -85.04 168.5 14.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.871 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -57.08 -28.43 62.6 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.494 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.59 -49.58 76.95 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.75 0.31 . . . . 0.0 110.269 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.401 ' HB3' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -68.47 -38.75 81.34 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.042 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.38 -55.77 27.78 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.434 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.15 94.43 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.136 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -62.75 -37.08 85.19 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.534 HD22 ' HD3' ' A' ' 63' ' ' ARG . 16.2 mt -70.83 -35.0 72.26 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.013 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.46 ' HG2' HG11 ' A' ' 60' ' ' VAL . 4.8 mtt -68.91 -40.99 78.79 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.096 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.5 t -67.53 -36.69 81.49 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.596 0.236 . . . . 0.0 110.614 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -88.59 56.24 3.7 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.888 0.375 . . . . 0.0 111.115 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.435 ' HB ' HG22 ' A' ' 84' ' ' VAL . 31.5 p -112.52 -175.14 2.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.635 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.9 m -102.0 -169.76 1.72 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -34.0 67.08 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.594 0.235 . . . . 0.0 110.968 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.547 ' CG1' HG23 ' A' ' 10' ' ' THR . 23.2 t -119.56 143.94 29.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.0 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.602 HG13 ' HB2' ' A' ' 61' ' ' ASP . 14.3 t -142.76 137.75 27.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.448 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.22 102.5 11.17 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.011 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.686 ' HB3' HD21 ' A' ' 57' ' ' LEU . 7.0 mp -94.56 117.22 29.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.074 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.496 ' HG2' ' HB ' ' A' ' 8' ' ' THR . 3.8 mm-40 -80.42 95.98 6.58 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.632 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 7' ' ' ILE . 35.8 m -86.98 170.39 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.35 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.717 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -138.38 125.95 22.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.094 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt . . . . . 0 C--O 1.234 0.265 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.674 179.813 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 89' ' ' ALA . 28.0 tt0 . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.937 0.398 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.739 HD13 ' HB2' ' A' ' 89' ' ' ALA . 22.2 mm -79.33 121.87 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.339 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 pt -145.35 146.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.373 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.1 t -121.18 124.77 45.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 110.961 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.6 t -120.89 145.94 26.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.197 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.587 HG22 ' CG2' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -90.91 112.24 24.01 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.677 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.1 152.69 29.27 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.254 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -110.1 158.81 17.91 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.496 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -99.97 133.7 43.96 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.206 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.2 -42.3 3.06 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.135 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -154.13 42.66 0.53 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.838 0.351 . . . . 0.0 110.983 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.44 -156.36 15.8 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.453 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.96 -58.66 2.04 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.492 0.187 . . . . 0.0 110.91 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.78 53.16 39.82 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.746 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.5 mt -142.88 116.71 9.31 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.66 0.266 . . . . 0.0 111.218 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.04 126.58 40.48 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.646 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.848 HG21 ' HE2' ' A' ' 77' ' ' MET . 1.5 pt -115.54 176.01 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.624 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.749 HG13 ' HB2' ' A' ' 35' ' ' TYR . 2.4 p -153.28 137.24 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.451 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.08 101.29 12.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.483 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -134.1 -179.66 5.69 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.411 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -114.04 169.11 9.25 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.19 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.06 -143.35 3.65 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.23 157.42 16.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.85 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.72 23.91 46.21 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.52 104.42 7.88 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.108 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.67 11.16 13.58 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.583 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.472 ' HB2' HG12 ' A' ' 66' ' ' VAL . 8.3 mmmm -146.06 -167.3 2.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.835 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 32' ' ' LEU . 6.1 tp -103.39 119.2 38.43 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.686 0.279 . . . . 0.0 110.593 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.63 177.73 25.87 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.739 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.541 HG21 ' HE1' ' A' ' 77' ' ' MET . 36.6 mm -103.77 150.93 6.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 120.733 0.302 . . . . 0.0 110.825 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.749 ' HB2' HG13 ' A' ' 22' ' ' VAL . 92.7 m-85 -137.92 150.26 46.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.03 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.7 t -80.72 95.39 2.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.628 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -42.19 98.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.965 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.1 t -175.33 166.52 3.36 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.417 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 46' ' ' ASP . 11.2 t -126.77 137.9 56.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.837 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -82.48 119.92 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.374 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -63.56 110.04 1.86 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.838 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.1 -3.2 14.31 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.518 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -79.12 -139.2 1.69 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.433 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.08 -62.2 1.27 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.487 0.184 . . . . 0.0 111.436 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . -63.0 -33.79 76.17 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.411 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.462 ' HB2' HG12 ' A' ' 39' ' ' VAL . 11.1 t70 -60.67 -39.91 90.16 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.223 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 43' ' ' GLY . 42.3 t -67.25 -39.98 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.636 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -59.32 -55.33 36.14 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.6 0.238 . . . . 0.0 111.29 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.62 19.53 37.46 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.312 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -33.65 26.37 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.147 0.474 . . . . 0.0 110.862 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.593 HD22 HG21 ' A' ' 88' ' ' VAL . 2.1 pp -123.99 163.68 20.88 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.17 175.64 9.92 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.276 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.23 145.13 56.63 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.196 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.68 47.04 8.17 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.97 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.26 -176.99 3.41 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.612 0.244 . . . . 0.0 110.844 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.806 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 10.5 tm0? -118.83 153.77 33.97 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.151 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.006 HD11 HD12 ' A' ' 86' ' ' LEU . 8.1 tt -137.77 135.75 36.63 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.809 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.07 -59.03 2.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.793 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.2 p -116.65 158.02 24.45 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.137 0.494 . . . . 0.0 112.097 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.737 HG11 ' HG3' ' A' ' 77' ' ' MET . 23.5 t -140.11 119.36 12.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.53 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t0 60.31 35.13 20.76 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.023 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.43 -5.91 71.09 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.581 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.3 mtt-85 -91.95 148.83 21.91 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 117.484 0.642 . . . . 0.0 111.187 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.5 m -89.12 139.81 30.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.237 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.597 HD13 HG23 ' A' ' 60' ' ' VAL . 5.0 mp -136.39 79.4 1.76 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.962 0.41 . . . . 0.0 111.377 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' A' ' 31' ' ' LYS . 16.6 t -130.45 95.37 2.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.363 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.97 -26.48 4.23 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.891 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 mt -73.13 176.11 6.14 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.836 0.351 . . . . 0.0 111.449 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 m -109.45 -178.25 3.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.039 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -59.04 -35.09 72.71 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.347 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -58.2 -59.04 5.92 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.624 0.249 . . . . 0.0 110.966 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.6 mmt-85 -61.88 -44.72 96.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.93 -54.92 41.63 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.104 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 78' ' ' THR . . . -59.48 -48.31 82.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.092 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.76 -38.64 78.89 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.982 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 80' ' ' THR . 7.6 mt -76.07 -35.88 59.23 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.097 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.848 ' HE2' HG21 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -76.43 -35.19 58.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.532 HG23 ' HG3' ' A' ' 79' ' ' ARG . 13.3 t -71.13 -39.06 72.22 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.538 0.208 . . . . 0.0 110.956 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.532 ' HG3' HG23 ' A' ' 78' ' ' THR . 46.4 mtp180 -93.77 59.96 2.89 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.882 0.373 . . . . 0.0 111.016 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 76' ' ' LEU . 31.7 p -117.06 169.41 9.44 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.995 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.99 -169.17 0.45 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.754 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.3 p -79.83 -52.49 7.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.808 0.337 . . . . 0.0 110.377 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.587 ' CG2' HG22 ' A' ' 10' ' ' THR . 7.6 p -89.34 74.49 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.581 0.705 . . . . 0.0 110.795 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.1 t -89.18 148.4 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.972 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.531 HG23 HG23 ' A' ' 10' ' ' THR . 3.1 p -110.61 117.04 32.42 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.661 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.006 HD12 HD11 ' A' ' 57' ' ' LEU . 4.2 mm? -111.73 122.22 47.22 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.296 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -87.65 83.17 7.23 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.035 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.593 HG21 HD22 ' A' ' 51' ' ' LEU . 22.0 t -89.3 145.9 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.536 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.806 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -110.2 117.12 32.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.166 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt . . . . . 0 C--O 1.233 0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 179.662 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 57.7 tt0 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.888 0.375 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.54 HD13 ' HB2' ' A' ' 89' ' ' ALA . 23.2 mm -82.04 126.41 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.196 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 pt -148.49 149.57 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.363 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 14.5 m -113.61 123.95 51.17 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.629 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.555 HG11 ' CG ' ' A' ' 50' ' ' ARG . 20.7 t -122.13 138.28 52.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.375 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.6 HG23 HG23 ' A' ' 85' ' ' THR . 0.2 OUTLIER -110.69 135.5 51.21 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.657 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -147.97 176.03 10.5 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.031 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -119.61 144.57 47.05 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.147 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -79.74 146.47 32.35 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.354 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -50.32 4.26 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.365 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -161.39 43.19 0.16 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.999 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.79 -160.54 19.41 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.53 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 90.4 mtp -142.61 101.75 3.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.92 80.63 0.63 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.369 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.539 HD21 ' CB ' ' A' ' 45' ' ' ALA . 1.2 mp -147.17 117.16 7.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.647 0.261 . . . . 0.0 110.494 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 p -82.0 131.55 35.25 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.949 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.649 HD13 HG23 ' A' ' 34' ' ' ILE . 1.5 pp -124.37 174.12 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.089 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.49 HG13 ' HB2' ' A' ' 35' ' ' TYR . 7.6 p -157.67 140.84 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.138 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.27 104.01 16.0 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.996 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.573 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -137.28 176.4 8.75 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.819 0.342 . . . . 0.0 111.691 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -101.93 175.1 5.66 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.311 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.33 -142.66 3.47 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.56 151.17 27.14 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.034 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.85 19.35 36.28 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.401 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.83 108.85 5.72 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.769 0.318 . . . . 0.0 111.185 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -95.15 30.8 2.06 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.322 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.447 ' CB ' HG12 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -130.96 -148.2 0.35 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tp -143.14 113.79 7.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.73 0.3 . . . . 0.0 110.753 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.75 152.97 19.16 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.564 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.649 HG23 HD13 ' A' ' 21' ' ' ILE . 31.4 mm -80.63 100.19 4.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.854 0.359 . . . . 0.0 110.444 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.573 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 17.5 m-85 -84.53 156.38 21.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.039 0.447 . . . . 0.0 111.258 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -105.68 112.94 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.763 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.36 -36.78 22.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.129 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -164.85 165.39 20.53 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.831 0.348 . . . . 0.0 111.224 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.9 t -130.39 112.78 23.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.859 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -60.95 130.49 25.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.092 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.7 149.52 46.48 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.07 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.24 -31.09 8.89 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.545 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -64.31 142.87 46.49 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.521 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.3 -38.57 53.6 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 1.04 ' HB1' HD12 ' A' ' 51' ' ' LEU . . . -52.82 -53.72 44.46 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.683 0.277 . . . . 0.0 111.4 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.84 -44.59 85.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.048 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 43' ' ' GLY . 33.5 t -61.82 -37.3 77.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.469 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.14 -53.32 59.09 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.083 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.88 44.49 1.51 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.159 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.555 ' CG ' HG11 ' A' ' 9' ' ' VAL . 4.5 mmp_? -142.79 31.89 1.43 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.736 0.268 . . . . 0.0 110.983 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.04 HD12 ' HB1' ' A' ' 45' ' ' ALA . 6.5 mt -149.87 168.62 23.23 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.447 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -171.12 151.97 3.34 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.125 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.23 152.18 45.41 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.886 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.11 52.68 26.38 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.782 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.11 171.36 11.97 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.72 0.295 . . . . 0.0 111.187 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.825 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 1.9 tm0? -110.18 154.54 23.21 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.825 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.735 HD21 HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -137.57 119.8 15.68 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.573 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tt -107.79 -55.99 2.29 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.024 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.8 t -103.42 145.69 29.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.05 0.452 . . . . 0.0 112.176 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.739 ' CG2' HD21 ' A' ' 65' ' ' LEU . 21.3 t -140.97 119.81 10.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.763 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' HG12 ' A' ' 60' ' ' VAL . 7.2 m-20 56.65 44.41 23.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.133 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.82 27.39 73.31 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.083 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -130.74 138.07 49.8 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.677 0.275 . . . . 0.0 110.33 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.7 m -92.85 124.61 36.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.789 ' HB2' HD12 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -130.53 83.18 2.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.266 0.555 . . . . 0.0 111.084 179.704 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' A' ' 31' ' ' LYS . 15.2 t -110.12 94.94 3.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.803 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.78 36.85 1.02 Allowed Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.488 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.789 HD12 ' HB2' ' A' ' 65' ' ' LEU . 32.6 mt -116.05 157.55 24.51 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.727 0.299 . . . . 0.0 110.792 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -77.11 160.58 28.92 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.524 ' HG3' HD12 ' A' ' 21' ' ' ILE . 58.4 tt0 -54.36 -35.24 62.56 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.954 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.37 -43.44 81.39 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.459 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -61.12 -53.34 58.23 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.492 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.45 98.79 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.316 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.75 80.77 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.603 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.523 ' O ' HG22 ' A' ' 78' ' ' THR . 1.6 tp10 -65.6 -35.7 81.59 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.248 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.424 HD23 ' HD2' ' A' ' 79' ' ' ARG . 16.2 mt -74.84 -35.87 62.38 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.095 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.9 mtt -69.15 -29.1 67.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.365 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 75' ' ' GLU . 14.7 t -79.7 -30.62 41.07 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 121.297 -0.161 . . . . 0.0 111.24 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.424 ' HD2' HD23 ' A' ' 76' ' ' LEU . 15.5 ptp180 -93.44 40.33 1.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.714 0.292 . . . . 0.0 111.216 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.8 p -93.11 170.08 9.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 111.515 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.6 m -103.57 -165.02 1.12 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.46 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.78 -35.89 71.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.135 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.6 t -93.17 149.66 4.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.799 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 t -134.43 91.69 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.109 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.6 HG23 HG23 ' A' ' 10' ' ' THR . 4.8 m -89.25 88.68 7.61 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.767 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.701 HD22 HD11 ' A' ' 57' ' ' LEU . 9.0 mt -106.36 139.89 40.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.511 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 12.1 tt0 -113.97 105.74 13.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.087 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.676 HG12 HD12 ' A' ' 57' ' ' LEU . 23.8 m -102.53 172.61 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.045 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.825 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -136.17 131.56 34.8 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.526 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 48.8 mmtt . . . . . 0 C--O 1.234 0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.802 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.068 0.461 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.66 121.87 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.759 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 pp -141.97 137.06 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.315 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.613 ' OG1' HG22 ' A' ' 85' ' ' THR . 3.7 t -99.04 138.89 35.49 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.069 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.55 136.06 46.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.421 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.626 HG23 HG23 ' A' ' 85' ' ' THR . 0.7 OUTLIER -80.15 95.9 6.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.869 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.97 134.31 34.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -90.98 176.7 6.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.059 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.28 130.75 54.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.148 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.02 -45.26 4.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.587 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -161.73 43.21 0.15 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.26 -164.25 14.52 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.794 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 16.3 mtp -119.05 99.99 7.07 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.731 0.301 . . . . 0.0 110.464 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.614 ' HA3' ' CG2' ' A' ' 40' ' ' VAL . . . -90.65 75.72 1.63 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.093 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.463 HD21 HD11 ' A' ' 51' ' ' LEU . 5.0 mp -147.93 108.41 4.13 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.571 0.224 . . . . 0.0 110.871 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -85.62 82.41 8.25 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.055 0.455 . . . . 0.0 110.27 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.849 HD13 HG23 ' A' ' 34' ' ' ILE . 1.2 pp -82.86 175.88 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.049 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' ' 35' ' ' TYR . 7.7 p -153.16 145.75 14.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.415 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -98.55 100.04 11.25 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.83 176.09 9.01 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.805 0.336 . . . . 0.0 111.566 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 178.47 4.55 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.19 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.81 -142.3 3.45 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.0 147.5 32.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.967 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.47 16.91 30.74 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.377 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.55 108.54 5.44 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.733 -0.234 . . . . 0.0 110.852 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -93.34 23.58 4.4 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.862 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.06 -158.51 0.72 Allowed 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 32' ' ' LEU . 0.9 OUTLIER -132.9 106.81 7.92 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.737 0.303 . . . . 0.0 110.943 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.22 153.38 24.37 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.699 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.849 HG23 HD13 ' A' ' 21' ' ' ILE . 33.5 mm -80.97 90.7 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-O 120.817 0.341 . . . . 0.0 110.523 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.402 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 20.2 m-85 -81.25 161.43 23.94 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.525 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 21' ' ' ILE . 47.6 t -122.93 126.01 73.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.639 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.21 -29.68 6.19 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.1 t -136.65 156.57 48.36 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.032 0.444 . . . . 0.0 111.852 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.02 133.48 26.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.481 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.614 ' CG2' ' HA3' ' A' ' 18' ' ' GLY . 30.0 m -61.07 134.02 26.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.885 0.374 . . . . 0.0 111.366 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.63 93.44 6.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.429 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.26 30.04 4.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.297 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.65 -139.39 10.26 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.688 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.86 -33.56 10.49 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.812 0.306 . . . . 0.0 111.76 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.22 -47.25 11.01 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.374 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -58.58 -38.82 78.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.345 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 t -76.63 -33.73 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.089 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -46.34 90.08 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.978 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.27 29.53 24.82 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.623 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -100.68 -41.63 6.84 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.703 0.287 . . . . 0.0 110.867 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.463 HD11 HD21 ' A' ' 19' ' ' LEU . 4.4 pp -129.44 162.11 28.84 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.781 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.91 -175.14 5.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.25 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.61 135.38 52.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.258 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.0 46.28 3.39 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.347 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -133.36 173.02 11.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.711 0.291 . . . . 0.0 111.296 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 49.1 tt0 -131.11 143.87 50.98 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.883 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.706 ' CD2' HD22 ' A' ' 86' ' ' LEU . 1.9 mp -112.97 122.26 47.09 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.252 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tt -94.34 -58.41 2.22 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.743 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 m -138.99 156.25 47.37 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.955 0.407 . . . . 0.0 111.524 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.704 HG13 ' CD2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -102.9 -167.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.141 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.524 ' H ' HG12 ' A' ' 60' ' ' VAL . 5.1 p-10 -67.22 68.81 0.08 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.09 0.471 . . . . 0.0 110.83 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 60' ' ' VAL . . . 98.99 25.37 9.67 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.559 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.504 ' HD3' HD22 ' A' ' 76' ' ' LEU . 5.0 mtm180 -135.61 147.67 48.73 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.653 0.227 . . . . 0.0 110.633 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 m -113.43 110.9 21.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.924 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.668 HD11 HG22 ' A' ' 60' ' ' VAL . 7.1 mt -102.02 68.6 1.13 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.672 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.18 97.55 3.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.34 -32.11 5.0 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.589 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.518 HD21 ' HA ' ' A' ' 65' ' ' LEU . 4.3 pp -68.29 168.72 11.85 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.004 0.431 . . . . 0.0 111.477 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.5 p -91.23 167.15 12.53 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.073 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.437 ' HG3' HD12 ' A' ' 21' ' ' ILE . 30.2 tt0 -55.42 -26.06 39.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.562 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.52 -46.92 71.42 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.804 0.335 . . . . 0.0 110.609 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -49.04 79.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.252 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.49 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -58.38 -51.7 68.7 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.111 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.98 -43.8 82.05 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -34.7 78.94 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.204 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.504 HD22 ' HD3' ' A' ' 63' ' ' ARG . 9.0 mt -74.82 -35.61 62.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.642 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.496 ' CE ' HG21 ' A' ' 34' ' ' ILE . 9.3 mtt -72.67 -38.31 67.66 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.063 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.0 t -68.06 -31.15 70.59 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 121.233 -0.187 . . . . 0.0 111.002 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -89.32 53.18 2.56 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.761 0.315 . . . . 0.0 111.423 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.506 ' HB ' HG22 ' A' ' 84' ' ' VAL . 52.7 p -127.06 166.77 16.97 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.228 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.31 -170.23 3.03 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.381 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 m -54.11 -43.9 70.82 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.253 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.5 t -103.2 135.73 39.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.938 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.506 HG22 ' HB ' ' A' ' 80' ' ' THR . 18.5 t -139.92 121.99 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.537 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.626 HG23 HG23 ' A' ' 10' ' ' THR . 0.2 OUTLIER -92.02 123.89 35.72 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.588 179.391 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.706 HD22 ' CD2' ' A' ' 57' ' ' LEU . 6.3 mt -131.47 134.08 45.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.707 0.289 . . . . 0.0 111.148 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 1.5 mt-10 -81.43 112.11 18.39 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.883 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.0 t -99.72 132.41 45.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.557 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -109.23 142.17 40.45 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.934 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp . . . . . 0 C--O 1.234 0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.899 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--O 1.234 0.275 0 CA-C-O 120.811 0.339 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.485 ' H ' HD12 ' A' ' 6' ' ' ILE . 3.8 mp -80.1 98.05 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.961 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 pt -106.26 157.78 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.324 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.1 m -124.46 128.79 49.53 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.871 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.458 HG11 ' HG3' ' A' ' 50' ' ' ARG . 20.3 t -137.4 151.73 26.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.406 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.93 106.31 18.33 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.717 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.07 154.9 17.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -117.84 137.82 52.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.057 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -72.44 111.44 7.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 110.924 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.53 86.37 2.4 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.599 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 56.61 38.14 29.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.134 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.92 -159.55 14.41 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 mmt -136.67 99.59 4.1 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.758 0.313 . . . . 0.0 110.96 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.28 72.34 1.34 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.657 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mp -142.19 128.44 19.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.632 0.253 . . . . 0.0 110.676 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.95 132.29 33.84 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.163 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 pt -133.84 171.08 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.973 0.416 . . . . 0.0 111.933 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.589 HG13 ' HB2' ' A' ' 35' ' ' TYR . 4.5 p -157.24 138.72 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.002 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.87 97.47 9.31 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.74 -179.82 5.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.511 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.25 -179.59 3.99 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.289 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.25 -142.36 3.41 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.97 155.86 17.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.795 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.55 23.6 43.65 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.408 -0.901 . . . . 0.0 110.955 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.26 103.39 7.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.534 -0.333 . . . . 0.0 111.272 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.448 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 10.5 t70 -87.22 9.21 20.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.435 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.931 ' HB2' HG12 ' A' ' 66' ' ' VAL . 4.3 mttt -142.59 -167.46 2.51 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.192 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tp -112.01 132.74 54.61 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.635 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.55 153.16 17.74 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.567 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.572 HD11 ' CB ' ' A' ' 73' ' ' ALA . 47.3 mm -83.5 101.32 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.892 0.377 . . . . 0.0 110.63 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.589 ' HB2' HG13 ' A' ' 22' ' ' VAL . 19.9 m-85 -87.96 136.75 32.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.551 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.81 115.66 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.104 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -73.73 -44.75 55.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.785 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.35 172.22 3.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 111.501 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.8 t -124.77 136.88 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.19 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.61 142.64 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.407 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -72.11 138.97 48.14 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.814 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.49 -14.2 65.36 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.25 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.64 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -73.93 -168.19 16.81 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.558 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.04 -54.5 6.46 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.831 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . -58.63 -39.96 81.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.299 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -58.99 -44.83 91.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.083 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 43' ' ' GLY . 38.4 t -75.56 -34.2 28.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.096 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.88 -38.99 70.89 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.114 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.19 27.03 71.88 Favored Glycine 0 CA--C 1.521 0.469 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.897 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.458 ' HG3' HG11 ' A' ' 9' ' ' VAL . 7.6 mmt180 -102.51 -34.37 9.15 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.553 0.216 . . . . 0.0 111.015 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.831 HD11 ' HB1' ' A' ' 45' ' ' ALA . 4.3 pp -122.38 175.98 6.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.05 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.96 -171.03 3.49 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.287 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.15 153.55 42.43 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.188 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.31 53.15 14.37 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.085 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.13 160.22 24.18 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.743 0.306 . . . . 0.0 111.135 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.548 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 4.9 tm0? -113.44 109.88 19.4 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.443 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.783 ' HG ' HG12 ' A' ' 88' ' ' VAL . 2.2 mt -85.76 119.31 25.95 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.364 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.64 -61.38 1.47 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.57 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.414 ' H ' ' HG2' ' A' ' 87' ' ' GLU . 2.9 m -120.61 156.99 30.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 111.705 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.666 HG22 ' CD1' ' A' ' 86' ' ' LEU . 38.5 t -135.54 113.87 15.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.559 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t0 64.47 20.69 12.24 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.311 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.36 -23.46 26.75 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.642 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.06 142.71 27.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.494 0.647 . . . . 0.0 111.148 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.76 122.84 36.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.95 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.8 mt -102.79 39.94 1.46 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.931 HG12 ' HB2' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -96.04 97.08 6.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.267 179.731 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.408 ' CA ' ' HB3' ' A' ' 31' ' ' LYS . . . 119.04 38.19 0.76 Allowed Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.305 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.5 mt -138.5 174.89 10.06 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.704 0.288 . . . . 0.0 110.757 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.6 m -94.8 165.81 12.29 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -55.65 -31.84 62.69 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.968 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -57.72 8.88 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.335 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -53.72 -48.23 69.82 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.664 -0.243 . . . . 0.0 111.621 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.572 ' CB ' HD11 ' A' ' 34' ' ' ILE . . . -65.01 -48.59 73.37 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.714 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.34 90.31 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.025 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -59.73 -26.9 66.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.361 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.3 mt -87.66 -48.27 8.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.593 0.235 . . . . 0.0 111.115 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.656 ' HE3' HD13 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -59.89 -31.36 69.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.076 179.731 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.442 HG23 ' HG2' ' A' ' 79' ' ' ARG . 15.2 t -74.25 -31.22 62.49 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.629 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.442 ' HG2' HG23 ' A' ' 78' ' ' THR . 12.5 mmt180 -87.1 49.67 1.86 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.734 0.302 . . . . 0.0 111.377 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.412 ' HB ' ' CG2' ' A' ' 84' ' ' VAL . 1.5 p -103.63 169.09 8.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.841 0.353 . . . . 0.0 111.234 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.87 -168.1 1.5 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.57 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 96.9 p -55.38 -36.84 66.82 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.271 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.8 t -122.96 138.33 53.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.621 0.248 . . . . 0.0 111.256 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.412 ' CG2' ' HB ' ' A' ' 80' ' ' THR . 3.6 t -141.37 147.76 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.504 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.4 m -102.7 99.26 9.22 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.856 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.727 HD12 HD22 ' A' ' 57' ' ' LEU . 4.5 mm? -106.55 136.47 46.27 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.259 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 59' ' ' SER . 1.2 pm0 -117.29 101.0 8.06 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.661 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.783 HG12 ' HG ' ' A' ' 57' ' ' LEU . 34.1 m -104.05 166.56 2.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.254 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -122.18 113.57 19.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.769 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? . . . . . 0 C--O 1.234 0.283 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.912 -179.884 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 C--O 1.233 0.209 0 CA-C-O 120.862 0.363 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.88 122.43 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.867 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 pt -127.17 150.37 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.508 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 m -88.92 120.63 30.5 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.093 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.18 138.81 37.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.113 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.534 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -115.33 107.13 14.83 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.821 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 51' ' ' LEU . 5.1 mt -100.7 164.97 11.62 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.139 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.459 ' HE2' HG22 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -138.62 111.08 7.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.131 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.25 103.76 0.12 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.325 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -53.11 5.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.738 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -149.54 38.81 0.78 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.985 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.34 -171.32 15.86 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.5 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.3 mtp -136.01 80.19 1.81 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.851 0.357 . . . . 0.0 111.027 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.55 80.87 1.76 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.727 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.526 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -153.36 139.09 17.92 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.85 0.357 . . . . 0.0 110.914 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.4 m -100.61 135.59 41.81 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 pp -126.73 178.18 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.798 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.454 ' CG2' ' HB2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -131.96 167.01 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.975 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 70' ' ' GLN . . . -145.41 80.9 1.61 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.546 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.44 -179.34 7.0 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.673 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.86 172.08 14.26 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.755 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -151.16 -143.95 3.82 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.666 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.76 151.52 27.67 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.855 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.56 18.88 39.4 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.086 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.31 112.77 5.61 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.657 -0.271 . . . . 0.0 110.877 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.52 23.9 4.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.96 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.661 ' CB ' HG12 ' A' ' 66' ' ' VAL . 15.6 mmtp -124.21 -149.58 0.43 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 32' ' ' LEU . 1.6 tp -129.5 119.14 23.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.691 0.281 . . . . 0.0 110.788 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.82 164.74 12.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.102 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 28.3 mm -99.55 133.06 43.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.454 ' HB2' ' CG2' ' A' ' 22' ' ' VAL . 54.8 m-85 -117.0 168.6 10.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.666 0.269 . . . . 0.0 111.178 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.22 108.99 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.855 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -73.41 -41.96 62.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.76 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.35 166.04 2.77 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.178 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.1 t -123.45 128.55 74.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.47 146.36 7.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.414 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.6 tptt -65.73 143.38 57.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.833 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.32 -32.62 6.95 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.598 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.19 150.35 46.7 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.62 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.54 -36.78 56.34 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.73 -46.85 74.13 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.56 0.219 . . . . 0.0 111.143 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.85 -40.35 88.27 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.027 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 37.8 t -74.0 -31.94 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.253 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.71 -55.97 26.86 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.336 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.2 29.3 31.22 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.922 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -99.2 -45.87 5.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.887 0.343 . . . . 0.0 110.731 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -109.37 177.95 4.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.914 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.81 177.54 10.89 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.6 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.74 152.43 45.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.271 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.33 49.08 41.27 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.978 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.56 173.71 7.01 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.761 0.315 . . . . 0.0 111.541 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.812 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 5.2 tm0? -115.85 161.29 18.99 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.979 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.685 ' CD2' HG12 ' A' ' 88' ' ' VAL . 0.2 OUTLIER -143.91 129.13 18.77 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.897 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.99 -60.56 1.62 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.461 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.432 ' H ' ' HG3' ' A' ' 87' ' ' GLU . 30.3 m -119.29 152.69 36.27 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.445 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.644 HG13 ' HG ' ' A' ' 86' ' ' LEU . 44.0 t -136.01 131.64 49.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.815 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t70 54.92 36.86 27.71 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.779 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.52 28.69 73.05 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.083 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.08 145.49 48.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.922 0.361 . . . . 0.0 110.856 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.9 m -90.94 111.56 23.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.774 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.725 ' CB ' HD21 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -123.58 76.71 1.44 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.156 0.503 . . . . 0.0 110.995 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.661 HG12 ' CB ' ' A' ' 31' ' ' LYS . 4.8 t -121.1 96.25 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.542 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.73 -30.75 2.93 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.743 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.725 HD21 ' CB ' ' A' ' 65' ' ' LEU . 4.0 pp -67.27 168.86 9.72 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.048 0.451 . . . . 0.0 111.86 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 m -91.39 172.3 8.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.527 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 10.8 tt0 -54.94 -28.63 52.57 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.054 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -61.81 -48.87 78.66 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-O 120.717 0.294 . . . . 0.0 110.77 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.567 ' HB3' HD22 ' A' ' 68' ' ' LEU . 6.1 mpt_? -63.78 -49.77 71.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.292 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.443 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -59.89 -54.32 47.5 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.511 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.84 94.36 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.882 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 78' ' ' THR . 0.5 OUTLIER -65.52 -35.35 80.61 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 179.472 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 mt -67.12 -30.06 69.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.148 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.4 mtt -73.81 -39.7 63.9 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.247 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 75' ' ' GLU . 11.6 t -68.93 -30.99 69.56 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.554 0.216 . . . . 0.0 111.194 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -89.79 49.54 1.74 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.84 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.2 p -123.92 172.16 9.14 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.912 0.387 . . . . 0.0 111.381 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.28 -171.42 3.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.637 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 p -51.71 -46.62 64.01 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.534 ' CG1' HG22 ' A' ' 10' ' ' THR . 22.5 t -97.96 137.97 24.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.661 HG12 HD12 ' A' ' 86' ' ' LEU . 3.5 t -128.54 130.93 69.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.92 98.43 8.28 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.271 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.661 HD12 HG12 ' A' ' 84' ' ' VAL . 0.5 OUTLIER -114.03 115.02 26.94 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.737 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -84.88 104.89 15.23 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.978 0.418 . . . . 0.0 110.773 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.685 HG12 ' CD2' ' A' ' 57' ' ' LEU . 32.5 m -92.01 168.31 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.803 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.812 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -127.64 133.52 49.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.659 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt . . . . . 0 C--O 1.232 0.18 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.319 -179.745 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 N--CA 1.463 0.218 0 CA-C-O 121.126 0.489 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.98 133.79 29.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.303 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.24 138.16 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.392 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.775 HG23 ' HB2' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -104.23 120.02 40.23 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.474 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -118.67 170.72 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.646 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.726 HG23 HG23 ' A' ' 85' ' ' THR . 0.2 OUTLIER -134.17 116.34 15.27 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.857 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.518 HD22 ' NE ' ' A' ' 50' ' ' ARG . 4.3 mp -126.07 165.91 17.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.142 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HG3' HG22 ' A' ' 83' ' ' VAL . 1.3 mptt -107.95 135.67 48.94 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.088 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 125.06 22.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.115 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -102.59 66.1 0.95 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.677 179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 56.99 38.49 29.39 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.3 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.13 -152.81 24.59 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.374 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.694 ' HB3' HD12 ' A' ' 19' ' ' LEU . 1.7 mtt -147.61 -72.99 0.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.709 0.254 . . . . 0.0 111.484 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.17 63.87 2.43 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.604 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 17' ' ' MET . 1.4 mp -143.82 123.8 13.57 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.499 0.19 . . . . 0.0 110.607 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -85.1 125.31 32.67 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.697 0.284 . . . . 0.0 110.989 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 pt -127.88 171.46 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.607 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 35' ' ' TYR . 6.4 p -159.6 138.5 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.302 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -99.2 97.26 8.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.817 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -131.15 -179.76 5.53 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.633 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HG3' HD12 ' A' ' 32' ' ' LEU . 1.1 ttmt -119.72 -179.91 4.04 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.84 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.13 -144.14 3.91 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.789 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.02 163.41 14.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.666 0.269 . . . . 0.0 110.918 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.44 20.93 52.97 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.564 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.94 -164.65 1.26 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.023 0.439 . . . . 0.0 110.092 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.539 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -173.39 21.24 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.254 178.73 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.539 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -154.35 -168.92 3.08 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.741 0.416 . . . . 0.0 110.221 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.4 HD12 ' HG3' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -113.24 116.94 30.55 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.873 0.368 . . . . 0.0 110.575 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.23 144.62 16.03 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.699 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.426 HD11 HD12 ' A' ' 68' ' ' LEU . 46.5 mm -77.55 99.59 2.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 120.955 0.407 . . . . 0.0 110.606 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.524 ' HB2' HG13 ' A' ' 22' ' ' VAL . 22.4 m-85 -86.89 144.84 26.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.404 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.431 HG11 HD13 ' A' ' 51' ' ' LEU . 18.4 t -93.95 118.73 40.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.985 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -80.21 -42.54 23.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.854 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.8 172.08 4.98 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.437 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.8 t -124.53 132.13 71.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.022 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.73 142.77 14.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.0 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 155.44 39.23 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.344 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.91 16.66 70.68 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.003 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.537 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -99.2 153.55 19.74 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.349 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . . . -54.0 -35.78 62.25 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.1 -32.64 56.76 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.344 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -76.43 -44.32 36.34 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.21 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 43' ' ' GLY . 34.6 t -65.47 -48.42 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.233 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.85 -31.97 61.79 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.33 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.9 54.98 2.91 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.935 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.518 ' NE ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -78.22 -62.94 1.52 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.701 0.286 . . . . 0.0 111.08 -179.659 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.946 HD23 HG21 ' A' ' 88' ' ' VAL . 1.9 pp -131.07 161.11 32.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.907 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.35 -177.06 3.67 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.08 144.32 57.33 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.412 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.01 44.08 46.87 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.546 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -112.71 179.84 3.86 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.648 0.261 . . . . 0.0 111.143 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.772 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 13.2 tm0? -127.31 158.53 36.97 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.082 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.63 HD22 HD22 ' A' ' 86' ' ' LEU . 6.0 mt -143.81 130.61 20.33 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.55 0.215 . . . . 0.0 111.18 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.71 HD23 HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -120.8 -59.59 1.73 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.787 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.5 m -90.48 139.66 30.48 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.024 0.44 . . . . 0.0 112.152 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.598 HG21 HD12 ' A' ' 65' ' ' LEU . 21.3 t -141.54 110.68 2.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.742 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 56.74 37.13 28.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.119 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.62 28.63 60.95 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.004 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -118.99 148.08 43.38 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.808 0.304 . . . . 0.0 110.68 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.4 91.81 7.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.774 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.659 ' HB3' HD21 ' A' ' 68' ' ' LEU . 24.9 mt -96.61 93.29 6.67 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.995 0.426 . . . . 0.0 110.945 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.71 HG22 HD23 ' A' ' 58' ' ' LEU . 8.2 t -138.86 94.74 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.137 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.9 37.25 0.97 Allowed Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.815 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.659 HD21 ' HB3' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -130.32 157.51 42.35 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.887 0.375 . . . . 0.0 111.057 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 p -74.29 168.13 20.24 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.374 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -58.57 -40.58 83.51 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.9 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -55.04 -40.32 70.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.945 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -66.54 -48.31 70.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.215 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.61 -49.1 67.41 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.235 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.75 -43.63 90.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.803 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HA ' HG22 ' A' ' 78' ' ' THR . 1.5 tp10 -64.98 -37.4 87.53 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.5 mt -73.27 -36.71 66.39 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.235 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.4 mtp -76.37 -34.52 58.91 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.801 -0.182 . . . . 0.0 111.429 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 75' ' ' GLU . 15.1 t -73.37 -39.89 64.78 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 121.216 -0.193 . . . . 0.0 110.851 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.429 ' HG3' HG23 ' A' ' 78' ' ' THR . 73.2 mtp85 -90.68 59.03 4.08 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.0 0.429 . . . . 0.0 110.57 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.418 ' HB ' HG22 ' A' ' 84' ' ' VAL . 43.4 p -114.29 164.29 14.11 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.289 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.1 p -79.4 -165.69 0.83 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.573 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.5 -51.98 67.27 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.538 0.208 . . . . 0.0 110.902 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.675 ' CG1' HG22 ' A' ' 10' ' ' THR . 26.3 t -100.61 138.47 24.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.018 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 80' ' ' THR . 19.4 t -132.82 127.55 55.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.563 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.726 HG23 HG23 ' A' ' 10' ' ' THR . 0.7 OUTLIER -97.59 107.31 19.79 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.472 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.63 HD22 HD22 ' A' ' 57' ' ' LEU . 24.4 mt -116.35 136.91 52.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.96 0.41 . . . . 0.0 111.452 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.775 ' HB2' HG23 ' A' ' 8' ' ' THR . 38.4 tt0 -106.66 97.3 7.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.109 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.946 HG21 HD23 ' A' ' 51' ' ' LEU . 19.7 t -98.8 139.05 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.785 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.772 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -100.84 118.28 36.59 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.677 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.258 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.866 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 . . . . . 0 C--O 1.233 0.22 0 CA-C-O 121.255 0.55 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.6 mm -91.6 128.43 43.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.83 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 pt -147.84 149.15 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.516 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.656 HG22 HG22 ' A' ' 85' ' ' THR . 1.3 m -118.91 130.96 56.0 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.848 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.755 HG11 ' HG3' ' A' ' 50' ' ' ARG . 13.6 t -125.89 141.09 46.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.409 ' HB ' ' CG1' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -83.74 92.61 7.76 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.632 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.566 HD21 ' HA ' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -84.89 131.64 34.48 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.27 138.86 31.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -68.81 155.33 40.37 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.918 0.39 . . . . 0.0 111.356 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.54 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -144.31 66.6 1.27 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.531 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 57.49 35.95 26.42 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.127 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.58 -172.54 27.1 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.508 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 11.7 mmm -112.31 -73.48 0.67 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.616 0.246 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.82 49.44 7.1 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.836 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.701 ' HG ' HG13 ' A' ' 39' ' ' VAL . 4.5 mp -148.54 110.15 4.47 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.604 0.24 . . . . 0.0 110.744 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 t -80.59 130.47 35.14 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.648 HD13 HG23 ' A' ' 34' ' ' ILE . 2.8 pp -130.15 178.32 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.658 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.2 p -148.52 145.19 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.409 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.14 84.92 2.41 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.329 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.76 179.21 4.21 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.531 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.84 176.97 9.24 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.745 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.33 145.14 13.28 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.16 155.56 40.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.873 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.39 19.87 48.83 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.49 -159.8 0.99 Allowed 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 123.421 0.689 . . . . 0.0 109.737 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -173.78 31.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.923 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.78 -171.57 3.72 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.624 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.62 106.01 15.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.72 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.66 174.81 33.62 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.801 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.648 HG23 HD13 ' A' ' 21' ' ' ILE . 30.7 mm -102.27 111.49 32.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.657 0.265 . . . . 0.0 110.711 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.454 ' CE1' ' HG2' ' A' ' 56' ' ' GLN . 81.7 m-85 -104.35 153.82 20.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.36 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.05 125.45 53.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.128 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.38 -34.81 8.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.337 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 m -164.87 168.32 17.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.763 0.316 . . . . 0.0 111.417 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.701 HG13 ' HG ' ' A' ' 19' ' ' LEU . 26.7 t -135.74 138.44 47.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.991 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.09 133.99 29.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.33 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.65 140.36 49.66 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.074 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.6 -14.46 64.87 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.304 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.55 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -72.22 -161.66 5.53 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.405 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.54 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . . . -90.77 -36.71 14.12 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.591 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -62.16 -51.37 68.13 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.87 -38.99 83.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.447 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 43' ' ' GLY . 41.6 t -73.45 -31.88 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.031 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.7 -44.05 85.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.099 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.8 51.78 14.22 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.681 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.755 ' HG3' HG11 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -121.71 -45.93 2.26 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.611 0.244 . . . . 0.0 111.294 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 pp -135.58 172.51 12.91 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.006 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.9 -160.12 1.09 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.381 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.8 152.96 43.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.574 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.03 48.1 21.67 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.159 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -121.31 170.61 9.44 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.736 0.303 . . . . 0.0 111.422 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.775 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 7.5 tm0? -119.45 135.01 54.94 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.916 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -120.97 129.32 53.38 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.804 0.335 . . . . 0.0 111.014 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.47 -61.4 1.6 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.459 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.3 p -111.45 146.63 36.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.061 0.458 . . . . 0.0 111.867 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.495 HG11 ' HG2' ' A' ' 77' ' ' MET . 21.9 t -132.11 119.19 39.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.479 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t70 59.95 35.26 21.64 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.04 -16.04 56.53 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.678 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -92.1 138.29 31.66 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 117.381 0.59 . . . . 0.0 111.096 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.15 114.44 25.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.825 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.2 mt -100.74 76.89 1.83 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.711 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 t -122.25 91.5 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.034 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.11 32.6 1.98 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.574 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.4 mt -123.15 155.67 36.57 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.744 0.307 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.1 m -74.03 158.75 33.74 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -55.06 -35.79 64.9 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.956 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.02 -44.21 97.2 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.919 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.31 -52.89 56.28 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.224 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.28 -52.04 66.37 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.569 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.64 -46.85 86.21 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.018 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.44 ' O ' HG22 ' A' ' 78' ' ' THR . 1.8 tp10 -62.54 -36.96 84.26 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.677 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.1 mt -69.39 -34.05 73.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.961 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.495 ' HG2' HG11 ' A' ' 60' ' ' VAL . 2.0 mtt -71.99 -39.53 69.2 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.114 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 75' ' ' GLU . 11.1 t -68.53 -32.35 72.23 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.564 0.221 . . . . 0.0 110.983 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -91.52 48.24 1.45 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.542 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.8 p -109.38 174.3 5.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.764 0.316 . . . . 0.0 111.207 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -84.9 -170.25 3.04 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.67 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -56.14 -37.83 70.02 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.684 0.278 . . . . 0.0 111.094 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 10' ' ' THR . 25.4 t -113.47 139.23 39.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.097 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.1 t -130.37 119.62 46.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.082 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.656 HG22 HG22 ' A' ' 8' ' ' THR . 0.3 OUTLIER -89.91 98.31 11.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.826 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.47 ' HG ' HG13 ' A' ' 60' ' ' VAL . 5.0 mp -103.17 127.15 50.55 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.12 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 4.6 tt0 -91.94 96.29 10.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.543 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.4 p -93.32 147.58 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.874 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.775 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -113.72 135.01 54.41 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.101 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.191 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.062 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--O 1.234 0.267 0 CA-C-O 120.991 0.424 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.825 HG22 ' HG2' ' A' ' 87' ' ' GLU . 1.4 mp -94.49 126.01 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.815 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.5 pt -138.41 143.21 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.403 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.54 HG22 HG22 ' A' ' 85' ' ' THR . 25.3 m -96.4 134.49 39.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.828 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -117.92 127.08 75.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.24 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.687 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -86.07 99.78 11.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.797 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.8 mt -107.79 157.58 18.02 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.965 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HG2' HG22 ' A' ' 83' ' ' VAL . 2.3 mttt -118.93 138.61 52.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.828 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -72.21 114.67 10.58 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.304 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.49 -41.1 7.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.611 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -160.39 44.12 0.2 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.49 -177.6 29.66 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.576 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.0 mtt -120.19 93.57 4.1 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.819 0.342 . . . . 0.0 110.895 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.8 71.38 3.0 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.486 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 45' ' ' ALA . 1.6 mp -146.09 115.56 7.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.571 0.224 . . . . 0.0 110.466 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m -80.07 129.52 34.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.906 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.526 HD13 HG23 ' A' ' 34' ' ' ILE . 2.9 pp -124.22 176.16 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.017 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.89 151.47 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.617 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' GLY . . . -107.13 115.2 29.76 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.785 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.65 -179.58 8.21 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.896 0.379 . . . . 0.0 111.909 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -94.43 167.11 11.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.861 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.05 -141.76 3.45 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.25 147.74 30.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.986 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.63 16.42 37.31 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.267 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.99 107.9 4.34 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.573 0.225 . . . . 0.0 110.951 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -93.37 25.15 3.52 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.946 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.29 -157.77 0.72 Allowed 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -132.68 108.53 9.1 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.808 0.337 . . . . 0.0 110.677 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 23' ' ' ALA . . . -107.31 -178.23 22.58 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.768 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.536 HD11 ' CB ' ' A' ' 73' ' ' ALA . 36.3 mm -97.48 129.04 48.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.617 0.246 . . . . 0.0 110.759 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.525 ' CE2' ' HG3' ' A' ' 56' ' ' GLN . 15.3 m-85 -114.2 166.03 12.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.139 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.21 109.55 28.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.844 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.05 -34.95 22.17 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.201 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.46 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 3.7 t -169.58 170.88 7.89 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.707 0.289 . . . . 0.0 111.518 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.404 HG13 ' HG ' ' A' ' 19' ' ' LEU . 17.0 t -130.7 151.41 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.213 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 t -101.53 139.86 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.147 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -58.74 136.29 57.69 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.043 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.28 -22.48 37.64 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.01 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -62.29 135.08 45.41 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.468 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.22 -36.34 19.83 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.587 ' HB3' HD21 ' A' ' 19' ' ' LEU . . . -60.25 -50.53 73.27 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 111.361 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -70.93 -45.56 64.01 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 43' ' ' GLY . 40.3 t -59.88 -36.42 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.396 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.62 -49.84 29.34 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.657 0.265 . . . . 0.0 110.914 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.04 60.56 1.06 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.809 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -123.37 -50.9 1.87 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.681 0.277 . . . . 0.0 110.936 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 pp -122.57 175.99 6.17 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.28 -174.89 5.14 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.305 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -69.75 165.81 20.59 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.356 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.59 45.72 88.14 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.34 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.22 172.98 11.94 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.799 0.333 . . . . 0.0 111.423 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.666 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -112.64 173.29 6.44 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.706 179.5 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.837 HD21 HD23 ' A' ' 86' ' ' LEU . 3.1 tp -155.84 133.05 10.77 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.066 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.657 HD12 HG22 ' A' ' 66' ' ' VAL . 3.9 mm? -115.4 -60.52 1.87 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.34 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 5.7 t -97.43 146.15 25.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.189 0.519 . . . . 0.0 112.14 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.698 HG23 HD21 ' A' ' 65' ' ' LEU . 34.4 t -140.41 126.66 21.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.596 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.8 t0 54.99 38.37 30.42 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.05 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.81 -12.92 45.93 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.707 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -90.73 158.78 16.69 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 117.399 0.6 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.57 108.04 16.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.43 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.698 HD21 HG23 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -110.83 96.76 6.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 110.988 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.657 HG22 HD12 ' A' ' 58' ' ' LEU . 17.2 t -125.03 92.61 2.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.814 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.16 36.24 0.88 Allowed Glycine 0 CA--C 1.518 0.271 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.313 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.522 HD22 ' HG2' ' A' ' 72' ' ' ARG . 12.4 mt -120.08 174.78 6.27 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.773 0.32 . . . . 0.0 110.728 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -98.23 163.71 12.61 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -57.09 -28.42 62.61 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.454 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -66.2 -49.2 68.11 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.739 0.304 . . . . 0.0 110.695 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.522 ' HG2' HD22 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -65.7 -45.5 82.58 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.365 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.536 ' CB ' HD11 ' A' ' 34' ' ' ILE . . . -64.81 -51.45 62.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.593 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.17 -37.04 78.96 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.749 0.309 . . . . 0.0 110.695 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 78' ' ' THR . 2.0 tp10 -67.9 -37.49 81.79 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.818 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mt -73.47 -40.81 63.85 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.163 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -32.66 74.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.172 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 75' ' ' GLU . 14.4 t -79.63 -33.5 41.33 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.881 -0.145 . . . . 0.0 111.388 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.81 46.04 1.35 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.688 0.28 . . . . 0.0 111.499 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 71.5 p -106.39 168.78 8.92 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.812 0.339 . . . . 0.0 111.026 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -80.62 -167.01 1.21 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.536 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.2 p -59.88 -39.8 86.52 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.674 0.273 . . . . 0.0 110.693 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.687 ' CG1' HG22 ' A' ' 10' ' ' THR . 19.6 t -105.03 142.73 17.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.804 179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.7 t -135.98 143.73 35.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.229 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.682 HG23 HG23 ' A' ' 10' ' ' THR . 0.0 OUTLIER -122.3 118.89 29.57 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.695 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.837 HD23 HD21 ' A' ' 57' ' ' LEU . 4.8 mp -120.2 120.81 37.22 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.415 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.825 ' HG2' HG22 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -81.68 93.19 6.72 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.476 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.544 ' HA ' HD12 ' A' ' 57' ' ' LEU . 9.1 p -88.18 137.31 21.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.641 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.666 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -105.62 126.57 52.29 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.038 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp . . . . . 0 C--O 1.233 0.208 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.445 179.859 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 41.1 tt0 . . . . . 0 C--O 1.234 0.279 0 CA-C-O 121.039 0.447 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 6' ' ' ILE . 3.7 mp -84.12 126.72 40.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.657 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 pt -145.86 146.65 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.566 ' OG1' HG22 ' A' ' 85' ' ' THR . 13.2 t -115.42 141.69 47.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.775 0.321 . . . . 0.0 111.107 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.579 HG11 HH11 ' A' ' 50' ' ' ARG . 2.0 m -141.73 148.78 20.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.502 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.691 ' CG2' HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -79.83 128.53 33.55 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.998 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.998 HD21 ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -120.4 121.93 39.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.712 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -101.04 99.13 9.53 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.701 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.3 130.28 43.89 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.176 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -78.95 -59.34 2.82 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.503 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -158.01 37.4 0.25 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.077 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.05 -163.96 28.62 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.359 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.1 mmt -139.4 101.46 4.24 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.674 0.273 . . . . 0.0 111.047 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.7 77.36 0.71 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.729 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.557 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -157.14 137.41 12.81 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 111.058 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -105.45 109.0 20.82 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.776 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 pt -102.91 178.29 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.473 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.461 HG13 ' HB2' ' A' ' 35' ' ' TYR . 2.5 p -155.42 134.42 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.228 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.29 104.24 16.13 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.63 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -143.74 -179.72 6.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.186 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.628 ' HG3' HD12 ' A' ' 32' ' ' LEU . 5.4 mtpt -101.46 179.36 4.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.846 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.53 -145.4 4.23 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.83 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.33 163.19 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.652 0.263 . . . . 0.0 110.921 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.49 20.13 44.14 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.555 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.81 -163.11 0.94 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.203 0.525 . . . . 0.0 109.962 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.437 ' C ' ' HG2' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -168.13 18.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.62 178.72 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HB2' HG12 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -156.97 -170.79 3.41 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.628 HD12 ' HG3' ' A' ' 25' ' ' LYS . 4.9 tp -99.54 123.96 44.29 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.607 0.241 . . . . 0.0 110.864 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.452 ' C ' HD12 ' A' ' 34' ' ' ILE . . . -118.16 175.03 15.54 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.806 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.564 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.6 mp -103.46 154.0 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 O-C-N 122.774 -0.25 . . . . 0.0 110.456 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.461 ' HB2' HG13 ' A' ' 22' ' ' VAL . 68.2 m-85 -136.14 158.46 44.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.249 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.468 HG21 HD13 ' A' ' 51' ' ' LEU . 22.4 t -102.94 108.84 25.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HD2' ' HB ' ' A' ' 22' ' ' VAL . 23.8 mtpt -81.71 -38.92 25.02 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.821 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.0 t -175.23 158.39 2.38 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.094 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.414 ' CG1' ' HB2' ' A' ' 46' ' ' ASP . 10.9 t -128.07 146.13 34.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.901 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.68 140.32 16.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.968 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -68.28 91.08 0.37 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.434 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.63 -32.35 0.48 Allowed Glycine 0 CA--C 1.519 0.342 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.493 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.602 ' O ' HG12 ' A' ' 47' ' ' VAL . . . -59.56 148.15 41.91 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.049 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -55.09 -21.08 11.49 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.998 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -86.94 -33.73 19.58 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.504 0.192 . . . . 0.0 111.442 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.414 ' HB2' ' CG1' ' A' ' 39' ' ' VAL . 0.7 OUTLIER -86.21 -49.13 7.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.264 -179.811 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 43' ' ' GLY . 8.2 p -62.83 -29.88 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.829 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.423 ' OD1' HG13 ' A' ' 47' ' ' VAL . 11.6 m-20 -86.83 -50.04 7.0 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.554 0.216 . . . . 0.0 110.552 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.52 93.14 2.28 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.389 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.579 HH11 HG11 ' A' ' 9' ' ' VAL . 2.9 mmp_? -143.18 -50.62 0.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.442 0.163 . . . . 0.0 111.056 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.704 HD22 HG11 ' A' ' 88' ' ' VAL . 2.4 pp -135.37 138.86 43.75 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.752 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.14 -170.52 1.67 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.304 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.28 153.66 42.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 111.121 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.83 37.29 65.91 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.284 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.46 173.88 6.12 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.769 0.318 . . . . 0.0 111.062 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.879 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -122.63 156.6 33.96 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.795 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.443 ' CD2' HG12 ' A' ' 88' ' ' VAL . 7.3 mt -133.95 135.13 43.32 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.152 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.658 HD23 ' CG2' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -120.41 -55.93 2.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.555 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.3 m -115.0 156.06 25.79 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.652 HG13 ' CD2' ' A' ' 86' ' ' LEU . 26.1 t -140.14 139.25 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.138 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.867 ' HB3' HG13 ' A' ' 84' ' ' VAL . 5.6 p-10 43.47 41.75 3.48 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.167 0.587 . . . . 0.0 111.793 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.8 32.55 74.13 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.807 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -132.75 145.37 50.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.932 0.366 . . . . 0.0 110.7 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.8 m -92.55 126.15 37.51 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.641 HD21 HG23 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -136.48 61.43 1.64 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.334 0.588 . . . . 0.0 111.022 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.658 ' CG2' HD23 ' A' ' 58' ' ' LEU . 10.5 t -102.74 98.44 6.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.676 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.6 -26.21 2.67 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.068 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' ' 65' ' ' LEU . 2.0 mt -76.54 174.09 10.75 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.802 0.334 . . . . 0.0 111.083 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.5 t -96.94 -176.57 3.6 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.972 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -60.1 -32.81 71.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 2.0 mp0 -58.54 -58.85 6.73 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.958 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.419 ' HB2' ' HB3' ' A' ' 68' ' ' LEU . 10.7 mmm180 -63.38 -42.78 98.85 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.267 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.08 -48.41 81.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.272 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.21 -44.85 71.24 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.749 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -60.46 -31.88 70.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.05 179.511 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mt -71.17 -36.54 72.03 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.727 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.592 ' HG2' HG11 ' A' ' 60' ' ' VAL . 3.2 mtt -67.62 -46.36 72.74 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.133 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.8 t -64.4 -27.92 69.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 121.213 -0.195 . . . . 0.0 111.043 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.4 mtm-85 -91.19 51.68 1.97 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.407 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.3 p -130.48 -177.29 4.27 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.865 0.364 . . . . 0.0 110.998 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 t -110.58 -165.5 1.0 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.562 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 t -54.73 -49.93 69.6 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.117 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.691 HG13 ' CG2' ' A' ' 10' ' ' THR . 60.2 t -86.95 126.15 40.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.217 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.867 HG13 ' HB3' ' A' ' 61' ' ' ASP . 25.4 t -145.9 110.2 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.231 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.566 HG22 ' OG1' ' A' ' 8' ' ' THR . 0.2 OUTLIER -84.35 120.14 25.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.658 179.791 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.652 ' CD2' HG13 ' A' ' 60' ' ' VAL . 49.8 mt -110.44 115.15 29.14 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.719 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 2.2 tt0 -87.2 92.16 8.97 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.353 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.704 HG11 HD22 ' A' ' 51' ' ' LEU . 30.8 m -94.39 173.55 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.354 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.879 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -128.88 120.67 26.63 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.076 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 8.9 mmtt . . . . . 0 C--O 1.234 0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.6 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 C--O 1.233 0.195 0 CA-C-O 121.215 0.531 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.2 mt -93.52 138.75 19.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.57 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 pp -145.35 141.99 22.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.438 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 2.2 m -101.9 114.41 28.48 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.816 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -127.97 162.34 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.642 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.36 142.36 29.33 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.188 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -114.13 129.3 56.62 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.832 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 82' ' ' SER . 6.8 mmtt -94.63 107.89 19.87 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.72 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -66.7 124.81 23.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.248 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -97.48 -53.57 3.41 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.857 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -154.46 36.3 0.42 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.32 -149.91 17.96 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.273 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.4 mmt -141.9 105.5 4.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.854 0.359 . . . . 0.0 111.055 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.12 36.2 4.2 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.475 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.7 ' HG ' HG13 ' A' ' 39' ' ' VAL . 3.9 mp -111.71 106.97 15.92 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 p -79.67 128.45 33.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.007 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.34 172.58 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.964 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.76 143.19 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.453 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.16 112.83 25.65 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.524 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -154.16 172.24 17.88 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.924 0.392 . . . . 0.0 111.779 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -113.83 161.2 17.86 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.063 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.79 -140.3 3.56 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.2 158.98 16.22 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.863 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.53 25.57 42.74 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.404 -0.903 . . . . 0.0 110.902 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.65 104.19 7.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.396 -0.402 . . . . 0.0 111.088 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -88.08 14.04 9.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.478 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.489 ' CB ' HG12 ' A' ' 66' ' ' VAL . 69.9 mmtt -145.85 -162.01 1.43 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.03 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.435 ' HA ' HD13 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -108.99 141.76 40.63 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.688 0.28 . . . . 0.0 110.672 179.491 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -123.41 144.49 15.64 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.658 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.506 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 35.8 mm -94.04 108.93 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -96.28 168.71 10.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 0.0 111.778 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.35 108.57 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.674 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -40.13 77.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.944 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.28 170.25 4.32 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.887 0.375 . . . . 0.0 111.552 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.7 HG13 ' HG ' ' A' ' 19' ' ' LEU . 37.1 t -134.84 127.67 49.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.597 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.96 137.81 23.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.136 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -65.27 152.92 42.53 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.36 20.34 69.42 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.928 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.39 -147.68 8.59 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.371 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.15 -43.41 6.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.658 0.266 . . . . 0.0 111.443 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.589 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -81.91 -34.03 30.13 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.239 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.74 -39.49 94.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.107 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.09 -35.89 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.847 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -42.06 72.56 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.272 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.03 76.56 1.13 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.478 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -133.88 -49.58 0.82 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.535 0.168 . . . . 0.0 111.264 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.705 HD22 HG11 ' A' ' 88' ' ' VAL . 2.4 pp -135.03 148.17 49.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 111.212 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -126.73 -169.47 2.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.161 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.37 145.37 56.16 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.933 0.397 . . . . 0.0 111.931 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.28 30.14 54.97 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.068 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -101.72 176.05 5.35 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.973 0.387 . . . . 0.0 111.655 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.624 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 5.0 tm0? -116.74 169.91 9.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.835 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.816 HD11 HD22 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -155.69 139.09 15.8 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.705 179.649 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 66' ' ' VAL . 7.3 mt -121.05 -58.49 1.8 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.1 m -121.82 153.85 37.79 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.735 HG13 ' HG ' ' A' ' 86' ' ' LEU . 21.3 t -140.51 122.06 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.847 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 t0 57.67 33.8 23.69 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.207 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.54 -8.49 71.66 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.341 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -84.81 155.24 21.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.133 0.466 . . . . 0.0 111.177 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.9 t -99.29 139.95 34.18 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.036 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 73' ' ' ALA . 4.3 mp -136.02 36.49 2.81 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.984 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.489 HG12 ' CB ' ' A' ' 31' ' ' LYS . 11.6 t -97.85 92.6 2.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.48 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.93 -25.47 4.14 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.644 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.533 HD22 ' HG2' ' A' ' 72' ' ' ARG . 13.8 mt -74.4 -177.32 3.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.866 0.365 . . . . 0.0 111.254 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.7 t -115.82 -171.81 2.04 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.008 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -62.57 -30.3 71.22 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.465 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.75 -50.73 69.89 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.775 0.321 . . . . 0.0 110.817 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.533 ' HG2' HD22 ' A' ' 68' ' ' LEU . 3.6 mpt_? -69.73 -42.49 73.91 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.987 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.534 ' HA ' HD23 ' A' ' 65' ' ' LEU . . . -55.43 -47.71 75.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.376 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.99 -69.18 0.29 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.263 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -37.88 -39.93 0.41 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.7 mt -70.73 -40.1 72.97 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.528 0.204 . . . . 0.0 111.384 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.46 ' CG ' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -85.21 -7.17 59.16 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.14 -29.13 28.89 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 122.376 -0.203 . . . . 0.0 110.97 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -90.85 31.93 1.03 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.432 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 54.0 p -79.89 176.01 10.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.821 0.343 . . . . 0.0 110.811 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.35 -160.68 1.05 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.587 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 19.6 m -56.12 -27.65 54.76 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.34 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 t -132.97 142.73 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.945 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.0 p -158.3 127.09 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.341 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.49 106.22 15.91 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.068 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.816 HD22 HD11 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -109.6 115.25 29.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.824 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 36.3 tt0 -88.7 109.15 19.9 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.508 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.705 HG11 HD22 ' A' ' 51' ' ' LEU . 19.0 m -117.02 169.91 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.708 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.624 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -120.33 131.16 54.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.698 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.812 0.339 . . . . 0.0 110.412 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptm . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.684 0.278 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.54 132.7 42.06 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.88 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -128.1 89.5 50.03 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.29 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 59.2 Cg_endo -71.6 -174.19 1.2 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.858 2.372 . . . . 0.0 112.817 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -126.0 105.38 8.85 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.194 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.667 HG22 ' HG2' ' A' ' 87' ' ' GLU . 21.4 mt -95.45 127.31 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.006 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.42 139.27 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.502 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 86.2 m -89.11 113.79 24.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.851 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 86' ' ' LEU . 14.4 p -105.84 149.27 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.384 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -120.66 112.66 19.16 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.733 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.67 163.02 27.02 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.188 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -103.73 174.31 5.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.219 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -107.58 115.88 30.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.398 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.37 -41.3 10.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.615 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -163.4 47.08 0.13 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.689 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.44 -146.73 18.29 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.481 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 30.4 mtt -138.97 95.46 2.96 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.682 0.277 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.41 74.09 2.13 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.548 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.61 143.68 13.26 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.616 0.246 . . . . 0.0 111.012 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -87.64 147.25 25.35 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.187 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.486 HD12 ' HG3' ' A' ' 70' ' ' GLN . 1.2 pp -138.77 164.32 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.699 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.506 ' CG1' ' HB2' ' A' ' 35' ' ' TYR . 7.3 p -151.48 144.12 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.388 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.46 91.97 3.86 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.999 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.03 179.84 6.11 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.249 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 -179.99 4.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.716 0.293 . . . . 0.0 110.945 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.41 -138.82 2.56 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.708 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.57 149.79 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.866 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.53 18.22 36.48 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.489 -0.862 . . . . 0.0 110.986 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.34 105.66 3.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.729 0.299 . . . . 0.0 110.859 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.08 26.77 2.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.987 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.442 ' HG3' HG12 ' A' ' 66' ' ' VAL . 8.4 mmtt -122.1 -158.81 0.79 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.8 100.22 5.41 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.826 0.346 . . . . 0.0 110.703 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.18 155.36 28.53 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.763 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.2 mm -88.31 93.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 CA-C-O 120.951 0.405 . . . . 0.0 110.473 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.506 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 91.8 m-85 -83.65 145.88 28.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.759 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.54 107.89 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.211 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -68.06 -42.97 79.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.941 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.6 t -168.03 171.76 9.38 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.139 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.7 t -128.99 120.94 53.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.578 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.35 130.47 34.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.85 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.13 126.55 27.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.55 -20.77 22.43 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.726 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.88 157.02 48.96 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.712 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.48 -39.9 64.91 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.438 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -72.54 -36.68 68.35 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.469 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -70.39 -49.19 51.66 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.28 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 43' ' ' GLY . 38.9 t -61.48 -40.99 88.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.269 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.96 -50.85 69.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.164 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.13 46.57 3.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.442 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.26 -67.82 0.91 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.638 0.256 . . . . 0.0 110.91 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.513 ' HB3' HG21 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -87.78 158.4 18.78 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.811 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.35 176.06 8.44 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.58 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.35 147.69 44.15 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.473 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.99 45.36 57.33 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.412 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.401 ' HB3' ' CG1' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -117.39 179.64 3.99 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.478 0.18 . . . . 0.0 110.974 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.691 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 65.3 tt0 -123.46 147.97 46.65 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.208 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.661 ' CD2' HG22 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -123.76 127.76 48.6 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.304 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.51 ' CD1' HG22 ' A' ' 66' ' ' VAL . 4.0 mm? -109.07 -62.71 1.44 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.027 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.0 m -102.75 143.01 32.94 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.52 HG21 HD11 ' A' ' 65' ' ' LEU . 22.0 t -137.39 110.21 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.56 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.3 40.4 24.58 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.273 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.69 -26.46 12.38 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.11 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.75 175.39 10.72 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.963 0.382 . . . . 0.0 110.846 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.21 121.51 24.95 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.781 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.52 HD11 HG21 ' A' ' 60' ' ' VAL . 36.9 mt -96.86 51.19 1.13 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.798 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.51 HG22 ' CD1' ' A' ' 58' ' ' LEU . 17.3 t -95.98 90.94 2.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.77 31.56 2.91 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.526 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.484 HD22 ' HG3' ' A' ' 72' ' ' ARG . 33.7 mt -118.41 157.56 26.94 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.854 0.359 . . . . 0.0 110.97 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.8 p -79.71 166.29 21.95 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.976 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.486 ' HG3' HD12 ' A' ' 21' ' ' ILE . 26.8 tt0 -58.49 -37.96 76.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.719 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -64.66 -48.98 72.77 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.945 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HG3' HD22 ' A' ' 68' ' ' LEU . 3.9 mmt180 -56.22 -47.57 78.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.356 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.98 -53.3 32.86 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.313 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' A' ' 21' ' ' ILE . . . -57.44 -42.78 83.09 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.052 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.446 ' O ' HG22 ' A' ' 78' ' ' THR . 0.5 OUTLIER -66.4 -35.96 81.65 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.084 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 80' ' ' THR . 13.3 mt -71.93 -38.57 69.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.781 -0.19 . . . . 0.0 110.909 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 56.5 mtt -62.37 -37.26 85.03 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.235 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 75' ' ' GLU . 10.1 t -74.86 -32.51 61.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.585 0.231 . . . . 0.0 110.769 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -88.74 50.98 2.06 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.413 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 76' ' ' LEU . 40.2 p -120.03 170.89 8.87 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.812 0.339 . . . . 0.0 111.194 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.22 -169.62 2.35 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.755 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.0 m -54.9 -48.0 73.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.592 0.234 . . . . 0.0 110.994 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.66 138.74 20.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.796 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.439 HG12 HD11 ' A' ' 86' ' ' LEU . 15.6 t -133.91 114.33 19.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.18 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.25 132.36 36.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.538 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.63 ' O ' HG12 ' A' ' 9' ' ' VAL . 4.5 mp -138.95 132.75 30.81 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.62 0.247 . . . . 0.0 111.141 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.667 ' HG2' HG22 ' A' ' 6' ' ' ILE . 28.0 tt0 -100.86 101.72 12.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.681 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.661 HG22 ' CD2' ' A' ' 57' ' ' LEU . 21.6 t -91.85 149.86 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.767 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -115.18 119.36 36.1 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.231 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -71.39 102.34 2.61 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.767 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -156.19 -161.98 1.21 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.958 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.47 139.12 2.58 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.489 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.432 179.846 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.1 mtm . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 120.492 0.187 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.11 112.49 24.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.852 0.358 . . . . 0.0 110.8 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -104.53 148.87 36.72 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.965 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.634 ' HG2' HD11 ' A' ' 6' ' ' ILE . 55.3 Cg_endo -69.86 -166.2 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.814 2.342 . . . . 0.0 112.327 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -72.04 83.42 0.98 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.276 0.56 . . . . 0.0 111.029 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.74 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 19.4 mm -92.05 125.2 44.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.919 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.63 139.72 47.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.141 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.537 ' HB ' ' HG3' ' A' ' 87' ' ' GLU . 2.4 t -95.39 140.88 29.64 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.077 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.534 HG11 ' HB3' ' A' ' 50' ' ' ARG . 31.3 m -118.78 124.93 73.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.083 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.564 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -84.04 116.06 22.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.8 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.628 HD22 ' HB1' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -139.76 143.08 36.78 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.401 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -101.93 170.34 8.2 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.171 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -101.18 119.72 39.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.366 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.43 -40.54 5.33 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -152.87 32.26 0.49 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.974 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.12 177.59 22.75 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.235 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.1 mmm -115.27 96.61 5.75 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.749 0.309 . . . . 0.0 110.75 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.09 72.14 2.85 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.555 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.563 HD21 ' CB ' ' A' ' 45' ' ' ALA . 4.6 mp -139.8 115.95 10.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.634 0.254 . . . . 0.0 110.646 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 m -85.99 100.07 11.88 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.956 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.706 HD11 ' HB2' ' A' ' 74' ' ' ALA . 1.9 pt -81.31 174.79 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.574 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.738 HG13 ' HB2' ' A' ' 35' ' ' TYR . 3.5 p -158.85 144.55 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.34 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.43 ' HB2' ' N ' ' A' ' 70' ' ' GLN . . . -104.59 124.3 49.07 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.835 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.6 -179.54 8.26 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.966 0.412 . . . . 0.0 111.62 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.439 ' HG3' HD12 ' A' ' 32' ' ' LEU . 4.4 mttt -101.87 164.84 11.51 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.91 -143.55 3.88 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.1 153.65 26.63 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.022 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.45 19.15 39.74 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.169 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.46 111.01 5.62 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.71 0.291 . . . . 0.0 110.898 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -94.37 24.84 4.2 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.888 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -123.66 -147.44 0.38 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.439 HD12 ' HG3' ' A' ' 25' ' ' LYS . 4.4 tp -136.29 112.41 9.72 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.752 0.311 . . . . 0.0 110.555 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.38 176.89 24.63 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.816 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 73' ' ' ALA . 26.4 mm -97.11 151.5 4.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.715 0.293 . . . . 0.0 110.765 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.738 ' HB2' HG13 ' A' ' 22' ' ' VAL . 85.1 m-85 -140.38 156.41 46.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.157 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.68 100.59 11.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.713 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -74.53 -39.0 62.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.541 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.44 162.14 8.18 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.205 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.81 109.53 20.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.558 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.3 t -65.95 127.4 27.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.307 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -60.85 143.03 55.61 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.007 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.81 -14.76 62.62 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.921 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -75.05 -173.84 33.01 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.312 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.628 ' HB1' HD22 ' A' ' 11' ' ' LEU . . . -71.15 -51.1 26.88 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.834 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -61.75 -37.74 85.38 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -64.07 -49.2 73.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.456 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 43' ' ' GLY . 44.9 t -64.46 -36.1 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.374 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.49 -54.25 11.2 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.75 69.86 1.36 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.719 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.534 ' HB3' HG11 ' A' ' 9' ' ' VAL . 2.4 mtt180 -139.74 27.44 2.23 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.549 0.214 . . . . 0.0 111.51 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.834 HD21 ' HB1' ' A' ' 45' ' ' ALA . 0.7 OUTLIER -175.63 179.48 1.41 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.596 0.236 . . . . 0.0 111.036 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.11 -176.97 6.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.603 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.36 146.99 38.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.161 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.53 47.64 15.58 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.375 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -116.98 177.76 4.59 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.672 0.272 . . . . 0.0 111.1 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.745 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 9.3 tm0? -112.45 165.15 12.48 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.125 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.655 ' HG ' HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -148.16 126.3 12.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.782 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.25 -63.12 1.36 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.318 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.7 m -115.73 152.48 33.15 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 111.666 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.692 HG11 ' HG2' ' A' ' 77' ' ' MET . 39.0 t -133.14 113.81 20.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.875 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.2 36.44 23.85 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.208 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.55 -14.25 60.26 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.209 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -80.53 143.87 32.93 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 117.158 0.479 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.3 p -92.56 137.41 32.39 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.046 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.514 HD13 HG23 ' A' ' 60' ' ' VAL . 4.4 mp -137.91 87.54 2.26 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.267 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.6 t -135.87 87.11 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.752 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.73 -24.01 3.35 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.644 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.4 mt -72.71 175.12 6.71 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.198 0.523 . . . . 0.0 111.814 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -101.51 176.25 5.3 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.999 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.43 ' N ' ' HB2' ' A' ' 23' ' ' ALA . 44.1 tt0 -61.38 -39.16 89.65 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.091 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.23 -53.16 61.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.164 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -58.62 -48.36 81.27 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.137 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -59.44 -50.77 72.64 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.652 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.706 ' HB2' HD11 ' A' ' 21' ' ' ILE . . . -62.14 -40.5 96.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.777 0.322 . . . . 0.0 110.806 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.562 ' O ' HG22 ' A' ' 78' ' ' THR . 3.8 tp10 -64.86 -31.39 72.6 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.116 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.6 mt -79.35 -30.47 42.67 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.007 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.692 ' HG2' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -66.37 -29.8 70.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.391 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 75' ' ' GLU . 11.0 t -77.2 -31.24 55.17 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 121.156 -0.218 . . . . 0.0 110.787 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -95.35 56.81 1.9 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.816 0.341 . . . . 0.0 111.52 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.3 p -116.64 179.33 4.04 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.087 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.19 -174.13 4.08 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.797 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -53.56 -52.62 59.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.973 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.564 ' CG1' HG22 ' A' ' 10' ' ' THR . 19.2 t -92.79 146.34 6.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.83 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.7 t -135.0 133.62 53.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.27 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.88 101.6 8.42 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.512 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.65 ' CD2' HG13 ' A' ' 60' ' ' VAL . 4.1 mt -99.95 113.28 25.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.578 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.669 ' HG2' HG22 ' A' ' 6' ' ' ILE . 3.1 tt0 -81.37 95.53 7.05 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.994 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.655 HG12 ' HG ' ' A' ' 57' ' ' LEU . 31.9 m -101.28 166.32 2.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.142 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.745 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -119.98 142.53 48.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.656 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.86 70.83 2.65 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.701 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -101.28 -165.78 1.24 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.219 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.25 138.44 2.42 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.514 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.989 179.853 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mmt . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.655 0.265 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.0 96.58 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.042 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 59.11 78.82 0.33 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.224 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.76 167.39 27.33 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.816 2.344 . . . . 0.0 112.838 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -112.91 97.25 6.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.018 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.58 HG22 ' HG2' ' A' ' 87' ' ' GLU . 3.7 mt -85.59 128.95 38.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.03 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 pt -146.01 149.63 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.972 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.481 ' HB ' ' HG3' ' A' ' 87' ' ' GLU . 6.4 t -106.72 142.61 36.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 110.825 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.477 HG23 HD11 ' A' ' 11' ' ' LEU . 2.9 m -131.3 137.14 56.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.532 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.2 m -87.1 112.34 21.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.761 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.477 HD11 HG23 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -122.28 164.39 17.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.738 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -122.58 148.69 44.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.73 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -85.08 107.28 17.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.706 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.82 56.8 2.7 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.619 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 57.31 39.52 28.42 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.167 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.73 171.41 39.6 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.66 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -138.71 -68.34 0.45 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.536 0.208 . . . . 0.0 111.069 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.76 65.5 3.5 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.106 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.438 HD23 HG22 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -144.48 108.94 4.85 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.594 0.235 . . . . 0.0 111.053 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.3 m -81.02 97.06 7.33 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.709 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pt -98.23 175.44 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.692 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' A' ' 35' ' ' TYR . 6.5 p -159.53 138.79 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.274 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.73 107.46 18.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.028 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -148.63 179.84 7.52 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.926 0.393 . . . . 0.0 111.583 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -97.12 168.47 10.43 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.27 -142.28 3.46 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.79 149.91 27.63 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.844 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.19 17.57 31.48 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.287 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.34 108.24 4.36 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.714 0.292 . . . . 0.0 110.786 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.69 25.38 3.12 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.765 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.9 mmtm -121.47 -155.43 0.64 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.239 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.6 99.02 4.51 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.845 0.355 . . . . 0.0 110.631 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.43 154.91 25.53 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.928 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.527 HD11 ' HB2' ' A' ' 73' ' ' ALA . 35.2 mm -88.95 100.14 10.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.882 0.372 . . . . 0.0 110.662 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.465 ' HB2' HG13 ' A' ' 22' ' ' VAL . 82.7 m-85 -89.84 153.89 20.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.605 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -99.97 113.61 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.758 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -82.52 -40.94 20.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.627 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 m -164.06 173.23 12.77 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.284 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.438 HG22 HD23 ' A' ' 19' ' ' LEU . 19.4 t -137.44 152.02 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.199 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.8 t -101.71 140.96 19.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.085 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.32 109.96 1.75 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.772 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.82 -24.83 4.78 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.0 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -62.63 159.94 33.92 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.813 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.9 -55.59 25.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.515 0.198 . . . . 0.0 111.475 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.74 -32.24 69.05 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.332 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.74 -55.28 8.99 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.018 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 43' ' ' GLY . 26.9 t -63.69 -46.69 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.283 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.56 -33.31 75.3 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.284 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.29 36.9 92.35 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.825 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -85.01 -32.21 23.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.525 0.202 . . . . 0.0 111.094 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.471 HD22 HG11 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -137.05 175.44 9.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.867 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.81 -171.08 3.17 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.01 149.76 47.37 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.152 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.06 50.94 25.77 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.418 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -120.51 176.2 5.62 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.631 0.253 . . . . 0.0 111.091 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.74 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 24.4 tm0? -128.69 139.06 52.42 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.107 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.625 HD21 HD23 ' A' ' 86' ' ' LEU . 6.4 mp -119.51 135.45 54.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.981 0.42 . . . . 0.0 111.206 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.558 HD12 HE22 ' A' ' 56' ' ' GLN . 0.1 OUTLIER -101.66 -59.52 1.69 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.466 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.7 m -117.68 163.21 16.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.898 0.38 . . . . 0.0 111.864 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 86' ' ' LEU . 47.8 t -145.85 136.4 18.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.96 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.47 ' HB3' HG22 ' A' ' 80' ' ' THR . 5.4 p-10 44.17 37.05 1.7 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.952 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.26 40.69 40.6 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.746 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.424 ' O ' HD12 ' A' ' 65' ' ' LEU . 69.0 mtt-85 -140.97 156.29 46.08 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.721 0.261 . . . . 0.0 110.679 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 m -86.49 128.33 34.95 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.831 0.348 . . . . 0.0 111.001 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.62 HD23 ' HA ' ' A' ' 73' ' ' ALA . 5.4 mp -137.88 37.01 2.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.437 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.46 ' O ' HG22 ' A' ' 66' ' ' VAL . 13.2 p -114.07 45.5 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.66 0.743 . . . . 0.0 110.665 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.51 36.27 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.174 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.486 HD21 ' HA ' ' A' ' 65' ' ' LEU . 1.7 pp -144.82 169.99 16.97 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.671 0.272 . . . . 0.0 110.926 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.55 177.42 8.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.199 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -63.34 -34.06 76.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.289 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -50.93 71.9 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.652 0.263 . . . . 0.0 110.92 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -62.62 -42.74 99.76 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.458 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.62 ' HA ' HD23 ' A' ' 65' ' ' LEU . . . -67.0 -54.14 24.64 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.509 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.35 -35.69 74.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.826 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.404 ' O ' HG22 ' A' ' 78' ' ' THR . 3.8 tp10 -69.86 -29.41 66.64 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.133 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.57 HD23 ' HD2' ' A' ' 79' ' ' ARG . 24.3 mt -79.48 -37.62 36.38 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.77 -0.196 . . . . 0.0 111.028 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.484 ' CG ' HG11 ' A' ' 60' ' ' VAL . 5.9 mtm -68.76 -32.38 72.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.405 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 75' ' ' GLU . 15.1 t -73.79 -30.29 62.66 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.491 0.186 . . . . 0.0 111.217 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.57 ' HD2' HD23 ' A' ' 76' ' ' LEU . 17.6 ptp180 -92.71 44.3 1.15 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.448 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 61' ' ' ASP . 17.2 p -102.89 161.04 14.07 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.831 0.348 . . . . 0.0 111.434 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.2 p -95.86 -166.49 1.44 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -39.17 68.87 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.868 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 t -103.46 142.06 18.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.087 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.532 HG12 ' CD1' ' A' ' 86' ' ' LEU . 16.9 t -145.74 142.14 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.271 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.426 HG22 ' OG1' ' A' ' 8' ' ' THR . 0.1 OUTLIER -123.16 112.62 17.92 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.457 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.625 HD23 HD21 ' A' ' 57' ' ' LEU . 10.3 mp -110.39 119.56 39.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.239 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.58 ' HG2' HG22 ' A' ' 6' ' ' ILE . 3.5 tt0 -81.44 85.44 6.47 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.335 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.471 HG11 HD22 ' A' ' 51' ' ' LEU . 25.6 m -80.31 173.08 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.417 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.74 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -143.66 125.92 15.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.633 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -66.45 87.95 0.13 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.827 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -110.55 -168.16 1.28 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.039 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 145.62 140.13 3.48 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.348 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.047 -0.977 . . . . 0.0 111.468 -179.861 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ptm . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.445 0.164 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? 64.27 75.42 0.38 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.452 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 68.45 146.29 0.11 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.768 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.578 ' HG2' HD11 ' A' ' 6' ' ' ILE . 72.8 Cg_endo -74.86 177.93 7.89 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.514 2.143 . . . . 0.0 112.569 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 89' ' ' ALA . 3.0 tt0 -100.66 92.17 4.98 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.882 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.935 HG22 ' HG2' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -110.58 123.78 66.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.633 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.663 HD12 ' CG2' ' A' ' 9' ' ' VAL . 1.1 pt -126.3 138.58 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.388 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 1.6 m -94.03 120.4 34.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.875 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.663 ' CG2' HD12 ' A' ' 7' ' ' ILE . 21.8 t -124.45 142.64 40.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.891 0.377 . . . . 0.0 111.224 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.404 HG22 HG23 ' A' ' 85' ' ' THR . 2.2 p -80.3 147.34 31.19 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.2 mt -144.49 128.82 17.85 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.831 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -91.34 146.53 23.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.939 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -69.42 110.71 4.85 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.601 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -101.04 68.69 1.27 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.567 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.5 t30 57.98 40.13 25.85 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.145 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.3 177.7 14.99 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.79 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.9 mmm -129.94 103.32 6.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.626 0.25 . . . . 0.0 110.693 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.409 ' HA3' ' HB ' ' A' ' 40' ' ' VAL . . . -98.59 79.85 0.57 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.865 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.541 HD21 ' CB ' ' A' ' 45' ' ' ALA . 4.5 mp -146.63 124.26 11.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.585 0.231 . . . . 0.0 110.853 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.1 m -89.5 138.56 31.35 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.031 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.459 HG21 ' HE3' ' A' ' 77' ' ' MET . 1.2 pp -136.85 169.08 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.755 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 35' ' ' TYR . 7.3 p -157.79 141.42 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.294 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.07 94.74 7.33 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.636 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.425 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -129.71 179.17 5.99 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.462 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -123.38 -179.82 4.46 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.289 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.29 -141.77 3.22 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.01 153.52 19.82 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.735 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.41 22.59 38.63 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.094 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.21 102.06 7.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.541 -0.329 . . . . 0.0 111.133 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.38 16.6 8.48 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 -168.95 2.94 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.109 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.461 HD12 ' HA ' ' A' ' 32' ' ' LEU . 3.2 tp -119.68 133.58 55.57 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.56 0.219 . . . . 0.0 110.689 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.06 147.68 18.88 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.662 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 57' ' ' LEU . 39.3 mm -80.89 92.03 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.876 0.369 . . . . 0.0 110.223 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.427 ' HB2' HG13 ' A' ' 22' ' ' VAL . 20.2 m-85 -75.18 155.24 37.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.488 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.5 t -102.36 109.07 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.585 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.12 -42.85 75.5 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.804 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.77 179.44 0.71 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.183 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.44 146.93 28.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.019 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.409 ' HB ' ' HA3' ' A' ' 18' ' ' GLY . 22.3 t -95.96 131.07 43.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.364 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.6 139.01 58.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.864 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.5 -17.24 59.64 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.082 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -72.31 -164.83 7.61 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.716 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.601 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . . . -87.37 -43.44 12.12 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.541 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -68.64 -42.59 77.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.783 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -59.12 -45.86 89.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.404 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 43' ' ' GLY . 29.1 t -73.39 -33.71 41.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.41 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -55.38 34.17 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.292 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.74 61.12 1.63 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.608 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.464 ' CD ' HG11 ' A' ' 9' ' ' VAL . 1.8 mmp_? -121.49 -44.49 2.35 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.527 0.203 . . . . 0.0 111.189 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.402 ' HB3' HG11 ' A' ' 88' ' ' VAL . 1.3 pp -130.32 174.2 10.07 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.865 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.95 -168.06 2.83 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.3 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.11 142.91 50.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.192 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.07 49.53 4.97 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.325 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.21 -179.85 5.08 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.458 0.17 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.67 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 46.6 tt0 -130.84 134.0 46.43 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.723 0.297 . . . . 0.0 111.354 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.61 HD22 HD12 ' A' ' 86' ' ' LEU . 87.7 mt -110.85 131.27 55.19 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.486 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.21 -56.77 2.16 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.687 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -117.9 147.27 43.27 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.003 0.43 . . . . 0.0 111.987 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.809 HG22 HD11 ' A' ' 86' ' ' LEU . 57.7 t -126.94 103.92 11.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.318 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.487 ' HB2' HG23 ' A' ' 84' ' ' VAL . 4.4 t0 60.78 39.39 17.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.992 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.67 -23.29 29.05 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.299 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -74.31 132.45 42.08 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 117.227 0.513 . . . . 0.0 110.934 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.0 p -91.2 120.5 32.17 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.673 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.741 ' HA ' HD12 ' A' ' 68' ' ' LEU . 3.1 mp -110.09 43.41 1.37 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.851 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.99 86.55 2.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.66 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.0 27.47 3.99 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.584 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 65' ' ' LEU . 29.0 mt -109.02 176.01 5.25 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.883 0.373 . . . . 0.0 110.934 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.5 m -107.36 168.44 9.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.024 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.419 ' HG3' HD12 ' A' ' 21' ' ' ILE . 35.3 tt0 -57.52 -35.46 70.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.118 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -58.76 -54.61 45.16 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.907 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.42 ' HG3' HD22 ' A' ' 68' ' ' LEU . 49.2 mmt-85 -61.7 -46.11 91.07 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.985 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.07 -55.37 35.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.392 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.26 81.39 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.154 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -60.62 -33.06 72.21 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.315 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.2 mt -81.19 -40.73 23.44 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.019 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.459 ' HE3' HG21 ' A' ' 21' ' ' ILE . 11.7 mtp -66.84 -41.48 87.33 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.191 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.675 HG23 ' HG3' ' A' ' 79' ' ' ARG . 13.2 t -61.64 -33.29 73.68 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.173 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.675 ' HG3' HG23 ' A' ' 78' ' ' THR . 84.5 mtm180 -101.72 65.1 1.0 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.803 0.335 . . . . 0.0 111.126 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.465 HG21 HG21 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -104.88 159.99 15.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.873 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 t -76.7 -172.23 2.17 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.835 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.9 p -53.0 -33.51 52.01 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.128 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.9 t -131.28 127.68 60.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.191 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 61' ' ' ASP . 9.3 p -113.1 129.37 68.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.538 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.404 HG23 HG22 ' A' ' 10' ' ' THR . 0.0 OUTLIER -97.45 85.73 3.7 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.874 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.809 HD11 HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -87.13 119.03 26.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.335 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.935 ' HG2' HG22 ' A' ' 6' ' ' ILE . 27.2 tt0 -88.76 102.6 15.16 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.859 0.361 . . . . 0.0 110.227 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.477 ' HA ' HD23 ' A' ' 57' ' ' LEU . 12.5 p -96.19 147.99 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.963 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.67 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -113.52 129.88 56.46 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.544 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.83 83.57 0.11 Allowed 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.375 0.422 . . . . 0.0 110.852 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -108.02 -168.49 1.38 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.047 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.53 139.92 4.73 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.409 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.616 179.845 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.71 0.291 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.98 129.17 11.91 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.706 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 61.94 98.05 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.71 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.93 -178.19 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.093 2.529 . . . . 0.0 113.121 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.34 92.81 6.51 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.376 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.458 HG22 ' CG ' ' A' ' 87' ' ' GLU . 3.4 mp -91.54 128.01 43.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.532 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.832 HD12 HG13 ' A' ' 9' ' ' VAL . 1.1 pt -139.44 143.62 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.82 0.343 . . . . 0.0 111.583 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.68 HG23 ' HB2' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -98.28 111.75 23.98 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.84 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.832 HG13 HD12 ' A' ' 7' ' ' ILE . 14.6 m -107.42 144.03 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.441 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.3 m -99.4 143.41 29.68 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.998 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.509 HD21 ' N ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -145.53 167.72 22.32 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.222 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.61 ' CD ' HG22 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -119.1 137.81 53.32 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.525 179.617 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -64.1 100.69 0.34 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.922 0.391 . . . . 0.0 111.049 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.21 73.59 2.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.433 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.58 36.78 28.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.097 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 130.24 -159.43 22.73 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.306 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.2 mmt -127.32 -59.11 1.25 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.654 0.264 . . . . 0.0 110.988 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.11 55.52 4.77 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.505 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.714 ' HG ' HG13 ' A' ' 39' ' ' VAL . 4.1 mp -145.58 118.46 8.73 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.555 0.217 . . . . 0.0 110.774 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -80.76 100.77 8.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.862 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 pt -100.69 174.69 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.65 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 35' ' ' TYR . 2.8 p -157.77 135.91 2.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.257 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.05 89.75 3.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.499 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.52 178.52 6.41 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.738 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.35 168.11 11.8 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.869 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -151.43 -143.28 3.68 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.86 152.1 26.2 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.93 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.56 19.26 33.8 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.183 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.41 109.18 4.74 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.737 0.303 . . . . 0.0 110.957 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -92.75 25.02 3.29 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.713 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -124.01 -151.54 0.48 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.66 109.46 8.64 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.672 0.273 . . . . 0.0 110.443 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.53 164.42 15.52 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.748 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 73' ' ' ALA . 31.1 mm -91.85 138.39 19.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.661 0.267 . . . . 0.0 110.667 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.433 ' HB2' HG13 ' A' ' 22' ' ' VAL . 97.8 m-85 -130.13 138.41 50.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.183 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.22 99.83 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.929 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -73.21 -38.84 65.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.472 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 t -161.02 160.03 30.09 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.203 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.714 HG13 ' HG ' ' A' ' 19' ' ' LEU . 21.4 t -125.7 119.24 54.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.698 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.97 135.75 27.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.419 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -72.44 145.29 47.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.899 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.74 -15.08 63.29 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.181 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -71.61 -167.16 8.34 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.538 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.19 -38.18 16.61 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.509 ' N ' HD21 ' A' ' 11' ' ' LEU . . . -72.36 -43.73 63.59 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.27 -34.87 78.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.682 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 43' ' ' GLY . 39.7 t -81.7 -39.71 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 120.567 0.222 . . . . 0.0 111.119 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.2 -35.04 77.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.24 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.27 31.16 43.08 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.656 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -86.76 -41.29 14.23 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.609 0.242 . . . . 0.0 110.925 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.521 HD11 HD21 ' A' ' 19' ' ' LEU . 1.9 pp -141.77 169.36 17.74 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.945 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.13 -170.83 3.35 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.483 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.83 154.6 41.68 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.533 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.44 25.05 73.73 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.753 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.24 173.11 6.45 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.814 0.307 . . . . 0.0 111.35 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.586 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 9.8 tm0? -109.25 162.37 14.36 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.988 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.628 ' CD2' HD23 ' A' ' 86' ' ' LEU . 4.5 mt -141.46 125.47 17.22 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.965 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.458 HD12 HE22 ' A' ' 56' ' ' GLN . 0.0 OUTLIER -113.48 -63.54 1.43 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.556 -179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.2 p -113.91 146.98 39.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.948 0.404 . . . . 0.0 111.84 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.702 HG13 ' HG ' ' A' ' 86' ' ' LEU . 54.1 t -139.87 125.86 21.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.475 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.516 ' HB2' HG13 ' A' ' 84' ' ' VAL . 10.4 t70 58.24 37.53 26.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.575 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.84 28.66 72.9 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.057 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -123.6 153.27 40.92 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.939 0.369 . . . . 0.0 110.845 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.6 p -95.19 135.65 36.5 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.138 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.755 HD21 HD12 ' A' ' 76' ' ' LEU . 10.0 mt -126.9 38.82 4.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.045 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.4 t -99.16 94.72 3.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.976 0.417 . . . . 0.0 110.405 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.86 33.81 2.33 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.462 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.825 HD22 ' HG2' ' A' ' 72' ' ' ARG . 37.8 mt -123.66 176.57 6.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.72 0.295 . . . . 0.0 110.685 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.7 m -98.86 165.31 11.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.153 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -58.53 -29.1 66.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.193 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -68.67 -34.77 76.26 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.611 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.825 ' HG2' HD22 ' A' ' 68' ' ' LEU . 1.8 mpt_? -67.45 -54.39 20.63 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.146 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.412 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -60.46 -41.23 93.72 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.649 0.262 . . . . 0.0 111.272 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.61 -40.1 92.25 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.99 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -77.72 -30.56 51.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.518 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.755 HD12 HD21 ' A' ' 65' ' ' LEU . 10.2 mt -68.91 -41.41 78.25 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.313 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.445 ' HG2' HG11 ' A' ' 60' ' ' VAL . 54.8 mtt -60.45 -45.37 93.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.014 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.7 t -67.02 -29.74 69.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.677 0.275 . . . . 0.0 110.53 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -87.42 50.35 1.99 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.349 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.7 p -125.99 172.18 10.16 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.769 0.319 . . . . 0.0 110.917 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.6 p -86.88 -171.26 3.44 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.182 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 m -55.36 -36.7 66.61 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.018 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.61 HG22 ' CD ' ' A' ' 12' ' ' LYS . 29.3 t -108.01 139.91 28.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.165 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 61' ' ' ASP . 16.0 t -139.27 137.9 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.13 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.643 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -112.72 109.71 19.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.79 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.702 ' HG ' HG13 ' A' ' 60' ' ' VAL . 3.4 mp -105.32 122.56 46.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.179 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.68 ' HB2' HG23 ' A' ' 8' ' ' THR . 29.4 tt0 -92.92 106.75 18.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.408 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.613 HG12 ' HG ' ' A' ' 57' ' ' LEU . 20.7 m -109.67 171.38 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.654 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -124.75 128.89 49.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.808 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.2 83.97 0.09 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.117 0.484 . . . . 0.0 110.943 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -118.34 162.95 17.45 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.754 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.42 136.06 2.08 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.56 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.443 179.741 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.773 0.32 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.85 142.67 49.43 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.782 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.92 105.08 16.93 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.954 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.47 -173.26 0.78 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.646 2.231 . . . . 0.0 112.578 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.59 105.95 10.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.996 0.427 . . . . 0.0 111.008 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 22.1 mm -80.42 128.44 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.959 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.712 HD12 HG13 ' A' ' 9' ' ' VAL . 1.7 pt -147.53 144.83 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.18 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 1.3 m -103.44 105.47 15.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.414 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.712 HG13 HD12 ' A' ' 7' ' ' ILE . 14.1 m -93.66 145.03 8.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.993 0.425 . . . . 0.0 111.596 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.4 m -95.71 101.96 13.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.524 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.683 HD11 ' HA ' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -102.24 141.79 34.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -109.65 115.43 29.86 Favored 'General case' 0 CA--C 1.526 0.054 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.767 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.63 122.8 12.9 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.252 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.835 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 0.4 OUTLIER -115.06 73.16 0.82 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.351 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 60.34 38.2 19.75 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.017 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.81 153.81 6.4 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.591 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.4 mtp -100.72 -65.21 0.98 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.615 0.245 . . . . 0.0 110.778 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.409 ' HA3' ' HB ' ' A' ' 40' ' ' VAL . . . 73.96 65.28 2.23 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.125 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.504 HD21 ' HB1' ' A' ' 45' ' ' ALA . 3.9 mp -142.2 111.8 6.68 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.777 0.322 . . . . 0.0 110.815 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 m -80.21 112.97 18.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.699 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 pt -114.68 173.71 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.594 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' A' ' 35' ' ' TYR . 4.3 p -148.17 137.65 16.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.232 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.98 108.6 21.34 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.51 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.446 ' N ' HD11 ' A' ' 32' ' ' LEU . . . -153.07 176.42 11.92 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.331 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HG3' HD22 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -108.91 172.66 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.01 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.57 -143.31 3.63 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.33 157.74 16.94 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.79 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.45 25.1 40.64 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -126.79 104.84 8.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.92 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -86.55 10.46 15.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.466 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.464 ' HB2' HG12 ' A' ' 66' ' ' VAL . 5.2 mmmt -144.53 -162.65 1.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.02 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.493 HD13 ' N ' ' A' ' 33' ' ' GLY . 0.4 OUTLIER -103.3 134.55 46.5 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.672 0.272 . . . . 0.0 110.308 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.493 ' N ' HD13 ' A' ' 32' ' ' LEU . . . -117.61 152.23 17.75 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.663 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.8 mm -93.52 132.27 38.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 120.679 0.276 . . . . 0.0 110.498 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.506 ' HB2' HG13 ' A' ' 22' ' ' VAL . 69.5 m-85 -121.94 163.47 19.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.224 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.42 ' CG2' HD23 ' A' ' 57' ' ' LEU . 22.0 t -115.83 135.46 55.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.099 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.29 -33.78 5.52 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.581 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.5 165.5 35.47 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.746 0.307 . . . . 0.0 111.325 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.4 HG13 ' HG ' ' A' ' 19' ' ' LEU . 23.7 t -140.31 126.14 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.576 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.409 ' HB ' ' HA3' ' A' ' 18' ' ' GLY . 34.1 t -62.34 131.58 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.427 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -80.51 98.18 7.47 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.607 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.83 -39.37 0.64 Allowed Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.697 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -68.83 160.15 52.26 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.538 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.835 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . . . -51.15 -38.82 54.28 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.683 ' HA ' HD11 ' A' ' 11' ' ' LEU . . . -55.69 -43.39 76.38 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.708 0.289 . . . . 0.0 111.166 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -76.53 -35.65 58.16 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.111 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 43' ' ' GLY . 38.2 t -68.64 -42.57 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.057 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.13 -44.5 87.84 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.247 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.47 27.56 65.32 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.667 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -82.72 -33.84 27.44 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.744 0.272 . . . . 0.0 110.884 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.46 ' C ' HD12 ' A' ' 51' ' ' LEU . 4.1 pp -130.39 -178.98 5.0 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.78 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.91 -162.48 1.53 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.255 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.3 151.0 20.06 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.009 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.47 50.56 9.55 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.425 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -132.54 179.19 6.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.741 0.305 . . . . 0.0 111.105 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 7.2 tm0? -116.34 161.1 19.55 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.681 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.649 ' HB3' HG12 ' A' ' 88' ' ' VAL . 2.3 pp -164.93 155.61 14.26 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.927 0.394 . . . . 0.0 111.776 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -145.18 -54.76 0.31 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.513 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -76.4 132.91 39.98 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.843 0.354 . . . . 0.0 111.558 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.739 HG11 ' HG2' ' A' ' 77' ' ' MET . 24.2 t -145.34 117.17 2.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.515 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.57 ' HB2' HG13 ' A' ' 84' ' ' VAL . 5.0 t0 58.53 40.3 23.94 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.039 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.26 23.14 78.42 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.984 -0.626 . . . . 0.0 112.984 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.0 mtt-85 -128.68 128.14 43.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.711 0.256 . . . . 0.0 110.324 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m -83.98 116.8 23.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.3 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.7 mt -98.77 76.98 2.21 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.594 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.464 HG12 ' HB2' ' A' ' 31' ' ' LYS . 25.5 t -122.54 96.64 4.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.6 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.25 37.77 0.91 Allowed Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.532 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 mp -135.03 179.31 6.4 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.785 0.326 . . . . 0.0 110.928 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.4 m -107.81 176.74 5.04 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.95 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -58.21 -39.88 80.16 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.679 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -51.12 70.7 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.907 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 47.1 mmt-85 -59.2 -50.87 72.36 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.17 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.94 -52.6 64.71 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.329 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.11 -45.64 92.3 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.051 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.47 -36.28 77.91 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.901 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 80' ' ' THR . 14.4 mt -77.11 -39.45 49.42 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.728 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.739 ' HG2' HG11 ' A' ' 60' ' ' VAL . 2.2 mtt -65.78 -32.82 74.56 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.04 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.2 t -78.9 -32.43 45.75 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.559 0.219 . . . . 0.0 110.905 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 43.6 mtp85 -89.63 50.54 1.92 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.703 0.287 . . . . 0.0 111.563 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 76' ' ' LEU . 13.5 p -120.68 -179.86 4.12 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.936 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -89.0 -173.02 3.91 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.08 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.6 p -56.6 -49.77 73.93 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.505 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.89 133.32 36.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.737 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 61' ' ' ASP . 21.3 t -139.46 125.68 23.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.22 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.84 111.92 23.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.708 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 59' ' ' SER . 2.7 mp -109.98 123.01 48.88 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.985 0.422 . . . . 0.0 111.421 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 19.2 tt0 -91.42 98.45 11.69 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.16 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.649 HG12 ' HB3' ' A' ' 57' ' ' LEU . 21.4 m -102.26 171.49 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.928 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.635 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -125.67 131.55 52.59 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.586 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -66.28 91.56 0.17 Allowed 'General case' 0 C--O 1.234 0.256 0 O-C-N 123.345 0.403 . . . . 0.0 110.602 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -113.07 -165.87 1.03 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.138 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.97 137.51 2.21 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.485 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.585 -0.722 . . . . 0.0 111.9 -179.917 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mmt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -99.92 165.16 11.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.719 0.295 . . . . 0.0 111.252 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -128.8 148.04 67.02 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.977 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HG2' HD11 ' A' ' 6' ' ' ILE . 50.7 Cg_endo -69.63 165.45 30.76 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.813 2.342 . . . . 0.0 112.595 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -75.67 82.88 2.66 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.165 0.507 . . . . 0.0 110.959 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.471 HG22 ' HB2' ' A' ' 87' ' ' GLU . 26.2 mm -92.81 94.64 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.89 137.06 34.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.265 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.442 ' CG2' HG22 ' A' ' 85' ' ' THR . 6.9 m -89.01 130.68 35.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.002 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 9' ' ' VAL . 27.4 m -113.41 111.31 35.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.114 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.41 101.55 13.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.39 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.562 HD22 ' CG ' ' A' ' 48' ' ' ASP . 81.6 mt -122.5 161.98 22.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.939 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 150.95 24.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.774 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.25 114.42 26.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.007 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.95 -38.1 6.74 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.192 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -160.32 42.54 0.19 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.047 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.29 -170.71 30.28 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.3 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.2 mmm -107.09 -48.03 3.56 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.508 0.194 . . . . 0.0 111.131 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.13 78.49 0.18 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.734 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.693 HD13 HG23 ' A' ' 21' ' ' ILE . 0.8 OUTLIER -158.23 144.56 17.35 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.815 0.34 . . . . 0.0 111.179 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -94.41 90.87 6.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.628 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.693 HG23 HD13 ' A' ' 19' ' ' LEU . 1.8 pt -96.38 163.42 2.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.614 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.7 p -141.04 138.54 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.147 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.34 89.99 3.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.675 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.82 176.06 7.56 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.515 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -96.88 168.76 10.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.28 -143.14 3.59 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.06 153.92 22.42 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.023 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.29 18.84 30.26 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.243 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.58 108.42 4.71 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -95.22 37.26 1.18 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.568 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.646 ' HB2' HG22 ' A' ' 66' ' ' VAL . 38.7 mmtm -140.21 -148.5 0.25 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.648 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -132.77 103.19 5.98 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 110.517 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.9 145.94 21.89 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.888 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.6 mm -87.47 99.32 8.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.805 0.336 . . . . 0.0 110.701 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -90.59 147.53 23.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.531 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.53 120.83 51.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.845 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -96.27 -35.36 11.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.972 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 t -162.51 158.96 24.3 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.054 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.1 t -123.71 128.38 74.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.621 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.4 t -68.37 120.89 16.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.056 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -59.58 109.01 0.81 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.742 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.39 -21.27 5.16 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.626 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.557 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.52 158.17 51.37 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.147 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.66 -41.1 21.59 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.13 -52.9 52.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.367 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -39.29 85.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.5 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 43' ' ' GLY . 40.9 t -71.82 -40.86 69.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.537 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.562 ' CG ' HD22 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -63.82 -54.72 30.62 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.588 0.232 . . . . 0.0 111.304 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.18 79.43 1.39 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.764 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.481 ' HG3' HD21 ' A' ' 11' ' ' LEU . 9.0 mmt-85 -144.1 -51.39 0.31 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.719 0.295 . . . . 0.0 110.943 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 pp -113.39 167.79 10.28 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.912 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.08 -166.8 2.17 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.241 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.02 150.04 26.59 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.271 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.22 40.99 8.77 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.721 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -131.62 177.04 7.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.791 0.329 . . . . 0.0 111.246 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.682 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 46.8 tt0 -122.13 150.32 42.36 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.002 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.6 mt -128.44 123.9 34.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.476 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.18 -63.63 1.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.424 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.7 m -111.37 151.77 28.07 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.929 0.395 . . . . 0.0 111.703 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.813 HG11 ' HG2' ' A' ' 77' ' ' MET . 42.9 t -141.45 132.33 26.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.654 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 t70 56.9 27.72 13.49 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.451 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.32 -7.78 81.28 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.862 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.453 ' NH1' HD22 ' A' ' 76' ' ' LEU . 12.2 ptp180 -111.23 135.35 51.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 117.427 0.613 . . . . 0.0 110.926 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.5 m -71.63 130.44 41.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.327 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.531 HD12 ' CG2' ' A' ' 60' ' ' VAL . 55.7 mt -112.78 33.61 4.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.893 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 31' ' ' LYS . 7.7 p -109.56 90.26 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.236 0.541 . . . . 0.0 110.382 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 31' ' ' LYS . . . 151.14 -30.26 0.98 Allowed Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.425 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.455 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -83.04 -169.64 2.62 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.684 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -98.51 169.66 9.37 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.665 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -55.6 -31.41 62.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.864 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.89 -48.08 60.09 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.242 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.455 ' HG3' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -56.29 -38.69 71.58 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.533 0.206 . . . . 0.0 111.018 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.26 -53.37 12.69 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.176 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.76 -37.93 74.51 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.408 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.67 -33.59 64.52 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.599 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.453 HD22 ' NH1' ' A' ' 63' ' ' ARG . 35.0 mt -79.71 -39.11 31.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.475 0.178 . . . . 0.0 111.123 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.813 ' HG2' HG11 ' A' ' 60' ' ' VAL . 12.2 mtp -66.45 -34.43 77.92 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.051 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.6 t -71.67 -38.14 70.69 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.87 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -91.21 58.02 3.57 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.925 0.393 . . . . 0.0 110.75 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 p -109.85 160.84 16.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.006 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.7 m -75.25 -179.23 4.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.943 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.4 m -53.5 -38.83 64.06 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.304 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.7 t -106.1 136.22 41.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.728 0.299 . . . . 0.0 110.707 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.419 ' CG1' HD11 ' A' ' 86' ' ' LEU . 16.3 t -124.71 142.66 40.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.474 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.442 HG22 ' CG2' ' A' ' 8' ' ' THR . 0.2 OUTLIER -124.39 100.19 6.56 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.728 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.669 ' CD2' HG13 ' A' ' 60' ' ' VAL . 2.1 mp -115.26 139.24 50.13 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.073 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.471 ' HB2' HG22 ' A' ' 6' ' ' ILE . 7.2 pt-20 -107.3 101.23 10.62 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.035 0.445 . . . . 0.0 110.292 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.3 p -89.0 137.61 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.751 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.682 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -95.85 119.31 34.12 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.264 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -99.79 115.64 30.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.646 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -140.92 -169.13 2.75 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.681 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.08 -138.83 1.61 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.548 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.439 -0.791 . . . . 0.0 111.167 -179.947 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.2 mtt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.529 0.204 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? 59.01 39.15 23.82 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.894 0.378 . . . . 0.0 110.951 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.5 145.92 98.3 Favored Pre-proline 0 CA--C 1.529 0.171 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.039 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.22 175.28 10.16 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.749 2.299 . . . . 0.0 112.871 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 1.5 tt0 -102.81 92.54 4.64 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.057 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.687 HG22 ' HG2' ' A' ' 87' ' ' GLU . 16.6 mm -90.83 108.19 19.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.839 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -135.69 138.63 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.418 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.474 ' HB ' ' HG3' ' A' ' 87' ' ' GLU . 6.1 t -104.38 143.17 33.36 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.238 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.768 HG21 ' HG3' ' A' ' 50' ' ' ARG . 13.6 p -128.93 137.33 57.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.304 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.456 HG23 HG23 ' A' ' 85' ' ' THR . 0.2 OUTLIER -81.21 96.64 7.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.899 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.611 HD21 ' HB3' ' A' ' 44' ' ' ALA . 8.7 tp -85.48 132.45 34.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.21 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.666 ' HG2' HG22 ' A' ' 83' ' ' VAL . 1.5 mmtt -108.46 115.78 30.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.376 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -67.36 120.7 14.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.374 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.08 -41.79 7.0 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.711 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -164.91 38.57 0.07 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.877 0.37 . . . . 0.0 111.187 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.73 -168.64 23.5 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.567 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.5 mtp -129.6 -66.47 0.8 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.543 0.211 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.475 ' HA3' ' HB ' ' A' ' 40' ' ' VAL . . . 65.81 74.17 0.54 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.174 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.1 mt -142.2 108.32 5.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.744 0.306 . . . . 0.0 111.046 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.7 91.05 5.83 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.554 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.685 HD13 HG23 ' A' ' 34' ' ' ILE . 1.6 pp -97.12 177.59 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.608 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.2 p -156.67 135.91 3.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.262 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.7 87.48 3.16 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.541 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.75 176.79 6.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.619 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 176.26 5.59 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.117 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.82 -143.45 3.68 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.95 150.31 27.91 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.899 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.76 18.03 37.3 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.342 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.77 108.83 5.2 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.642 0.258 . . . . 0.0 111.008 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.97 25.56 3.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.802 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.487 ' CB ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -120.99 -154.38 0.58 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 32' ' ' LEU . 1.5 tp -136.49 106.73 6.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.614 0.245 . . . . 0.0 110.576 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.84 152.26 20.93 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.93 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.685 HG23 HD13 ' A' ' 21' ' ' ILE . 40.5 mm -91.25 96.84 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.874 0.368 . . . . 0.0 110.673 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.418 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 77.3 m-85 -89.04 150.83 22.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.612 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 21' ' ' ILE . 30.7 t -106.85 131.04 57.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.704 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 pttp -116.89 -30.18 5.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.901 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.69 155.13 42.79 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.956 0.408 . . . . 0.0 111.777 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.8 t -138.18 120.86 19.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.171 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.475 ' HB ' ' HA3' ' A' ' 18' ' ' GLY . 32.3 t -64.43 127.89 25.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.811 0.338 . . . . 0.0 111.477 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 103.7 1.64 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.337 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.5 -10.66 4.34 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.419 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.535 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -73.55 -158.14 4.95 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.413 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.611 ' HB3' HD21 ' A' ' 11' ' ' LEU . . . -91.17 -38.79 12.5 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.435 ' N ' HD11 ' A' ' 11' ' ' LEU . . . -71.62 -37.7 70.86 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -66.96 -35.31 79.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.482 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 43' ' ' GLY . 24.1 t -80.75 -42.21 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.607 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -53.79 54.29 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.63 0.252 . . . . 0.0 111.427 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.38 51.81 2.65 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.579 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.768 ' HG3' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -120.57 -51.03 2.18 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.621 0.248 . . . . 0.0 110.626 179.655 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 pp -109.13 139.03 44.57 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.536 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.0 177.35 5.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.26 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.53 150.8 46.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.796 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.53 40.62 18.2 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.102 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -126.16 177.71 6.23 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.739 0.304 . . . . 0.0 111.306 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.794 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 20.0 tm0? -124.47 149.02 47.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.439 HD22 HD12 ' A' ' 86' ' ' LEU . 29.3 mt -123.76 121.69 36.13 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.706 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.66 -53.21 3.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.785 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.87 157.17 40.04 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.171 0.51 . . . . 0.0 112.338 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.785 ' CG2' HD11 ' A' ' 65' ' ' LEU . 21.8 t -141.17 109.67 2.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.757 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.27 35.89 26.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.13 17.73 60.51 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.457 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.498 ' HD2' HD22 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -124.44 123.04 39.28 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.222 0.511 . . . . 0.0 110.408 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 m -82.63 135.4 35.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.205 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.785 HD11 ' CG2' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -110.31 -3.1 16.38 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.591 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.55 ' O ' HG13 ' A' ' 66' ' ' VAL . 7.7 p -67.58 87.07 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.418 0.627 . . . . 0.0 110.911 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.79 -18.61 2.77 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 113.008 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -91.65 -170.99 2.75 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.917 0.359 . . . . 0.0 111.105 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.18 176.99 4.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.368 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -59.38 -31.02 68.84 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.267 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -68.02 -38.77 82.97 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.515 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -67.06 -40.11 87.02 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.457 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.544 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -69.62 -52.93 21.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.518 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.12 -37.84 84.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.913 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.464 ' O ' HG22 ' A' ' 78' ' ' THR . 29.4 tp10 -71.24 -32.01 68.25 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.262 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.498 HD22 ' HD2' ' A' ' 63' ' ' ARG . 11.9 mt -78.01 -35.23 50.16 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.435 0.159 . . . . 0.0 111.358 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 12.4 mtt -70.67 -31.72 68.73 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.342 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 75' ' ' GLU . 13.1 t -74.43 -30.6 61.97 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.46 0.17 . . . . 0.0 111.46 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.417 ' HD2' HD23 ' A' ' 76' ' ' LEU . 4.7 ptp180 -89.17 49.18 1.73 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.745 0.307 . . . . 0.0 111.415 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.502 ' HB ' HG22 ' A' ' 84' ' ' VAL . 67.7 p -121.53 171.37 8.85 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.724 0.297 . . . . 0.0 111.351 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.4 p -90.01 -165.7 1.41 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.467 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 80.0 p -59.61 -34.37 72.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.156 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.666 HG22 ' HG2' ' A' ' 12' ' ' LYS . 32.2 t -111.9 139.34 36.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.741 0.305 . . . . 0.0 110.982 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.502 HG22 ' HB ' ' A' ' 80' ' ' THR . 15.5 t -142.73 130.38 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.286 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.456 HG23 HG23 ' A' ' 10' ' ' THR . 0.1 OUTLIER -92.21 116.3 28.83 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.691 HD13 HG22 ' A' ' 60' ' ' VAL . 4.0 mm? -111.37 114.03 26.9 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.113 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.687 ' HG2' HG22 ' A' ' 6' ' ' ILE . 2.1 tt0 -81.22 101.36 9.66 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.5 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.0 p -94.06 147.63 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.811 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.794 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -119.04 126.08 50.86 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.122 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -96.05 131.27 42.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.1 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -161.3 -169.9 2.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.976 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 170.42 136.85 2.16 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.519 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.137 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.685 0.279 . . . . 0.0 111.503 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.29 33.93 23.15 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.795 0.331 . . . . 0.0 111.034 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -128.28 152.46 78.0 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.945 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.43 173.45 6.43 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.985 2.457 . . . . 0.0 112.866 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -89.41 89.59 7.94 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.223 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 23.8 mm -85.23 111.03 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.839 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.52 141.56 46.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.14 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 8.0 t -106.63 141.6 37.64 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.834 0.349 . . . . 0.0 111.299 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.9 p -119.5 128.45 75.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.349 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.0 m -82.95 94.5 7.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 mt -93.44 155.39 17.38 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.135 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HD2' HG22 ' A' ' 83' ' ' VAL . 1.0 OUTLIER -117.1 110.51 18.29 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.075 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -57.08 116.78 3.44 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.266 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -86.34 -47.73 9.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.556 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -166.21 42.54 0.06 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.46 -167.69 19.75 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.527 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.1 mmm -133.52 100.83 4.92 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.643 0.258 . . . . 0.0 110.791 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.22 79.98 0.6 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.547 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 mp -145.96 127.25 14.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.62 0.248 . . . . 0.0 110.749 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.32 99.27 11.04 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.882 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pt -96.61 175.4 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.472 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.647 HG13 ' HB2' ' A' ' 35' ' ' TYR . 3.4 p -159.81 148.3 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.598 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.78 124.76 46.88 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.464 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.36 -179.14 7.45 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -114.79 164.82 13.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.792 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.33 -144.17 3.85 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.59 164.03 13.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.811 0.339 . . . . 0.0 111.148 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.44 19.98 49.51 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.455 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.415 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -122.65 -165.8 1.34 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.137 0.494 . . . . 0.0 110.187 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.45 ' C ' ' HG2' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -169.84 20.39 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.36 178.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.767 ' HB2' HG22 ' A' ' 66' ' ' VAL . 6.0 mmmt -156.08 -164.17 1.64 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 32' ' ' LEU . 0.9 OUTLIER -114.01 106.32 14.27 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.838 0.352 . . . . 0.0 110.523 179.175 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.79 -173.05 27.94 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.212 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.635 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 9.2 mm -99.33 152.91 4.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.603 0.239 . . . . 0.0 110.725 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.647 ' HB2' HG13 ' A' ' 22' ' ' VAL . 18.9 m-85 -135.37 164.22 28.24 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.351 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.62 115.78 44.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -101.58 -33.11 10.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.946 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.2 161.13 21.96 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.926 0.393 . . . . 0.0 111.386 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.4 t -135.7 115.72 17.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.683 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.46 136.48 26.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.416 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 145.09 53.39 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.022 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.08 -22.67 39.45 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.959 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.592 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.04 174.62 36.71 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.775 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.94 -37.57 75.91 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.701 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -72.6 -37.76 68.02 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -67.75 -49.05 64.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.502 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 43' ' ' GLY . 46.9 t -63.86 -31.15 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.632 0.253 . . . . 0.0 111.314 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.78 -55.97 16.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.404 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.2 31.69 16.25 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.889 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -111.27 27.38 9.73 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.753 0.311 . . . . 0.0 110.933 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.701 HD21 ' HB1' ' A' ' 45' ' ' ALA . 3.4 pp -172.82 171.91 4.23 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.966 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.64 171.52 16.77 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.468 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.32 136.85 57.54 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.024 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.06 49.27 3.13 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.091 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -130.83 179.18 6.12 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.744 0.307 . . . . 0.0 111.243 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.87 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -118.45 173.14 7.0 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.918 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 86' ' ' LEU . 6.0 mt -151.67 119.23 6.06 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.668 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.35 -64.02 1.19 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.196 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.8 m -126.08 151.5 47.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.569 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.777 HG13 ' HG ' ' A' ' 86' ' ' LEU . 52.6 t -135.78 118.16 21.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.773 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.517 ' HB2' HG13 ' A' ' 84' ' ' VAL . 3.2 t0 58.33 40.31 24.59 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.965 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.24 29.13 68.9 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.834 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.447 ' HD3' HD22 ' A' ' 76' ' ' LEU . 32.9 mtt-85 -123.84 144.25 49.85 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 m -91.16 120.78 32.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.788 0.328 . . . . 0.0 111.39 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.669 ' HA ' HD21 ' A' ' 68' ' ' LEU . 4.2 mp -111.54 -5.74 14.5 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.821 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.767 HG22 ' HB2' ' A' ' 31' ' ' LYS . 12.0 p -81.99 71.38 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.857 0.837 . . . . 0.0 110.181 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 155.07 40.23 0.02 OUTLIER Glycine 0 CA--C 1.523 0.571 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.275 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.669 HD21 ' HA ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -158.54 177.79 10.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.741 0.305 . . . . 0.0 111.048 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.55 179.29 5.19 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.268 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -61.6 -35.54 78.15 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.322 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -54.6 -52.5 61.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.72 0.295 . . . . 0.0 110.798 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -62.65 -41.78 99.24 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.812 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.635 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -56.25 -56.21 23.79 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.499 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.38 93.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.022 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.5 ' HA ' HG22 ' A' ' 78' ' ' THR . 7.6 tt0 -66.68 -28.4 68.42 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.24 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.447 HD22 ' HD3' ' A' ' 63' ' ' ARG . 25.3 mt -75.49 -34.39 60.86 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.676 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 mtt -77.99 -39.2 43.12 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.321 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 75' ' ' GLU . 12.7 t -63.34 -32.8 74.31 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.778 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -90.9 57.65 3.58 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.192 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.413 ' HB ' HG22 ' A' ' 84' ' ' VAL . 51.7 p -122.79 178.47 5.02 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.096 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 m -108.43 -167.2 1.2 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.783 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.7 p -57.26 -30.32 64.55 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.478 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.501 HG22 ' HD2' ' A' ' 12' ' ' LYS . 21.9 t -117.44 137.7 50.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 120.652 0.263 . . . . 0.0 111.209 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.517 HG13 ' HB2' ' A' ' 61' ' ' ASP . 19.0 t -143.79 134.65 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.414 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.46 120.37 42.21 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.692 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.777 ' HG ' HG13 ' A' ' 60' ' ' VAL . 3.4 mp -114.67 117.13 29.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.283 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 1.6 mt-10 -81.28 93.04 6.45 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.646 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.572 HG13 ' HE3' ' A' ' 90' ' ' LYS . 10.9 p -87.61 141.22 14.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.541 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.87 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -106.94 139.74 40.85 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.146 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.572 ' HE3' HG13 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -102.81 109.26 20.78 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.731 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -146.61 -173.89 4.33 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.894 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 157.92 139.26 2.67 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.488 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.156 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.368 0.128 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.75 111.28 19.46 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.699 0.285 . . . . 0.0 110.966 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -114.05 94.37 34.07 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.948 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.62 162.44 10.49 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.023 2.482 . . . . 0.0 112.982 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -99.51 93.88 6.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.92 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 88' ' ' VAL . 4.0 mt -90.21 127.31 42.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.052 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.488 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.8 pt -141.67 146.79 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.264 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.496 ' HB ' ' HG2' ' A' ' 87' ' ' GLU . 2.7 t -101.49 147.16 26.7 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.156 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.604 HG11 ' HB3' ' A' ' 50' ' ' ARG . 26.9 m -124.99 128.86 73.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.462 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.547 HG23 ' CG1' ' A' ' 83' ' ' VAL . 88.0 m -87.78 102.5 14.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.487 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.412 HD21 ' HA ' ' A' ' 45' ' ' ALA . 3.4 mp -125.04 167.38 14.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.366 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -126.0 170.82 11.34 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.044 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -69.09 94.01 0.63 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.888 0.375 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.402 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -101.98 81.95 2.18 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.512 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 57.54 36.18 26.6 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.088 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.08 173.4 30.19 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.629 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.6 mmt -87.27 -73.02 0.49 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.559 0.219 . . . . 0.0 110.749 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.83 66.74 1.82 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.651 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.43 ' CD2' HD11 ' A' ' 51' ' ' LEU . 4.9 mp -145.74 117.89 8.35 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.646 0.26 . . . . 0.0 110.658 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.5 m -80.62 96.33 6.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.741 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.547 HG22 HG22 ' A' ' 36' ' ' VAL . 2.1 pt -105.11 175.99 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.59 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -156.32 141.24 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.241 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.28 92.82 6.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.639 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.508 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . . . -124.44 178.39 5.42 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.281 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HG3' HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -112.79 179.97 3.82 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.288 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.81 -143.7 3.74 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.676 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.49 161.82 18.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.702 0.286 . . . . 0.0 111.075 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.81 19.92 45.62 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.853 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.68 -163.01 0.9 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.231 0.539 . . . . 0.0 110.173 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -170.29 20.64 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.227 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.888 ' HB2' HG12 ' A' ' 66' ' ' VAL . 5.1 mttp -159.92 -168.81 2.33 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.48 0.312 . . . . 0.0 110.268 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.447 HD12 ' HG3' ' A' ' 25' ' ' LYS . 1.5 tp -105.44 127.44 53.0 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.798 0.332 . . . . 0.0 110.994 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.88 147.55 16.27 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.518 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.505 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.6 mp -81.41 97.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.976 0.417 . . . . 0.0 109.981 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.508 ' CD2' ' HB3' ' A' ' 24' ' ' ALA . 22.7 m-85 -87.86 143.96 26.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.28 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 21' ' ' ILE . 38.9 t -103.52 122.8 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.847 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -92.09 -40.61 10.96 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.885 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 m -165.02 175.82 9.13 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.727 0.298 . . . . 0.0 111.168 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.412 HG13 ' HG ' ' A' ' 19' ' ' LEU . 21.3 t -126.39 145.37 34.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.154 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.9 t -84.49 146.55 6.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.529 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.39 140.97 52.21 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.062 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.19 18.12 80.12 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.506 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -96.38 176.22 32.53 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.234 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 14' ' ' GLN . . . -60.42 -62.18 2.06 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.412 ' HA ' HD21 ' A' ' 11' ' ' LEU . . . -57.64 -33.24 68.08 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.694 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -67.89 -56.81 7.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.109 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 43' ' ' GLY . 44.6 t -66.07 -35.25 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.75 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.13 -48.84 49.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.616 0.246 . . . . 0.0 110.896 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.46 87.59 0.72 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.627 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.604 ' HB3' HG11 ' A' ' 9' ' ' VAL . 8.3 mmt180 -146.27 -67.13 0.28 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.59 0.233 . . . . 0.0 110.857 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.43 HD11 ' CD2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -103.37 152.2 21.86 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.067 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.81 -162.2 1.18 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.181 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.36 144.08 53.54 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.516 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.71 50.58 6.42 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.248 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -130.62 131.95 45.21 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.449 0.166 . . . . 0.0 110.966 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.717 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 53.5 tt0 -92.73 145.85 24.1 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.745 0.307 . . . . 0.0 111.182 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -116.78 121.8 42.61 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.723 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -96.9 -47.16 5.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.209 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.5 m -138.94 152.83 48.04 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.099 0.476 . . . . 0.0 111.542 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.66 HG13 ' HG ' ' A' ' 86' ' ' LEU . 44.0 t -136.03 114.23 15.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.157 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.602 ' HB2' HG13 ' A' ' 84' ' ' VAL . 2.3 t70 62.07 35.93 15.62 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.443 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.38 -18.72 35.75 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.583 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.534 ' HD3' HD22 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -75.72 147.77 39.1 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 117.436 0.618 . . . . 0.0 111.038 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 p -95.83 116.26 28.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.818 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.595 ' HA ' HD21 ' A' ' 68' ' ' LEU . 5.1 mp -101.47 37.59 1.77 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.964 0.412 . . . . 0.0 110.7 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.888 HG12 ' HB2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -110.46 100.72 11.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.16 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.16 4.48 18.33 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.18 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.595 HD21 ' HA ' ' A' ' 65' ' ' LEU . 1.2 pp -113.29 163.32 14.97 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 117.184 0.492 . . . . 0.0 110.867 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 p -85.04 168.5 14.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.871 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -57.08 -28.43 62.6 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.494 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.59 -49.58 76.95 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.75 0.31 . . . . 0.0 110.269 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.401 ' HB3' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -68.47 -38.75 81.34 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.042 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.38 -55.77 27.78 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.434 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.15 94.43 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.136 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -62.75 -37.08 85.19 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.534 HD22 ' HD3' ' A' ' 63' ' ' ARG . 16.2 mt -70.83 -35.0 72.26 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.013 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.46 ' HG2' HG11 ' A' ' 60' ' ' VAL . 4.8 mtt -68.91 -40.99 78.79 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.096 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.5 t -67.53 -36.69 81.49 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.596 0.236 . . . . 0.0 110.614 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -88.59 56.24 3.7 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.888 0.375 . . . . 0.0 111.115 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.435 ' HB ' HG22 ' A' ' 84' ' ' VAL . 31.5 p -112.52 -175.14 2.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.635 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.9 m -102.0 -169.76 1.72 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -34.0 67.08 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.594 0.235 . . . . 0.0 110.968 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.547 ' CG1' HG23 ' A' ' 10' ' ' THR . 23.2 t -119.56 143.94 29.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.0 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.602 HG13 ' HB2' ' A' ' 61' ' ' ASP . 14.3 t -142.76 137.75 27.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.448 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.22 102.5 11.17 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.011 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.686 ' HB3' HD21 ' A' ' 57' ' ' LEU . 7.0 mp -94.56 117.22 29.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.074 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.496 ' HG2' ' HB ' ' A' ' 8' ' ' THR . 3.8 mm-40 -80.42 95.98 6.58 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.632 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 7' ' ' ILE . 35.8 m -86.98 170.39 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.35 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.717 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -138.38 125.95 22.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.094 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -85.18 116.26 23.43 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.674 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -152.58 -167.93 2.9 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.077 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.13 137.03 2.15 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.507 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.953 179.914 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mtm . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -127.06 33.45 4.91 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.653 0.263 . . . . 0.0 110.864 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -115.77 97.24 48.59 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.777 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.0 170.61 2.04 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.172 2.581 . . . . 0.0 113.305 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 89' ' ' ALA . 28.0 tt0 -103.52 96.99 7.1 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.104 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.739 HD13 ' HB2' ' A' ' 89' ' ' ALA . 22.2 mm -79.33 121.87 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.339 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 pt -145.35 146.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.373 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.1 t -121.18 124.77 45.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 110.961 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.6 t -120.89 145.94 26.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.197 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.587 HG22 ' CG2' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -90.91 112.24 24.01 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.677 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.1 152.69 29.27 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.254 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -110.1 158.81 17.91 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.496 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -99.97 133.7 43.96 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.206 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.2 -42.3 3.06 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.135 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -154.13 42.66 0.53 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.838 0.351 . . . . 0.0 110.983 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.44 -156.36 15.8 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.453 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.96 -58.66 2.04 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.492 0.187 . . . . 0.0 110.91 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.78 53.16 39.82 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.746 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.5 mt -142.88 116.71 9.31 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.66 0.266 . . . . 0.0 111.218 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.04 126.58 40.48 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.646 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.848 HG21 ' HE2' ' A' ' 77' ' ' MET . 1.5 pt -115.54 176.01 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.624 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.749 HG13 ' HB2' ' A' ' 35' ' ' TYR . 2.4 p -153.28 137.24 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.451 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.08 101.29 12.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.483 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -134.1 -179.66 5.69 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.411 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -114.04 169.11 9.25 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.19 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.06 -143.35 3.65 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.23 157.42 16.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.85 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.72 23.91 46.21 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.52 104.42 7.88 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.108 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.67 11.16 13.58 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.583 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.472 ' HB2' HG12 ' A' ' 66' ' ' VAL . 8.3 mmmm -146.06 -167.3 2.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.835 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 32' ' ' LEU . 6.1 tp -103.39 119.2 38.43 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.686 0.279 . . . . 0.0 110.593 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.63 177.73 25.87 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.739 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.541 HG21 ' HE1' ' A' ' 77' ' ' MET . 36.6 mm -103.77 150.93 6.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 120.733 0.302 . . . . 0.0 110.825 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.749 ' HB2' HG13 ' A' ' 22' ' ' VAL . 92.7 m-85 -137.92 150.26 46.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.03 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.7 t -80.72 95.39 2.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.628 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -42.19 98.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.965 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.1 t -175.33 166.52 3.36 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.417 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 46' ' ' ASP . 11.2 t -126.77 137.9 56.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.837 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -82.48 119.92 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.374 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -63.56 110.04 1.86 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.838 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.1 -3.2 14.31 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.518 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -79.12 -139.2 1.69 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.433 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.08 -62.2 1.27 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.487 0.184 . . . . 0.0 111.436 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . -63.0 -33.79 76.17 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.411 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.462 ' HB2' HG12 ' A' ' 39' ' ' VAL . 11.1 t70 -60.67 -39.91 90.16 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.223 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 43' ' ' GLY . 42.3 t -67.25 -39.98 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.636 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -59.32 -55.33 36.14 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.6 0.238 . . . . 0.0 111.29 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.62 19.53 37.46 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.312 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -33.65 26.37 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.147 0.474 . . . . 0.0 110.862 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.593 HD22 HG21 ' A' ' 88' ' ' VAL . 2.1 pp -123.99 163.68 20.88 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.17 175.64 9.92 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.276 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.23 145.13 56.63 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.196 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.68 47.04 8.17 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.97 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.26 -176.99 3.41 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.612 0.244 . . . . 0.0 110.844 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.806 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 10.5 tm0? -118.83 153.77 33.97 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.151 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.006 HD11 HD12 ' A' ' 86' ' ' LEU . 8.1 tt -137.77 135.75 36.63 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.809 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.07 -59.03 2.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.793 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.2 p -116.65 158.02 24.45 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.137 0.494 . . . . 0.0 112.097 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.737 HG11 ' HG3' ' A' ' 77' ' ' MET . 23.5 t -140.11 119.36 12.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.53 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t0 60.31 35.13 20.76 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.023 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.43 -5.91 71.09 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.581 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.3 mtt-85 -91.95 148.83 21.91 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 117.484 0.642 . . . . 0.0 111.187 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.5 m -89.12 139.81 30.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.237 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.597 HD13 HG23 ' A' ' 60' ' ' VAL . 5.0 mp -136.39 79.4 1.76 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.962 0.41 . . . . 0.0 111.377 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' A' ' 31' ' ' LYS . 16.6 t -130.45 95.37 2.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.363 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.97 -26.48 4.23 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.891 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 mt -73.13 176.11 6.14 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.836 0.351 . . . . 0.0 111.449 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 m -109.45 -178.25 3.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.039 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -59.04 -35.09 72.71 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.347 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -58.2 -59.04 5.92 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.624 0.249 . . . . 0.0 110.966 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.6 mmt-85 -61.88 -44.72 96.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.93 -54.92 41.63 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.104 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 78' ' ' THR . . . -59.48 -48.31 82.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.092 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.76 -38.64 78.89 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.982 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 80' ' ' THR . 7.6 mt -76.07 -35.88 59.23 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.097 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.848 ' HE2' HG21 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -76.43 -35.19 58.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.532 HG23 ' HG3' ' A' ' 79' ' ' ARG . 13.3 t -71.13 -39.06 72.22 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.538 0.208 . . . . 0.0 110.956 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.532 ' HG3' HG23 ' A' ' 78' ' ' THR . 46.4 mtp180 -93.77 59.96 2.89 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.882 0.373 . . . . 0.0 111.016 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 76' ' ' LEU . 31.7 p -117.06 169.41 9.44 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.995 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.99 -169.17 0.45 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.754 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.3 p -79.83 -52.49 7.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.808 0.337 . . . . 0.0 110.377 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.587 ' CG2' HG22 ' A' ' 10' ' ' THR . 7.6 p -89.34 74.49 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.581 0.705 . . . . 0.0 110.795 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.1 t -89.18 148.4 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.972 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.531 HG23 HG23 ' A' ' 10' ' ' THR . 3.1 p -110.61 117.04 32.42 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.661 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.006 HD12 HD11 ' A' ' 57' ' ' LEU . 4.2 mm? -111.73 122.22 47.22 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.296 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -87.65 83.17 7.23 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.035 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.593 HG21 HD22 ' A' ' 51' ' ' LEU . 22.0 t -89.3 145.9 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.536 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.806 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -110.2 117.12 32.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.166 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -83.7 122.65 28.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.54 -159.41 0.92 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.73 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.83 -137.44 1.05 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.119 -0.563 . . . . 0.0 112.491 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.119 179.915 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmm . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.644 0.259 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.18 167.1 16.91 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.972 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -99.9 139.85 21.1 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.346 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -76.77 172.64 15.83 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.847 2.364 . . . . 0.0 112.804 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 57.7 tt0 -111.66 96.54 6.15 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.54 HD13 ' HB2' ' A' ' 89' ' ' ALA . 23.2 mm -82.04 126.41 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.196 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 pt -148.49 149.57 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.363 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 14.5 m -113.61 123.95 51.17 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.629 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.555 HG11 ' CG ' ' A' ' 50' ' ' ARG . 20.7 t -122.13 138.28 52.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.375 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.6 HG23 HG23 ' A' ' 85' ' ' THR . 0.2 OUTLIER -110.69 135.5 51.21 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.657 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -147.97 176.03 10.5 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.031 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -119.61 144.57 47.05 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.147 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -79.74 146.47 32.35 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.354 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -50.32 4.26 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.365 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -161.39 43.19 0.16 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.999 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.79 -160.54 19.41 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.53 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 90.4 mtp -142.61 101.75 3.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.92 80.63 0.63 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.369 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.539 HD21 ' CB ' ' A' ' 45' ' ' ALA . 1.2 mp -147.17 117.16 7.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.647 0.261 . . . . 0.0 110.494 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 p -82.0 131.55 35.25 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.949 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.649 HD13 HG23 ' A' ' 34' ' ' ILE . 1.5 pp -124.37 174.12 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.089 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.49 HG13 ' HB2' ' A' ' 35' ' ' TYR . 7.6 p -157.67 140.84 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.138 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.27 104.01 16.0 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.996 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.573 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -137.28 176.4 8.75 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.819 0.342 . . . . 0.0 111.691 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -101.93 175.1 5.66 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.311 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.33 -142.66 3.47 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.56 151.17 27.14 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.034 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.85 19.35 36.28 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.401 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.83 108.85 5.72 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.769 0.318 . . . . 0.0 111.185 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -95.15 30.8 2.06 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.322 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.447 ' CB ' HG12 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -130.96 -148.2 0.35 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tp -143.14 113.79 7.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.73 0.3 . . . . 0.0 110.753 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.75 152.97 19.16 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.564 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.649 HG23 HD13 ' A' ' 21' ' ' ILE . 31.4 mm -80.63 100.19 4.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.854 0.359 . . . . 0.0 110.444 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.573 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 17.5 m-85 -84.53 156.38 21.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.039 0.447 . . . . 0.0 111.258 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -105.68 112.94 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.763 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.36 -36.78 22.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.129 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -164.85 165.39 20.53 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.831 0.348 . . . . 0.0 111.224 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.9 t -130.39 112.78 23.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.859 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -60.95 130.49 25.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.092 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.7 149.52 46.48 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.07 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.24 -31.09 8.89 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.545 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -64.31 142.87 46.49 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.521 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.3 -38.57 53.6 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 1.04 ' HB1' HD12 ' A' ' 51' ' ' LEU . . . -52.82 -53.72 44.46 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.683 0.277 . . . . 0.0 111.4 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.84 -44.59 85.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.048 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 43' ' ' GLY . 33.5 t -61.82 -37.3 77.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.469 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.14 -53.32 59.09 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.083 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.88 44.49 1.51 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.159 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.555 ' CG ' HG11 ' A' ' 9' ' ' VAL . 4.5 mmp_? -142.79 31.89 1.43 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.736 0.268 . . . . 0.0 110.983 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.04 HD12 ' HB1' ' A' ' 45' ' ' ALA . 6.5 mt -149.87 168.62 23.23 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.447 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -171.12 151.97 3.34 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.125 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.23 152.18 45.41 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.886 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.11 52.68 26.38 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.782 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.11 171.36 11.97 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.72 0.295 . . . . 0.0 111.187 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.825 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 1.9 tm0? -110.18 154.54 23.21 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.825 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.735 HD21 HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -137.57 119.8 15.68 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.573 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tt -107.79 -55.99 2.29 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.024 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.8 t -103.42 145.69 29.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.05 0.452 . . . . 0.0 112.176 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.739 ' CG2' HD21 ' A' ' 65' ' ' LEU . 21.3 t -140.97 119.81 10.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.763 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' HG12 ' A' ' 60' ' ' VAL . 7.2 m-20 56.65 44.41 23.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.133 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.82 27.39 73.31 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.083 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -130.74 138.07 49.8 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.677 0.275 . . . . 0.0 110.33 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.7 m -92.85 124.61 36.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.789 ' HB2' HD12 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -130.53 83.18 2.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.266 0.555 . . . . 0.0 111.084 179.704 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' A' ' 31' ' ' LYS . 15.2 t -110.12 94.94 3.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.803 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.78 36.85 1.02 Allowed Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.488 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.789 HD12 ' HB2' ' A' ' 65' ' ' LEU . 32.6 mt -116.05 157.55 24.51 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.727 0.299 . . . . 0.0 110.792 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -77.11 160.58 28.92 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.524 ' HG3' HD12 ' A' ' 21' ' ' ILE . 58.4 tt0 -54.36 -35.24 62.56 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.954 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.37 -43.44 81.39 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.459 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -61.12 -53.34 58.23 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.492 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.45 98.79 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.316 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.75 80.77 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.603 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.523 ' O ' HG22 ' A' ' 78' ' ' THR . 1.6 tp10 -65.6 -35.7 81.59 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.248 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.424 HD23 ' HD2' ' A' ' 79' ' ' ARG . 16.2 mt -74.84 -35.87 62.38 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.095 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.9 mtt -69.15 -29.1 67.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.365 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 75' ' ' GLU . 14.7 t -79.7 -30.62 41.07 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 121.297 -0.161 . . . . 0.0 111.24 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.424 ' HD2' HD23 ' A' ' 76' ' ' LEU . 15.5 ptp180 -93.44 40.33 1.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.714 0.292 . . . . 0.0 111.216 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.8 p -93.11 170.08 9.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 111.515 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.6 m -103.57 -165.02 1.12 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.46 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.78 -35.89 71.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.135 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.6 t -93.17 149.66 4.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.799 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 t -134.43 91.69 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.109 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.6 HG23 HG23 ' A' ' 10' ' ' THR . 4.8 m -89.25 88.68 7.61 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.767 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.701 HD22 HD11 ' A' ' 57' ' ' LEU . 9.0 mt -106.36 139.89 40.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.511 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 12.1 tt0 -113.97 105.74 13.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.087 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.676 HG12 HD12 ' A' ' 57' ' ' LEU . 23.8 m -102.53 172.61 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.045 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.825 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -136.17 131.56 34.8 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.526 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 48.8 mmtt -76.3 118.87 19.45 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.802 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -148.01 -159.28 1.01 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.77 -135.66 0.53 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.408 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.364 -0.827 . . . . 0.0 111.203 179.951 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptt? . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.677 0.275 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -115.26 165.69 12.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.757 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 67.29 114.19 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.052 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.422 ' O ' HD12 ' A' ' 6' ' ' ILE . 53.2 Cg_exo -55.7 176.35 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.882 2.388 . . . . 0.0 112.84 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -90.54 86.09 6.31 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.068 0.461 . . . . 0.0 111.242 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 4' ' ' PRO . 3.4 mp -99.66 121.87 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.759 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 pp -141.97 137.06 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.315 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.613 ' OG1' HG22 ' A' ' 85' ' ' THR . 3.7 t -99.04 138.89 35.49 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.069 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.55 136.06 46.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.421 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.626 HG23 HG23 ' A' ' 85' ' ' THR . 0.7 OUTLIER -80.15 95.9 6.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.869 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.97 134.31 34.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -90.98 176.7 6.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.059 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.28 130.75 54.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.148 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.02 -45.26 4.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.587 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -161.73 43.21 0.15 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.26 -164.25 14.52 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.794 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 16.3 mtp -119.05 99.99 7.07 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.731 0.301 . . . . 0.0 110.464 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.614 ' HA3' ' CG2' ' A' ' 40' ' ' VAL . . . -90.65 75.72 1.63 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.093 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.463 HD21 HD11 ' A' ' 51' ' ' LEU . 5.0 mp -147.93 108.41 4.13 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.571 0.224 . . . . 0.0 110.871 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -85.62 82.41 8.25 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.055 0.455 . . . . 0.0 110.27 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.849 HD13 HG23 ' A' ' 34' ' ' ILE . 1.2 pp -82.86 175.88 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.049 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' ' 35' ' ' TYR . 7.7 p -153.16 145.75 14.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.415 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -98.55 100.04 11.25 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.83 176.09 9.01 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.805 0.336 . . . . 0.0 111.566 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 178.47 4.55 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.19 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.81 -142.3 3.45 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.0 147.5 32.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.967 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.47 16.91 30.74 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.377 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.55 108.54 5.44 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.733 -0.234 . . . . 0.0 110.852 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -93.34 23.58 4.4 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.862 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.06 -158.51 0.72 Allowed 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 32' ' ' LEU . 0.9 OUTLIER -132.9 106.81 7.92 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.737 0.303 . . . . 0.0 110.943 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.22 153.38 24.37 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.699 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.849 HG23 HD13 ' A' ' 21' ' ' ILE . 33.5 mm -80.97 90.7 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-O 120.817 0.341 . . . . 0.0 110.523 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.402 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 20.2 m-85 -81.25 161.43 23.94 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.525 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 21' ' ' ILE . 47.6 t -122.93 126.01 73.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.639 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.21 -29.68 6.19 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.1 t -136.65 156.57 48.36 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.032 0.444 . . . . 0.0 111.852 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.02 133.48 26.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.481 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.614 ' CG2' ' HA3' ' A' ' 18' ' ' GLY . 30.0 m -61.07 134.02 26.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.885 0.374 . . . . 0.0 111.366 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.63 93.44 6.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.429 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.26 30.04 4.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.297 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.65 -139.39 10.26 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.688 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.86 -33.56 10.49 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.812 0.306 . . . . 0.0 111.76 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.22 -47.25 11.01 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.374 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -58.58 -38.82 78.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.345 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 t -76.63 -33.73 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.089 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -46.34 90.08 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.978 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.27 29.53 24.82 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.623 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -100.68 -41.63 6.84 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.703 0.287 . . . . 0.0 110.867 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.463 HD11 HD21 ' A' ' 19' ' ' LEU . 4.4 pp -129.44 162.11 28.84 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.781 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.91 -175.14 5.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.25 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.61 135.38 52.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.258 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.0 46.28 3.39 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.347 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -133.36 173.02 11.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.711 0.291 . . . . 0.0 111.296 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 49.1 tt0 -131.11 143.87 50.98 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.883 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.706 ' CD2' HD22 ' A' ' 86' ' ' LEU . 1.9 mp -112.97 122.26 47.09 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.252 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tt -94.34 -58.41 2.22 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.743 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 m -138.99 156.25 47.37 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.955 0.407 . . . . 0.0 111.524 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.704 HG13 ' CD2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -102.9 -167.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.141 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.524 ' H ' HG12 ' A' ' 60' ' ' VAL . 5.1 p-10 -67.22 68.81 0.08 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.09 0.471 . . . . 0.0 110.83 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 60' ' ' VAL . . . 98.99 25.37 9.67 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.559 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.504 ' HD3' HD22 ' A' ' 76' ' ' LEU . 5.0 mtm180 -135.61 147.67 48.73 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.653 0.227 . . . . 0.0 110.633 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 m -113.43 110.9 21.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.924 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.668 HD11 HG22 ' A' ' 60' ' ' VAL . 7.1 mt -102.02 68.6 1.13 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.672 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.18 97.55 3.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.34 -32.11 5.0 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.589 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.518 HD21 ' HA ' ' A' ' 65' ' ' LEU . 4.3 pp -68.29 168.72 11.85 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.004 0.431 . . . . 0.0 111.477 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.5 p -91.23 167.15 12.53 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.073 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.437 ' HG3' HD12 ' A' ' 21' ' ' ILE . 30.2 tt0 -55.42 -26.06 39.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.562 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.52 -46.92 71.42 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.804 0.335 . . . . 0.0 110.609 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -49.04 79.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.252 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.49 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -58.38 -51.7 68.7 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.111 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.98 -43.8 82.05 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -34.7 78.94 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.204 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.504 HD22 ' HD3' ' A' ' 63' ' ' ARG . 9.0 mt -74.82 -35.61 62.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.642 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.496 ' CE ' HG21 ' A' ' 34' ' ' ILE . 9.3 mtt -72.67 -38.31 67.66 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.063 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.0 t -68.06 -31.15 70.59 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 121.233 -0.187 . . . . 0.0 111.002 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -89.32 53.18 2.56 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.761 0.315 . . . . 0.0 111.423 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.506 ' HB ' HG22 ' A' ' 84' ' ' VAL . 52.7 p -127.06 166.77 16.97 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.228 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.31 -170.23 3.03 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.381 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 m -54.11 -43.9 70.82 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.253 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.5 t -103.2 135.73 39.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.938 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.506 HG22 ' HB ' ' A' ' 80' ' ' THR . 18.5 t -139.92 121.99 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.537 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.626 HG23 HG23 ' A' ' 10' ' ' THR . 0.2 OUTLIER -92.02 123.89 35.72 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.588 179.391 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.706 HD22 ' CD2' ' A' ' 57' ' ' LEU . 6.3 mt -131.47 134.08 45.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.707 0.289 . . . . 0.0 111.148 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 1.5 mt-10 -81.43 112.11 18.39 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.883 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.0 t -99.72 132.41 45.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.557 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -109.23 142.17 40.45 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.934 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -102.44 122.31 44.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -159.93 -171.38 3.22 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.088 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.78 138.0 2.32 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.462 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.416 -0.802 . . . . 0.0 111.048 179.902 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.469 0.176 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -98.65 172.45 7.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.776 0.322 . . . . 0.0 110.941 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -127.67 116.27 20.99 Favored Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.095 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.61 144.12 53.78 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.624 2.216 . . . . 0.0 112.622 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -116.52 99.35 7.1 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.856 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.485 ' H ' HD12 ' A' ' 6' ' ' ILE . 3.8 mp -80.1 98.05 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.961 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 pt -106.26 157.78 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.324 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.1 m -124.46 128.79 49.53 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.871 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.458 HG11 ' HG3' ' A' ' 50' ' ' ARG . 20.3 t -137.4 151.73 26.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.406 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.93 106.31 18.33 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.717 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.07 154.9 17.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -117.84 137.82 52.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.057 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -72.44 111.44 7.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 110.924 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.53 86.37 2.4 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.599 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 56.61 38.14 29.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.134 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.92 -159.55 14.41 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 mmt -136.67 99.59 4.1 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.758 0.313 . . . . 0.0 110.96 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.28 72.34 1.34 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.657 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mp -142.19 128.44 19.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.632 0.253 . . . . 0.0 110.676 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.95 132.29 33.84 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.163 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 pt -133.84 171.08 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.973 0.416 . . . . 0.0 111.933 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.589 HG13 ' HB2' ' A' ' 35' ' ' TYR . 4.5 p -157.24 138.72 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.002 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.87 97.47 9.31 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.74 -179.82 5.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.511 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.25 -179.59 3.99 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.289 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.25 -142.36 3.41 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.97 155.86 17.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.795 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.55 23.6 43.65 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.408 -0.901 . . . . 0.0 110.955 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.26 103.39 7.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.534 -0.333 . . . . 0.0 111.272 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.448 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 10.5 t70 -87.22 9.21 20.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.435 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.931 ' HB2' HG12 ' A' ' 66' ' ' VAL . 4.3 mttt -142.59 -167.46 2.51 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.192 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tp -112.01 132.74 54.61 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.635 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.55 153.16 17.74 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.567 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.572 HD11 ' CB ' ' A' ' 73' ' ' ALA . 47.3 mm -83.5 101.32 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.892 0.377 . . . . 0.0 110.63 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.589 ' HB2' HG13 ' A' ' 22' ' ' VAL . 19.9 m-85 -87.96 136.75 32.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.551 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.81 115.66 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.104 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -73.73 -44.75 55.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.785 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.35 172.22 3.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 111.501 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.8 t -124.77 136.88 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.19 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.61 142.64 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.407 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -72.11 138.97 48.14 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.814 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.49 -14.2 65.36 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.25 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.64 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -73.93 -168.19 16.81 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.558 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.04 -54.5 6.46 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.831 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . -58.63 -39.96 81.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.299 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -58.99 -44.83 91.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.083 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 43' ' ' GLY . 38.4 t -75.56 -34.2 28.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.096 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.88 -38.99 70.89 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.114 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.19 27.03 71.88 Favored Glycine 0 CA--C 1.521 0.469 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.897 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.458 ' HG3' HG11 ' A' ' 9' ' ' VAL . 7.6 mmt180 -102.51 -34.37 9.15 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.553 0.216 . . . . 0.0 111.015 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.831 HD11 ' HB1' ' A' ' 45' ' ' ALA . 4.3 pp -122.38 175.98 6.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.05 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.96 -171.03 3.49 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.287 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.15 153.55 42.43 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.188 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.31 53.15 14.37 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.085 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.13 160.22 24.18 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.743 0.306 . . . . 0.0 111.135 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.548 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 4.9 tm0? -113.44 109.88 19.4 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.443 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.783 ' HG ' HG12 ' A' ' 88' ' ' VAL . 2.2 mt -85.76 119.31 25.95 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.364 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.64 -61.38 1.47 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.57 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.414 ' H ' ' HG2' ' A' ' 87' ' ' GLU . 2.9 m -120.61 156.99 30.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 111.705 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.666 HG22 ' CD1' ' A' ' 86' ' ' LEU . 38.5 t -135.54 113.87 15.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.559 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t0 64.47 20.69 12.24 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.311 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.36 -23.46 26.75 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.642 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.06 142.71 27.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.494 0.647 . . . . 0.0 111.148 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.76 122.84 36.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.95 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.8 mt -102.79 39.94 1.46 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.931 HG12 ' HB2' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -96.04 97.08 6.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.267 179.731 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.408 ' CA ' ' HB3' ' A' ' 31' ' ' LYS . . . 119.04 38.19 0.76 Allowed Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.305 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.5 mt -138.5 174.89 10.06 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.704 0.288 . . . . 0.0 110.757 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.6 m -94.8 165.81 12.29 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -55.65 -31.84 62.69 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.968 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -57.72 8.88 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.335 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -53.72 -48.23 69.82 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.664 -0.243 . . . . 0.0 111.621 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.572 ' CB ' HD11 ' A' ' 34' ' ' ILE . . . -65.01 -48.59 73.37 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.714 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.34 90.31 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.025 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -59.73 -26.9 66.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.361 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.3 mt -87.66 -48.27 8.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.593 0.235 . . . . 0.0 111.115 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.656 ' HE3' HD13 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -59.89 -31.36 69.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.076 179.731 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.442 HG23 ' HG2' ' A' ' 79' ' ' ARG . 15.2 t -74.25 -31.22 62.49 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.629 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.442 ' HG2' HG23 ' A' ' 78' ' ' THR . 12.5 mmt180 -87.1 49.67 1.86 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.734 0.302 . . . . 0.0 111.377 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.412 ' HB ' ' CG2' ' A' ' 84' ' ' VAL . 1.5 p -103.63 169.09 8.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.841 0.353 . . . . 0.0 111.234 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.87 -168.1 1.5 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.57 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 96.9 p -55.38 -36.84 66.82 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.271 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.8 t -122.96 138.33 53.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.621 0.248 . . . . 0.0 111.256 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.412 ' CG2' ' HB ' ' A' ' 80' ' ' THR . 3.6 t -141.37 147.76 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.504 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.4 m -102.7 99.26 9.22 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.856 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.727 HD12 HD22 ' A' ' 57' ' ' LEU . 4.5 mm? -106.55 136.47 46.27 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.259 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 59' ' ' SER . 1.2 pm0 -117.29 101.0 8.06 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.661 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.783 HG12 ' HG ' ' A' ' 57' ' ' LEU . 34.1 m -104.05 166.56 2.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.254 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -122.18 113.57 19.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.769 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -78.57 131.22 36.68 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.912 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.19 -165.8 1.42 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.005 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.36 135.99 2.21 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.558 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.096 179.898 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mtm . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.677 0.275 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -158.62 29.85 0.23 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.655 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -148.85 83.26 6.88 Favored Pre-proline 0 N--CA 1.465 0.307 0 CA-C-O 120.664 0.269 . . . . 0.0 111.1 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' HG2' HD11 ' A' ' 6' ' ' ILE . 56.1 Cg_endo -70.44 169.46 19.73 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.806 2.337 . . . . 0.0 112.952 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -105.86 94.0 4.94 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.123 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.443 HD11 ' HG2' ' A' ' 4' ' ' PRO . 2.3 mp -96.88 122.43 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.867 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 pt -127.17 150.37 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.508 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 m -88.92 120.63 30.5 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.093 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.18 138.81 37.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.113 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.534 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -115.33 107.13 14.83 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.821 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 51' ' ' LEU . 5.1 mt -100.7 164.97 11.62 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.139 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.459 ' HE2' HG22 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -138.62 111.08 7.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.131 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.25 103.76 0.12 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.325 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -53.11 5.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.738 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -149.54 38.81 0.78 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.985 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.34 -171.32 15.86 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.5 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.3 mtp -136.01 80.19 1.81 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.851 0.357 . . . . 0.0 111.027 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.55 80.87 1.76 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.727 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.526 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -153.36 139.09 17.92 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.85 0.357 . . . . 0.0 110.914 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.4 m -100.61 135.59 41.81 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 pp -126.73 178.18 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.798 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.454 ' CG2' ' HB2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -131.96 167.01 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.975 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 70' ' ' GLN . . . -145.41 80.9 1.61 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.546 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.44 -179.34 7.0 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.673 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.86 172.08 14.26 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.755 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -151.16 -143.95 3.82 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.666 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.76 151.52 27.67 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.855 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.56 18.88 39.4 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.086 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.31 112.77 5.61 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.657 -0.271 . . . . 0.0 110.877 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.52 23.9 4.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.96 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.661 ' CB ' HG12 ' A' ' 66' ' ' VAL . 15.6 mmtp -124.21 -149.58 0.43 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 32' ' ' LEU . 1.6 tp -129.5 119.14 23.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.691 0.281 . . . . 0.0 110.788 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.82 164.74 12.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.102 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 28.3 mm -99.55 133.06 43.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.454 ' HB2' ' CG2' ' A' ' 22' ' ' VAL . 54.8 m-85 -117.0 168.6 10.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.666 0.269 . . . . 0.0 111.178 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.22 108.99 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.855 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -73.41 -41.96 62.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.76 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.35 166.04 2.77 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.178 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.1 t -123.45 128.55 74.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.47 146.36 7.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.414 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.6 tptt -65.73 143.38 57.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.833 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.32 -32.62 6.95 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.598 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.19 150.35 46.7 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.62 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.54 -36.78 56.34 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.73 -46.85 74.13 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.56 0.219 . . . . 0.0 111.143 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.85 -40.35 88.27 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.027 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 37.8 t -74.0 -31.94 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.253 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.71 -55.97 26.86 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.336 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.2 29.3 31.22 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.922 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -99.2 -45.87 5.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.887 0.343 . . . . 0.0 110.731 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -109.37 177.95 4.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.914 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.81 177.54 10.89 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.6 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.74 152.43 45.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.271 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.33 49.08 41.27 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.978 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.56 173.71 7.01 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.761 0.315 . . . . 0.0 111.541 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.812 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 5.2 tm0? -115.85 161.29 18.99 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.979 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.685 ' CD2' HG12 ' A' ' 88' ' ' VAL . 0.2 OUTLIER -143.91 129.13 18.77 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.897 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.99 -60.56 1.62 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.461 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.432 ' H ' ' HG3' ' A' ' 87' ' ' GLU . 30.3 m -119.29 152.69 36.27 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.445 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.644 HG13 ' HG ' ' A' ' 86' ' ' LEU . 44.0 t -136.01 131.64 49.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.815 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t70 54.92 36.86 27.71 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.779 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.52 28.69 73.05 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.083 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.08 145.49 48.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.922 0.361 . . . . 0.0 110.856 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.9 m -90.94 111.56 23.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.774 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.725 ' CB ' HD21 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -123.58 76.71 1.44 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.156 0.503 . . . . 0.0 110.995 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.661 HG12 ' CB ' ' A' ' 31' ' ' LYS . 4.8 t -121.1 96.25 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.542 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.73 -30.75 2.93 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.743 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.725 HD21 ' CB ' ' A' ' 65' ' ' LEU . 4.0 pp -67.27 168.86 9.72 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.048 0.451 . . . . 0.0 111.86 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 m -91.39 172.3 8.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.527 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 10.8 tt0 -54.94 -28.63 52.57 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.054 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -61.81 -48.87 78.66 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-O 120.717 0.294 . . . . 0.0 110.77 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.567 ' HB3' HD22 ' A' ' 68' ' ' LEU . 6.1 mpt_? -63.78 -49.77 71.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.292 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.443 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -59.89 -54.32 47.5 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.511 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.84 94.36 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.882 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 78' ' ' THR . 0.5 OUTLIER -65.52 -35.35 80.61 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 179.472 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 mt -67.12 -30.06 69.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.148 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.4 mtt -73.81 -39.7 63.9 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.247 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 75' ' ' GLU . 11.6 t -68.93 -30.99 69.56 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.554 0.216 . . . . 0.0 111.194 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -89.79 49.54 1.74 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.84 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.2 p -123.92 172.16 9.14 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.912 0.387 . . . . 0.0 111.381 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.28 -171.42 3.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.637 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 p -51.71 -46.62 64.01 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.534 ' CG1' HG22 ' A' ' 10' ' ' THR . 22.5 t -97.96 137.97 24.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.661 HG12 HD12 ' A' ' 86' ' ' LEU . 3.5 t -128.54 130.93 69.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.92 98.43 8.28 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.271 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.661 HD12 HG12 ' A' ' 84' ' ' VAL . 0.5 OUTLIER -114.03 115.02 26.94 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.737 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -84.88 104.89 15.23 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.978 0.418 . . . . 0.0 110.773 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.685 HG12 ' CD2' ' A' ' 57' ' ' LEU . 32.5 m -92.01 168.31 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.803 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.812 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -127.64 133.52 49.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.659 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -94.56 123.1 37.79 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.319 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -163.12 -167.01 1.37 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.13 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.78 138.17 2.49 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.304 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.346 -179.961 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mtp . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 111.475 0.176 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -90.14 52.9 2.36 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.912 0.387 . . . . 0.0 110.924 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -69.64 146.45 95.91 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.02 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.08 169.67 2.65 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.965 2.443 . . . . 0.0 112.9 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -79.86 84.62 5.61 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.087 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.98 133.79 29.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.303 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.24 138.16 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.392 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.775 HG23 ' HB2' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -104.23 120.02 40.23 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.474 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -118.67 170.72 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.646 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.726 HG23 HG23 ' A' ' 85' ' ' THR . 0.2 OUTLIER -134.17 116.34 15.27 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.857 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.518 HD22 ' NE ' ' A' ' 50' ' ' ARG . 4.3 mp -126.07 165.91 17.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.142 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HG3' HG22 ' A' ' 83' ' ' VAL . 1.3 mptt -107.95 135.67 48.94 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.088 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 125.06 22.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.115 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -102.59 66.1 0.95 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.677 179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 56.99 38.49 29.39 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.3 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.13 -152.81 24.59 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.374 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.694 ' HB3' HD12 ' A' ' 19' ' ' LEU . 1.7 mtt -147.61 -72.99 0.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.709 0.254 . . . . 0.0 111.484 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.17 63.87 2.43 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.604 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 17' ' ' MET . 1.4 mp -143.82 123.8 13.57 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.499 0.19 . . . . 0.0 110.607 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -85.1 125.31 32.67 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.697 0.284 . . . . 0.0 110.989 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 pt -127.88 171.46 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.607 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 35' ' ' TYR . 6.4 p -159.6 138.5 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.302 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -99.2 97.26 8.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.817 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -131.15 -179.76 5.53 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.633 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HG3' HD12 ' A' ' 32' ' ' LEU . 1.1 ttmt -119.72 -179.91 4.04 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.84 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.13 -144.14 3.91 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.789 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.02 163.41 14.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.666 0.269 . . . . 0.0 110.918 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.44 20.93 52.97 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.564 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.94 -164.65 1.26 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.023 0.439 . . . . 0.0 110.092 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.539 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -173.39 21.24 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.254 178.73 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.539 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -154.35 -168.92 3.08 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.741 0.416 . . . . 0.0 110.221 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.4 HD12 ' HG3' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -113.24 116.94 30.55 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.873 0.368 . . . . 0.0 110.575 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.23 144.62 16.03 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.699 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.426 HD11 HD12 ' A' ' 68' ' ' LEU . 46.5 mm -77.55 99.59 2.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 120.955 0.407 . . . . 0.0 110.606 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.524 ' HB2' HG13 ' A' ' 22' ' ' VAL . 22.4 m-85 -86.89 144.84 26.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.404 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.431 HG11 HD13 ' A' ' 51' ' ' LEU . 18.4 t -93.95 118.73 40.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.985 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -80.21 -42.54 23.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.854 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.8 172.08 4.98 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.437 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.8 t -124.53 132.13 71.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.022 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.73 142.77 14.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.0 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 155.44 39.23 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.344 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.91 16.66 70.68 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.003 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.537 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -99.2 153.55 19.74 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.349 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . . . -54.0 -35.78 62.25 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.1 -32.64 56.76 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.344 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -76.43 -44.32 36.34 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.21 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 43' ' ' GLY . 34.6 t -65.47 -48.42 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.233 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.85 -31.97 61.79 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.33 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.9 54.98 2.91 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.935 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.518 ' NE ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -78.22 -62.94 1.52 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.701 0.286 . . . . 0.0 111.08 -179.659 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.946 HD23 HG21 ' A' ' 88' ' ' VAL . 1.9 pp -131.07 161.11 32.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.907 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.35 -177.06 3.67 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.08 144.32 57.33 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.412 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.01 44.08 46.87 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.546 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -112.71 179.84 3.86 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.648 0.261 . . . . 0.0 111.143 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.772 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 13.2 tm0? -127.31 158.53 36.97 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.082 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.63 HD22 HD22 ' A' ' 86' ' ' LEU . 6.0 mt -143.81 130.61 20.33 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.55 0.215 . . . . 0.0 111.18 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.71 HD23 HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -120.8 -59.59 1.73 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.787 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.5 m -90.48 139.66 30.48 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.024 0.44 . . . . 0.0 112.152 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.598 HG21 HD12 ' A' ' 65' ' ' LEU . 21.3 t -141.54 110.68 2.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.742 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 56.74 37.13 28.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.119 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.62 28.63 60.95 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.004 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -118.99 148.08 43.38 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.808 0.304 . . . . 0.0 110.68 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.4 91.81 7.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.774 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.659 ' HB3' HD21 ' A' ' 68' ' ' LEU . 24.9 mt -96.61 93.29 6.67 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.995 0.426 . . . . 0.0 110.945 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.71 HG22 HD23 ' A' ' 58' ' ' LEU . 8.2 t -138.86 94.74 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.137 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.9 37.25 0.97 Allowed Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.815 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.659 HD21 ' HB3' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -130.32 157.51 42.35 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.887 0.375 . . . . 0.0 111.057 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 p -74.29 168.13 20.24 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.374 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -58.57 -40.58 83.51 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.9 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -55.04 -40.32 70.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.945 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -66.54 -48.31 70.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.215 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.61 -49.1 67.41 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.235 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.75 -43.63 90.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.803 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HA ' HG22 ' A' ' 78' ' ' THR . 1.5 tp10 -64.98 -37.4 87.53 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.5 mt -73.27 -36.71 66.39 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.235 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.4 mtp -76.37 -34.52 58.91 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.801 -0.182 . . . . 0.0 111.429 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 75' ' ' GLU . 15.1 t -73.37 -39.89 64.78 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 121.216 -0.193 . . . . 0.0 110.851 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.429 ' HG3' HG23 ' A' ' 78' ' ' THR . 73.2 mtp85 -90.68 59.03 4.08 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.0 0.429 . . . . 0.0 110.57 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.418 ' HB ' HG22 ' A' ' 84' ' ' VAL . 43.4 p -114.29 164.29 14.11 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.289 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.1 p -79.4 -165.69 0.83 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.573 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.5 -51.98 67.27 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.538 0.208 . . . . 0.0 110.902 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.675 ' CG1' HG22 ' A' ' 10' ' ' THR . 26.3 t -100.61 138.47 24.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.018 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 80' ' ' THR . 19.4 t -132.82 127.55 55.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.563 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.726 HG23 HG23 ' A' ' 10' ' ' THR . 0.7 OUTLIER -97.59 107.31 19.79 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.472 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.63 HD22 HD22 ' A' ' 57' ' ' LEU . 24.4 mt -116.35 136.91 52.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.96 0.41 . . . . 0.0 111.452 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.775 ' HB2' HG23 ' A' ' 8' ' ' THR . 38.4 tt0 -106.66 97.3 7.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.109 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.946 HG21 HD23 ' A' ' 51' ' ' LEU . 19.7 t -98.8 139.05 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.785 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.772 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -100.84 118.28 36.59 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.677 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.57 123.76 22.16 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.866 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -169.92 -177.89 2.75 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.228 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.85 135.99 1.98 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.507 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.769 -0.634 . . . . 0.0 112.185 179.922 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ptt? . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.523 0.201 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.08 136.45 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.231 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -99.45 107.79 47.09 Favored Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.046 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.83 170.36 1.03 Allowed 'Trans proline' 0 C--N 1.351 0.711 0 C-N-CA 123.072 2.515 . . . . 0.0 112.956 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -75.7 86.14 2.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.006 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.6 mm -91.6 128.43 43.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.83 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 pt -147.84 149.15 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.516 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.656 HG22 HG22 ' A' ' 85' ' ' THR . 1.3 m -118.91 130.96 56.0 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.848 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.755 HG11 ' HG3' ' A' ' 50' ' ' ARG . 13.6 t -125.89 141.09 46.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.409 ' HB ' ' CG1' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -83.74 92.61 7.76 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.632 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.566 HD21 ' HA ' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -84.89 131.64 34.48 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.27 138.86 31.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -68.81 155.33 40.37 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.918 0.39 . . . . 0.0 111.356 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.54 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -144.31 66.6 1.27 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.531 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 57.49 35.95 26.42 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.127 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.58 -172.54 27.1 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.508 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 11.7 mmm -112.31 -73.48 0.67 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.616 0.246 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.82 49.44 7.1 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.836 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.701 ' HG ' HG13 ' A' ' 39' ' ' VAL . 4.5 mp -148.54 110.15 4.47 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.604 0.24 . . . . 0.0 110.744 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 t -80.59 130.47 35.14 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.648 HD13 HG23 ' A' ' 34' ' ' ILE . 2.8 pp -130.15 178.32 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.658 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.2 p -148.52 145.19 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.409 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.14 84.92 2.41 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.329 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.76 179.21 4.21 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.531 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.84 176.97 9.24 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.745 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.33 145.14 13.28 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.16 155.56 40.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.873 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.39 19.87 48.83 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.49 -159.8 0.99 Allowed 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 123.421 0.689 . . . . 0.0 109.737 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -173.78 31.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.923 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.78 -171.57 3.72 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.624 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.62 106.01 15.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.72 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.66 174.81 33.62 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.801 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.648 HG23 HD13 ' A' ' 21' ' ' ILE . 30.7 mm -102.27 111.49 32.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.657 0.265 . . . . 0.0 110.711 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.454 ' CE1' ' HG2' ' A' ' 56' ' ' GLN . 81.7 m-85 -104.35 153.82 20.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.36 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.05 125.45 53.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.128 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.38 -34.81 8.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.337 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 m -164.87 168.32 17.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.763 0.316 . . . . 0.0 111.417 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.701 HG13 ' HG ' ' A' ' 19' ' ' LEU . 26.7 t -135.74 138.44 47.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.991 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.09 133.99 29.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.33 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.65 140.36 49.66 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.074 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.6 -14.46 64.87 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.304 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.55 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -72.22 -161.66 5.53 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.405 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.54 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . . . -90.77 -36.71 14.12 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.591 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -62.16 -51.37 68.13 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.87 -38.99 83.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.447 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 43' ' ' GLY . 41.6 t -73.45 -31.88 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.031 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.7 -44.05 85.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.099 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.8 51.78 14.22 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.681 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.755 ' HG3' HG11 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -121.71 -45.93 2.26 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.611 0.244 . . . . 0.0 111.294 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 pp -135.58 172.51 12.91 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.006 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.9 -160.12 1.09 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.381 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.8 152.96 43.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.574 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.03 48.1 21.67 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.159 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -121.31 170.61 9.44 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.736 0.303 . . . . 0.0 111.422 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.775 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 7.5 tm0? -119.45 135.01 54.94 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.916 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -120.97 129.32 53.38 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.804 0.335 . . . . 0.0 111.014 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.47 -61.4 1.6 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.459 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.3 p -111.45 146.63 36.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.061 0.458 . . . . 0.0 111.867 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.495 HG11 ' HG2' ' A' ' 77' ' ' MET . 21.9 t -132.11 119.19 39.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.479 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t70 59.95 35.26 21.64 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.04 -16.04 56.53 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.678 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -92.1 138.29 31.66 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 117.381 0.59 . . . . 0.0 111.096 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.15 114.44 25.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.825 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.2 mt -100.74 76.89 1.83 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.711 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 t -122.25 91.5 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.034 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.11 32.6 1.98 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.574 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.4 mt -123.15 155.67 36.57 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.744 0.307 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.1 m -74.03 158.75 33.74 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -55.06 -35.79 64.9 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.956 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.02 -44.21 97.2 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.919 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.31 -52.89 56.28 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.224 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.28 -52.04 66.37 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.569 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.64 -46.85 86.21 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.018 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' O ' HG22 ' A' ' 78' ' ' THR . 1.8 tp10 -62.54 -36.96 84.26 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.677 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.1 mt -69.39 -34.05 73.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.961 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.495 ' HG2' HG11 ' A' ' 60' ' ' VAL . 2.0 mtt -71.99 -39.53 69.2 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.114 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 75' ' ' GLU . 11.1 t -68.53 -32.35 72.23 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.564 0.221 . . . . 0.0 110.983 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -91.52 48.24 1.45 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.542 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.8 p -109.38 174.3 5.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.764 0.316 . . . . 0.0 111.207 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -84.9 -170.25 3.04 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.67 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -56.14 -37.83 70.02 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.684 0.278 . . . . 0.0 111.094 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 10' ' ' THR . 25.4 t -113.47 139.23 39.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.097 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.1 t -130.37 119.62 46.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.082 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.656 HG22 HG22 ' A' ' 8' ' ' THR . 0.3 OUTLIER -89.91 98.31 11.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.826 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.47 ' HG ' HG13 ' A' ' 60' ' ' VAL . 5.0 mp -103.17 127.15 50.55 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.12 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 4.6 tt0 -91.94 96.29 10.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.543 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.4 p -93.32 147.58 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.874 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.775 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -113.72 135.01 54.41 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.101 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.98 126.93 42.47 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -160.96 -166.77 1.66 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.849 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 174.05 137.18 2.38 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.393 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.119 -0.943 . . . . 0.0 111.179 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.796 0.331 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -144.71 168.05 21.1 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.807 0.337 . . . . 0.0 111.088 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -117.99 116.23 36.18 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.172 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.47 -173.89 1.09 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.793 2.329 . . . . 0.0 112.762 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.56 103.07 9.1 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.991 0.424 . . . . 0.0 111.12 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.825 HG22 ' HG2' ' A' ' 87' ' ' GLU . 1.4 mp -94.49 126.01 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.815 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.5 pt -138.41 143.21 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.403 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.54 HG22 HG22 ' A' ' 85' ' ' THR . 25.3 m -96.4 134.49 39.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.828 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -117.92 127.08 75.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.24 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.687 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -86.07 99.78 11.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.797 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.8 mt -107.79 157.58 18.02 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.965 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HG2' HG22 ' A' ' 83' ' ' VAL . 2.3 mttt -118.93 138.61 52.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.828 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -72.21 114.67 10.58 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.304 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.49 -41.1 7.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.611 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -160.39 44.12 0.2 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.49 -177.6 29.66 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.576 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.0 mtt -120.19 93.57 4.1 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.819 0.342 . . . . 0.0 110.895 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.8 71.38 3.0 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.486 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 45' ' ' ALA . 1.6 mp -146.09 115.56 7.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.571 0.224 . . . . 0.0 110.466 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m -80.07 129.52 34.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.906 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.526 HD13 HG23 ' A' ' 34' ' ' ILE . 2.9 pp -124.22 176.16 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.017 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.89 151.47 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.617 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' GLY . . . -107.13 115.2 29.76 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.785 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.65 -179.58 8.21 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.896 0.379 . . . . 0.0 111.909 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -94.43 167.11 11.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.861 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.05 -141.76 3.45 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.25 147.74 30.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.986 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.63 16.42 37.31 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.267 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.99 107.9 4.34 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.573 0.225 . . . . 0.0 110.951 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -93.37 25.15 3.52 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.946 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.29 -157.77 0.72 Allowed 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -132.68 108.53 9.1 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.808 0.337 . . . . 0.0 110.677 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 23' ' ' ALA . . . -107.31 -178.23 22.58 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.768 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.536 HD11 ' CB ' ' A' ' 73' ' ' ALA . 36.3 mm -97.48 129.04 48.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.617 0.246 . . . . 0.0 110.759 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.525 ' CE2' ' HG3' ' A' ' 56' ' ' GLN . 15.3 m-85 -114.2 166.03 12.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.139 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.21 109.55 28.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.844 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.05 -34.95 22.17 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.201 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.46 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 3.7 t -169.58 170.88 7.89 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.707 0.289 . . . . 0.0 111.518 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.404 HG13 ' HG ' ' A' ' 19' ' ' LEU . 17.0 t -130.7 151.41 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.213 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 t -101.53 139.86 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.147 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -58.74 136.29 57.69 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.043 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.28 -22.48 37.64 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.01 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -62.29 135.08 45.41 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.468 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.22 -36.34 19.83 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.587 ' HB3' HD21 ' A' ' 19' ' ' LEU . . . -60.25 -50.53 73.27 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 111.361 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -70.93 -45.56 64.01 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 43' ' ' GLY . 40.3 t -59.88 -36.42 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.396 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.62 -49.84 29.34 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.657 0.265 . . . . 0.0 110.914 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.04 60.56 1.06 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.809 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -123.37 -50.9 1.87 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.681 0.277 . . . . 0.0 110.936 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 pp -122.57 175.99 6.17 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.28 -174.89 5.14 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.305 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -69.75 165.81 20.59 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.356 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.59 45.72 88.14 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.34 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.22 172.98 11.94 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.799 0.333 . . . . 0.0 111.423 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.666 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -112.64 173.29 6.44 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.706 179.5 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.837 HD21 HD23 ' A' ' 86' ' ' LEU . 3.1 tp -155.84 133.05 10.77 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.066 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.657 HD12 HG22 ' A' ' 66' ' ' VAL . 3.9 mm? -115.4 -60.52 1.87 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.34 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 5.7 t -97.43 146.15 25.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.189 0.519 . . . . 0.0 112.14 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.698 HG23 HD21 ' A' ' 65' ' ' LEU . 34.4 t -140.41 126.66 21.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.596 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.8 t0 54.99 38.37 30.42 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.05 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.81 -12.92 45.93 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.707 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -90.73 158.78 16.69 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 117.399 0.6 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.57 108.04 16.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.43 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.698 HD21 HG23 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -110.83 96.76 6.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 110.988 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.657 HG22 HD12 ' A' ' 58' ' ' LEU . 17.2 t -125.03 92.61 2.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.814 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.16 36.24 0.88 Allowed Glycine 0 CA--C 1.518 0.271 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.313 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.522 HD22 ' HG2' ' A' ' 72' ' ' ARG . 12.4 mt -120.08 174.78 6.27 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.773 0.32 . . . . 0.0 110.728 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -98.23 163.71 12.61 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -57.09 -28.42 62.61 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.454 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -66.2 -49.2 68.11 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.739 0.304 . . . . 0.0 110.695 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.522 ' HG2' HD22 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -65.7 -45.5 82.58 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.365 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.536 ' CB ' HD11 ' A' ' 34' ' ' ILE . . . -64.81 -51.45 62.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.593 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.17 -37.04 78.96 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.749 0.309 . . . . 0.0 110.695 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 78' ' ' THR . 2.0 tp10 -67.9 -37.49 81.79 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.818 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mt -73.47 -40.81 63.85 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.163 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -32.66 74.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.172 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 75' ' ' GLU . 14.4 t -79.63 -33.5 41.33 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.881 -0.145 . . . . 0.0 111.388 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.81 46.04 1.35 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.688 0.28 . . . . 0.0 111.499 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 71.5 p -106.39 168.78 8.92 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.812 0.339 . . . . 0.0 111.026 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -80.62 -167.01 1.21 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.536 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.2 p -59.88 -39.8 86.52 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.674 0.273 . . . . 0.0 110.693 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.687 ' CG1' HG22 ' A' ' 10' ' ' THR . 19.6 t -105.03 142.73 17.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.804 179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.7 t -135.98 143.73 35.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.229 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.682 HG23 HG23 ' A' ' 10' ' ' THR . 0.0 OUTLIER -122.3 118.89 29.57 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.695 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.837 HD23 HD21 ' A' ' 57' ' ' LEU . 4.8 mp -120.2 120.81 37.22 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.415 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.825 ' HG2' HG22 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -81.68 93.19 6.72 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.476 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.544 ' HA ' HD12 ' A' ' 57' ' ' LEU . 9.1 p -88.18 137.31 21.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.641 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.666 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -105.62 126.57 52.29 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.038 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -94.38 101.21 13.14 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.445 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -135.5 -172.9 3.2 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.16 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 157.07 140.83 3.03 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.356 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.634 179.953 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 111.323 0.12 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 mttp 67.08 156.85 0.11 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.949 0.404 . . . . 0.0 111.412 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -77.66 148.79 76.97 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.142 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.12 158.68 53.31 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.851 2.367 . . . . 0.0 112.726 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 41.1 tt0 -100.24 91.23 4.65 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.272 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 6' ' ' ILE . 3.7 mp -84.12 126.72 40.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.657 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 pt -145.86 146.65 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.566 ' OG1' HG22 ' A' ' 85' ' ' THR . 13.2 t -115.42 141.69 47.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.775 0.321 . . . . 0.0 111.107 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.579 HG11 HH11 ' A' ' 50' ' ' ARG . 2.0 m -141.73 148.78 20.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.502 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.691 ' CG2' HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -79.83 128.53 33.55 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.998 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.998 HD21 ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -120.4 121.93 39.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.712 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -101.04 99.13 9.53 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.701 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.3 130.28 43.89 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.176 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -78.95 -59.34 2.82 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.503 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -158.01 37.4 0.25 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.077 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.05 -163.96 28.62 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.359 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.1 mmt -139.4 101.46 4.24 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.674 0.273 . . . . 0.0 111.047 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.7 77.36 0.71 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.729 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.557 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -157.14 137.41 12.81 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 111.058 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -105.45 109.0 20.82 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.776 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 pt -102.91 178.29 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.473 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.461 HG13 ' HB2' ' A' ' 35' ' ' TYR . 2.5 p -155.42 134.42 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.228 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.29 104.24 16.13 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.63 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -143.74 -179.72 6.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.186 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.628 ' HG3' HD12 ' A' ' 32' ' ' LEU . 5.4 mtpt -101.46 179.36 4.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.846 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.53 -145.4 4.23 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.83 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.33 163.19 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.652 0.263 . . . . 0.0 110.921 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.49 20.13 44.14 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.555 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.81 -163.11 0.94 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.203 0.525 . . . . 0.0 109.962 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.437 ' C ' ' HG2' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -168.13 18.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.62 178.72 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HB2' HG12 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -156.97 -170.79 3.41 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.628 HD12 ' HG3' ' A' ' 25' ' ' LYS . 4.9 tp -99.54 123.96 44.29 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.607 0.241 . . . . 0.0 110.864 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.452 ' C ' HD12 ' A' ' 34' ' ' ILE . . . -118.16 175.03 15.54 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.806 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.564 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.6 mp -103.46 154.0 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 O-C-N 122.774 -0.25 . . . . 0.0 110.456 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.461 ' HB2' HG13 ' A' ' 22' ' ' VAL . 68.2 m-85 -136.14 158.46 44.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.249 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.468 HG21 HD13 ' A' ' 51' ' ' LEU . 22.4 t -102.94 108.84 25.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HD2' ' HB ' ' A' ' 22' ' ' VAL . 23.8 mtpt -81.71 -38.92 25.02 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.821 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.0 t -175.23 158.39 2.38 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.094 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.414 ' CG1' ' HB2' ' A' ' 46' ' ' ASP . 10.9 t -128.07 146.13 34.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.901 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.68 140.32 16.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.968 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -68.28 91.08 0.37 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.434 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.63 -32.35 0.48 Allowed Glycine 0 CA--C 1.519 0.342 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.493 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.602 ' O ' HG12 ' A' ' 47' ' ' VAL . . . -59.56 148.15 41.91 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.049 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -55.09 -21.08 11.49 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.998 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -86.94 -33.73 19.58 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.504 0.192 . . . . 0.0 111.442 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.414 ' HB2' ' CG1' ' A' ' 39' ' ' VAL . 0.7 OUTLIER -86.21 -49.13 7.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.264 -179.811 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 43' ' ' GLY . 8.2 p -62.83 -29.88 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.829 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' OD1' HG13 ' A' ' 47' ' ' VAL . 11.6 m-20 -86.83 -50.04 7.0 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.554 0.216 . . . . 0.0 110.552 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.52 93.14 2.28 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.389 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.579 HH11 HG11 ' A' ' 9' ' ' VAL . 2.9 mmp_? -143.18 -50.62 0.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.442 0.163 . . . . 0.0 111.056 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.704 HD22 HG11 ' A' ' 88' ' ' VAL . 2.4 pp -135.37 138.86 43.75 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.752 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.14 -170.52 1.67 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.304 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.28 153.66 42.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 111.121 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.83 37.29 65.91 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.284 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.46 173.88 6.12 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.769 0.318 . . . . 0.0 111.062 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.879 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -122.63 156.6 33.96 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.795 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.443 ' CD2' HG12 ' A' ' 88' ' ' VAL . 7.3 mt -133.95 135.13 43.32 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.152 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.658 HD23 ' CG2' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -120.41 -55.93 2.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.555 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.3 m -115.0 156.06 25.79 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.652 HG13 ' CD2' ' A' ' 86' ' ' LEU . 26.1 t -140.14 139.25 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.138 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.867 ' HB3' HG13 ' A' ' 84' ' ' VAL . 5.6 p-10 43.47 41.75 3.48 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.167 0.587 . . . . 0.0 111.793 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.8 32.55 74.13 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.807 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -132.75 145.37 50.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.932 0.366 . . . . 0.0 110.7 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.8 m -92.55 126.15 37.51 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.641 HD21 HG23 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -136.48 61.43 1.64 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.334 0.588 . . . . 0.0 111.022 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.658 ' CG2' HD23 ' A' ' 58' ' ' LEU . 10.5 t -102.74 98.44 6.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.676 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.6 -26.21 2.67 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.068 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' ' 65' ' ' LEU . 2.0 mt -76.54 174.09 10.75 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.802 0.334 . . . . 0.0 111.083 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.5 t -96.94 -176.57 3.6 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.972 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -60.1 -32.81 71.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 2.0 mp0 -58.54 -58.85 6.73 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.958 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.419 ' HB2' ' HB3' ' A' ' 68' ' ' LEU . 10.7 mmm180 -63.38 -42.78 98.85 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.267 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.08 -48.41 81.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.272 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.21 -44.85 71.24 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.749 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -60.46 -31.88 70.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.05 179.511 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mt -71.17 -36.54 72.03 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.727 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.592 ' HG2' HG11 ' A' ' 60' ' ' VAL . 3.2 mtt -67.62 -46.36 72.74 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.133 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.8 t -64.4 -27.92 69.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 121.213 -0.195 . . . . 0.0 111.043 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.4 mtm-85 -91.19 51.68 1.97 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.407 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.3 p -130.48 -177.29 4.27 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.865 0.364 . . . . 0.0 110.998 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 t -110.58 -165.5 1.0 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.562 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 t -54.73 -49.93 69.6 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.117 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.691 HG13 ' CG2' ' A' ' 10' ' ' THR . 60.2 t -86.95 126.15 40.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.217 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.867 HG13 ' HB3' ' A' ' 61' ' ' ASP . 25.4 t -145.9 110.2 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.231 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.566 HG22 ' OG1' ' A' ' 8' ' ' THR . 0.2 OUTLIER -84.35 120.14 25.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.658 179.791 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.652 ' CD2' HG13 ' A' ' 60' ' ' VAL . 49.8 mt -110.44 115.15 29.14 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.719 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 2.2 tt0 -87.2 92.16 8.97 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.353 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.704 HG11 HD22 ' A' ' 51' ' ' LEU . 30.8 m -94.39 173.55 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.354 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.879 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -128.88 120.67 26.63 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.076 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 8.9 mmtt -84.59 94.26 8.56 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.6 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -162.89 -177.18 5.34 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.58 137.15 2.14 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.577 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.425 -0.797 . . . . 0.0 111.186 179.808 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.1 mmt . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.627 0.251 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.7 125.13 22.55 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 64.66 102.22 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.262 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.63 167.49 2.08 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.091 2.527 . . . . 0.0 113.151 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.89 88.88 7.63 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.469 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.2 mt -93.52 138.75 19.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.57 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 pp -145.35 141.99 22.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.438 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 2.2 m -101.9 114.41 28.48 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.816 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -127.97 162.34 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.642 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.36 142.36 29.33 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.188 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -114.13 129.3 56.62 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.832 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 82' ' ' SER . 6.8 mmtt -94.63 107.89 19.87 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.72 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -66.7 124.81 23.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.248 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -97.48 -53.57 3.41 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.857 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -154.46 36.3 0.42 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.32 -149.91 17.96 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.273 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.4 mmt -141.9 105.5 4.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.854 0.359 . . . . 0.0 111.055 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.12 36.2 4.2 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.475 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.7 ' HG ' HG13 ' A' ' 39' ' ' VAL . 3.9 mp -111.71 106.97 15.92 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 p -79.67 128.45 33.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.007 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.34 172.58 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.964 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.76 143.19 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.453 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.16 112.83 25.65 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.524 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -154.16 172.24 17.88 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.924 0.392 . . . . 0.0 111.779 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -113.83 161.2 17.86 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.063 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.79 -140.3 3.56 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.2 158.98 16.22 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.863 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.53 25.57 42.74 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.404 -0.903 . . . . 0.0 110.902 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.65 104.19 7.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.396 -0.402 . . . . 0.0 111.088 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -88.08 14.04 9.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.478 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.489 ' CB ' HG12 ' A' ' 66' ' ' VAL . 69.9 mmtt -145.85 -162.01 1.43 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.03 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.435 ' HA ' HD13 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -108.99 141.76 40.63 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.688 0.28 . . . . 0.0 110.672 179.491 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -123.41 144.49 15.64 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.658 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.506 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 35.8 mm -94.04 108.93 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -96.28 168.71 10.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 0.0 111.778 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.35 108.57 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.674 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -40.13 77.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.944 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.28 170.25 4.32 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.887 0.375 . . . . 0.0 111.552 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.7 HG13 ' HG ' ' A' ' 19' ' ' LEU . 37.1 t -134.84 127.67 49.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.597 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.96 137.81 23.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.136 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -65.27 152.92 42.53 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.36 20.34 69.42 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.928 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.39 -147.68 8.59 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.371 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.15 -43.41 6.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.658 0.266 . . . . 0.0 111.443 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.589 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -81.91 -34.03 30.13 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.239 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.74 -39.49 94.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.107 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.09 -35.89 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.847 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -42.06 72.56 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.272 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.03 76.56 1.13 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.478 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -133.88 -49.58 0.82 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.535 0.168 . . . . 0.0 111.264 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.705 HD22 HG11 ' A' ' 88' ' ' VAL . 2.4 pp -135.03 148.17 49.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 111.212 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -126.73 -169.47 2.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.161 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.37 145.37 56.16 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.933 0.397 . . . . 0.0 111.931 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.28 30.14 54.97 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.068 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -101.72 176.05 5.35 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.973 0.387 . . . . 0.0 111.655 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.624 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 5.0 tm0? -116.74 169.91 9.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.835 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.816 HD11 HD22 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -155.69 139.09 15.8 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.705 179.649 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 66' ' ' VAL . 7.3 mt -121.05 -58.49 1.8 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.1 m -121.82 153.85 37.79 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.735 HG13 ' HG ' ' A' ' 86' ' ' LEU . 21.3 t -140.51 122.06 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.847 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 t0 57.67 33.8 23.69 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.207 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.54 -8.49 71.66 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.341 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -84.81 155.24 21.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.133 0.466 . . . . 0.0 111.177 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.9 t -99.29 139.95 34.18 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.036 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 73' ' ' ALA . 4.3 mp -136.02 36.49 2.81 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.984 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.489 HG12 ' CB ' ' A' ' 31' ' ' LYS . 11.6 t -97.85 92.6 2.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.48 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.93 -25.47 4.14 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.644 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.533 HD22 ' HG2' ' A' ' 72' ' ' ARG . 13.8 mt -74.4 -177.32 3.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.866 0.365 . . . . 0.0 111.254 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.7 t -115.82 -171.81 2.04 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.008 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -62.57 -30.3 71.22 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.465 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.75 -50.73 69.89 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.775 0.321 . . . . 0.0 110.817 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.533 ' HG2' HD22 ' A' ' 68' ' ' LEU . 3.6 mpt_? -69.73 -42.49 73.91 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.987 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.534 ' HA ' HD23 ' A' ' 65' ' ' LEU . . . -55.43 -47.71 75.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.376 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.99 -69.18 0.29 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.263 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -37.88 -39.93 0.41 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.7 mt -70.73 -40.1 72.97 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.528 0.204 . . . . 0.0 111.384 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.46 ' CG ' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -85.21 -7.17 59.16 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.14 -29.13 28.89 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 122.376 -0.203 . . . . 0.0 110.97 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -90.85 31.93 1.03 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.432 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 54.0 p -79.89 176.01 10.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.821 0.343 . . . . 0.0 110.811 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.35 -160.68 1.05 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.587 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 19.6 m -56.12 -27.65 54.76 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.34 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 t -132.97 142.73 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.945 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.0 p -158.3 127.09 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.341 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.49 106.22 15.91 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.068 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.816 HD22 HD11 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -109.6 115.25 29.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.824 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 36.3 tt0 -88.7 109.15 19.9 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.508 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.705 HG11 HD22 ' A' ' 51' ' ' LEU . 19.0 m -117.02 169.91 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.708 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.624 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -120.33 131.16 54.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.698 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 75.14 3.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.812 0.339 . . . . 0.0 110.412 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -124.55 -165.71 1.42 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.994 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.81 142.4 3.85 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.474 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.537 -0.744 . . . . 0.0 111.33 179.73 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.903 0.382 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.667 HG22 ' HG2' ' A' ' 87' ' ' GLU . 21.4 mt -95.45 127.31 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.006 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.42 139.27 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.502 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 86.2 m -89.11 113.79 24.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.851 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 86' ' ' LEU . 14.4 p -105.84 149.27 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.384 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -120.66 112.66 19.16 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.733 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.67 163.02 27.02 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.188 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -103.73 174.31 5.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.219 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -107.58 115.88 30.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.398 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.37 -41.3 10.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.615 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -163.4 47.08 0.13 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.689 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.44 -146.73 18.29 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.481 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 30.4 mtt -138.97 95.46 2.96 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.682 0.277 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.41 74.09 2.13 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.548 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.61 143.68 13.26 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.616 0.246 . . . . 0.0 111.012 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -87.64 147.25 25.35 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.187 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.486 HD12 ' HG3' ' A' ' 70' ' ' GLN . 1.2 pp -138.77 164.32 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.699 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.506 ' CG1' ' HB2' ' A' ' 35' ' ' TYR . 7.3 p -151.48 144.12 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.388 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.46 91.97 3.86 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.999 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.03 179.84 6.11 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.249 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 -179.99 4.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.716 0.293 . . . . 0.0 110.945 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.41 -138.82 2.56 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.708 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.57 149.79 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.866 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.53 18.22 36.48 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.489 -0.862 . . . . 0.0 110.986 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.34 105.66 3.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.729 0.299 . . . . 0.0 110.859 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.08 26.77 2.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.987 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.442 ' HG3' HG12 ' A' ' 66' ' ' VAL . 8.4 mmtt -122.1 -158.81 0.79 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.8 100.22 5.41 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.826 0.346 . . . . 0.0 110.703 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.18 155.36 28.53 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.763 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.2 mm -88.31 93.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 CA-C-O 120.951 0.405 . . . . 0.0 110.473 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.506 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 91.8 m-85 -83.65 145.88 28.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.759 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.54 107.89 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.211 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -68.06 -42.97 79.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.941 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.6 t -168.03 171.76 9.38 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.139 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.7 t -128.99 120.94 53.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.578 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.35 130.47 34.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.85 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.13 126.55 27.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.55 -20.77 22.43 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.726 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.88 157.02 48.96 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.712 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.48 -39.9 64.91 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.438 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -72.54 -36.68 68.35 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.469 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -70.39 -49.19 51.66 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.28 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 43' ' ' GLY . 38.9 t -61.48 -40.99 88.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.269 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.96 -50.85 69.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.164 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.13 46.57 3.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.442 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.26 -67.82 0.91 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.638 0.256 . . . . 0.0 110.91 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.513 ' HB3' HG21 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -87.78 158.4 18.78 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.811 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.35 176.06 8.44 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.58 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.35 147.69 44.15 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.473 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.99 45.36 57.33 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.412 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.401 ' HB3' ' CG1' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -117.39 179.64 3.99 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.478 0.18 . . . . 0.0 110.974 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.691 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 65.3 tt0 -123.46 147.97 46.65 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.208 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.661 ' CD2' HG22 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -123.76 127.76 48.6 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.304 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.51 ' CD1' HG22 ' A' ' 66' ' ' VAL . 4.0 mm? -109.07 -62.71 1.44 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.027 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.0 m -102.75 143.01 32.94 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.52 HG21 HD11 ' A' ' 65' ' ' LEU . 22.0 t -137.39 110.21 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.56 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.3 40.4 24.58 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.273 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.69 -26.46 12.38 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.11 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.75 175.39 10.72 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.963 0.382 . . . . 0.0 110.846 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.21 121.51 24.95 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.781 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.52 HD11 HG21 ' A' ' 60' ' ' VAL . 36.9 mt -96.86 51.19 1.13 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.798 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.51 HG22 ' CD1' ' A' ' 58' ' ' LEU . 17.3 t -95.98 90.94 2.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.77 31.56 2.91 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.526 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.484 HD22 ' HG3' ' A' ' 72' ' ' ARG . 33.7 mt -118.41 157.56 26.94 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.854 0.359 . . . . 0.0 110.97 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.8 p -79.71 166.29 21.95 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.976 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.486 ' HG3' HD12 ' A' ' 21' ' ' ILE . 26.8 tt0 -58.49 -37.96 76.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.719 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -64.66 -48.98 72.77 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.945 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HG3' HD22 ' A' ' 68' ' ' LEU . 3.9 mmt180 -56.22 -47.57 78.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.356 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.98 -53.3 32.86 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.313 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' A' ' 21' ' ' ILE . . . -57.44 -42.78 83.09 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.052 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.446 ' O ' HG22 ' A' ' 78' ' ' THR . 0.5 OUTLIER -66.4 -35.96 81.65 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.084 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 80' ' ' THR . 13.3 mt -71.93 -38.57 69.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.781 -0.19 . . . . 0.0 110.909 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 56.5 mtt -62.37 -37.26 85.03 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.235 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 75' ' ' GLU . 10.1 t -74.86 -32.51 61.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.585 0.231 . . . . 0.0 110.769 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -88.74 50.98 2.06 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.413 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 76' ' ' LEU . 40.2 p -120.03 170.89 8.87 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.812 0.339 . . . . 0.0 111.194 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.22 -169.62 2.35 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.755 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.0 m -54.9 -48.0 73.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.592 0.234 . . . . 0.0 110.994 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.66 138.74 20.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.796 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.439 HG12 HD11 ' A' ' 86' ' ' LEU . 15.6 t -133.91 114.33 19.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.18 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.25 132.36 36.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.538 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.63 ' O ' HG12 ' A' ' 9' ' ' VAL . 4.5 mp -138.95 132.75 30.81 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.62 0.247 . . . . 0.0 111.141 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.667 ' HG2' HG22 ' A' ' 6' ' ' ILE . 28.0 tt0 -100.86 101.72 12.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.681 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.661 HG22 ' CD2' ' A' ' 57' ' ' LEU . 21.6 t -91.85 149.86 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.767 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -115.18 119.36 36.1 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.231 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? . . . . . 0 N--CA 1.463 0.223 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.767 179.731 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 C--O 1.235 0.315 0 CA-C-O 121.276 0.56 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.74 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 19.4 mm -92.05 125.2 44.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.919 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.63 139.72 47.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.141 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.537 ' HB ' ' HG3' ' A' ' 87' ' ' GLU . 2.4 t -95.39 140.88 29.64 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.077 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.534 HG11 ' HB3' ' A' ' 50' ' ' ARG . 31.3 m -118.78 124.93 73.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.083 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.564 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -84.04 116.06 22.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.8 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.628 HD22 ' HB1' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -139.76 143.08 36.78 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.401 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -101.93 170.34 8.2 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.171 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -101.18 119.72 39.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.366 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.43 -40.54 5.33 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -152.87 32.26 0.49 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.974 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.12 177.59 22.75 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.235 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.1 mmm -115.27 96.61 5.75 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.749 0.309 . . . . 0.0 110.75 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.09 72.14 2.85 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.555 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.563 HD21 ' CB ' ' A' ' 45' ' ' ALA . 4.6 mp -139.8 115.95 10.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.634 0.254 . . . . 0.0 110.646 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 m -85.99 100.07 11.88 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.956 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.706 HD11 ' HB2' ' A' ' 74' ' ' ALA . 1.9 pt -81.31 174.79 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.574 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.738 HG13 ' HB2' ' A' ' 35' ' ' TYR . 3.5 p -158.85 144.55 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.34 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.43 ' HB2' ' N ' ' A' ' 70' ' ' GLN . . . -104.59 124.3 49.07 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.835 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.6 -179.54 8.26 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.966 0.412 . . . . 0.0 111.62 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.439 ' HG3' HD12 ' A' ' 32' ' ' LEU . 4.4 mttt -101.87 164.84 11.51 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.91 -143.55 3.88 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.1 153.65 26.63 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.022 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.45 19.15 39.74 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.169 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.46 111.01 5.62 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.71 0.291 . . . . 0.0 110.898 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -94.37 24.84 4.2 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.888 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -123.66 -147.44 0.38 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.439 HD12 ' HG3' ' A' ' 25' ' ' LYS . 4.4 tp -136.29 112.41 9.72 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.752 0.311 . . . . 0.0 110.555 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.38 176.89 24.63 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.816 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 73' ' ' ALA . 26.4 mm -97.11 151.5 4.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.715 0.293 . . . . 0.0 110.765 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.738 ' HB2' HG13 ' A' ' 22' ' ' VAL . 85.1 m-85 -140.38 156.41 46.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.157 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.68 100.59 11.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.713 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -74.53 -39.0 62.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.541 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.44 162.14 8.18 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.205 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.81 109.53 20.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.558 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.3 t -65.95 127.4 27.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.307 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -60.85 143.03 55.61 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.007 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.81 -14.76 62.62 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.921 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -75.05 -173.84 33.01 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.312 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.628 ' HB1' HD22 ' A' ' 11' ' ' LEU . . . -71.15 -51.1 26.88 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.834 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -61.75 -37.74 85.38 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -64.07 -49.2 73.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.456 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 43' ' ' GLY . 44.9 t -64.46 -36.1 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.374 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.49 -54.25 11.2 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.75 69.86 1.36 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.719 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.534 ' HB3' HG11 ' A' ' 9' ' ' VAL . 2.4 mtt180 -139.74 27.44 2.23 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.549 0.214 . . . . 0.0 111.51 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.834 HD21 ' HB1' ' A' ' 45' ' ' ALA . 0.7 OUTLIER -175.63 179.48 1.41 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.596 0.236 . . . . 0.0 111.036 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.11 -176.97 6.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.603 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.36 146.99 38.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.161 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.53 47.64 15.58 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.375 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -116.98 177.76 4.59 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.672 0.272 . . . . 0.0 111.1 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.745 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 9.3 tm0? -112.45 165.15 12.48 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.125 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.655 ' HG ' HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -148.16 126.3 12.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.782 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.25 -63.12 1.36 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.318 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.7 m -115.73 152.48 33.15 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 111.666 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.692 HG11 ' HG2' ' A' ' 77' ' ' MET . 39.0 t -133.14 113.81 20.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.875 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.2 36.44 23.85 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.208 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.55 -14.25 60.26 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.209 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -80.53 143.87 32.93 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 117.158 0.479 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.3 p -92.56 137.41 32.39 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.046 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.514 HD13 HG23 ' A' ' 60' ' ' VAL . 4.4 mp -137.91 87.54 2.26 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.267 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.6 t -135.87 87.11 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.752 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.73 -24.01 3.35 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.644 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.4 mt -72.71 175.12 6.71 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.198 0.523 . . . . 0.0 111.814 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -101.51 176.25 5.3 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.999 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.43 ' N ' ' HB2' ' A' ' 23' ' ' ALA . 44.1 tt0 -61.38 -39.16 89.65 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.091 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.23 -53.16 61.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.164 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -58.62 -48.36 81.27 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.137 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -59.44 -50.77 72.64 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.652 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.706 ' HB2' HD11 ' A' ' 21' ' ' ILE . . . -62.14 -40.5 96.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.777 0.322 . . . . 0.0 110.806 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.562 ' O ' HG22 ' A' ' 78' ' ' THR . 3.8 tp10 -64.86 -31.39 72.6 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.116 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.6 mt -79.35 -30.47 42.67 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.007 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.692 ' HG2' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -66.37 -29.8 70.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.391 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 75' ' ' GLU . 11.0 t -77.2 -31.24 55.17 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 121.156 -0.218 . . . . 0.0 110.787 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -95.35 56.81 1.9 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.816 0.341 . . . . 0.0 111.52 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.3 p -116.64 179.33 4.04 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.087 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.19 -174.13 4.08 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.797 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -53.56 -52.62 59.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.973 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.564 ' CG1' HG22 ' A' ' 10' ' ' THR . 19.2 t -92.79 146.34 6.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.83 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.7 t -135.0 133.62 53.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.27 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.88 101.6 8.42 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.512 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.65 ' CD2' HG13 ' A' ' 60' ' ' VAL . 4.1 mt -99.95 113.28 25.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.578 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.669 ' HG2' HG22 ' A' ' 6' ' ' ILE . 3.1 tt0 -81.37 95.53 7.05 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.994 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.655 HG12 ' HG ' ' A' ' 57' ' ' LEU . 31.9 m -101.28 166.32 2.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.142 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.745 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -119.98 142.53 48.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.656 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.237 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.701 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.821 0.343 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.58 HG22 ' HG2' ' A' ' 87' ' ' GLU . 3.7 mt -85.59 128.95 38.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.03 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 pt -146.01 149.63 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.972 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.481 ' HB ' ' HG3' ' A' ' 87' ' ' GLU . 6.4 t -106.72 142.61 36.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 110.825 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.477 HG23 HD11 ' A' ' 11' ' ' LEU . 2.9 m -131.3 137.14 56.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.532 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.2 m -87.1 112.34 21.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.761 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.477 HD11 HG23 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -122.28 164.39 17.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.738 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -122.58 148.69 44.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.73 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -85.08 107.28 17.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.706 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.82 56.8 2.7 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.619 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 57.31 39.52 28.42 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.167 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.73 171.41 39.6 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.66 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -138.71 -68.34 0.45 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.536 0.208 . . . . 0.0 111.069 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.76 65.5 3.5 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.106 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.438 HD23 HG22 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -144.48 108.94 4.85 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.594 0.235 . . . . 0.0 111.053 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.3 m -81.02 97.06 7.33 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.709 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pt -98.23 175.44 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.692 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' A' ' 35' ' ' TYR . 6.5 p -159.53 138.79 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.274 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.73 107.46 18.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.028 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -148.63 179.84 7.52 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.926 0.393 . . . . 0.0 111.583 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -97.12 168.47 10.43 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.27 -142.28 3.46 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.79 149.91 27.63 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.844 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.19 17.57 31.48 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.287 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.34 108.24 4.36 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.714 0.292 . . . . 0.0 110.786 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.69 25.38 3.12 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.765 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.9 mmtm -121.47 -155.43 0.64 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.239 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.6 99.02 4.51 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.845 0.355 . . . . 0.0 110.631 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.43 154.91 25.53 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.928 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.527 HD11 ' HB2' ' A' ' 73' ' ' ALA . 35.2 mm -88.95 100.14 10.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.882 0.372 . . . . 0.0 110.662 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.465 ' HB2' HG13 ' A' ' 22' ' ' VAL . 82.7 m-85 -89.84 153.89 20.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.605 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -99.97 113.61 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.758 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -82.52 -40.94 20.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.627 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 m -164.06 173.23 12.77 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.284 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.438 HG22 HD23 ' A' ' 19' ' ' LEU . 19.4 t -137.44 152.02 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.199 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.8 t -101.71 140.96 19.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.085 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.32 109.96 1.75 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.772 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.82 -24.83 4.78 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.0 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -62.63 159.94 33.92 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.813 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.9 -55.59 25.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.515 0.198 . . . . 0.0 111.475 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.74 -32.24 69.05 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.332 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.74 -55.28 8.99 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.018 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 43' ' ' GLY . 26.9 t -63.69 -46.69 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.283 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.56 -33.31 75.3 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.284 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.29 36.9 92.35 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.825 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -85.01 -32.21 23.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.525 0.202 . . . . 0.0 111.094 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.471 HD22 HG11 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -137.05 175.44 9.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.867 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.81 -171.08 3.17 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.01 149.76 47.37 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.152 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.06 50.94 25.77 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.418 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -120.51 176.2 5.62 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.631 0.253 . . . . 0.0 111.091 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.74 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 24.4 tm0? -128.69 139.06 52.42 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.107 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.625 HD21 HD23 ' A' ' 86' ' ' LEU . 6.4 mp -119.51 135.45 54.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.981 0.42 . . . . 0.0 111.206 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.558 HD12 HE22 ' A' ' 56' ' ' GLN . 0.1 OUTLIER -101.66 -59.52 1.69 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.466 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.7 m -117.68 163.21 16.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.898 0.38 . . . . 0.0 111.864 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 86' ' ' LEU . 47.8 t -145.85 136.4 18.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.96 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.47 ' HB3' HG22 ' A' ' 80' ' ' THR . 5.4 p-10 44.17 37.05 1.7 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.952 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.26 40.69 40.6 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.746 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.424 ' O ' HD12 ' A' ' 65' ' ' LEU . 69.0 mtt-85 -140.97 156.29 46.08 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.721 0.261 . . . . 0.0 110.679 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 m -86.49 128.33 34.95 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.831 0.348 . . . . 0.0 111.001 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.62 HD23 ' HA ' ' A' ' 73' ' ' ALA . 5.4 mp -137.88 37.01 2.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.437 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 66' ' ' VAL . 13.2 p -114.07 45.5 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.66 0.743 . . . . 0.0 110.665 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.51 36.27 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.174 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.486 HD21 ' HA ' ' A' ' 65' ' ' LEU . 1.7 pp -144.82 169.99 16.97 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.671 0.272 . . . . 0.0 110.926 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.55 177.42 8.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.199 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -63.34 -34.06 76.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.289 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -50.93 71.9 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.652 0.263 . . . . 0.0 110.92 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -62.62 -42.74 99.76 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.458 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.62 ' HA ' HD23 ' A' ' 65' ' ' LEU . . . -67.0 -54.14 24.64 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.509 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.35 -35.69 74.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.826 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.404 ' O ' HG22 ' A' ' 78' ' ' THR . 3.8 tp10 -69.86 -29.41 66.64 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.133 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.57 HD23 ' HD2' ' A' ' 79' ' ' ARG . 24.3 mt -79.48 -37.62 36.38 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.77 -0.196 . . . . 0.0 111.028 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.484 ' CG ' HG11 ' A' ' 60' ' ' VAL . 5.9 mtm -68.76 -32.38 72.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.405 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 75' ' ' GLU . 15.1 t -73.79 -30.29 62.66 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.491 0.186 . . . . 0.0 111.217 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.57 ' HD2' HD23 ' A' ' 76' ' ' LEU . 17.6 ptp180 -92.71 44.3 1.15 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.448 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 61' ' ' ASP . 17.2 p -102.89 161.04 14.07 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.831 0.348 . . . . 0.0 111.434 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.2 p -95.86 -166.49 1.44 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -39.17 68.87 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.868 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 t -103.46 142.06 18.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.087 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.532 HG12 ' CD1' ' A' ' 86' ' ' LEU . 16.9 t -145.74 142.14 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.271 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.426 HG22 ' OG1' ' A' ' 8' ' ' THR . 0.1 OUTLIER -123.16 112.62 17.92 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.457 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.625 HD23 HD21 ' A' ' 57' ' ' LEU . 10.3 mp -110.39 119.56 39.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.239 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.58 ' HG2' HG22 ' A' ' 6' ' ' ILE . 3.5 tt0 -81.44 85.44 6.47 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.335 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.471 HG11 HD22 ' A' ' 51' ' ' LEU . 25.6 m -80.31 173.08 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.417 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.74 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -143.66 125.92 15.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.633 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.827 -179.911 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 89' ' ' ALA . 3.0 tt0 . . . . . 0 C--O 1.234 0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.935 HG22 ' HG2' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -110.58 123.78 66.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.633 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.663 HD12 ' CG2' ' A' ' 9' ' ' VAL . 1.1 pt -126.3 138.58 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.388 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 1.6 m -94.03 120.4 34.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.875 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.663 ' CG2' HD12 ' A' ' 7' ' ' ILE . 21.8 t -124.45 142.64 40.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.891 0.377 . . . . 0.0 111.224 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.404 HG22 HG23 ' A' ' 85' ' ' THR . 2.2 p -80.3 147.34 31.19 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.2 mt -144.49 128.82 17.85 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.831 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -91.34 146.53 23.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.939 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -69.42 110.71 4.85 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.601 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -101.04 68.69 1.27 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.567 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.5 t30 57.98 40.13 25.85 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.145 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.3 177.7 14.99 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.79 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.9 mmm -129.94 103.32 6.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.626 0.25 . . . . 0.0 110.693 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.409 ' HA3' ' HB ' ' A' ' 40' ' ' VAL . . . -98.59 79.85 0.57 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.865 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.541 HD21 ' CB ' ' A' ' 45' ' ' ALA . 4.5 mp -146.63 124.26 11.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.585 0.231 . . . . 0.0 110.853 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.1 m -89.5 138.56 31.35 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.031 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.459 HG21 ' HE3' ' A' ' 77' ' ' MET . 1.2 pp -136.85 169.08 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.755 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 35' ' ' TYR . 7.3 p -157.79 141.42 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.294 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.07 94.74 7.33 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.636 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.425 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -129.71 179.17 5.99 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.462 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -123.38 -179.82 4.46 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.289 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.29 -141.77 3.22 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.01 153.52 19.82 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.735 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.41 22.59 38.63 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.094 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.21 102.06 7.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.541 -0.329 . . . . 0.0 111.133 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.38 16.6 8.48 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 -168.95 2.94 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.109 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.461 ' HA ' HD12 ' A' ' 32' ' ' LEU . 3.2 tp -119.68 133.58 55.57 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.56 0.219 . . . . 0.0 110.689 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.06 147.68 18.88 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.662 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 57' ' ' LEU . 39.3 mm -80.89 92.03 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.876 0.369 . . . . 0.0 110.223 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.427 ' HB2' HG13 ' A' ' 22' ' ' VAL . 20.2 m-85 -75.18 155.24 37.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.488 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.5 t -102.36 109.07 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.585 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.12 -42.85 75.5 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.804 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.77 179.44 0.71 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.183 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.44 146.93 28.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.019 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.409 ' HB ' ' HA3' ' A' ' 18' ' ' GLY . 22.3 t -95.96 131.07 43.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.364 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.6 139.01 58.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.864 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.5 -17.24 59.64 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.082 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -72.31 -164.83 7.61 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.716 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.601 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . . . -87.37 -43.44 12.12 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.541 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -68.64 -42.59 77.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.783 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -59.12 -45.86 89.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.404 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 43' ' ' GLY . 29.1 t -73.39 -33.71 41.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.41 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -55.38 34.17 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.292 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.74 61.12 1.63 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.608 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.464 ' CD ' HG11 ' A' ' 9' ' ' VAL . 1.8 mmp_? -121.49 -44.49 2.35 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.527 0.203 . . . . 0.0 111.189 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.402 ' HB3' HG11 ' A' ' 88' ' ' VAL . 1.3 pp -130.32 174.2 10.07 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.865 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.95 -168.06 2.83 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.3 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.11 142.91 50.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.192 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.07 49.53 4.97 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.325 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.21 -179.85 5.08 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.458 0.17 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.67 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 46.6 tt0 -130.84 134.0 46.43 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.723 0.297 . . . . 0.0 111.354 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.61 HD22 HD12 ' A' ' 86' ' ' LEU . 87.7 mt -110.85 131.27 55.19 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.486 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.21 -56.77 2.16 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.687 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -117.9 147.27 43.27 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.003 0.43 . . . . 0.0 111.987 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.809 HG22 HD11 ' A' ' 86' ' ' LEU . 57.7 t -126.94 103.92 11.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.318 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.487 ' HB2' HG23 ' A' ' 84' ' ' VAL . 4.4 t0 60.78 39.39 17.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.992 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.67 -23.29 29.05 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.299 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -74.31 132.45 42.08 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 117.227 0.513 . . . . 0.0 110.934 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.0 p -91.2 120.5 32.17 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.673 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.741 ' HA ' HD12 ' A' ' 68' ' ' LEU . 3.1 mp -110.09 43.41 1.37 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.851 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.99 86.55 2.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.66 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.0 27.47 3.99 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.584 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 65' ' ' LEU . 29.0 mt -109.02 176.01 5.25 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.883 0.373 . . . . 0.0 110.934 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.5 m -107.36 168.44 9.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.024 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.419 ' HG3' HD12 ' A' ' 21' ' ' ILE . 35.3 tt0 -57.52 -35.46 70.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.118 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -58.76 -54.61 45.16 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.907 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.42 ' HG3' HD22 ' A' ' 68' ' ' LEU . 49.2 mmt-85 -61.7 -46.11 91.07 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.985 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.07 -55.37 35.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.392 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.26 81.39 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.154 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -60.62 -33.06 72.21 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.315 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.2 mt -81.19 -40.73 23.44 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.019 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.459 ' HE3' HG21 ' A' ' 21' ' ' ILE . 11.7 mtp -66.84 -41.48 87.33 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.191 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.675 HG23 ' HG3' ' A' ' 79' ' ' ARG . 13.2 t -61.64 -33.29 73.68 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.173 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.675 ' HG3' HG23 ' A' ' 78' ' ' THR . 84.5 mtm180 -101.72 65.1 1.0 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.803 0.335 . . . . 0.0 111.126 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.465 HG21 HG21 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -104.88 159.99 15.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.873 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 t -76.7 -172.23 2.17 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.835 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.9 p -53.0 -33.51 52.01 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.128 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.9 t -131.28 127.68 60.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.191 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 61' ' ' ASP . 9.3 p -113.1 129.37 68.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.538 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.404 HG23 HG22 ' A' ' 10' ' ' THR . 0.0 OUTLIER -97.45 85.73 3.7 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.874 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.809 HD11 HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -87.13 119.03 26.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.335 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.935 ' HG2' HG22 ' A' ' 6' ' ' ILE . 27.2 tt0 -88.76 102.6 15.16 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.859 0.361 . . . . 0.0 110.227 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.477 ' HA ' HD23 ' A' ' 57' ' ' LEU . 12.5 p -96.19 147.99 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.963 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.67 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -113.52 129.88 56.46 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.544 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.246 0 O-C-N 123.375 0.422 . . . . 0.0 110.852 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.095 0.474 . . . . 0.0 111.376 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.458 HG22 ' CG ' ' A' ' 87' ' ' GLU . 3.4 mp -91.54 128.01 43.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.532 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.832 HD12 HG13 ' A' ' 9' ' ' VAL . 1.1 pt -139.44 143.62 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.82 0.343 . . . . 0.0 111.583 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.68 HG23 ' HB2' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -98.28 111.75 23.98 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.84 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.832 HG13 HD12 ' A' ' 7' ' ' ILE . 14.6 m -107.42 144.03 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.441 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.3 m -99.4 143.41 29.68 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.998 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.509 HD21 ' N ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -145.53 167.72 22.32 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.222 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.61 ' CD ' HG22 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -119.1 137.81 53.32 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.525 179.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -64.1 100.69 0.34 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.922 0.391 . . . . 0.0 111.049 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.21 73.59 2.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.433 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.58 36.78 28.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.097 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 130.24 -159.43 22.73 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.306 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.2 mmt -127.32 -59.11 1.25 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.654 0.264 . . . . 0.0 110.988 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.11 55.52 4.77 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.505 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.714 ' HG ' HG13 ' A' ' 39' ' ' VAL . 4.1 mp -145.58 118.46 8.73 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.555 0.217 . . . . 0.0 110.774 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -80.76 100.77 8.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.862 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 pt -100.69 174.69 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.65 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 35' ' ' TYR . 2.8 p -157.77 135.91 2.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.257 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.05 89.75 3.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.499 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.52 178.52 6.41 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.738 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.35 168.11 11.8 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.869 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -151.43 -143.28 3.68 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.86 152.1 26.2 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.93 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.56 19.26 33.8 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.183 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.41 109.18 4.74 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.737 0.303 . . . . 0.0 110.957 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -92.75 25.02 3.29 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.713 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -124.01 -151.54 0.48 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.66 109.46 8.64 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.672 0.273 . . . . 0.0 110.443 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.53 164.42 15.52 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.748 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 73' ' ' ALA . 31.1 mm -91.85 138.39 19.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.661 0.267 . . . . 0.0 110.667 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.433 ' HB2' HG13 ' A' ' 22' ' ' VAL . 97.8 m-85 -130.13 138.41 50.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.183 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.22 99.83 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.929 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -73.21 -38.84 65.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.472 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 t -161.02 160.03 30.09 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.203 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.714 HG13 ' HG ' ' A' ' 19' ' ' LEU . 21.4 t -125.7 119.24 54.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.698 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.97 135.75 27.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.419 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -72.44 145.29 47.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.899 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.74 -15.08 63.29 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.181 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -71.61 -167.16 8.34 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.538 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.19 -38.18 16.61 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.509 ' N ' HD21 ' A' ' 11' ' ' LEU . . . -72.36 -43.73 63.59 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.27 -34.87 78.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.682 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 43' ' ' GLY . 39.7 t -81.7 -39.71 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 120.567 0.222 . . . . 0.0 111.119 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.2 -35.04 77.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.24 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.27 31.16 43.08 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.656 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -86.76 -41.29 14.23 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.609 0.242 . . . . 0.0 110.925 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.521 HD11 HD21 ' A' ' 19' ' ' LEU . 1.9 pp -141.77 169.36 17.74 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.945 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.13 -170.83 3.35 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.483 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.83 154.6 41.68 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.533 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.44 25.05 73.73 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.753 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.24 173.11 6.45 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.814 0.307 . . . . 0.0 111.35 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.586 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 9.8 tm0? -109.25 162.37 14.36 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.988 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.628 ' CD2' HD23 ' A' ' 86' ' ' LEU . 4.5 mt -141.46 125.47 17.22 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.965 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.458 HD12 HE22 ' A' ' 56' ' ' GLN . 0.0 OUTLIER -113.48 -63.54 1.43 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.556 -179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.2 p -113.91 146.98 39.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.948 0.404 . . . . 0.0 111.84 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.702 HG13 ' HG ' ' A' ' 86' ' ' LEU . 54.1 t -139.87 125.86 21.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.475 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.516 ' HB2' HG13 ' A' ' 84' ' ' VAL . 10.4 t70 58.24 37.53 26.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.575 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.84 28.66 72.9 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.057 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -123.6 153.27 40.92 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.939 0.369 . . . . 0.0 110.845 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.6 p -95.19 135.65 36.5 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.138 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.755 HD21 HD12 ' A' ' 76' ' ' LEU . 10.0 mt -126.9 38.82 4.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.045 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.4 t -99.16 94.72 3.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.976 0.417 . . . . 0.0 110.405 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.86 33.81 2.33 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.462 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.825 HD22 ' HG2' ' A' ' 72' ' ' ARG . 37.8 mt -123.66 176.57 6.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.72 0.295 . . . . 0.0 110.685 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.7 m -98.86 165.31 11.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.153 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -58.53 -29.1 66.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.193 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -68.67 -34.77 76.26 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.611 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.825 ' HG2' HD22 ' A' ' 68' ' ' LEU . 1.8 mpt_? -67.45 -54.39 20.63 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.146 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.412 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -60.46 -41.23 93.72 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.649 0.262 . . . . 0.0 111.272 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.61 -40.1 92.25 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.99 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -77.72 -30.56 51.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.518 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.755 HD12 HD21 ' A' ' 65' ' ' LEU . 10.2 mt -68.91 -41.41 78.25 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.313 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.445 ' HG2' HG11 ' A' ' 60' ' ' VAL . 54.8 mtt -60.45 -45.37 93.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.014 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.7 t -67.02 -29.74 69.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.677 0.275 . . . . 0.0 110.53 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -87.42 50.35 1.99 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.349 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.7 p -125.99 172.18 10.16 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.769 0.319 . . . . 0.0 110.917 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.6 p -86.88 -171.26 3.44 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.182 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 m -55.36 -36.7 66.61 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.018 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.61 HG22 ' CD ' ' A' ' 12' ' ' LYS . 29.3 t -108.01 139.91 28.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.165 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 61' ' ' ASP . 16.0 t -139.27 137.9 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.13 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.643 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -112.72 109.71 19.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.79 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.702 ' HG ' HG13 ' A' ' 60' ' ' VAL . 3.4 mp -105.32 122.56 46.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.179 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.68 ' HB2' HG23 ' A' ' 8' ' ' THR . 29.4 tt0 -92.92 106.75 18.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.408 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.613 HG12 ' HG ' ' A' ' 57' ' ' LEU . 20.7 m -109.67 171.38 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.654 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -124.75 128.89 49.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.808 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.249 0 CA-C-O 121.117 0.484 . . . . 0.0 110.943 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.304 0 CA-C-O 120.996 0.427 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 22.1 mm -80.42 128.44 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.959 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.712 HD12 HG13 ' A' ' 9' ' ' VAL . 1.7 pt -147.53 144.83 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.18 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 1.3 m -103.44 105.47 15.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.414 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.712 HG13 HD12 ' A' ' 7' ' ' ILE . 14.1 m -93.66 145.03 8.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.993 0.425 . . . . 0.0 111.596 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.4 m -95.71 101.96 13.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.524 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.683 HD11 ' HA ' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -102.24 141.79 34.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -109.65 115.43 29.86 Favored 'General case' 0 CA--C 1.526 0.054 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.767 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.63 122.8 12.9 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.252 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.835 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 0.4 OUTLIER -115.06 73.16 0.82 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.351 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 60.34 38.2 19.75 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.017 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.81 153.81 6.4 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.591 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.4 mtp -100.72 -65.21 0.98 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.615 0.245 . . . . 0.0 110.778 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.409 ' HA3' ' HB ' ' A' ' 40' ' ' VAL . . . 73.96 65.28 2.23 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.125 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.504 HD21 ' HB1' ' A' ' 45' ' ' ALA . 3.9 mp -142.2 111.8 6.68 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.777 0.322 . . . . 0.0 110.815 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 m -80.21 112.97 18.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.699 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 pt -114.68 173.71 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.594 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' A' ' 35' ' ' TYR . 4.3 p -148.17 137.65 16.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.232 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.98 108.6 21.34 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.51 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.446 ' N ' HD11 ' A' ' 32' ' ' LEU . . . -153.07 176.42 11.92 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.331 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HG3' HD22 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -108.91 172.66 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.01 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.57 -143.31 3.63 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.33 157.74 16.94 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.79 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.45 25.1 40.64 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.79 104.84 8.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.92 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -86.55 10.46 15.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.466 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.464 ' HB2' HG12 ' A' ' 66' ' ' VAL . 5.2 mmmt -144.53 -162.65 1.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.02 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.493 HD13 ' N ' ' A' ' 33' ' ' GLY . 0.4 OUTLIER -103.3 134.55 46.5 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.672 0.272 . . . . 0.0 110.308 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.493 ' N ' HD13 ' A' ' 32' ' ' LEU . . . -117.61 152.23 17.75 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.663 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.8 mm -93.52 132.27 38.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 120.679 0.276 . . . . 0.0 110.498 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.506 ' HB2' HG13 ' A' ' 22' ' ' VAL . 69.5 m-85 -121.94 163.47 19.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.224 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.42 ' CG2' HD23 ' A' ' 57' ' ' LEU . 22.0 t -115.83 135.46 55.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.099 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.29 -33.78 5.52 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.581 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.5 165.5 35.47 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.746 0.307 . . . . 0.0 111.325 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.4 HG13 ' HG ' ' A' ' 19' ' ' LEU . 23.7 t -140.31 126.14 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.576 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.409 ' HB ' ' HA3' ' A' ' 18' ' ' GLY . 34.1 t -62.34 131.58 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.427 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -80.51 98.18 7.47 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.607 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.83 -39.37 0.64 Allowed Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.697 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -68.83 160.15 52.26 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.538 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.835 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . . . -51.15 -38.82 54.28 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.683 ' HA ' HD11 ' A' ' 11' ' ' LEU . . . -55.69 -43.39 76.38 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.708 0.289 . . . . 0.0 111.166 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -76.53 -35.65 58.16 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.111 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 43' ' ' GLY . 38.2 t -68.64 -42.57 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.057 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.13 -44.5 87.84 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.247 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.47 27.56 65.32 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.667 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -82.72 -33.84 27.44 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.744 0.272 . . . . 0.0 110.884 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.46 ' C ' HD12 ' A' ' 51' ' ' LEU . 4.1 pp -130.39 -178.98 5.0 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.78 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.91 -162.48 1.53 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.255 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.3 151.0 20.06 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.009 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.47 50.56 9.55 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.425 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -132.54 179.19 6.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.741 0.305 . . . . 0.0 111.105 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 7.2 tm0? -116.34 161.1 19.55 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.681 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.649 ' HB3' HG12 ' A' ' 88' ' ' VAL . 2.3 pp -164.93 155.61 14.26 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.927 0.394 . . . . 0.0 111.776 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -145.18 -54.76 0.31 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.513 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -76.4 132.91 39.98 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.843 0.354 . . . . 0.0 111.558 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.739 HG11 ' HG2' ' A' ' 77' ' ' MET . 24.2 t -145.34 117.17 2.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.515 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.57 ' HB2' HG13 ' A' ' 84' ' ' VAL . 5.0 t0 58.53 40.3 23.94 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.039 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.26 23.14 78.42 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.984 -0.626 . . . . 0.0 112.984 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.0 mtt-85 -128.68 128.14 43.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.711 0.256 . . . . 0.0 110.324 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m -83.98 116.8 23.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.3 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.7 mt -98.77 76.98 2.21 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.594 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.464 HG12 ' HB2' ' A' ' 31' ' ' LYS . 25.5 t -122.54 96.64 4.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.6 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.25 37.77 0.91 Allowed Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.532 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 mp -135.03 179.31 6.4 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.785 0.326 . . . . 0.0 110.928 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.4 m -107.81 176.74 5.04 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.95 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -58.21 -39.88 80.16 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.679 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -51.12 70.7 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.907 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 47.1 mmt-85 -59.2 -50.87 72.36 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.17 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.94 -52.6 64.71 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.329 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.11 -45.64 92.3 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.051 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.47 -36.28 77.91 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.901 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 80' ' ' THR . 14.4 mt -77.11 -39.45 49.42 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.728 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.739 ' HG2' HG11 ' A' ' 60' ' ' VAL . 2.2 mtt -65.78 -32.82 74.56 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.04 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.2 t -78.9 -32.43 45.75 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.559 0.219 . . . . 0.0 110.905 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 43.6 mtp85 -89.63 50.54 1.92 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.703 0.287 . . . . 0.0 111.563 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 76' ' ' LEU . 13.5 p -120.68 -179.86 4.12 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.936 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -89.0 -173.02 3.91 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.08 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.6 p -56.6 -49.77 73.93 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.505 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.89 133.32 36.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.737 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 61' ' ' ASP . 21.3 t -139.46 125.68 23.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.22 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.84 111.92 23.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.708 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 59' ' ' SER . 2.7 mp -109.98 123.01 48.88 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.985 0.422 . . . . 0.0 111.421 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 19.2 tt0 -91.42 98.45 11.69 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.16 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.649 HG12 ' HB3' ' A' ' 57' ' ' LEU . 21.4 m -102.26 171.49 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.928 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.635 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -125.67 131.55 52.59 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.586 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp . . . . . 0 C--O 1.234 0.256 0 O-C-N 123.345 0.403 . . . . 0.0 110.602 179.775 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 . . . . . 0 C--O 1.234 0.262 0 CA-C-O 121.165 0.507 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.471 HG22 ' HB2' ' A' ' 87' ' ' GLU . 26.2 mm -92.81 94.64 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.89 137.06 34.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.265 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.442 ' CG2' HG22 ' A' ' 85' ' ' THR . 6.9 m -89.01 130.68 35.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.002 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 9' ' ' VAL . 27.4 m -113.41 111.31 35.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.114 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.41 101.55 13.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.39 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.562 HD22 ' CG ' ' A' ' 48' ' ' ASP . 81.6 mt -122.5 161.98 22.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.939 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 150.95 24.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.774 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.25 114.42 26.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.007 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.95 -38.1 6.74 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.192 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -160.32 42.54 0.19 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.047 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.29 -170.71 30.28 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.3 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.2 mmm -107.09 -48.03 3.56 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.508 0.194 . . . . 0.0 111.131 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.13 78.49 0.18 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.734 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.693 HD13 HG23 ' A' ' 21' ' ' ILE . 0.8 OUTLIER -158.23 144.56 17.35 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.815 0.34 . . . . 0.0 111.179 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -94.41 90.87 6.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.628 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.693 HG23 HD13 ' A' ' 19' ' ' LEU . 1.8 pt -96.38 163.42 2.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.614 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.7 p -141.04 138.54 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.147 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.34 89.99 3.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.675 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.82 176.06 7.56 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.515 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -96.88 168.76 10.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.28 -143.14 3.59 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.06 153.92 22.42 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.023 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.29 18.84 30.26 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.243 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.58 108.42 4.71 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -95.22 37.26 1.18 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.568 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.646 ' HB2' HG22 ' A' ' 66' ' ' VAL . 38.7 mmtm -140.21 -148.5 0.25 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.648 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -132.77 103.19 5.98 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 110.517 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.9 145.94 21.89 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.888 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.6 mm -87.47 99.32 8.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.805 0.336 . . . . 0.0 110.701 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -90.59 147.53 23.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.531 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.53 120.83 51.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.845 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -96.27 -35.36 11.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.972 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 t -162.51 158.96 24.3 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.054 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.1 t -123.71 128.38 74.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.621 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.4 t -68.37 120.89 16.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.056 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -59.58 109.01 0.81 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.742 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.39 -21.27 5.16 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.626 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.557 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.52 158.17 51.37 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.147 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.66 -41.1 21.59 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.13 -52.9 52.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.367 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -39.29 85.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.5 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 43' ' ' GLY . 40.9 t -71.82 -40.86 69.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.537 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.562 ' CG ' HD22 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -63.82 -54.72 30.62 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.588 0.232 . . . . 0.0 111.304 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.18 79.43 1.39 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.764 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.481 ' HG3' HD21 ' A' ' 11' ' ' LEU . 9.0 mmt-85 -144.1 -51.39 0.31 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.719 0.295 . . . . 0.0 110.943 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 pp -113.39 167.79 10.28 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.912 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.08 -166.8 2.17 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.241 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.02 150.04 26.59 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.271 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.22 40.99 8.77 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.721 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -131.62 177.04 7.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.791 0.329 . . . . 0.0 111.246 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.682 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 46.8 tt0 -122.13 150.32 42.36 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.002 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.6 mt -128.44 123.9 34.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.476 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.18 -63.63 1.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.424 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.7 m -111.37 151.77 28.07 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.929 0.395 . . . . 0.0 111.703 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.813 HG11 ' HG2' ' A' ' 77' ' ' MET . 42.9 t -141.45 132.33 26.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.654 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 t70 56.9 27.72 13.49 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.451 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.32 -7.78 81.28 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.862 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.453 ' NH1' HD22 ' A' ' 76' ' ' LEU . 12.2 ptp180 -111.23 135.35 51.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 117.427 0.613 . . . . 0.0 110.926 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.5 m -71.63 130.44 41.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.327 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.531 HD12 ' CG2' ' A' ' 60' ' ' VAL . 55.7 mt -112.78 33.61 4.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.893 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 31' ' ' LYS . 7.7 p -109.56 90.26 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.236 0.541 . . . . 0.0 110.382 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 31' ' ' LYS . . . 151.14 -30.26 0.98 Allowed Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.425 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.455 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -83.04 -169.64 2.62 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.684 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -98.51 169.66 9.37 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.665 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -55.6 -31.41 62.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.864 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.89 -48.08 60.09 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.242 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.455 ' HG3' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -56.29 -38.69 71.58 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.533 0.206 . . . . 0.0 111.018 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.26 -53.37 12.69 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.176 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.76 -37.93 74.51 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.408 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.67 -33.59 64.52 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.599 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.453 HD22 ' NH1' ' A' ' 63' ' ' ARG . 35.0 mt -79.71 -39.11 31.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.475 0.178 . . . . 0.0 111.123 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.813 ' HG2' HG11 ' A' ' 60' ' ' VAL . 12.2 mtp -66.45 -34.43 77.92 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.051 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.6 t -71.67 -38.14 70.69 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.87 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -91.21 58.02 3.57 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.925 0.393 . . . . 0.0 110.75 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 p -109.85 160.84 16.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.006 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.7 m -75.25 -179.23 4.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.943 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.4 m -53.5 -38.83 64.06 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.304 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.7 t -106.1 136.22 41.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.728 0.299 . . . . 0.0 110.707 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.419 ' CG1' HD11 ' A' ' 86' ' ' LEU . 16.3 t -124.71 142.66 40.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.474 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.442 HG22 ' CG2' ' A' ' 8' ' ' THR . 0.2 OUTLIER -124.39 100.19 6.56 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.728 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.669 ' CD2' HG13 ' A' ' 60' ' ' VAL . 2.1 mp -115.26 139.24 50.13 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.073 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.471 ' HB2' HG22 ' A' ' 6' ' ' ILE . 7.2 pt-20 -107.3 101.23 10.62 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.035 0.445 . . . . 0.0 110.292 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.3 p -89.0 137.61 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.751 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.682 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -95.85 119.31 34.12 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.264 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.646 179.611 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 1.5 tt0 . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.941 0.4 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.687 HG22 ' HG2' ' A' ' 87' ' ' GLU . 16.6 mm -90.83 108.19 19.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.839 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -135.69 138.63 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.418 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.474 ' HB ' ' HG3' ' A' ' 87' ' ' GLU . 6.1 t -104.38 143.17 33.36 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.238 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.768 HG21 ' HG3' ' A' ' 50' ' ' ARG . 13.6 p -128.93 137.33 57.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.304 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.456 HG23 HG23 ' A' ' 85' ' ' THR . 0.2 OUTLIER -81.21 96.64 7.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.899 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.611 HD21 ' HB3' ' A' ' 44' ' ' ALA . 8.7 tp -85.48 132.45 34.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.21 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.666 ' HG2' HG22 ' A' ' 83' ' ' VAL . 1.5 mmtt -108.46 115.78 30.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.376 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -67.36 120.7 14.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.374 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.08 -41.79 7.0 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.711 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -164.91 38.57 0.07 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.877 0.37 . . . . 0.0 111.187 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.73 -168.64 23.5 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.567 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.5 mtp -129.6 -66.47 0.8 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.543 0.211 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.475 ' HA3' ' HB ' ' A' ' 40' ' ' VAL . . . 65.81 74.17 0.54 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.174 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.1 mt -142.2 108.32 5.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.744 0.306 . . . . 0.0 111.046 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.7 91.05 5.83 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.554 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.685 HD13 HG23 ' A' ' 34' ' ' ILE . 1.6 pp -97.12 177.59 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.608 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.2 p -156.67 135.91 3.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.262 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.7 87.48 3.16 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.541 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.75 176.79 6.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.619 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 176.26 5.59 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.117 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.82 -143.45 3.68 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.95 150.31 27.91 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.899 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.76 18.03 37.3 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.342 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.77 108.83 5.2 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.642 0.258 . . . . 0.0 111.008 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.97 25.56 3.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.802 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.487 ' CB ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -120.99 -154.38 0.58 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 32' ' ' LEU . 1.5 tp -136.49 106.73 6.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.614 0.245 . . . . 0.0 110.576 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.84 152.26 20.93 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.93 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.685 HG23 HD13 ' A' ' 21' ' ' ILE . 40.5 mm -91.25 96.84 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.874 0.368 . . . . 0.0 110.673 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.418 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 77.3 m-85 -89.04 150.83 22.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.612 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 21' ' ' ILE . 30.7 t -106.85 131.04 57.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.704 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 pttp -116.89 -30.18 5.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.901 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.69 155.13 42.79 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.956 0.408 . . . . 0.0 111.777 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.8 t -138.18 120.86 19.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.171 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.475 ' HB ' ' HA3' ' A' ' 18' ' ' GLY . 32.3 t -64.43 127.89 25.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.811 0.338 . . . . 0.0 111.477 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 103.7 1.64 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.337 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.5 -10.66 4.34 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.419 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.535 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -73.55 -158.14 4.95 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.413 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.611 ' HB3' HD21 ' A' ' 11' ' ' LEU . . . -91.17 -38.79 12.5 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.435 ' N ' HD11 ' A' ' 11' ' ' LEU . . . -71.62 -37.7 70.86 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -66.96 -35.31 79.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.482 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 43' ' ' GLY . 24.1 t -80.75 -42.21 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.607 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -53.79 54.29 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.63 0.252 . . . . 0.0 111.427 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.38 51.81 2.65 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.579 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.768 ' HG3' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -120.57 -51.03 2.18 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.621 0.248 . . . . 0.0 110.626 179.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 pp -109.13 139.03 44.57 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.536 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.0 177.35 5.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.26 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.53 150.8 46.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.796 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.53 40.62 18.2 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.102 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -126.16 177.71 6.23 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.739 0.304 . . . . 0.0 111.306 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.794 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 20.0 tm0? -124.47 149.02 47.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.439 HD22 HD12 ' A' ' 86' ' ' LEU . 29.3 mt -123.76 121.69 36.13 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.706 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.66 -53.21 3.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.785 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.87 157.17 40.04 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.171 0.51 . . . . 0.0 112.338 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.785 ' CG2' HD11 ' A' ' 65' ' ' LEU . 21.8 t -141.17 109.67 2.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.757 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.27 35.89 26.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.13 17.73 60.51 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.457 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.498 ' HD2' HD22 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -124.44 123.04 39.28 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.222 0.511 . . . . 0.0 110.408 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 m -82.63 135.4 35.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.205 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.785 HD11 ' CG2' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -110.31 -3.1 16.38 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.591 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 66' ' ' VAL . 7.7 p -67.58 87.07 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.418 0.627 . . . . 0.0 110.911 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.79 -18.61 2.77 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 113.008 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.496 ' N ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -91.65 -170.99 2.75 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.917 0.359 . . . . 0.0 111.105 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.18 176.99 4.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.368 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -59.38 -31.02 68.84 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.267 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -68.02 -38.77 82.97 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.515 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -67.06 -40.11 87.02 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.457 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.544 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -69.62 -52.93 21.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.518 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.12 -37.84 84.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.913 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.464 ' O ' HG22 ' A' ' 78' ' ' THR . 29.4 tp10 -71.24 -32.01 68.25 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.262 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.498 HD22 ' HD2' ' A' ' 63' ' ' ARG . 11.9 mt -78.01 -35.23 50.16 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.435 0.159 . . . . 0.0 111.358 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 12.4 mtt -70.67 -31.72 68.73 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.342 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 75' ' ' GLU . 13.1 t -74.43 -30.6 61.97 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.46 0.17 . . . . 0.0 111.46 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.417 ' HD2' HD23 ' A' ' 76' ' ' LEU . 4.7 ptp180 -89.17 49.18 1.73 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.745 0.307 . . . . 0.0 111.415 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.502 ' HB ' HG22 ' A' ' 84' ' ' VAL . 67.7 p -121.53 171.37 8.85 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.724 0.297 . . . . 0.0 111.351 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.4 p -90.01 -165.7 1.41 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.467 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 80.0 p -59.61 -34.37 72.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.156 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.666 HG22 ' HG2' ' A' ' 12' ' ' LYS . 32.2 t -111.9 139.34 36.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.741 0.305 . . . . 0.0 110.982 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.502 HG22 ' HB ' ' A' ' 80' ' ' THR . 15.5 t -142.73 130.38 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.286 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.456 HG23 HG23 ' A' ' 10' ' ' THR . 0.1 OUTLIER -92.21 116.3 28.83 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.691 HD13 HG22 ' A' ' 60' ' ' VAL . 4.0 mm? -111.37 114.03 26.9 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.113 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.687 ' HG2' HG22 ' A' ' 6' ' ' ILE . 2.1 tt0 -81.22 101.36 9.66 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.5 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.0 p -94.06 147.63 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.811 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.794 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -119.04 126.08 50.86 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.122 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.246 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.1 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 . . . . . 0 C--O 1.234 0.282 0 CA-C-O 121.104 0.478 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 23.8 mm -85.23 111.03 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.839 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.52 141.56 46.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.14 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 8.0 t -106.63 141.6 37.64 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.834 0.349 . . . . 0.0 111.299 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.9 p -119.5 128.45 75.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.349 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.0 m -82.95 94.5 7.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 mt -93.44 155.39 17.38 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.135 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HD2' HG22 ' A' ' 83' ' ' VAL . 1.0 OUTLIER -117.1 110.51 18.29 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.075 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -57.08 116.78 3.44 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.266 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -86.34 -47.73 9.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.556 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -166.21 42.54 0.06 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.46 -167.69 19.75 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.527 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.1 mmm -133.52 100.83 4.92 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.643 0.258 . . . . 0.0 110.791 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.22 79.98 0.6 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.547 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 mp -145.96 127.25 14.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.62 0.248 . . . . 0.0 110.749 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.32 99.27 11.04 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.882 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pt -96.61 175.4 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.472 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.647 HG13 ' HB2' ' A' ' 35' ' ' TYR . 3.4 p -159.81 148.3 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.598 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.78 124.76 46.88 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.464 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.36 -179.14 7.45 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -114.79 164.82 13.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.792 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.33 -144.17 3.85 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.59 164.03 13.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.811 0.339 . . . . 0.0 111.148 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.44 19.98 49.51 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.455 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.415 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -122.65 -165.8 1.34 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.137 0.494 . . . . 0.0 110.187 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.45 ' C ' ' HG2' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -169.84 20.39 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.36 178.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.767 ' HB2' HG22 ' A' ' 66' ' ' VAL . 6.0 mmmt -156.08 -164.17 1.64 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 32' ' ' LEU . 0.9 OUTLIER -114.01 106.32 14.27 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.838 0.352 . . . . 0.0 110.523 179.175 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.79 -173.05 27.94 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.212 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.635 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 9.2 mm -99.33 152.91 4.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.603 0.239 . . . . 0.0 110.725 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.647 ' HB2' HG13 ' A' ' 22' ' ' VAL . 18.9 m-85 -135.37 164.22 28.24 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.351 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.62 115.78 44.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -101.58 -33.11 10.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.946 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.2 161.13 21.96 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.926 0.393 . . . . 0.0 111.386 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.4 t -135.7 115.72 17.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.683 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.46 136.48 26.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.416 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 145.09 53.39 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.022 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.08 -22.67 39.45 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.959 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.592 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.04 174.62 36.71 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.775 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.94 -37.57 75.91 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.701 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -72.6 -37.76 68.02 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -67.75 -49.05 64.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.502 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 43' ' ' GLY . 46.9 t -63.86 -31.15 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.632 0.253 . . . . 0.0 111.314 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.78 -55.97 16.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.404 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.2 31.69 16.25 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.889 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -111.27 27.38 9.73 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.753 0.311 . . . . 0.0 110.933 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.701 HD21 ' HB1' ' A' ' 45' ' ' ALA . 3.4 pp -172.82 171.91 4.23 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.966 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.64 171.52 16.77 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.468 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.32 136.85 57.54 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.024 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.06 49.27 3.13 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.091 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -130.83 179.18 6.12 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.744 0.307 . . . . 0.0 111.243 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.87 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -118.45 173.14 7.0 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.918 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 86' ' ' LEU . 6.0 mt -151.67 119.23 6.06 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.668 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.35 -64.02 1.19 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.196 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.8 m -126.08 151.5 47.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.569 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.777 HG13 ' HG ' ' A' ' 86' ' ' LEU . 52.6 t -135.78 118.16 21.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.773 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.517 ' HB2' HG13 ' A' ' 84' ' ' VAL . 3.2 t0 58.33 40.31 24.59 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.965 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.24 29.13 68.9 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.834 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.447 ' HD3' HD22 ' A' ' 76' ' ' LEU . 32.9 mtt-85 -123.84 144.25 49.85 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 m -91.16 120.78 32.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.788 0.328 . . . . 0.0 111.39 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.669 ' HA ' HD21 ' A' ' 68' ' ' LEU . 4.2 mp -111.54 -5.74 14.5 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.821 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.767 HG22 ' HB2' ' A' ' 31' ' ' LYS . 12.0 p -81.99 71.38 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.857 0.837 . . . . 0.0 110.181 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 155.07 40.23 0.02 OUTLIER Glycine 0 CA--C 1.523 0.571 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.275 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.669 HD21 ' HA ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -158.54 177.79 10.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.741 0.305 . . . . 0.0 111.048 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.55 179.29 5.19 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.268 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -61.6 -35.54 78.15 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.322 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -54.6 -52.5 61.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.72 0.295 . . . . 0.0 110.798 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -62.65 -41.78 99.24 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.812 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.635 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -56.25 -56.21 23.79 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.499 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.38 93.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.022 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.5 ' HA ' HG22 ' A' ' 78' ' ' THR . 7.6 tt0 -66.68 -28.4 68.42 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.24 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.447 HD22 ' HD3' ' A' ' 63' ' ' ARG . 25.3 mt -75.49 -34.39 60.86 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.676 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 mtt -77.99 -39.2 43.12 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.321 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 75' ' ' GLU . 12.7 t -63.34 -32.8 74.31 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.778 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -90.9 57.65 3.58 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.192 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.413 ' HB ' HG22 ' A' ' 84' ' ' VAL . 51.7 p -122.79 178.47 5.02 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.096 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 m -108.43 -167.2 1.2 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.783 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.7 p -57.26 -30.32 64.55 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.478 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.501 HG22 ' HD2' ' A' ' 12' ' ' LYS . 21.9 t -117.44 137.7 50.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 120.652 0.263 . . . . 0.0 111.209 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.517 HG13 ' HB2' ' A' ' 61' ' ' ASP . 19.0 t -143.79 134.65 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.414 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.46 120.37 42.21 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.692 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.777 ' HG ' HG13 ' A' ' 60' ' ' VAL . 3.4 mp -114.67 117.13 29.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.283 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 1.6 mt-10 -81.28 93.04 6.45 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.646 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.572 HG13 ' HE3' ' A' ' 90' ' ' LYS . 10.9 p -87.61 141.22 14.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.541 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.87 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -106.94 139.74 40.85 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.146 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.572 ' HE3' HG13 ' A' ' 88' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.731 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.015 0.436 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 88' ' ' VAL . 4.0 mt -90.21 127.31 42.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.052 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.488 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.8 pt -141.67 146.79 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.264 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.496 ' HB ' ' HG2' ' A' ' 87' ' ' GLU . 2.7 t -101.49 147.16 26.7 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.156 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.604 HG11 ' HB3' ' A' ' 50' ' ' ARG . 26.9 m -124.99 128.86 73.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.462 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.547 HG23 ' CG1' ' A' ' 83' ' ' VAL . 88.0 m -87.78 102.5 14.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.487 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.412 HD21 ' HA ' ' A' ' 45' ' ' ALA . 3.4 mp -125.04 167.38 14.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.366 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -126.0 170.82 11.34 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.044 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -69.09 94.01 0.63 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.888 0.375 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.402 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -101.98 81.95 2.18 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.512 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 57.54 36.18 26.6 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.088 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.08 173.4 30.19 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.629 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.6 mmt -87.27 -73.02 0.49 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.559 0.219 . . . . 0.0 110.749 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.83 66.74 1.82 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.651 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.43 ' CD2' HD11 ' A' ' 51' ' ' LEU . 4.9 mp -145.74 117.89 8.35 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.646 0.26 . . . . 0.0 110.658 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.5 m -80.62 96.33 6.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.741 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.547 HG22 HG22 ' A' ' 36' ' ' VAL . 2.1 pt -105.11 175.99 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.59 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -156.32 141.24 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.241 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.28 92.82 6.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.639 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.508 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . . . -124.44 178.39 5.42 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.281 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HG3' HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -112.79 179.97 3.82 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.288 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.81 -143.7 3.74 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.676 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.49 161.82 18.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.702 0.286 . . . . 0.0 111.075 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.81 19.92 45.62 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.853 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.68 -163.01 0.9 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.231 0.539 . . . . 0.0 110.173 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -170.29 20.64 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.227 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.888 ' HB2' HG12 ' A' ' 66' ' ' VAL . 5.1 mttp -159.92 -168.81 2.33 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.48 0.312 . . . . 0.0 110.268 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.447 HD12 ' HG3' ' A' ' 25' ' ' LYS . 1.5 tp -105.44 127.44 53.0 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.798 0.332 . . . . 0.0 110.994 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.88 147.55 16.27 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.518 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.505 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.6 mp -81.41 97.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.976 0.417 . . . . 0.0 109.981 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.508 ' CD2' ' HB3' ' A' ' 24' ' ' ALA . 22.7 m-85 -87.86 143.96 26.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.28 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 21' ' ' ILE . 38.9 t -103.52 122.8 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.847 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -92.09 -40.61 10.96 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.885 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 m -165.02 175.82 9.13 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.727 0.298 . . . . 0.0 111.168 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.412 HG13 ' HG ' ' A' ' 19' ' ' LEU . 21.3 t -126.39 145.37 34.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.154 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.9 t -84.49 146.55 6.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.529 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.39 140.97 52.21 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.062 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.19 18.12 80.12 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.506 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -96.38 176.22 32.53 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.234 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 14' ' ' GLN . . . -60.42 -62.18 2.06 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.412 ' HA ' HD21 ' A' ' 11' ' ' LEU . . . -57.64 -33.24 68.08 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.694 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -67.89 -56.81 7.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.109 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 43' ' ' GLY . 44.6 t -66.07 -35.25 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.75 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.13 -48.84 49.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.616 0.246 . . . . 0.0 110.896 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.46 87.59 0.72 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.627 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.604 ' HB3' HG11 ' A' ' 9' ' ' VAL . 8.3 mmt180 -146.27 -67.13 0.28 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.59 0.233 . . . . 0.0 110.857 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.43 HD11 ' CD2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -103.37 152.2 21.86 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.067 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.81 -162.2 1.18 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.181 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.36 144.08 53.54 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.516 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.71 50.58 6.42 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.248 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -130.62 131.95 45.21 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.449 0.166 . . . . 0.0 110.966 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.717 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 53.5 tt0 -92.73 145.85 24.1 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.745 0.307 . . . . 0.0 111.182 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -116.78 121.8 42.61 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.723 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -96.9 -47.16 5.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.209 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.5 m -138.94 152.83 48.04 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.099 0.476 . . . . 0.0 111.542 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.66 HG13 ' HG ' ' A' ' 86' ' ' LEU . 44.0 t -136.03 114.23 15.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.157 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.602 ' HB2' HG13 ' A' ' 84' ' ' VAL . 2.3 t70 62.07 35.93 15.62 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.443 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.38 -18.72 35.75 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.583 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.534 ' HD3' HD22 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -75.72 147.77 39.1 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 117.436 0.618 . . . . 0.0 111.038 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 p -95.83 116.26 28.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.818 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.595 ' HA ' HD21 ' A' ' 68' ' ' LEU . 5.1 mp -101.47 37.59 1.77 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.964 0.412 . . . . 0.0 110.7 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.888 HG12 ' HB2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -110.46 100.72 11.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.16 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.16 4.48 18.33 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.18 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.595 HD21 ' HA ' ' A' ' 65' ' ' LEU . 1.2 pp -113.29 163.32 14.97 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 117.184 0.492 . . . . 0.0 110.867 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 p -85.04 168.5 14.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.871 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -57.08 -28.43 62.6 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.494 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.59 -49.58 76.95 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.75 0.31 . . . . 0.0 110.269 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.401 ' HB3' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -68.47 -38.75 81.34 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.042 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.38 -55.77 27.78 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.434 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.15 94.43 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.136 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -62.75 -37.08 85.19 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.534 HD22 ' HD3' ' A' ' 63' ' ' ARG . 16.2 mt -70.83 -35.0 72.26 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.013 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.46 ' HG2' HG11 ' A' ' 60' ' ' VAL . 4.8 mtt -68.91 -40.99 78.79 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.096 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.5 t -67.53 -36.69 81.49 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.596 0.236 . . . . 0.0 110.614 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -88.59 56.24 3.7 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.888 0.375 . . . . 0.0 111.115 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.435 ' HB ' HG22 ' A' ' 84' ' ' VAL . 31.5 p -112.52 -175.14 2.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.635 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.9 m -102.0 -169.76 1.72 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -34.0 67.08 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.594 0.235 . . . . 0.0 110.968 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.547 ' CG1' HG23 ' A' ' 10' ' ' THR . 23.2 t -119.56 143.94 29.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.0 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.602 HG13 ' HB2' ' A' ' 61' ' ' ASP . 14.3 t -142.76 137.75 27.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.448 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.22 102.5 11.17 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.011 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.686 ' HB3' HD21 ' A' ' 57' ' ' LEU . 7.0 mp -94.56 117.22 29.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.074 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.496 ' HG2' ' HB ' ' A' ' 8' ' ' THR . 3.8 mm-40 -80.42 95.98 6.58 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.632 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 7' ' ' ILE . 35.8 m -86.98 170.39 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.35 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.717 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -138.38 125.95 22.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.094 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt . . . . . 0 C--O 1.234 0.265 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.674 179.813 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 89' ' ' ALA . 28.0 tt0 . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.937 0.398 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.739 HD13 ' HB2' ' A' ' 89' ' ' ALA . 22.2 mm -79.33 121.87 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.339 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 pt -145.35 146.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.373 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.1 t -121.18 124.77 45.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 110.961 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.6 t -120.89 145.94 26.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.197 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.587 HG22 ' CG2' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -90.91 112.24 24.01 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.677 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.1 152.69 29.27 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.254 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -110.1 158.81 17.91 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.496 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -99.97 133.7 43.96 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.206 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.2 -42.3 3.06 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.135 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -154.13 42.66 0.53 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.838 0.351 . . . . 0.0 110.983 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.44 -156.36 15.8 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.453 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.96 -58.66 2.04 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.492 0.187 . . . . 0.0 110.91 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.78 53.16 39.82 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.746 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.5 mt -142.88 116.71 9.31 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.66 0.266 . . . . 0.0 111.218 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.04 126.58 40.48 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.646 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.848 HG21 ' HE2' ' A' ' 77' ' ' MET . 1.5 pt -115.54 176.01 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.624 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.749 HG13 ' HB2' ' A' ' 35' ' ' TYR . 2.4 p -153.28 137.24 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.451 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.08 101.29 12.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.483 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -134.1 -179.66 5.69 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.411 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -114.04 169.11 9.25 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.19 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.06 -143.35 3.65 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.23 157.42 16.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.85 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.72 23.91 46.21 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.52 104.42 7.88 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.108 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.67 11.16 13.58 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.583 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.472 ' HB2' HG12 ' A' ' 66' ' ' VAL . 8.3 mmmm -146.06 -167.3 2.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.835 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.446 ' HA ' HD12 ' A' ' 32' ' ' LEU . 6.1 tp -103.39 119.2 38.43 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.686 0.279 . . . . 0.0 110.593 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.63 177.73 25.87 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.739 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.541 HG21 ' HE1' ' A' ' 77' ' ' MET . 36.6 mm -103.77 150.93 6.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 120.733 0.302 . . . . 0.0 110.825 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.749 ' HB2' HG13 ' A' ' 22' ' ' VAL . 92.7 m-85 -137.92 150.26 46.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.03 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.7 t -80.72 95.39 2.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.628 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -42.19 98.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.965 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.1 t -175.33 166.52 3.36 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.417 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 46' ' ' ASP . 11.2 t -126.77 137.9 56.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.837 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -82.48 119.92 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.374 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -63.56 110.04 1.86 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.838 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.1 -3.2 14.31 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.518 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -79.12 -139.2 1.69 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.433 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.08 -62.2 1.27 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.487 0.184 . . . . 0.0 111.436 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . -63.0 -33.79 76.17 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.411 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.462 ' HB2' HG12 ' A' ' 39' ' ' VAL . 11.1 t70 -60.67 -39.91 90.16 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.223 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 43' ' ' GLY . 42.3 t -67.25 -39.98 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.636 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -59.32 -55.33 36.14 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.6 0.238 . . . . 0.0 111.29 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.62 19.53 37.46 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.312 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -33.65 26.37 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.147 0.474 . . . . 0.0 110.862 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.593 HD22 HG21 ' A' ' 88' ' ' VAL . 2.1 pp -123.99 163.68 20.88 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.17 175.64 9.92 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.276 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.23 145.13 56.63 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.196 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.68 47.04 8.17 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.97 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.26 -176.99 3.41 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.612 0.244 . . . . 0.0 110.844 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.806 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 10.5 tm0? -118.83 153.77 33.97 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.151 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.006 HD11 HD12 ' A' ' 86' ' ' LEU . 8.1 tt -137.77 135.75 36.63 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.809 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.07 -59.03 2.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.793 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.2 p -116.65 158.02 24.45 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.137 0.494 . . . . 0.0 112.097 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.737 HG11 ' HG3' ' A' ' 77' ' ' MET . 23.5 t -140.11 119.36 12.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.53 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t0 60.31 35.13 20.76 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.023 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.43 -5.91 71.09 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.581 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.3 mtt-85 -91.95 148.83 21.91 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 117.484 0.642 . . . . 0.0 111.187 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.5 m -89.12 139.81 30.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.237 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.597 HD13 HG23 ' A' ' 60' ' ' VAL . 5.0 mp -136.39 79.4 1.76 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.962 0.41 . . . . 0.0 111.377 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' A' ' 31' ' ' LYS . 16.6 t -130.45 95.37 2.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.363 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.97 -26.48 4.23 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.891 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 mt -73.13 176.11 6.14 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.836 0.351 . . . . 0.0 111.449 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 m -109.45 -178.25 3.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.039 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -59.04 -35.09 72.71 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.347 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -58.2 -59.04 5.92 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.624 0.249 . . . . 0.0 110.966 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.6 mmt-85 -61.88 -44.72 96.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.93 -54.92 41.63 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.104 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 78' ' ' THR . . . -59.48 -48.31 82.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.092 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.76 -38.64 78.89 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.982 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 80' ' ' THR . 7.6 mt -76.07 -35.88 59.23 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.097 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.848 ' HE2' HG21 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -76.43 -35.19 58.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.532 HG23 ' HG3' ' A' ' 79' ' ' ARG . 13.3 t -71.13 -39.06 72.22 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.538 0.208 . . . . 0.0 110.956 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.532 ' HG3' HG23 ' A' ' 78' ' ' THR . 46.4 mtp180 -93.77 59.96 2.89 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.882 0.373 . . . . 0.0 111.016 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 76' ' ' LEU . 31.7 p -117.06 169.41 9.44 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.995 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.99 -169.17 0.45 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.754 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.3 p -79.83 -52.49 7.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.808 0.337 . . . . 0.0 110.377 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.587 ' CG2' HG22 ' A' ' 10' ' ' THR . 7.6 p -89.34 74.49 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.581 0.705 . . . . 0.0 110.795 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.1 t -89.18 148.4 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.972 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.531 HG23 HG23 ' A' ' 10' ' ' THR . 3.1 p -110.61 117.04 32.42 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.661 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.006 HD12 HD11 ' A' ' 57' ' ' LEU . 4.2 mm? -111.73 122.22 47.22 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.296 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -87.65 83.17 7.23 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.035 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.593 HG21 HD22 ' A' ' 51' ' ' LEU . 22.0 t -89.3 145.9 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.536 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.806 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -110.2 117.12 32.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.166 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt . . . . . 0 C--O 1.233 0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 179.662 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 57.7 tt0 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.888 0.375 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.54 HD13 ' HB2' ' A' ' 89' ' ' ALA . 23.2 mm -82.04 126.41 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.196 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 pt -148.49 149.57 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.363 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 14.5 m -113.61 123.95 51.17 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.629 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.555 HG11 ' CG ' ' A' ' 50' ' ' ARG . 20.7 t -122.13 138.28 52.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.375 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.6 HG23 HG23 ' A' ' 85' ' ' THR . 0.2 OUTLIER -110.69 135.5 51.21 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.657 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -147.97 176.03 10.5 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.031 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -119.61 144.57 47.05 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.147 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -79.74 146.47 32.35 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.354 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -50.32 4.26 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.365 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -161.39 43.19 0.16 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.999 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.79 -160.54 19.41 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.53 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 90.4 mtp -142.61 101.75 3.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.92 80.63 0.63 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.369 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.539 HD21 ' CB ' ' A' ' 45' ' ' ALA . 1.2 mp -147.17 117.16 7.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.647 0.261 . . . . 0.0 110.494 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 p -82.0 131.55 35.25 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.949 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.649 HD13 HG23 ' A' ' 34' ' ' ILE . 1.5 pp -124.37 174.12 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.089 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.49 HG13 ' HB2' ' A' ' 35' ' ' TYR . 7.6 p -157.67 140.84 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.138 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.27 104.01 16.0 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.996 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.573 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -137.28 176.4 8.75 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.819 0.342 . . . . 0.0 111.691 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -101.93 175.1 5.66 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.311 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.33 -142.66 3.47 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.56 151.17 27.14 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.034 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.85 19.35 36.28 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.401 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.83 108.85 5.72 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.769 0.318 . . . . 0.0 111.185 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -95.15 30.8 2.06 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.322 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.447 ' CB ' HG12 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -130.96 -148.2 0.35 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tp -143.14 113.79 7.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.73 0.3 . . . . 0.0 110.753 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.75 152.97 19.16 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.564 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.649 HG23 HD13 ' A' ' 21' ' ' ILE . 31.4 mm -80.63 100.19 4.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.854 0.359 . . . . 0.0 110.444 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.573 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 17.5 m-85 -84.53 156.38 21.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.039 0.447 . . . . 0.0 111.258 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -105.68 112.94 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.763 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.36 -36.78 22.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.129 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -164.85 165.39 20.53 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.831 0.348 . . . . 0.0 111.224 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.9 t -130.39 112.78 23.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.859 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -60.95 130.49 25.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.092 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.7 149.52 46.48 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.07 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.24 -31.09 8.89 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.545 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -64.31 142.87 46.49 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.521 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.3 -38.57 53.6 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 1.04 ' HB1' HD12 ' A' ' 51' ' ' LEU . . . -52.82 -53.72 44.46 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.683 0.277 . . . . 0.0 111.4 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.84 -44.59 85.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.048 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 43' ' ' GLY . 33.5 t -61.82 -37.3 77.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.469 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.14 -53.32 59.09 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.083 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.88 44.49 1.51 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.159 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.555 ' CG ' HG11 ' A' ' 9' ' ' VAL . 4.5 mmp_? -142.79 31.89 1.43 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.736 0.268 . . . . 0.0 110.983 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.04 HD12 ' HB1' ' A' ' 45' ' ' ALA . 6.5 mt -149.87 168.62 23.23 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.447 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -171.12 151.97 3.34 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.125 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.23 152.18 45.41 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.886 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.11 52.68 26.38 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.782 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.11 171.36 11.97 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.72 0.295 . . . . 0.0 111.187 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.825 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 1.9 tm0? -110.18 154.54 23.21 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.825 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.735 HD21 HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -137.57 119.8 15.68 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.573 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tt -107.79 -55.99 2.29 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.024 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.8 t -103.42 145.69 29.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.05 0.452 . . . . 0.0 112.176 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.739 ' CG2' HD21 ' A' ' 65' ' ' LEU . 21.3 t -140.97 119.81 10.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.763 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' HG12 ' A' ' 60' ' ' VAL . 7.2 m-20 56.65 44.41 23.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.133 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.82 27.39 73.31 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.083 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -130.74 138.07 49.8 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.677 0.275 . . . . 0.0 110.33 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.7 m -92.85 124.61 36.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.789 ' HB2' HD12 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -130.53 83.18 2.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.266 0.555 . . . . 0.0 111.084 179.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' A' ' 31' ' ' LYS . 15.2 t -110.12 94.94 3.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.803 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.78 36.85 1.02 Allowed Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.488 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.789 HD12 ' HB2' ' A' ' 65' ' ' LEU . 32.6 mt -116.05 157.55 24.51 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.727 0.299 . . . . 0.0 110.792 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -77.11 160.58 28.92 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.524 ' HG3' HD12 ' A' ' 21' ' ' ILE . 58.4 tt0 -54.36 -35.24 62.56 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.954 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.37 -43.44 81.39 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.459 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -61.12 -53.34 58.23 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.492 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.45 98.79 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.316 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.75 80.77 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.603 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.523 ' O ' HG22 ' A' ' 78' ' ' THR . 1.6 tp10 -65.6 -35.7 81.59 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.248 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.424 HD23 ' HD2' ' A' ' 79' ' ' ARG . 16.2 mt -74.84 -35.87 62.38 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.095 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.9 mtt -69.15 -29.1 67.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.365 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 75' ' ' GLU . 14.7 t -79.7 -30.62 41.07 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 121.297 -0.161 . . . . 0.0 111.24 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.424 ' HD2' HD23 ' A' ' 76' ' ' LEU . 15.5 ptp180 -93.44 40.33 1.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.714 0.292 . . . . 0.0 111.216 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.8 p -93.11 170.08 9.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 111.515 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.6 m -103.57 -165.02 1.12 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.46 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.78 -35.89 71.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.135 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.6 t -93.17 149.66 4.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.799 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 t -134.43 91.69 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.109 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.6 HG23 HG23 ' A' ' 10' ' ' THR . 4.8 m -89.25 88.68 7.61 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.767 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.701 HD22 HD11 ' A' ' 57' ' ' LEU . 9.0 mt -106.36 139.89 40.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.511 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 12.1 tt0 -113.97 105.74 13.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.087 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.676 HG12 HD12 ' A' ' 57' ' ' LEU . 23.8 m -102.53 172.61 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.045 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.825 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -136.17 131.56 34.8 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.526 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 48.8 mmtt . . . . . 0 C--O 1.234 0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.802 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.068 0.461 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.66 121.87 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.759 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 pp -141.97 137.06 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.315 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.613 ' OG1' HG22 ' A' ' 85' ' ' THR . 3.7 t -99.04 138.89 35.49 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.069 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.55 136.06 46.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.421 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.626 HG23 HG23 ' A' ' 85' ' ' THR . 0.7 OUTLIER -80.15 95.9 6.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.869 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.97 134.31 34.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -90.98 176.7 6.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.059 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.28 130.75 54.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.148 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.02 -45.26 4.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.587 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -161.73 43.21 0.15 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.26 -164.25 14.52 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.794 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 16.3 mtp -119.05 99.99 7.07 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.731 0.301 . . . . 0.0 110.464 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.614 ' HA3' ' CG2' ' A' ' 40' ' ' VAL . . . -90.65 75.72 1.63 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.093 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.463 HD21 HD11 ' A' ' 51' ' ' LEU . 5.0 mp -147.93 108.41 4.13 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.571 0.224 . . . . 0.0 110.871 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -85.62 82.41 8.25 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.055 0.455 . . . . 0.0 110.27 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.849 HD13 HG23 ' A' ' 34' ' ' ILE . 1.2 pp -82.86 175.88 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.049 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' ' 35' ' ' TYR . 7.7 p -153.16 145.75 14.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.415 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -98.55 100.04 11.25 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.83 176.09 9.01 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.805 0.336 . . . . 0.0 111.566 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 178.47 4.55 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.19 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.81 -142.3 3.45 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.0 147.5 32.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.967 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.47 16.91 30.74 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.377 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.55 108.54 5.44 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.733 -0.234 . . . . 0.0 110.852 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -93.34 23.58 4.4 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.862 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.06 -158.51 0.72 Allowed 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 32' ' ' LEU . 0.9 OUTLIER -132.9 106.81 7.92 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.737 0.303 . . . . 0.0 110.943 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.22 153.38 24.37 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.699 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.849 HG23 HD13 ' A' ' 21' ' ' ILE . 33.5 mm -80.97 90.7 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-O 120.817 0.341 . . . . 0.0 110.523 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.402 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 20.2 m-85 -81.25 161.43 23.94 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.525 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 21' ' ' ILE . 47.6 t -122.93 126.01 73.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.639 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.21 -29.68 6.19 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.1 t -136.65 156.57 48.36 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.032 0.444 . . . . 0.0 111.852 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.02 133.48 26.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.481 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.614 ' CG2' ' HA3' ' A' ' 18' ' ' GLY . 30.0 m -61.07 134.02 26.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.885 0.374 . . . . 0.0 111.366 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.63 93.44 6.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.429 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.26 30.04 4.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.297 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.65 -139.39 10.26 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.688 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.86 -33.56 10.49 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.812 0.306 . . . . 0.0 111.76 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.22 -47.25 11.01 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.374 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -58.58 -38.82 78.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.345 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 t -76.63 -33.73 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.089 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -46.34 90.08 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.978 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.27 29.53 24.82 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.623 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -100.68 -41.63 6.84 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.703 0.287 . . . . 0.0 110.867 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.463 HD11 HD21 ' A' ' 19' ' ' LEU . 4.4 pp -129.44 162.11 28.84 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.781 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.91 -175.14 5.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.25 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.61 135.38 52.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.258 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.0 46.28 3.39 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.347 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -133.36 173.02 11.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.711 0.291 . . . . 0.0 111.296 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 49.1 tt0 -131.11 143.87 50.98 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.883 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.706 ' CD2' HD22 ' A' ' 86' ' ' LEU . 1.9 mp -112.97 122.26 47.09 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.252 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tt -94.34 -58.41 2.22 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.743 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 m -138.99 156.25 47.37 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.955 0.407 . . . . 0.0 111.524 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.704 HG13 ' CD2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -102.9 -167.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.141 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.524 ' H ' HG12 ' A' ' 60' ' ' VAL . 5.1 p-10 -67.22 68.81 0.08 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.09 0.471 . . . . 0.0 110.83 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 60' ' ' VAL . . . 98.99 25.37 9.67 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.559 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.504 ' HD3' HD22 ' A' ' 76' ' ' LEU . 5.0 mtm180 -135.61 147.67 48.73 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.653 0.227 . . . . 0.0 110.633 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 m -113.43 110.9 21.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.924 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.668 HD11 HG22 ' A' ' 60' ' ' VAL . 7.1 mt -102.02 68.6 1.13 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.672 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.18 97.55 3.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.34 -32.11 5.0 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.589 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.518 HD21 ' HA ' ' A' ' 65' ' ' LEU . 4.3 pp -68.29 168.72 11.85 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.004 0.431 . . . . 0.0 111.477 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.5 p -91.23 167.15 12.53 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.073 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.437 ' HG3' HD12 ' A' ' 21' ' ' ILE . 30.2 tt0 -55.42 -26.06 39.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.562 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.52 -46.92 71.42 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.804 0.335 . . . . 0.0 110.609 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -49.04 79.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.252 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.49 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -58.38 -51.7 68.7 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.111 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.98 -43.8 82.05 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -34.7 78.94 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.204 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.504 HD22 ' HD3' ' A' ' 63' ' ' ARG . 9.0 mt -74.82 -35.61 62.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.642 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.496 ' CE ' HG21 ' A' ' 34' ' ' ILE . 9.3 mtt -72.67 -38.31 67.66 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.063 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.0 t -68.06 -31.15 70.59 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 121.233 -0.187 . . . . 0.0 111.002 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -89.32 53.18 2.56 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.761 0.315 . . . . 0.0 111.423 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.506 ' HB ' HG22 ' A' ' 84' ' ' VAL . 52.7 p -127.06 166.77 16.97 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.228 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.31 -170.23 3.03 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.381 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 m -54.11 -43.9 70.82 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.253 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.5 t -103.2 135.73 39.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.938 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.506 HG22 ' HB ' ' A' ' 80' ' ' THR . 18.5 t -139.92 121.99 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.537 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.626 HG23 HG23 ' A' ' 10' ' ' THR . 0.2 OUTLIER -92.02 123.89 35.72 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.588 179.391 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.706 HD22 ' CD2' ' A' ' 57' ' ' LEU . 6.3 mt -131.47 134.08 45.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.707 0.289 . . . . 0.0 111.148 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 1.5 mt-10 -81.43 112.11 18.39 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.883 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.0 t -99.72 132.41 45.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.557 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -109.23 142.17 40.45 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.934 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp . . . . . 0 C--O 1.234 0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.899 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--O 1.234 0.275 0 CA-C-O 120.811 0.339 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.485 ' H ' HD12 ' A' ' 6' ' ' ILE . 3.8 mp -80.1 98.05 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.961 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 pt -106.26 157.78 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.324 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.1 m -124.46 128.79 49.53 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.871 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.458 HG11 ' HG3' ' A' ' 50' ' ' ARG . 20.3 t -137.4 151.73 26.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.406 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.93 106.31 18.33 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.717 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.07 154.9 17.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -117.84 137.82 52.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.057 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -72.44 111.44 7.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 110.924 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.53 86.37 2.4 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.599 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 56.61 38.14 29.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.134 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.92 -159.55 14.41 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 mmt -136.67 99.59 4.1 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.758 0.313 . . . . 0.0 110.96 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.28 72.34 1.34 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.657 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mp -142.19 128.44 19.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.632 0.253 . . . . 0.0 110.676 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.95 132.29 33.84 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.163 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 pt -133.84 171.08 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.973 0.416 . . . . 0.0 111.933 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.589 HG13 ' HB2' ' A' ' 35' ' ' TYR . 4.5 p -157.24 138.72 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.002 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.87 97.47 9.31 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.74 -179.82 5.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.511 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.25 -179.59 3.99 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.289 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.25 -142.36 3.41 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.97 155.86 17.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.795 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.55 23.6 43.65 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.408 -0.901 . . . . 0.0 110.955 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.26 103.39 7.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.534 -0.333 . . . . 0.0 111.272 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.448 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 10.5 t70 -87.22 9.21 20.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.435 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.931 ' HB2' HG12 ' A' ' 66' ' ' VAL . 4.3 mttt -142.59 -167.46 2.51 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.192 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tp -112.01 132.74 54.61 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.635 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.55 153.16 17.74 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.567 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.572 HD11 ' CB ' ' A' ' 73' ' ' ALA . 47.3 mm -83.5 101.32 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.892 0.377 . . . . 0.0 110.63 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.589 ' HB2' HG13 ' A' ' 22' ' ' VAL . 19.9 m-85 -87.96 136.75 32.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.551 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.81 115.66 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.104 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -73.73 -44.75 55.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.785 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.35 172.22 3.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 111.501 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.8 t -124.77 136.88 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.19 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.61 142.64 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.407 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -72.11 138.97 48.14 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.814 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.49 -14.2 65.36 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.25 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.64 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -73.93 -168.19 16.81 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.558 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.04 -54.5 6.46 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.831 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . -58.63 -39.96 81.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.299 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -58.99 -44.83 91.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.083 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 43' ' ' GLY . 38.4 t -75.56 -34.2 28.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.096 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.88 -38.99 70.89 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.114 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.19 27.03 71.88 Favored Glycine 0 CA--C 1.521 0.469 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.897 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.458 ' HG3' HG11 ' A' ' 9' ' ' VAL . 7.6 mmt180 -102.51 -34.37 9.15 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.553 0.216 . . . . 0.0 111.015 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.831 HD11 ' HB1' ' A' ' 45' ' ' ALA . 4.3 pp -122.38 175.98 6.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.05 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.96 -171.03 3.49 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.287 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.15 153.55 42.43 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.188 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.31 53.15 14.37 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.085 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.13 160.22 24.18 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.743 0.306 . . . . 0.0 111.135 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.548 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 4.9 tm0? -113.44 109.88 19.4 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.443 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.783 ' HG ' HG12 ' A' ' 88' ' ' VAL . 2.2 mt -85.76 119.31 25.95 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.364 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.64 -61.38 1.47 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.57 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.414 ' H ' ' HG2' ' A' ' 87' ' ' GLU . 2.9 m -120.61 156.99 30.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 111.705 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.666 HG22 ' CD1' ' A' ' 86' ' ' LEU . 38.5 t -135.54 113.87 15.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.559 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t0 64.47 20.69 12.24 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.311 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.36 -23.46 26.75 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.642 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.06 142.71 27.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.494 0.647 . . . . 0.0 111.148 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.76 122.84 36.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.95 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.8 mt -102.79 39.94 1.46 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.931 HG12 ' HB2' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -96.04 97.08 6.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.267 179.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.408 ' CA ' ' HB3' ' A' ' 31' ' ' LYS . . . 119.04 38.19 0.76 Allowed Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.305 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.5 mt -138.5 174.89 10.06 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.704 0.288 . . . . 0.0 110.757 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.6 m -94.8 165.81 12.29 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -55.65 -31.84 62.69 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.968 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -57.72 8.88 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.335 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -53.72 -48.23 69.82 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.664 -0.243 . . . . 0.0 111.621 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.572 ' CB ' HD11 ' A' ' 34' ' ' ILE . . . -65.01 -48.59 73.37 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.714 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.34 90.31 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.025 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -59.73 -26.9 66.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.361 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.3 mt -87.66 -48.27 8.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.593 0.235 . . . . 0.0 111.115 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.656 ' HE3' HD13 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -59.89 -31.36 69.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.076 179.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.442 HG23 ' HG2' ' A' ' 79' ' ' ARG . 15.2 t -74.25 -31.22 62.49 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.629 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.442 ' HG2' HG23 ' A' ' 78' ' ' THR . 12.5 mmt180 -87.1 49.67 1.86 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.734 0.302 . . . . 0.0 111.377 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.412 ' HB ' ' CG2' ' A' ' 84' ' ' VAL . 1.5 p -103.63 169.09 8.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.841 0.353 . . . . 0.0 111.234 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.87 -168.1 1.5 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.57 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 96.9 p -55.38 -36.84 66.82 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.271 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.8 t -122.96 138.33 53.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.621 0.248 . . . . 0.0 111.256 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.412 ' CG2' ' HB ' ' A' ' 80' ' ' THR . 3.6 t -141.37 147.76 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.504 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.4 m -102.7 99.26 9.22 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.856 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.727 HD12 HD22 ' A' ' 57' ' ' LEU . 4.5 mm? -106.55 136.47 46.27 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.259 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 59' ' ' SER . 1.2 pm0 -117.29 101.0 8.06 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.661 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.783 HG12 ' HG ' ' A' ' 57' ' ' LEU . 34.1 m -104.05 166.56 2.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.254 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -122.18 113.57 19.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.769 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? . . . . . 0 C--O 1.234 0.283 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.912 -179.884 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 C--O 1.233 0.209 0 CA-C-O 120.862 0.363 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.88 122.43 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.867 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 pt -127.17 150.37 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.508 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 m -88.92 120.63 30.5 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.093 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.18 138.81 37.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.113 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.534 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -115.33 107.13 14.83 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.821 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 51' ' ' LEU . 5.1 mt -100.7 164.97 11.62 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.139 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.459 ' HE2' HG22 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -138.62 111.08 7.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.131 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.25 103.76 0.12 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.325 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -53.11 5.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.738 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -149.54 38.81 0.78 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.985 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.34 -171.32 15.86 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.5 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.3 mtp -136.01 80.19 1.81 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.851 0.357 . . . . 0.0 111.027 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.55 80.87 1.76 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.727 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.526 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -153.36 139.09 17.92 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.85 0.357 . . . . 0.0 110.914 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.4 m -100.61 135.59 41.81 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 pp -126.73 178.18 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.798 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.454 ' CG2' ' HB2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -131.96 167.01 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.975 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 70' ' ' GLN . . . -145.41 80.9 1.61 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.546 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.44 -179.34 7.0 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.673 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.86 172.08 14.26 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.755 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -151.16 -143.95 3.82 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.666 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.76 151.52 27.67 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.855 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.56 18.88 39.4 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.086 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.31 112.77 5.61 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.657 -0.271 . . . . 0.0 110.877 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.52 23.9 4.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.96 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.661 ' CB ' HG12 ' A' ' 66' ' ' VAL . 15.6 mmtp -124.21 -149.58 0.43 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 32' ' ' LEU . 1.6 tp -129.5 119.14 23.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.691 0.281 . . . . 0.0 110.788 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.82 164.74 12.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.102 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 28.3 mm -99.55 133.06 43.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.454 ' HB2' ' CG2' ' A' ' 22' ' ' VAL . 54.8 m-85 -117.0 168.6 10.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.666 0.269 . . . . 0.0 111.178 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.22 108.99 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.855 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -73.41 -41.96 62.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.76 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.35 166.04 2.77 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.178 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.1 t -123.45 128.55 74.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.47 146.36 7.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.414 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.6 tptt -65.73 143.38 57.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.833 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.32 -32.62 6.95 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.598 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.19 150.35 46.7 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.62 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.54 -36.78 56.34 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.73 -46.85 74.13 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.56 0.219 . . . . 0.0 111.143 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.85 -40.35 88.27 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.027 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 37.8 t -74.0 -31.94 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.253 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.71 -55.97 26.86 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.336 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.2 29.3 31.22 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.922 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -99.2 -45.87 5.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.887 0.343 . . . . 0.0 110.731 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -109.37 177.95 4.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.914 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.81 177.54 10.89 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.6 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.74 152.43 45.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.271 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.33 49.08 41.27 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.978 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.56 173.71 7.01 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.761 0.315 . . . . 0.0 111.541 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.812 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 5.2 tm0? -115.85 161.29 18.99 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.979 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.685 ' CD2' HG12 ' A' ' 88' ' ' VAL . 0.2 OUTLIER -143.91 129.13 18.77 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.897 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.99 -60.56 1.62 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.461 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.432 ' H ' ' HG3' ' A' ' 87' ' ' GLU . 30.3 m -119.29 152.69 36.27 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.445 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.644 HG13 ' HG ' ' A' ' 86' ' ' LEU . 44.0 t -136.01 131.64 49.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.815 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t70 54.92 36.86 27.71 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.779 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.52 28.69 73.05 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.083 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.08 145.49 48.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.922 0.361 . . . . 0.0 110.856 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.9 m -90.94 111.56 23.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.774 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.725 ' CB ' HD21 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -123.58 76.71 1.44 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.156 0.503 . . . . 0.0 110.995 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.661 HG12 ' CB ' ' A' ' 31' ' ' LYS . 4.8 t -121.1 96.25 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.542 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.73 -30.75 2.93 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.743 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.725 HD21 ' CB ' ' A' ' 65' ' ' LEU . 4.0 pp -67.27 168.86 9.72 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.048 0.451 . . . . 0.0 111.86 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 m -91.39 172.3 8.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.527 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 10.8 tt0 -54.94 -28.63 52.57 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.054 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -61.81 -48.87 78.66 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-O 120.717 0.294 . . . . 0.0 110.77 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.567 ' HB3' HD22 ' A' ' 68' ' ' LEU . 6.1 mpt_? -63.78 -49.77 71.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.292 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.443 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -59.89 -54.32 47.5 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.511 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.84 94.36 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.882 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 78' ' ' THR . 0.5 OUTLIER -65.52 -35.35 80.61 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 179.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 mt -67.12 -30.06 69.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.148 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.4 mtt -73.81 -39.7 63.9 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.247 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 75' ' ' GLU . 11.6 t -68.93 -30.99 69.56 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.554 0.216 . . . . 0.0 111.194 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -89.79 49.54 1.74 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.84 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.2 p -123.92 172.16 9.14 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.912 0.387 . . . . 0.0 111.381 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.28 -171.42 3.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.637 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 p -51.71 -46.62 64.01 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.534 ' CG1' HG22 ' A' ' 10' ' ' THR . 22.5 t -97.96 137.97 24.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.661 HG12 HD12 ' A' ' 86' ' ' LEU . 3.5 t -128.54 130.93 69.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.92 98.43 8.28 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.271 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.661 HD12 HG12 ' A' ' 84' ' ' VAL . 0.5 OUTLIER -114.03 115.02 26.94 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.737 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -84.88 104.89 15.23 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.978 0.418 . . . . 0.0 110.773 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.685 HG12 ' CD2' ' A' ' 57' ' ' LEU . 32.5 m -92.01 168.31 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.803 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.812 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -127.64 133.52 49.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.659 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt . . . . . 0 C--O 1.232 0.18 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.319 -179.745 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 N--CA 1.463 0.218 0 CA-C-O 121.126 0.489 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.98 133.79 29.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.303 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.24 138.16 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.392 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.775 HG23 ' HB2' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -104.23 120.02 40.23 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.474 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -118.67 170.72 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.646 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.726 HG23 HG23 ' A' ' 85' ' ' THR . 0.2 OUTLIER -134.17 116.34 15.27 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.857 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.518 HD22 ' NE ' ' A' ' 50' ' ' ARG . 4.3 mp -126.07 165.91 17.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.142 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HG3' HG22 ' A' ' 83' ' ' VAL . 1.3 mptt -107.95 135.67 48.94 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.088 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 125.06 22.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.115 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -102.59 66.1 0.95 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.677 179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 56.99 38.49 29.39 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.3 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.13 -152.81 24.59 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.374 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.694 ' HB3' HD12 ' A' ' 19' ' ' LEU . 1.7 mtt -147.61 -72.99 0.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.709 0.254 . . . . 0.0 111.484 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.17 63.87 2.43 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.604 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 17' ' ' MET . 1.4 mp -143.82 123.8 13.57 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.499 0.19 . . . . 0.0 110.607 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -85.1 125.31 32.67 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.697 0.284 . . . . 0.0 110.989 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 pt -127.88 171.46 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.607 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 35' ' ' TYR . 6.4 p -159.6 138.5 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.302 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -99.2 97.26 8.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.817 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -131.15 -179.76 5.53 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.633 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HG3' HD12 ' A' ' 32' ' ' LEU . 1.1 ttmt -119.72 -179.91 4.04 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.84 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.13 -144.14 3.91 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.789 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.02 163.41 14.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.666 0.269 . . . . 0.0 110.918 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.44 20.93 52.97 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.564 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.94 -164.65 1.26 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.023 0.439 . . . . 0.0 110.092 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.539 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -173.39 21.24 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.254 178.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.539 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -154.35 -168.92 3.08 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.741 0.416 . . . . 0.0 110.221 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.4 HD12 ' HG3' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -113.24 116.94 30.55 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.873 0.368 . . . . 0.0 110.575 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.23 144.62 16.03 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.699 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.426 HD11 HD12 ' A' ' 68' ' ' LEU . 46.5 mm -77.55 99.59 2.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 120.955 0.407 . . . . 0.0 110.606 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.524 ' HB2' HG13 ' A' ' 22' ' ' VAL . 22.4 m-85 -86.89 144.84 26.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.404 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.431 HG11 HD13 ' A' ' 51' ' ' LEU . 18.4 t -93.95 118.73 40.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.985 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -80.21 -42.54 23.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.854 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.8 172.08 4.98 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.437 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.8 t -124.53 132.13 71.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.022 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.73 142.77 14.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.0 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 155.44 39.23 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.344 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.91 16.66 70.68 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.003 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.537 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -99.2 153.55 19.74 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.349 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . . . -54.0 -35.78 62.25 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.1 -32.64 56.76 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.344 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -76.43 -44.32 36.34 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.21 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 43' ' ' GLY . 34.6 t -65.47 -48.42 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.233 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.85 -31.97 61.79 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.33 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.9 54.98 2.91 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.935 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.518 ' NE ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -78.22 -62.94 1.52 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.701 0.286 . . . . 0.0 111.08 -179.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.946 HD23 HG21 ' A' ' 88' ' ' VAL . 1.9 pp -131.07 161.11 32.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.907 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.35 -177.06 3.67 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.08 144.32 57.33 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.412 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.01 44.08 46.87 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.546 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -112.71 179.84 3.86 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.648 0.261 . . . . 0.0 111.143 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.772 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 13.2 tm0? -127.31 158.53 36.97 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.082 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.63 HD22 HD22 ' A' ' 86' ' ' LEU . 6.0 mt -143.81 130.61 20.33 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.55 0.215 . . . . 0.0 111.18 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.71 HD23 HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -120.8 -59.59 1.73 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.787 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.5 m -90.48 139.66 30.48 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.024 0.44 . . . . 0.0 112.152 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.598 HG21 HD12 ' A' ' 65' ' ' LEU . 21.3 t -141.54 110.68 2.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.742 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 56.74 37.13 28.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.119 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.62 28.63 60.95 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.004 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -118.99 148.08 43.38 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.808 0.304 . . . . 0.0 110.68 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.4 91.81 7.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.774 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.659 ' HB3' HD21 ' A' ' 68' ' ' LEU . 24.9 mt -96.61 93.29 6.67 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.995 0.426 . . . . 0.0 110.945 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.71 HG22 HD23 ' A' ' 58' ' ' LEU . 8.2 t -138.86 94.74 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.137 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.9 37.25 0.97 Allowed Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.815 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.659 HD21 ' HB3' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -130.32 157.51 42.35 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.887 0.375 . . . . 0.0 111.057 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 p -74.29 168.13 20.24 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.374 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -58.57 -40.58 83.51 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.9 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -55.04 -40.32 70.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.945 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -66.54 -48.31 70.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.215 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.61 -49.1 67.41 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.235 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.75 -43.63 90.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.803 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HA ' HG22 ' A' ' 78' ' ' THR . 1.5 tp10 -64.98 -37.4 87.53 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.5 mt -73.27 -36.71 66.39 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.235 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.4 mtp -76.37 -34.52 58.91 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.801 -0.182 . . . . 0.0 111.429 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 75' ' ' GLU . 15.1 t -73.37 -39.89 64.78 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 121.216 -0.193 . . . . 0.0 110.851 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.429 ' HG3' HG23 ' A' ' 78' ' ' THR . 73.2 mtp85 -90.68 59.03 4.08 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.0 0.429 . . . . 0.0 110.57 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.418 ' HB ' HG22 ' A' ' 84' ' ' VAL . 43.4 p -114.29 164.29 14.11 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.289 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.1 p -79.4 -165.69 0.83 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.573 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.5 -51.98 67.27 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.538 0.208 . . . . 0.0 110.902 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.675 ' CG1' HG22 ' A' ' 10' ' ' THR . 26.3 t -100.61 138.47 24.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.018 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 80' ' ' THR . 19.4 t -132.82 127.55 55.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.563 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.726 HG23 HG23 ' A' ' 10' ' ' THR . 0.7 OUTLIER -97.59 107.31 19.79 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.472 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.63 HD22 HD22 ' A' ' 57' ' ' LEU . 24.4 mt -116.35 136.91 52.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.96 0.41 . . . . 0.0 111.452 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.775 ' HB2' HG23 ' A' ' 8' ' ' THR . 38.4 tt0 -106.66 97.3 7.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.109 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.946 HG21 HD23 ' A' ' 51' ' ' LEU . 19.7 t -98.8 139.05 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.785 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.772 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -100.84 118.28 36.59 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.677 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.258 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.866 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 . . . . . 0 C--O 1.233 0.22 0 CA-C-O 121.255 0.55 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.6 mm -91.6 128.43 43.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.83 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 pt -147.84 149.15 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.516 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.656 HG22 HG22 ' A' ' 85' ' ' THR . 1.3 m -118.91 130.96 56.0 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.848 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.755 HG11 ' HG3' ' A' ' 50' ' ' ARG . 13.6 t -125.89 141.09 46.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.409 ' HB ' ' CG1' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -83.74 92.61 7.76 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.632 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.566 HD21 ' HA ' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -84.89 131.64 34.48 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.27 138.86 31.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -68.81 155.33 40.37 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.918 0.39 . . . . 0.0 111.356 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.54 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -144.31 66.6 1.27 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.531 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 57.49 35.95 26.42 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.127 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.58 -172.54 27.1 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.508 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 11.7 mmm -112.31 -73.48 0.67 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.616 0.246 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.82 49.44 7.1 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.836 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.701 ' HG ' HG13 ' A' ' 39' ' ' VAL . 4.5 mp -148.54 110.15 4.47 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.604 0.24 . . . . 0.0 110.744 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 t -80.59 130.47 35.14 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.648 HD13 HG23 ' A' ' 34' ' ' ILE . 2.8 pp -130.15 178.32 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.658 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.2 p -148.52 145.19 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.409 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.14 84.92 2.41 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.329 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.76 179.21 4.21 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.531 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.84 176.97 9.24 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.745 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.33 145.14 13.28 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.16 155.56 40.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.873 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.39 19.87 48.83 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.49 -159.8 0.99 Allowed 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 123.421 0.689 . . . . 0.0 109.737 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -173.78 31.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.923 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.78 -171.57 3.72 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.624 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.62 106.01 15.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.72 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.66 174.81 33.62 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.801 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.648 HG23 HD13 ' A' ' 21' ' ' ILE . 30.7 mm -102.27 111.49 32.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.657 0.265 . . . . 0.0 110.711 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.454 ' CE1' ' HG2' ' A' ' 56' ' ' GLN . 81.7 m-85 -104.35 153.82 20.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.36 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.05 125.45 53.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.128 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.38 -34.81 8.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.337 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 m -164.87 168.32 17.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.763 0.316 . . . . 0.0 111.417 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.701 HG13 ' HG ' ' A' ' 19' ' ' LEU . 26.7 t -135.74 138.44 47.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.991 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.09 133.99 29.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.33 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.65 140.36 49.66 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.074 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.6 -14.46 64.87 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.304 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.55 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -72.22 -161.66 5.53 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.405 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.54 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . . . -90.77 -36.71 14.12 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.591 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -62.16 -51.37 68.13 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.87 -38.99 83.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.447 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 43' ' ' GLY . 41.6 t -73.45 -31.88 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.031 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.7 -44.05 85.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.099 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.8 51.78 14.22 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.681 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.755 ' HG3' HG11 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -121.71 -45.93 2.26 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.611 0.244 . . . . 0.0 111.294 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 pp -135.58 172.51 12.91 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.006 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.9 -160.12 1.09 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.381 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.8 152.96 43.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.574 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.03 48.1 21.67 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.159 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -121.31 170.61 9.44 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.736 0.303 . . . . 0.0 111.422 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.775 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 7.5 tm0? -119.45 135.01 54.94 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.916 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -120.97 129.32 53.38 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.804 0.335 . . . . 0.0 111.014 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.47 -61.4 1.6 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.459 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.3 p -111.45 146.63 36.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.061 0.458 . . . . 0.0 111.867 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.495 HG11 ' HG2' ' A' ' 77' ' ' MET . 21.9 t -132.11 119.19 39.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.479 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t70 59.95 35.26 21.64 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.04 -16.04 56.53 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.678 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -92.1 138.29 31.66 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 117.381 0.59 . . . . 0.0 111.096 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.15 114.44 25.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.825 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.2 mt -100.74 76.89 1.83 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.711 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 t -122.25 91.5 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.034 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.11 32.6 1.98 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.574 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.4 mt -123.15 155.67 36.57 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.744 0.307 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.1 m -74.03 158.75 33.74 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -55.06 -35.79 64.9 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.956 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.02 -44.21 97.2 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.919 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.31 -52.89 56.28 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.224 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.28 -52.04 66.37 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.569 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.64 -46.85 86.21 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.018 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.44 ' O ' HG22 ' A' ' 78' ' ' THR . 1.8 tp10 -62.54 -36.96 84.26 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.677 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.1 mt -69.39 -34.05 73.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.961 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.495 ' HG2' HG11 ' A' ' 60' ' ' VAL . 2.0 mtt -71.99 -39.53 69.2 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.114 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 75' ' ' GLU . 11.1 t -68.53 -32.35 72.23 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.564 0.221 . . . . 0.0 110.983 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -91.52 48.24 1.45 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.542 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.8 p -109.38 174.3 5.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.764 0.316 . . . . 0.0 111.207 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -84.9 -170.25 3.04 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.67 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -56.14 -37.83 70.02 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.684 0.278 . . . . 0.0 111.094 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 10' ' ' THR . 25.4 t -113.47 139.23 39.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.097 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.1 t -130.37 119.62 46.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.082 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.656 HG22 HG22 ' A' ' 8' ' ' THR . 0.3 OUTLIER -89.91 98.31 11.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.826 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.47 ' HG ' HG13 ' A' ' 60' ' ' VAL . 5.0 mp -103.17 127.15 50.55 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.12 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 4.6 tt0 -91.94 96.29 10.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.543 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.4 p -93.32 147.58 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.874 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.775 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -113.72 135.01 54.41 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.101 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.191 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.062 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--O 1.234 0.267 0 CA-C-O 120.991 0.424 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.825 HG22 ' HG2' ' A' ' 87' ' ' GLU . 1.4 mp -94.49 126.01 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.815 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.5 pt -138.41 143.21 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.403 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.54 HG22 HG22 ' A' ' 85' ' ' THR . 25.3 m -96.4 134.49 39.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.828 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -117.92 127.08 75.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.24 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.687 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -86.07 99.78 11.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.797 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.8 mt -107.79 157.58 18.02 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.965 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HG2' HG22 ' A' ' 83' ' ' VAL . 2.3 mttt -118.93 138.61 52.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.828 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -72.21 114.67 10.58 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.304 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.49 -41.1 7.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.611 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -160.39 44.12 0.2 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.49 -177.6 29.66 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.576 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.0 mtt -120.19 93.57 4.1 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.819 0.342 . . . . 0.0 110.895 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.8 71.38 3.0 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.486 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 45' ' ' ALA . 1.6 mp -146.09 115.56 7.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.571 0.224 . . . . 0.0 110.466 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m -80.07 129.52 34.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.906 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.526 HD13 HG23 ' A' ' 34' ' ' ILE . 2.9 pp -124.22 176.16 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.017 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.89 151.47 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.617 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' GLY . . . -107.13 115.2 29.76 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.785 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.65 -179.58 8.21 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.896 0.379 . . . . 0.0 111.909 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -94.43 167.11 11.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.861 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.05 -141.76 3.45 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.25 147.74 30.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.986 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.63 16.42 37.31 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.267 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.99 107.9 4.34 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.573 0.225 . . . . 0.0 110.951 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -93.37 25.15 3.52 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.946 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.29 -157.77 0.72 Allowed 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -132.68 108.53 9.1 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.808 0.337 . . . . 0.0 110.677 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 23' ' ' ALA . . . -107.31 -178.23 22.58 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.768 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.536 HD11 ' CB ' ' A' ' 73' ' ' ALA . 36.3 mm -97.48 129.04 48.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.617 0.246 . . . . 0.0 110.759 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.525 ' CE2' ' HG3' ' A' ' 56' ' ' GLN . 15.3 m-85 -114.2 166.03 12.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.139 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.21 109.55 28.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.844 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.05 -34.95 22.17 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.201 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.46 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 3.7 t -169.58 170.88 7.89 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.707 0.289 . . . . 0.0 111.518 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.404 HG13 ' HG ' ' A' ' 19' ' ' LEU . 17.0 t -130.7 151.41 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.213 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 t -101.53 139.86 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.147 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -58.74 136.29 57.69 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.043 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.28 -22.48 37.64 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.01 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -62.29 135.08 45.41 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.468 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.22 -36.34 19.83 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.587 ' HB3' HD21 ' A' ' 19' ' ' LEU . . . -60.25 -50.53 73.27 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 111.361 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -70.93 -45.56 64.01 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 43' ' ' GLY . 40.3 t -59.88 -36.42 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.396 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.62 -49.84 29.34 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.657 0.265 . . . . 0.0 110.914 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.04 60.56 1.06 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.809 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -123.37 -50.9 1.87 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.681 0.277 . . . . 0.0 110.936 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 pp -122.57 175.99 6.17 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.28 -174.89 5.14 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.305 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -69.75 165.81 20.59 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.356 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.59 45.72 88.14 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.34 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.22 172.98 11.94 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.799 0.333 . . . . 0.0 111.423 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.666 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -112.64 173.29 6.44 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.706 179.5 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.837 HD21 HD23 ' A' ' 86' ' ' LEU . 3.1 tp -155.84 133.05 10.77 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.066 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.657 HD12 HG22 ' A' ' 66' ' ' VAL . 3.9 mm? -115.4 -60.52 1.87 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.34 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 5.7 t -97.43 146.15 25.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.189 0.519 . . . . 0.0 112.14 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.698 HG23 HD21 ' A' ' 65' ' ' LEU . 34.4 t -140.41 126.66 21.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.596 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.8 t0 54.99 38.37 30.42 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.05 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.81 -12.92 45.93 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.707 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -90.73 158.78 16.69 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 117.399 0.6 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.57 108.04 16.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.43 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.698 HD21 HG23 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -110.83 96.76 6.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 110.988 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.657 HG22 HD12 ' A' ' 58' ' ' LEU . 17.2 t -125.03 92.61 2.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.814 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.16 36.24 0.88 Allowed Glycine 0 CA--C 1.518 0.271 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.313 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.522 HD22 ' HG2' ' A' ' 72' ' ' ARG . 12.4 mt -120.08 174.78 6.27 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.773 0.32 . . . . 0.0 110.728 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -98.23 163.71 12.61 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -57.09 -28.42 62.61 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.454 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -66.2 -49.2 68.11 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.739 0.304 . . . . 0.0 110.695 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.522 ' HG2' HD22 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -65.7 -45.5 82.58 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.365 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.536 ' CB ' HD11 ' A' ' 34' ' ' ILE . . . -64.81 -51.45 62.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.593 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.17 -37.04 78.96 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.749 0.309 . . . . 0.0 110.695 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 78' ' ' THR . 2.0 tp10 -67.9 -37.49 81.79 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.818 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mt -73.47 -40.81 63.85 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.163 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -32.66 74.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.172 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 75' ' ' GLU . 14.4 t -79.63 -33.5 41.33 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.881 -0.145 . . . . 0.0 111.388 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.81 46.04 1.35 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.688 0.28 . . . . 0.0 111.499 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 71.5 p -106.39 168.78 8.92 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.812 0.339 . . . . 0.0 111.026 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -80.62 -167.01 1.21 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.536 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.2 p -59.88 -39.8 86.52 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.674 0.273 . . . . 0.0 110.693 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.687 ' CG1' HG22 ' A' ' 10' ' ' THR . 19.6 t -105.03 142.73 17.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.804 179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.7 t -135.98 143.73 35.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.229 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.682 HG23 HG23 ' A' ' 10' ' ' THR . 0.0 OUTLIER -122.3 118.89 29.57 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.695 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.837 HD23 HD21 ' A' ' 57' ' ' LEU . 4.8 mp -120.2 120.81 37.22 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.415 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.825 ' HG2' HG22 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -81.68 93.19 6.72 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.476 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.544 ' HA ' HD12 ' A' ' 57' ' ' LEU . 9.1 p -88.18 137.31 21.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.641 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.666 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -105.62 126.57 52.29 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.038 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp . . . . . 0 C--O 1.233 0.208 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.445 179.859 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 41.1 tt0 . . . . . 0 C--O 1.234 0.279 0 CA-C-O 121.039 0.447 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 6' ' ' ILE . 3.7 mp -84.12 126.72 40.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.657 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 pt -145.86 146.65 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.566 ' OG1' HG22 ' A' ' 85' ' ' THR . 13.2 t -115.42 141.69 47.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.775 0.321 . . . . 0.0 111.107 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.579 HG11 HH11 ' A' ' 50' ' ' ARG . 2.0 m -141.73 148.78 20.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.502 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.691 ' CG2' HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -79.83 128.53 33.55 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.998 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.998 HD21 ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -120.4 121.93 39.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.712 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -101.04 99.13 9.53 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.701 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.3 130.28 43.89 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.176 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -78.95 -59.34 2.82 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.503 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -158.01 37.4 0.25 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.077 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.05 -163.96 28.62 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.359 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.1 mmt -139.4 101.46 4.24 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.674 0.273 . . . . 0.0 111.047 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.7 77.36 0.71 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.729 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.557 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -157.14 137.41 12.81 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 111.058 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -105.45 109.0 20.82 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.776 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 pt -102.91 178.29 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.473 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.461 HG13 ' HB2' ' A' ' 35' ' ' TYR . 2.5 p -155.42 134.42 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.228 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.29 104.24 16.13 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.63 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -143.74 -179.72 6.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.186 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.628 ' HG3' HD12 ' A' ' 32' ' ' LEU . 5.4 mtpt -101.46 179.36 4.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.846 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.53 -145.4 4.23 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.83 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.33 163.19 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.652 0.263 . . . . 0.0 110.921 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.49 20.13 44.14 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.555 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.81 -163.11 0.94 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.203 0.525 . . . . 0.0 109.962 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.437 ' C ' ' HG2' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -168.13 18.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.62 178.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HB2' HG12 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -156.97 -170.79 3.41 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.628 HD12 ' HG3' ' A' ' 25' ' ' LYS . 4.9 tp -99.54 123.96 44.29 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.607 0.241 . . . . 0.0 110.864 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.452 ' C ' HD12 ' A' ' 34' ' ' ILE . . . -118.16 175.03 15.54 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.806 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.564 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.6 mp -103.46 154.0 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 O-C-N 122.774 -0.25 . . . . 0.0 110.456 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.461 ' HB2' HG13 ' A' ' 22' ' ' VAL . 68.2 m-85 -136.14 158.46 44.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.249 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.468 HG21 HD13 ' A' ' 51' ' ' LEU . 22.4 t -102.94 108.84 25.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HD2' ' HB ' ' A' ' 22' ' ' VAL . 23.8 mtpt -81.71 -38.92 25.02 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.821 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.0 t -175.23 158.39 2.38 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.094 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.414 ' CG1' ' HB2' ' A' ' 46' ' ' ASP . 10.9 t -128.07 146.13 34.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.901 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.68 140.32 16.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.968 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -68.28 91.08 0.37 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.434 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.63 -32.35 0.48 Allowed Glycine 0 CA--C 1.519 0.342 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.493 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.602 ' O ' HG12 ' A' ' 47' ' ' VAL . . . -59.56 148.15 41.91 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.049 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -55.09 -21.08 11.49 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.998 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -86.94 -33.73 19.58 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.504 0.192 . . . . 0.0 111.442 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.414 ' HB2' ' CG1' ' A' ' 39' ' ' VAL . 0.7 OUTLIER -86.21 -49.13 7.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.264 -179.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 43' ' ' GLY . 8.2 p -62.83 -29.88 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.829 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.423 ' OD1' HG13 ' A' ' 47' ' ' VAL . 11.6 m-20 -86.83 -50.04 7.0 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.554 0.216 . . . . 0.0 110.552 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.52 93.14 2.28 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.389 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.579 HH11 HG11 ' A' ' 9' ' ' VAL . 2.9 mmp_? -143.18 -50.62 0.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.442 0.163 . . . . 0.0 111.056 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.704 HD22 HG11 ' A' ' 88' ' ' VAL . 2.4 pp -135.37 138.86 43.75 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.752 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.14 -170.52 1.67 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.304 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.28 153.66 42.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 111.121 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.83 37.29 65.91 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.284 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.46 173.88 6.12 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.769 0.318 . . . . 0.0 111.062 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.879 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -122.63 156.6 33.96 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.795 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.443 ' CD2' HG12 ' A' ' 88' ' ' VAL . 7.3 mt -133.95 135.13 43.32 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.152 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.658 HD23 ' CG2' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -120.41 -55.93 2.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.555 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.3 m -115.0 156.06 25.79 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.652 HG13 ' CD2' ' A' ' 86' ' ' LEU . 26.1 t -140.14 139.25 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.138 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.867 ' HB3' HG13 ' A' ' 84' ' ' VAL . 5.6 p-10 43.47 41.75 3.48 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.167 0.587 . . . . 0.0 111.793 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.8 32.55 74.13 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.807 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -132.75 145.37 50.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.932 0.366 . . . . 0.0 110.7 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.8 m -92.55 126.15 37.51 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.641 HD21 HG23 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -136.48 61.43 1.64 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.334 0.588 . . . . 0.0 111.022 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.658 ' CG2' HD23 ' A' ' 58' ' ' LEU . 10.5 t -102.74 98.44 6.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.676 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.6 -26.21 2.67 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.068 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' ' 65' ' ' LEU . 2.0 mt -76.54 174.09 10.75 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.802 0.334 . . . . 0.0 111.083 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.5 t -96.94 -176.57 3.6 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.972 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -60.1 -32.81 71.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 2.0 mp0 -58.54 -58.85 6.73 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.958 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.419 ' HB2' ' HB3' ' A' ' 68' ' ' LEU . 10.7 mmm180 -63.38 -42.78 98.85 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.267 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.08 -48.41 81.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.272 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.21 -44.85 71.24 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.749 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -60.46 -31.88 70.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.05 179.511 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mt -71.17 -36.54 72.03 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.727 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.592 ' HG2' HG11 ' A' ' 60' ' ' VAL . 3.2 mtt -67.62 -46.36 72.74 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.133 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.8 t -64.4 -27.92 69.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 121.213 -0.195 . . . . 0.0 111.043 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.4 mtm-85 -91.19 51.68 1.97 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.407 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.3 p -130.48 -177.29 4.27 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.865 0.364 . . . . 0.0 110.998 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 t -110.58 -165.5 1.0 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.562 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 t -54.73 -49.93 69.6 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.117 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.691 HG13 ' CG2' ' A' ' 10' ' ' THR . 60.2 t -86.95 126.15 40.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.217 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.867 HG13 ' HB3' ' A' ' 61' ' ' ASP . 25.4 t -145.9 110.2 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.231 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.566 HG22 ' OG1' ' A' ' 8' ' ' THR . 0.2 OUTLIER -84.35 120.14 25.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.658 179.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.652 ' CD2' HG13 ' A' ' 60' ' ' VAL . 49.8 mt -110.44 115.15 29.14 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.719 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 2.2 tt0 -87.2 92.16 8.97 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.353 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.704 HG11 HD22 ' A' ' 51' ' ' LEU . 30.8 m -94.39 173.55 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.354 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.879 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -128.88 120.67 26.63 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.076 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 8.9 mmtt . . . . . 0 C--O 1.234 0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.6 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 C--O 1.233 0.195 0 CA-C-O 121.215 0.531 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.2 mt -93.52 138.75 19.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.57 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 pp -145.35 141.99 22.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.438 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 2.2 m -101.9 114.41 28.48 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.816 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -127.97 162.34 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.642 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.36 142.36 29.33 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.188 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -114.13 129.3 56.62 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.832 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 82' ' ' SER . 6.8 mmtt -94.63 107.89 19.87 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.72 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -66.7 124.81 23.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.248 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -97.48 -53.57 3.41 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.857 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -154.46 36.3 0.42 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.32 -149.91 17.96 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.273 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.4 mmt -141.9 105.5 4.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.854 0.359 . . . . 0.0 111.055 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.12 36.2 4.2 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.475 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.7 ' HG ' HG13 ' A' ' 39' ' ' VAL . 3.9 mp -111.71 106.97 15.92 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 p -79.67 128.45 33.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.007 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.34 172.58 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.964 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.76 143.19 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.453 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.16 112.83 25.65 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.524 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -154.16 172.24 17.88 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.924 0.392 . . . . 0.0 111.779 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -113.83 161.2 17.86 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.063 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.79 -140.3 3.56 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.2 158.98 16.22 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.863 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.53 25.57 42.74 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.404 -0.903 . . . . 0.0 110.902 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.65 104.19 7.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.396 -0.402 . . . . 0.0 111.088 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -88.08 14.04 9.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.478 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.489 ' CB ' HG12 ' A' ' 66' ' ' VAL . 69.9 mmtt -145.85 -162.01 1.43 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.03 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -108.99 141.76 40.63 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.688 0.28 . . . . 0.0 110.672 179.491 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -123.41 144.49 15.64 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.658 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.506 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 35.8 mm -94.04 108.93 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -96.28 168.71 10.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 0.0 111.778 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.35 108.57 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.674 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -40.13 77.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.944 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.28 170.25 4.32 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.887 0.375 . . . . 0.0 111.552 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.7 HG13 ' HG ' ' A' ' 19' ' ' LEU . 37.1 t -134.84 127.67 49.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.597 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.96 137.81 23.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.136 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -65.27 152.92 42.53 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.36 20.34 69.42 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.928 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.39 -147.68 8.59 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.371 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.15 -43.41 6.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.658 0.266 . . . . 0.0 111.443 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.589 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -81.91 -34.03 30.13 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.239 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.74 -39.49 94.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.107 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.09 -35.89 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.847 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -42.06 72.56 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.272 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.03 76.56 1.13 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.478 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -133.88 -49.58 0.82 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.535 0.168 . . . . 0.0 111.264 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.705 HD22 HG11 ' A' ' 88' ' ' VAL . 2.4 pp -135.03 148.17 49.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 111.212 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -126.73 -169.47 2.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.161 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.37 145.37 56.16 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.933 0.397 . . . . 0.0 111.931 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.28 30.14 54.97 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.068 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -101.72 176.05 5.35 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.973 0.387 . . . . 0.0 111.655 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.624 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 5.0 tm0? -116.74 169.91 9.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.835 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.816 HD11 HD22 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -155.69 139.09 15.8 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.705 179.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 66' ' ' VAL . 7.3 mt -121.05 -58.49 1.8 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.1 m -121.82 153.85 37.79 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.735 HG13 ' HG ' ' A' ' 86' ' ' LEU . 21.3 t -140.51 122.06 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.847 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 t0 57.67 33.8 23.69 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.207 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.54 -8.49 71.66 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.341 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -84.81 155.24 21.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.133 0.466 . . . . 0.0 111.177 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.9 t -99.29 139.95 34.18 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.036 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 73' ' ' ALA . 4.3 mp -136.02 36.49 2.81 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.984 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.489 HG12 ' CB ' ' A' ' 31' ' ' LYS . 11.6 t -97.85 92.6 2.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.48 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.93 -25.47 4.14 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.644 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.533 HD22 ' HG2' ' A' ' 72' ' ' ARG . 13.8 mt -74.4 -177.32 3.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.866 0.365 . . . . 0.0 111.254 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.7 t -115.82 -171.81 2.04 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.008 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -62.57 -30.3 71.22 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.465 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.75 -50.73 69.89 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.775 0.321 . . . . 0.0 110.817 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.533 ' HG2' HD22 ' A' ' 68' ' ' LEU . 3.6 mpt_? -69.73 -42.49 73.91 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.987 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.534 ' HA ' HD23 ' A' ' 65' ' ' LEU . . . -55.43 -47.71 75.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.376 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.99 -69.18 0.29 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.263 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -37.88 -39.93 0.41 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.7 mt -70.73 -40.1 72.97 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.528 0.204 . . . . 0.0 111.384 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.46 ' CG ' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -85.21 -7.17 59.16 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.14 -29.13 28.89 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 122.376 -0.203 . . . . 0.0 110.97 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -90.85 31.93 1.03 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.432 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 54.0 p -79.89 176.01 10.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.821 0.343 . . . . 0.0 110.811 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.35 -160.68 1.05 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.587 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 19.6 m -56.12 -27.65 54.76 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.34 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 t -132.97 142.73 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.945 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.0 p -158.3 127.09 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.341 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.49 106.22 15.91 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.068 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.816 HD22 HD11 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -109.6 115.25 29.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.824 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 36.3 tt0 -88.7 109.15 19.9 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.508 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.705 HG11 HD22 ' A' ' 51' ' ' LEU . 19.0 m -117.02 169.91 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.708 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.624 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -120.33 131.16 54.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.698 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.812 0.339 . . . . 0.0 110.412 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptm . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.684 0.278 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.54 132.7 42.06 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.88 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -128.1 89.5 50.03 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.29 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 59.2 Cg_endo -71.6 -174.19 1.2 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.858 2.372 . . . . 0.0 112.817 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -126.0 105.38 8.85 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.194 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.667 HG22 ' HG2' ' A' ' 87' ' ' GLU . 21.4 mt -95.45 127.31 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.006 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.42 139.27 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.502 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 86.2 m -89.11 113.79 24.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.851 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 86' ' ' LEU . 14.4 p -105.84 149.27 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.384 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -120.66 112.66 19.16 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.733 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.67 163.02 27.02 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.188 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -103.73 174.31 5.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.219 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -107.58 115.88 30.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.398 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.37 -41.3 10.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.615 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -163.4 47.08 0.13 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.689 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.44 -146.73 18.29 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.481 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 30.4 mtt -138.97 95.46 2.96 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.682 0.277 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.41 74.09 2.13 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.548 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.61 143.68 13.26 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.616 0.246 . . . . 0.0 111.012 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -87.64 147.25 25.35 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.187 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.486 HD12 ' HG3' ' A' ' 70' ' ' GLN . 1.2 pp -138.77 164.32 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.699 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.506 ' CG1' ' HB2' ' A' ' 35' ' ' TYR . 7.3 p -151.48 144.12 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.388 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.46 91.97 3.86 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.999 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.03 179.84 6.11 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.249 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 -179.99 4.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.716 0.293 . . . . 0.0 110.945 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.41 -138.82 2.56 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.708 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.57 149.79 27.62 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.866 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.53 18.22 36.48 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.489 -0.862 . . . . 0.0 110.986 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.34 105.66 3.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.729 0.299 . . . . 0.0 110.859 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.08 26.77 2.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.987 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.442 ' HG3' HG12 ' A' ' 66' ' ' VAL . 8.4 mmtt -122.1 -158.81 0.79 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.8 100.22 5.41 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.826 0.346 . . . . 0.0 110.703 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.18 155.36 28.53 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.763 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.2 mm -88.31 93.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 CA-C-O 120.951 0.405 . . . . 0.0 110.473 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.506 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 91.8 m-85 -83.65 145.88 28.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.759 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.54 107.89 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.211 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -68.06 -42.97 79.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.941 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.6 t -168.03 171.76 9.38 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.139 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.7 t -128.99 120.94 53.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.578 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.35 130.47 34.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.85 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.13 126.55 27.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.55 -20.77 22.43 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.726 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.88 157.02 48.96 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.712 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.48 -39.9 64.91 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.438 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -72.54 -36.68 68.35 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.469 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -70.39 -49.19 51.66 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.28 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 43' ' ' GLY . 38.9 t -61.48 -40.99 88.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.269 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.96 -50.85 69.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.164 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.13 46.57 3.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.442 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.26 -67.82 0.91 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.638 0.256 . . . . 0.0 110.91 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.513 ' HB3' HG21 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -87.78 158.4 18.78 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.811 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.35 176.06 8.44 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.58 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.35 147.69 44.15 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.473 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.99 45.36 57.33 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.412 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.401 ' HB3' ' CG1' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -117.39 179.64 3.99 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.478 0.18 . . . . 0.0 110.974 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.691 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 65.3 tt0 -123.46 147.97 46.65 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.208 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.661 ' CD2' HG22 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -123.76 127.76 48.6 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.304 179.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.51 ' CD1' HG22 ' A' ' 66' ' ' VAL . 4.0 mm? -109.07 -62.71 1.44 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.027 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.0 m -102.75 143.01 32.94 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.52 HG21 HD11 ' A' ' 65' ' ' LEU . 22.0 t -137.39 110.21 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.56 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.3 40.4 24.58 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.273 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.69 -26.46 12.38 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.11 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.75 175.39 10.72 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.963 0.382 . . . . 0.0 110.846 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.21 121.51 24.95 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.781 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.52 HD11 HG21 ' A' ' 60' ' ' VAL . 36.9 mt -96.86 51.19 1.13 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.798 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.51 HG22 ' CD1' ' A' ' 58' ' ' LEU . 17.3 t -95.98 90.94 2.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.77 31.56 2.91 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.526 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.484 HD22 ' HG3' ' A' ' 72' ' ' ARG . 33.7 mt -118.41 157.56 26.94 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.854 0.359 . . . . 0.0 110.97 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.8 p -79.71 166.29 21.95 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.976 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.486 ' HG3' HD12 ' A' ' 21' ' ' ILE . 26.8 tt0 -58.49 -37.96 76.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.719 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -64.66 -48.98 72.77 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.945 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HG3' HD22 ' A' ' 68' ' ' LEU . 3.9 mmt180 -56.22 -47.57 78.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.356 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.98 -53.3 32.86 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.313 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' A' ' 21' ' ' ILE . . . -57.44 -42.78 83.09 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.052 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.446 ' O ' HG22 ' A' ' 78' ' ' THR . 0.5 OUTLIER -66.4 -35.96 81.65 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.084 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.484 ' O ' HG23 ' A' ' 80' ' ' THR . 13.3 mt -71.93 -38.57 69.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.781 -0.19 . . . . 0.0 110.909 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 56.5 mtt -62.37 -37.26 85.03 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.235 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 75' ' ' GLU . 10.1 t -74.86 -32.51 61.92 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.585 0.231 . . . . 0.0 110.769 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -88.74 50.98 2.06 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.413 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 76' ' ' LEU . 40.2 p -120.03 170.89 8.87 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.812 0.339 . . . . 0.0 111.194 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.22 -169.62 2.35 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.755 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.0 m -54.9 -48.0 73.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.592 0.234 . . . . 0.0 110.994 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.66 138.74 20.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.796 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.439 HG12 HD11 ' A' ' 86' ' ' LEU . 15.6 t -133.91 114.33 19.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.18 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.25 132.36 36.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.538 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.63 ' O ' HG12 ' A' ' 9' ' ' VAL . 4.5 mp -138.95 132.75 30.81 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.62 0.247 . . . . 0.0 111.141 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.667 ' HG2' HG22 ' A' ' 6' ' ' ILE . 28.0 tt0 -100.86 101.72 12.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.681 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.661 HG22 ' CD2' ' A' ' 57' ' ' LEU . 21.6 t -91.85 149.86 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.767 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -115.18 119.36 36.1 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.231 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -71.39 102.34 2.61 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.767 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -156.19 -161.98 1.21 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.958 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.47 139.12 2.58 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.489 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.432 179.846 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.1 mtm . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 120.492 0.187 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.11 112.49 24.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.852 0.358 . . . . 0.0 110.8 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -104.53 148.87 36.72 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.965 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.634 ' HG2' HD11 ' A' ' 6' ' ' ILE . 55.3 Cg_endo -69.86 -166.2 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.814 2.342 . . . . 0.0 112.327 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -72.04 83.42 0.98 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.276 0.56 . . . . 0.0 111.029 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.74 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 19.4 mm -92.05 125.2 44.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.919 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.63 139.72 47.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.141 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.537 ' HB ' ' HG3' ' A' ' 87' ' ' GLU . 2.4 t -95.39 140.88 29.64 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.077 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.534 HG11 ' HB3' ' A' ' 50' ' ' ARG . 31.3 m -118.78 124.93 73.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.083 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.564 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -84.04 116.06 22.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.8 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.628 HD22 ' HB1' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -139.76 143.08 36.78 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.401 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -101.93 170.34 8.2 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.171 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -101.18 119.72 39.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.366 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.43 -40.54 5.33 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -152.87 32.26 0.49 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.974 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.12 177.59 22.75 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.235 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.1 mmm -115.27 96.61 5.75 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.749 0.309 . . . . 0.0 110.75 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.09 72.14 2.85 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.555 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.563 HD21 ' CB ' ' A' ' 45' ' ' ALA . 4.6 mp -139.8 115.95 10.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.634 0.254 . . . . 0.0 110.646 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.9 m -85.99 100.07 11.88 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.956 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.706 HD11 ' HB2' ' A' ' 74' ' ' ALA . 1.9 pt -81.31 174.79 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.574 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.738 HG13 ' HB2' ' A' ' 35' ' ' TYR . 3.5 p -158.85 144.55 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.34 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.43 ' HB2' ' N ' ' A' ' 70' ' ' GLN . . . -104.59 124.3 49.07 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.835 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.6 -179.54 8.26 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.966 0.412 . . . . 0.0 111.62 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.439 ' HG3' HD12 ' A' ' 32' ' ' LEU . 4.4 mttt -101.87 164.84 11.51 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.91 -143.55 3.88 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.1 153.65 26.63 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.022 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.45 19.15 39.74 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.169 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.46 111.01 5.62 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.71 0.291 . . . . 0.0 110.898 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -94.37 24.84 4.2 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.888 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -123.66 -147.44 0.38 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.439 HD12 ' HG3' ' A' ' 25' ' ' LYS . 4.4 tp -136.29 112.41 9.72 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.752 0.311 . . . . 0.0 110.555 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.38 176.89 24.63 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.816 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 73' ' ' ALA . 26.4 mm -97.11 151.5 4.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.715 0.293 . . . . 0.0 110.765 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.738 ' HB2' HG13 ' A' ' 22' ' ' VAL . 85.1 m-85 -140.38 156.41 46.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.157 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.68 100.59 11.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.713 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -74.53 -39.0 62.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.541 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.44 162.14 8.18 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.205 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.81 109.53 20.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.558 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.3 t -65.95 127.4 27.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.307 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -60.85 143.03 55.61 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.007 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.81 -14.76 62.62 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.921 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -75.05 -173.84 33.01 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.312 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.628 ' HB1' HD22 ' A' ' 11' ' ' LEU . . . -71.15 -51.1 26.88 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.834 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -61.75 -37.74 85.38 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -64.07 -49.2 73.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.456 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 43' ' ' GLY . 44.9 t -64.46 -36.1 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.374 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.49 -54.25 11.2 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.75 69.86 1.36 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.719 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.534 ' HB3' HG11 ' A' ' 9' ' ' VAL . 2.4 mtt180 -139.74 27.44 2.23 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.549 0.214 . . . . 0.0 111.51 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.834 HD21 ' HB1' ' A' ' 45' ' ' ALA . 0.7 OUTLIER -175.63 179.48 1.41 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.596 0.236 . . . . 0.0 111.036 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.11 -176.97 6.11 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.603 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.36 146.99 38.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.161 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.53 47.64 15.58 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.375 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -116.98 177.76 4.59 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.672 0.272 . . . . 0.0 111.1 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.745 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 9.3 tm0? -112.45 165.15 12.48 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.125 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.655 ' HG ' HG12 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -148.16 126.3 12.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.782 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.25 -63.12 1.36 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.318 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.7 m -115.73 152.48 33.15 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 111.666 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.692 HG11 ' HG2' ' A' ' 77' ' ' MET . 39.0 t -133.14 113.81 20.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.875 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.2 36.44 23.85 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.208 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.55 -14.25 60.26 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.209 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -80.53 143.87 32.93 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 117.158 0.479 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.3 p -92.56 137.41 32.39 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.046 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.514 HD13 HG23 ' A' ' 60' ' ' VAL . 4.4 mp -137.91 87.54 2.26 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.267 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.6 t -135.87 87.11 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.752 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.73 -24.01 3.35 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.644 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.4 mt -72.71 175.12 6.71 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.198 0.523 . . . . 0.0 111.814 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -101.51 176.25 5.3 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.999 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.43 ' N ' ' HB2' ' A' ' 23' ' ' ALA . 44.1 tt0 -61.38 -39.16 89.65 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.091 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.23 -53.16 61.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.164 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -58.62 -48.36 81.27 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.137 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -59.44 -50.77 72.64 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.652 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.706 ' HB2' HD11 ' A' ' 21' ' ' ILE . . . -62.14 -40.5 96.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.777 0.322 . . . . 0.0 110.806 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.562 ' O ' HG22 ' A' ' 78' ' ' THR . 3.8 tp10 -64.86 -31.39 72.6 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.116 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.6 mt -79.35 -30.47 42.67 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.007 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.692 ' HG2' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -66.37 -29.8 70.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.391 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 75' ' ' GLU . 11.0 t -77.2 -31.24 55.17 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 121.156 -0.218 . . . . 0.0 110.787 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -95.35 56.81 1.9 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.816 0.341 . . . . 0.0 111.52 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.3 p -116.64 179.33 4.04 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.087 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.19 -174.13 4.08 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.797 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.3 m -53.56 -52.62 59.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.973 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.564 ' CG1' HG22 ' A' ' 10' ' ' THR . 19.2 t -92.79 146.34 6.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.83 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.7 t -135.0 133.62 53.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.27 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.88 101.6 8.42 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.512 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.65 ' CD2' HG13 ' A' ' 60' ' ' VAL . 4.1 mt -99.95 113.28 25.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.578 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.669 ' HG2' HG22 ' A' ' 6' ' ' ILE . 3.1 tt0 -81.37 95.53 7.05 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.994 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.655 HG12 ' HG ' ' A' ' 57' ' ' LEU . 31.9 m -101.28 166.32 2.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.142 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.745 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -119.98 142.53 48.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.656 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.86 70.83 2.65 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.701 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -101.28 -165.78 1.24 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.219 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.25 138.44 2.42 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.514 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.989 179.853 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mmt . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.655 0.265 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.0 96.58 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.042 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 59.11 78.82 0.33 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.224 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.76 167.39 27.33 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.816 2.344 . . . . 0.0 112.838 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -112.91 97.25 6.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.018 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.58 HG22 ' HG2' ' A' ' 87' ' ' GLU . 3.7 mt -85.59 128.95 38.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.03 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 pt -146.01 149.63 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.972 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.481 ' HB ' ' HG3' ' A' ' 87' ' ' GLU . 6.4 t -106.72 142.61 36.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 110.825 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.477 HG23 HD11 ' A' ' 11' ' ' LEU . 2.9 m -131.3 137.14 56.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.532 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.2 m -87.1 112.34 21.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.761 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.477 HD11 HG23 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -122.28 164.39 17.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.738 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -122.58 148.69 44.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.73 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -85.08 107.28 17.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.706 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.82 56.8 2.7 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.619 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 57.31 39.52 28.42 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.167 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.73 171.41 39.6 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.66 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -138.71 -68.34 0.45 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.536 0.208 . . . . 0.0 111.069 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.76 65.5 3.5 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.106 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.438 HD23 HG22 ' A' ' 39' ' ' VAL . 0.9 OUTLIER -144.48 108.94 4.85 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.594 0.235 . . . . 0.0 111.053 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.3 m -81.02 97.06 7.33 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.709 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pt -98.23 175.44 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.692 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' A' ' 35' ' ' TYR . 6.5 p -159.53 138.79 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.274 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.73 107.46 18.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.028 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -148.63 179.84 7.52 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.926 0.393 . . . . 0.0 111.583 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -97.12 168.47 10.43 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.27 -142.28 3.46 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.79 149.91 27.63 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.844 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.19 17.57 31.48 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.287 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.34 108.24 4.36 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.714 0.292 . . . . 0.0 110.786 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.69 25.38 3.12 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.765 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.9 mmtm -121.47 -155.43 0.64 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.239 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.6 99.02 4.51 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.845 0.355 . . . . 0.0 110.631 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.43 154.91 25.53 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.928 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.527 HD11 ' HB2' ' A' ' 73' ' ' ALA . 35.2 mm -88.95 100.14 10.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.882 0.372 . . . . 0.0 110.662 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.465 ' HB2' HG13 ' A' ' 22' ' ' VAL . 82.7 m-85 -89.84 153.89 20.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.605 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -99.97 113.61 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.758 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -82.52 -40.94 20.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.627 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 m -164.06 173.23 12.77 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.284 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.438 HG22 HD23 ' A' ' 19' ' ' LEU . 19.4 t -137.44 152.02 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.199 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.8 t -101.71 140.96 19.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.085 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.32 109.96 1.75 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.772 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.82 -24.83 4.78 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.0 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -62.63 159.94 33.92 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.813 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.9 -55.59 25.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.515 0.198 . . . . 0.0 111.475 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.74 -32.24 69.05 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.332 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.74 -55.28 8.99 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.018 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 43' ' ' GLY . 26.9 t -63.69 -46.69 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.283 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.56 -33.31 75.3 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.284 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.29 36.9 92.35 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.825 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -85.01 -32.21 23.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.525 0.202 . . . . 0.0 111.094 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.471 HD22 HG11 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -137.05 175.44 9.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.867 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.81 -171.08 3.17 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.01 149.76 47.37 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.152 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.06 50.94 25.77 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.418 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -120.51 176.2 5.62 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.631 0.253 . . . . 0.0 111.091 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.74 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 24.4 tm0? -128.69 139.06 52.42 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.107 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.625 HD21 HD23 ' A' ' 86' ' ' LEU . 6.4 mp -119.51 135.45 54.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.981 0.42 . . . . 0.0 111.206 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.558 HD12 HE22 ' A' ' 56' ' ' GLN . 0.1 OUTLIER -101.66 -59.52 1.69 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.466 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.7 m -117.68 163.21 16.82 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.898 0.38 . . . . 0.0 111.864 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.578 HG13 HD11 ' A' ' 86' ' ' LEU . 47.8 t -145.85 136.4 18.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.96 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.47 ' HB3' HG22 ' A' ' 80' ' ' THR . 5.4 p-10 44.17 37.05 1.7 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.952 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.26 40.69 40.6 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.746 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.424 ' O ' HD12 ' A' ' 65' ' ' LEU . 69.0 mtt-85 -140.97 156.29 46.08 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.721 0.261 . . . . 0.0 110.679 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 m -86.49 128.33 34.95 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.831 0.348 . . . . 0.0 111.001 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.62 HD23 ' HA ' ' A' ' 73' ' ' ALA . 5.4 mp -137.88 37.01 2.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.437 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 66' ' ' VAL . 13.2 p -114.07 45.5 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.66 0.743 . . . . 0.0 110.665 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.51 36.27 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.174 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.486 HD21 ' HA ' ' A' ' 65' ' ' LEU . 1.7 pp -144.82 169.99 16.97 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.671 0.272 . . . . 0.0 110.926 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.55 177.42 8.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.199 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -63.34 -34.06 76.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.289 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -50.93 71.9 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.652 0.263 . . . . 0.0 110.92 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -62.62 -42.74 99.76 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.458 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.62 ' HA ' HD23 ' A' ' 65' ' ' LEU . . . -67.0 -54.14 24.64 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.509 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.35 -35.69 74.34 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.826 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.404 ' O ' HG22 ' A' ' 78' ' ' THR . 3.8 tp10 -69.86 -29.41 66.64 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.133 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.57 HD23 ' HD2' ' A' ' 79' ' ' ARG . 24.3 mt -79.48 -37.62 36.38 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.77 -0.196 . . . . 0.0 111.028 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.484 ' CG ' HG11 ' A' ' 60' ' ' VAL . 5.9 mtm -68.76 -32.38 72.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.405 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 75' ' ' GLU . 15.1 t -73.79 -30.29 62.66 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.491 0.186 . . . . 0.0 111.217 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.57 ' HD2' HD23 ' A' ' 76' ' ' LEU . 17.6 ptp180 -92.71 44.3 1.15 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.448 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 61' ' ' ASP . 17.2 p -102.89 161.04 14.07 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.831 0.348 . . . . 0.0 111.434 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.2 p -95.86 -166.49 1.44 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -39.17 68.87 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.868 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 t -103.46 142.06 18.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.087 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.532 HG12 ' CD1' ' A' ' 86' ' ' LEU . 16.9 t -145.74 142.14 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.271 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.426 HG22 ' OG1' ' A' ' 8' ' ' THR . 0.1 OUTLIER -123.16 112.62 17.92 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.457 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.625 HD23 HD21 ' A' ' 57' ' ' LEU . 10.3 mp -110.39 119.56 39.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.239 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.58 ' HG2' HG22 ' A' ' 6' ' ' ILE . 3.5 tt0 -81.44 85.44 6.47 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.335 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.471 HG11 HD22 ' A' ' 51' ' ' LEU . 25.6 m -80.31 173.08 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.417 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.74 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -143.66 125.92 15.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.633 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -66.45 87.95 0.13 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.827 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -110.55 -168.16 1.28 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.039 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 145.62 140.13 3.48 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.348 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.047 -0.977 . . . . 0.0 111.468 -179.861 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ptm . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.445 0.164 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? 64.27 75.42 0.38 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.452 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 68.45 146.29 0.11 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.768 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.578 ' HG2' HD11 ' A' ' 6' ' ' ILE . 72.8 Cg_endo -74.86 177.93 7.89 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.514 2.143 . . . . 0.0 112.569 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 89' ' ' ALA . 3.0 tt0 -100.66 92.17 4.98 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.882 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.935 HG22 ' HG2' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -110.58 123.78 66.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.633 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.663 HD12 ' CG2' ' A' ' 9' ' ' VAL . 1.1 pt -126.3 138.58 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.388 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 1.6 m -94.03 120.4 34.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.875 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.663 ' CG2' HD12 ' A' ' 7' ' ' ILE . 21.8 t -124.45 142.64 40.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.891 0.377 . . . . 0.0 111.224 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.404 HG22 HG23 ' A' ' 85' ' ' THR . 2.2 p -80.3 147.34 31.19 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.96 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.2 mt -144.49 128.82 17.85 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.831 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -91.34 146.53 23.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.939 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -69.42 110.71 4.85 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.601 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -101.04 68.69 1.27 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.567 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.5 t30 57.98 40.13 25.85 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.145 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.3 177.7 14.99 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.79 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.9 mmm -129.94 103.32 6.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.626 0.25 . . . . 0.0 110.693 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.409 ' HA3' ' HB ' ' A' ' 40' ' ' VAL . . . -98.59 79.85 0.57 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.865 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.541 HD21 ' CB ' ' A' ' 45' ' ' ALA . 4.5 mp -146.63 124.26 11.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.585 0.231 . . . . 0.0 110.853 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.1 m -89.5 138.56 31.35 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.031 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.459 HG21 ' HE3' ' A' ' 77' ' ' MET . 1.2 pp -136.85 169.08 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.755 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 35' ' ' TYR . 7.3 p -157.79 141.42 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.294 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.07 94.74 7.33 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.636 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.425 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -129.71 179.17 5.99 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.462 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -123.38 -179.82 4.46 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.289 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.29 -141.77 3.22 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.01 153.52 19.82 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.735 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.41 22.59 38.63 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.094 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.21 102.06 7.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.541 -0.329 . . . . 0.0 111.133 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.38 16.6 8.48 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 -168.95 2.94 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.109 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.461 ' HA ' HD12 ' A' ' 32' ' ' LEU . 3.2 tp -119.68 133.58 55.57 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.56 0.219 . . . . 0.0 110.689 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.06 147.68 18.88 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.662 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 57' ' ' LEU . 39.3 mm -80.89 92.03 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.876 0.369 . . . . 0.0 110.223 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.427 ' HB2' HG13 ' A' ' 22' ' ' VAL . 20.2 m-85 -75.18 155.24 37.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.488 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.5 t -102.36 109.07 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.585 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.12 -42.85 75.5 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.804 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.77 179.44 0.71 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.183 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.44 146.93 28.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.019 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.409 ' HB ' ' HA3' ' A' ' 18' ' ' GLY . 22.3 t -95.96 131.07 43.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.364 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.6 139.01 58.73 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.864 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.5 -17.24 59.64 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.082 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -72.31 -164.83 7.61 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.716 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.601 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . . . -87.37 -43.44 12.12 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.541 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -68.64 -42.59 77.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.783 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -59.12 -45.86 89.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.404 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 43' ' ' GLY . 29.1 t -73.39 -33.71 41.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.41 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -55.38 34.17 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.292 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.74 61.12 1.63 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.608 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.464 ' CD ' HG11 ' A' ' 9' ' ' VAL . 1.8 mmp_? -121.49 -44.49 2.35 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.527 0.203 . . . . 0.0 111.189 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.402 ' HB3' HG11 ' A' ' 88' ' ' VAL . 1.3 pp -130.32 174.2 10.07 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.865 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.95 -168.06 2.83 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.3 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.11 142.91 50.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.192 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.07 49.53 4.97 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.325 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.21 -179.85 5.08 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.458 0.17 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.67 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 46.6 tt0 -130.84 134.0 46.43 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.723 0.297 . . . . 0.0 111.354 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.61 HD22 HD12 ' A' ' 86' ' ' LEU . 87.7 mt -110.85 131.27 55.19 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.486 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.21 -56.77 2.16 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.687 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -117.9 147.27 43.27 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.003 0.43 . . . . 0.0 111.987 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.809 HG22 HD11 ' A' ' 86' ' ' LEU . 57.7 t -126.94 103.92 11.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.318 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.487 ' HB2' HG23 ' A' ' 84' ' ' VAL . 4.4 t0 60.78 39.39 17.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.992 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.67 -23.29 29.05 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.299 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -74.31 132.45 42.08 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 117.227 0.513 . . . . 0.0 110.934 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.0 p -91.2 120.5 32.17 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.673 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.741 ' HA ' HD12 ' A' ' 68' ' ' LEU . 3.1 mp -110.09 43.41 1.37 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.851 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.99 86.55 2.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.66 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.0 27.47 3.99 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.584 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 65' ' ' LEU . 29.0 mt -109.02 176.01 5.25 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.883 0.373 . . . . 0.0 110.934 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.5 m -107.36 168.44 9.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.024 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.419 ' HG3' HD12 ' A' ' 21' ' ' ILE . 35.3 tt0 -57.52 -35.46 70.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.118 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -58.76 -54.61 45.16 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.907 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.42 ' HG3' HD22 ' A' ' 68' ' ' LEU . 49.2 mmt-85 -61.7 -46.11 91.07 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.985 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.07 -55.37 35.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.392 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.26 81.39 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.154 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -60.62 -33.06 72.21 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.315 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.2 mt -81.19 -40.73 23.44 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.019 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.459 ' HE3' HG21 ' A' ' 21' ' ' ILE . 11.7 mtp -66.84 -41.48 87.33 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.191 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.675 HG23 ' HG3' ' A' ' 79' ' ' ARG . 13.2 t -61.64 -33.29 73.68 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.173 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.675 ' HG3' HG23 ' A' ' 78' ' ' THR . 84.5 mtm180 -101.72 65.1 1.0 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.803 0.335 . . . . 0.0 111.126 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.465 HG21 HG21 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -104.88 159.99 15.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.873 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 t -76.7 -172.23 2.17 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.835 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.9 p -53.0 -33.51 52.01 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.128 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.9 t -131.28 127.68 60.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.191 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 61' ' ' ASP . 9.3 p -113.1 129.37 68.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.538 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.404 HG23 HG22 ' A' ' 10' ' ' THR . 0.0 OUTLIER -97.45 85.73 3.7 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.874 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.809 HD11 HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -87.13 119.03 26.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.335 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.935 ' HG2' HG22 ' A' ' 6' ' ' ILE . 27.2 tt0 -88.76 102.6 15.16 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.859 0.361 . . . . 0.0 110.227 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.477 ' HA ' HD23 ' A' ' 57' ' ' LEU . 12.5 p -96.19 147.99 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.963 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.67 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -113.52 129.88 56.46 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.544 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.83 83.57 0.11 Allowed 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.375 0.422 . . . . 0.0 110.852 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -108.02 -168.49 1.38 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.047 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.53 139.92 4.73 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.409 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.624 -0.703 . . . . 0.0 111.616 179.845 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.71 0.291 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.98 129.17 11.91 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.706 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 61.94 98.05 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.71 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.93 -178.19 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.093 2.529 . . . . 0.0 113.121 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.34 92.81 6.51 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.376 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.458 HG22 ' CG ' ' A' ' 87' ' ' GLU . 3.4 mp -91.54 128.01 43.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.532 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.832 HD12 HG13 ' A' ' 9' ' ' VAL . 1.1 pt -139.44 143.62 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.82 0.343 . . . . 0.0 111.583 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.68 HG23 ' HB2' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -98.28 111.75 23.98 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.84 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.832 HG13 HD12 ' A' ' 7' ' ' ILE . 14.6 m -107.42 144.03 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.441 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.3 m -99.4 143.41 29.68 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.998 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.509 HD21 ' N ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -145.53 167.72 22.32 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.222 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.61 ' CD ' HG22 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -119.1 137.81 53.32 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.525 179.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -64.1 100.69 0.34 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.922 0.391 . . . . 0.0 111.049 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.21 73.59 2.49 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.433 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.58 36.78 28.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.097 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 130.24 -159.43 22.73 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.306 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.2 mmt -127.32 -59.11 1.25 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.654 0.264 . . . . 0.0 110.988 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.11 55.52 4.77 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.505 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.714 ' HG ' HG13 ' A' ' 39' ' ' VAL . 4.1 mp -145.58 118.46 8.73 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.555 0.217 . . . . 0.0 110.774 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -80.76 100.77 8.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.862 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 pt -100.69 174.69 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.65 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 35' ' ' TYR . 2.8 p -157.77 135.91 2.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.257 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.05 89.75 3.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.499 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.52 178.52 6.41 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.738 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.35 168.11 11.8 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.869 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -151.43 -143.28 3.68 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.86 152.1 26.2 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.93 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.56 19.26 33.8 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.183 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.41 109.18 4.74 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.737 0.303 . . . . 0.0 110.957 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -92.75 25.02 3.29 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.713 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -124.01 -151.54 0.48 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 tp -134.66 109.46 8.64 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.672 0.273 . . . . 0.0 110.443 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.53 164.42 15.52 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.748 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 73' ' ' ALA . 31.1 mm -91.85 138.39 19.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.661 0.267 . . . . 0.0 110.667 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.433 ' HB2' HG13 ' A' ' 22' ' ' VAL . 97.8 m-85 -130.13 138.41 50.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.183 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -88.22 99.83 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.929 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -73.21 -38.84 65.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.472 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 t -161.02 160.03 30.09 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.203 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.714 HG13 ' HG ' ' A' ' 19' ' ' LEU . 21.4 t -125.7 119.24 54.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.698 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.97 135.75 27.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.419 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -72.44 145.29 47.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.899 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.74 -15.08 63.29 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.181 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -71.61 -167.16 8.34 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.538 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.19 -38.18 16.61 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.509 ' N ' HD21 ' A' ' 11' ' ' LEU . . . -72.36 -43.73 63.59 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.27 -34.87 78.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.682 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 43' ' ' GLY . 39.7 t -81.7 -39.71 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 120.567 0.222 . . . . 0.0 111.119 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.2 -35.04 77.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.24 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.27 31.16 43.08 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.656 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -86.76 -41.29 14.23 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.609 0.242 . . . . 0.0 110.925 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.521 HD11 HD21 ' A' ' 19' ' ' LEU . 1.9 pp -141.77 169.36 17.74 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.945 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.13 -170.83 3.35 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.483 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.83 154.6 41.68 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.533 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.44 25.05 73.73 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.753 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.24 173.11 6.45 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.814 0.307 . . . . 0.0 111.35 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.586 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 9.8 tm0? -109.25 162.37 14.36 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.988 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.628 ' CD2' HD23 ' A' ' 86' ' ' LEU . 4.5 mt -141.46 125.47 17.22 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.965 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.458 HD12 HE22 ' A' ' 56' ' ' GLN . 0.0 OUTLIER -113.48 -63.54 1.43 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.556 -179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.2 p -113.91 146.98 39.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.948 0.404 . . . . 0.0 111.84 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.702 HG13 ' HG ' ' A' ' 86' ' ' LEU . 54.1 t -139.87 125.86 21.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.475 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.516 ' HB2' HG13 ' A' ' 84' ' ' VAL . 10.4 t70 58.24 37.53 26.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.575 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.84 28.66 72.9 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.057 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -123.6 153.27 40.92 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.939 0.369 . . . . 0.0 110.845 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.6 p -95.19 135.65 36.5 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.138 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.755 HD21 HD12 ' A' ' 76' ' ' LEU . 10.0 mt -126.9 38.82 4.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.045 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.4 t -99.16 94.72 3.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.976 0.417 . . . . 0.0 110.405 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.86 33.81 2.33 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.462 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.825 HD22 ' HG2' ' A' ' 72' ' ' ARG . 37.8 mt -123.66 176.57 6.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.72 0.295 . . . . 0.0 110.685 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.7 m -98.86 165.31 11.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.153 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -58.53 -29.1 66.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.193 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -68.67 -34.77 76.26 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.611 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.825 ' HG2' HD22 ' A' ' 68' ' ' LEU . 1.8 mpt_? -67.45 -54.39 20.63 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.146 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.412 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -60.46 -41.23 93.72 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.649 0.262 . . . . 0.0 111.272 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.61 -40.1 92.25 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.99 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -77.72 -30.56 51.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.518 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.755 HD12 HD21 ' A' ' 65' ' ' LEU . 10.2 mt -68.91 -41.41 78.25 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.313 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.445 ' HG2' HG11 ' A' ' 60' ' ' VAL . 54.8 mtt -60.45 -45.37 93.94 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.014 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.7 t -67.02 -29.74 69.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.677 0.275 . . . . 0.0 110.53 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -87.42 50.35 1.99 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.349 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.7 p -125.99 172.18 10.16 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.769 0.319 . . . . 0.0 110.917 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.6 p -86.88 -171.26 3.44 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.182 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 m -55.36 -36.7 66.61 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.018 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.61 HG22 ' CD ' ' A' ' 12' ' ' LYS . 29.3 t -108.01 139.91 28.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.165 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 61' ' ' ASP . 16.0 t -139.27 137.9 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.13 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.643 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -112.72 109.71 19.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.79 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.702 ' HG ' HG13 ' A' ' 60' ' ' VAL . 3.4 mp -105.32 122.56 46.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.179 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.68 ' HB2' HG23 ' A' ' 8' ' ' THR . 29.4 tt0 -92.92 106.75 18.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.408 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.613 HG12 ' HG ' ' A' ' 57' ' ' LEU . 20.7 m -109.67 171.38 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.654 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -124.75 128.89 49.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.808 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.2 83.97 0.09 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.117 0.484 . . . . 0.0 110.943 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -118.34 162.95 17.45 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.754 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.42 136.06 2.08 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.56 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.443 179.741 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.773 0.32 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.85 142.67 49.43 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.782 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.92 105.08 16.93 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.954 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.47 -173.26 0.78 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.646 2.231 . . . . 0.0 112.578 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.59 105.95 10.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.996 0.427 . . . . 0.0 111.008 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 22.1 mm -80.42 128.44 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.959 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.712 HD12 HG13 ' A' ' 9' ' ' VAL . 1.7 pt -147.53 144.83 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.18 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 1.3 m -103.44 105.47 15.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.414 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.712 HG13 HD12 ' A' ' 7' ' ' ILE . 14.1 m -93.66 145.03 8.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.993 0.425 . . . . 0.0 111.596 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.4 m -95.71 101.96 13.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.524 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.683 HD11 ' HA ' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -102.24 141.79 34.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -109.65 115.43 29.86 Favored 'General case' 0 CA--C 1.526 0.054 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.767 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.63 122.8 12.9 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.252 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.835 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 0.4 OUTLIER -115.06 73.16 0.82 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.351 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 60.34 38.2 19.75 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.017 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.81 153.81 6.4 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.591 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 44.4 mtp -100.72 -65.21 0.98 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.615 0.245 . . . . 0.0 110.778 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.409 ' HA3' ' HB ' ' A' ' 40' ' ' VAL . . . 73.96 65.28 2.23 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.125 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.504 HD21 ' HB1' ' A' ' 45' ' ' ALA . 3.9 mp -142.2 111.8 6.68 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.777 0.322 . . . . 0.0 110.815 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 m -80.21 112.97 18.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.699 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 pt -114.68 173.71 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.594 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' A' ' 35' ' ' TYR . 4.3 p -148.17 137.65 16.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.232 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.98 108.6 21.34 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.51 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.446 ' N ' HD11 ' A' ' 32' ' ' LEU . . . -153.07 176.42 11.92 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.331 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HG3' HD22 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -108.91 172.66 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.01 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.57 -143.31 3.63 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.33 157.74 16.94 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.79 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.45 25.1 40.64 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.79 104.84 8.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.92 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -86.55 10.46 15.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.466 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.464 ' HB2' HG12 ' A' ' 66' ' ' VAL . 5.2 mmmt -144.53 -162.65 1.53 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.02 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.493 HD13 ' N ' ' A' ' 33' ' ' GLY . 0.4 OUTLIER -103.3 134.55 46.5 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.672 0.272 . . . . 0.0 110.308 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.493 ' N ' HD13 ' A' ' 32' ' ' LEU . . . -117.61 152.23 17.75 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.663 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.8 mm -93.52 132.27 38.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 120.679 0.276 . . . . 0.0 110.498 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.506 ' HB2' HG13 ' A' ' 22' ' ' VAL . 69.5 m-85 -121.94 163.47 19.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.224 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.42 ' CG2' HD23 ' A' ' 57' ' ' LEU . 22.0 t -115.83 135.46 55.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.099 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.29 -33.78 5.52 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.581 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.5 165.5 35.47 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.746 0.307 . . . . 0.0 111.325 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.4 HG13 ' HG ' ' A' ' 19' ' ' LEU . 23.7 t -140.31 126.14 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.576 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.409 ' HB ' ' HA3' ' A' ' 18' ' ' GLY . 34.1 t -62.34 131.58 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.427 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -80.51 98.18 7.47 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.607 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.83 -39.37 0.64 Allowed Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.697 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -68.83 160.15 52.26 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.538 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.835 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . . . -51.15 -38.82 54.28 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.683 ' HA ' HD11 ' A' ' 11' ' ' LEU . . . -55.69 -43.39 76.38 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.708 0.289 . . . . 0.0 111.166 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -76.53 -35.65 58.16 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.111 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 43' ' ' GLY . 38.2 t -68.64 -42.57 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.057 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.13 -44.5 87.84 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.247 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.47 27.56 65.32 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.667 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -82.72 -33.84 27.44 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.744 0.272 . . . . 0.0 110.884 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.46 ' C ' HD12 ' A' ' 51' ' ' LEU . 4.1 pp -130.39 -178.98 5.0 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.78 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.91 -162.48 1.53 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.255 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.3 151.0 20.06 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.009 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.47 50.56 9.55 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.425 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -132.54 179.19 6.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.741 0.305 . . . . 0.0 111.105 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 7.2 tm0? -116.34 161.1 19.55 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.681 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.649 ' HB3' HG12 ' A' ' 88' ' ' VAL . 2.3 pp -164.93 155.61 14.26 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.927 0.394 . . . . 0.0 111.776 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -145.18 -54.76 0.31 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.513 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -76.4 132.91 39.98 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.843 0.354 . . . . 0.0 111.558 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.739 HG11 ' HG2' ' A' ' 77' ' ' MET . 24.2 t -145.34 117.17 2.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.515 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.57 ' HB2' HG13 ' A' ' 84' ' ' VAL . 5.0 t0 58.53 40.3 23.94 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.039 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.26 23.14 78.42 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.984 -0.626 . . . . 0.0 112.984 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.0 mtt-85 -128.68 128.14 43.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.711 0.256 . . . . 0.0 110.324 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m -83.98 116.8 23.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.3 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.7 mt -98.77 76.98 2.21 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.594 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.464 HG12 ' HB2' ' A' ' 31' ' ' LYS . 25.5 t -122.54 96.64 4.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.6 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.25 37.77 0.91 Allowed Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.532 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 mp -135.03 179.31 6.4 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.785 0.326 . . . . 0.0 110.928 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.4 m -107.81 176.74 5.04 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.95 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -58.21 -39.88 80.16 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.679 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -51.12 70.7 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.907 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 47.1 mmt-85 -59.2 -50.87 72.36 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.17 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.94 -52.6 64.71 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.329 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.11 -45.64 92.3 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.051 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.47 -36.28 77.91 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.901 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 80' ' ' THR . 14.4 mt -77.11 -39.45 49.42 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.728 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.739 ' HG2' HG11 ' A' ' 60' ' ' VAL . 2.2 mtt -65.78 -32.82 74.56 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.04 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.2 t -78.9 -32.43 45.75 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.559 0.219 . . . . 0.0 110.905 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 43.6 mtp85 -89.63 50.54 1.92 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.703 0.287 . . . . 0.0 111.563 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 76' ' ' LEU . 13.5 p -120.68 -179.86 4.12 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.936 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -89.0 -173.02 3.91 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.08 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.6 p -56.6 -49.77 73.93 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.505 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.89 133.32 36.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.737 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 61' ' ' ASP . 21.3 t -139.46 125.68 23.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.22 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.84 111.92 23.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.708 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 59' ' ' SER . 2.7 mp -109.98 123.01 48.88 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.985 0.422 . . . . 0.0 111.421 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 19.2 tt0 -91.42 98.45 11.69 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.16 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.649 HG12 ' HB3' ' A' ' 57' ' ' LEU . 21.4 m -102.26 171.49 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.928 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.635 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -125.67 131.55 52.59 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.586 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -66.28 91.56 0.17 Allowed 'General case' 0 C--O 1.234 0.256 0 O-C-N 123.345 0.403 . . . . 0.0 110.602 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -113.07 -165.87 1.03 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.138 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.97 137.51 2.21 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.485 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.585 -0.722 . . . . 0.0 111.9 -179.917 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mmt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -99.92 165.16 11.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.719 0.295 . . . . 0.0 111.252 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -128.8 148.04 67.02 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.977 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HG2' HD11 ' A' ' 6' ' ' ILE . 50.7 Cg_endo -69.63 165.45 30.76 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.813 2.342 . . . . 0.0 112.595 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -75.67 82.88 2.66 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.165 0.507 . . . . 0.0 110.959 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.471 HG22 ' HB2' ' A' ' 87' ' ' GLU . 26.2 mm -92.81 94.64 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.89 137.06 34.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.265 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.442 ' CG2' HG22 ' A' ' 85' ' ' THR . 6.9 m -89.01 130.68 35.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.002 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 9' ' ' VAL . 27.4 m -113.41 111.31 35.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.114 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.41 101.55 13.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.39 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.562 HD22 ' CG ' ' A' ' 48' ' ' ASP . 81.6 mt -122.5 161.98 22.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.939 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 150.95 24.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.774 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.25 114.42 26.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.007 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.95 -38.1 6.74 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.192 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -160.32 42.54 0.19 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.047 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.29 -170.71 30.28 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.3 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.2 mmm -107.09 -48.03 3.56 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.508 0.194 . . . . 0.0 111.131 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.13 78.49 0.18 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.734 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.693 HD13 HG23 ' A' ' 21' ' ' ILE . 0.8 OUTLIER -158.23 144.56 17.35 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.815 0.34 . . . . 0.0 111.179 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -94.41 90.87 6.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.628 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.693 HG23 HD13 ' A' ' 19' ' ' LEU . 1.8 pt -96.38 163.42 2.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.614 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.7 p -141.04 138.54 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.147 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.34 89.99 3.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.675 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.82 176.06 7.56 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.515 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -96.88 168.76 10.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.28 -143.14 3.59 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.06 153.92 22.42 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.023 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.29 18.84 30.26 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.243 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.58 108.42 4.71 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -95.22 37.26 1.18 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.568 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.646 ' HB2' HG22 ' A' ' 66' ' ' VAL . 38.7 mmtm -140.21 -148.5 0.25 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.648 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -132.77 103.19 5.98 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 110.517 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.9 145.94 21.89 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.888 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.6 mm -87.47 99.32 8.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.805 0.336 . . . . 0.0 110.701 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -90.59 147.53 23.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.531 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.53 120.83 51.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.845 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -96.27 -35.36 11.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.972 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 t -162.51 158.96 24.3 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.054 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.1 t -123.71 128.38 74.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.621 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.4 t -68.37 120.89 16.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.056 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -59.58 109.01 0.81 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.742 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.39 -21.27 5.16 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.626 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.557 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.52 158.17 51.37 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.147 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.66 -41.1 21.59 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.13 -52.9 52.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.367 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -39.29 85.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.5 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 43' ' ' GLY . 40.9 t -71.82 -40.86 69.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.537 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.562 ' CG ' HD22 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -63.82 -54.72 30.62 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.588 0.232 . . . . 0.0 111.304 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.18 79.43 1.39 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.764 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.481 ' HG3' HD21 ' A' ' 11' ' ' LEU . 9.0 mmt-85 -144.1 -51.39 0.31 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.719 0.295 . . . . 0.0 110.943 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 pp -113.39 167.79 10.28 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.912 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.08 -166.8 2.17 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.241 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.02 150.04 26.59 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.271 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.22 40.99 8.77 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.721 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -131.62 177.04 7.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.791 0.329 . . . . 0.0 111.246 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.682 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 46.8 tt0 -122.13 150.32 42.36 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.002 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.6 mt -128.44 123.9 34.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.476 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.18 -63.63 1.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.424 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.7 m -111.37 151.77 28.07 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.929 0.395 . . . . 0.0 111.703 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.813 HG11 ' HG2' ' A' ' 77' ' ' MET . 42.9 t -141.45 132.33 26.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.654 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 t70 56.9 27.72 13.49 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.451 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.32 -7.78 81.28 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.862 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.453 ' NH1' HD22 ' A' ' 76' ' ' LEU . 12.2 ptp180 -111.23 135.35 51.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 117.427 0.613 . . . . 0.0 110.926 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.5 m -71.63 130.44 41.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.327 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.531 HD12 ' CG2' ' A' ' 60' ' ' VAL . 55.7 mt -112.78 33.61 4.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.893 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 31' ' ' LYS . 7.7 p -109.56 90.26 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.236 0.541 . . . . 0.0 110.382 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 31' ' ' LYS . . . 151.14 -30.26 0.98 Allowed Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.425 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.455 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -83.04 -169.64 2.62 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.684 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -98.51 169.66 9.37 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.665 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -55.6 -31.41 62.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.864 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.89 -48.08 60.09 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.242 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.455 ' HG3' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -56.29 -38.69 71.58 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.533 0.206 . . . . 0.0 111.018 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.26 -53.37 12.69 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.176 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.76 -37.93 74.51 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.408 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.67 -33.59 64.52 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.599 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.453 HD22 ' NH1' ' A' ' 63' ' ' ARG . 35.0 mt -79.71 -39.11 31.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.475 0.178 . . . . 0.0 111.123 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.813 ' HG2' HG11 ' A' ' 60' ' ' VAL . 12.2 mtp -66.45 -34.43 77.92 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.051 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.6 t -71.67 -38.14 70.69 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.87 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -91.21 58.02 3.57 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.925 0.393 . . . . 0.0 110.75 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 p -109.85 160.84 16.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.006 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.7 m -75.25 -179.23 4.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.943 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.4 m -53.5 -38.83 64.06 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.304 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.7 t -106.1 136.22 41.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.728 0.299 . . . . 0.0 110.707 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.419 ' CG1' HD11 ' A' ' 86' ' ' LEU . 16.3 t -124.71 142.66 40.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.474 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.442 HG22 ' CG2' ' A' ' 8' ' ' THR . 0.2 OUTLIER -124.39 100.19 6.56 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.728 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.669 ' CD2' HG13 ' A' ' 60' ' ' VAL . 2.1 mp -115.26 139.24 50.13 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.073 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.471 ' HB2' HG22 ' A' ' 6' ' ' ILE . 7.2 pt-20 -107.3 101.23 10.62 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.035 0.445 . . . . 0.0 110.292 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.3 p -89.0 137.61 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.751 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.682 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -95.85 119.31 34.12 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.264 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -99.79 115.64 30.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.646 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -140.92 -169.13 2.75 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.681 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.08 -138.83 1.61 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.548 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.439 -0.791 . . . . 0.0 111.167 -179.947 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.2 mtt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.529 0.204 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? 59.01 39.15 23.82 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.894 0.378 . . . . 0.0 110.951 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.5 145.92 98.3 Favored Pre-proline 0 CA--C 1.529 0.171 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.039 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.22 175.28 10.16 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.749 2.299 . . . . 0.0 112.871 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 1.5 tt0 -102.81 92.54 4.64 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.057 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.687 HG22 ' HG2' ' A' ' 87' ' ' GLU . 16.6 mm -90.83 108.19 19.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.839 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -135.69 138.63 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.418 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.474 ' HB ' ' HG3' ' A' ' 87' ' ' GLU . 6.1 t -104.38 143.17 33.36 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.238 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.768 HG21 ' HG3' ' A' ' 50' ' ' ARG . 13.6 p -128.93 137.33 57.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.304 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.456 HG23 HG23 ' A' ' 85' ' ' THR . 0.2 OUTLIER -81.21 96.64 7.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.899 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.611 HD21 ' HB3' ' A' ' 44' ' ' ALA . 8.7 tp -85.48 132.45 34.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.21 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.666 ' HG2' HG22 ' A' ' 83' ' ' VAL . 1.5 mmtt -108.46 115.78 30.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.376 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -67.36 120.7 14.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.374 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.08 -41.79 7.0 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.711 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -164.91 38.57 0.07 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.877 0.37 . . . . 0.0 111.187 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.73 -168.64 23.5 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.567 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.5 mtp -129.6 -66.47 0.8 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.543 0.211 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.475 ' HA3' ' HB ' ' A' ' 40' ' ' VAL . . . 65.81 74.17 0.54 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.174 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.1 mt -142.2 108.32 5.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.744 0.306 . . . . 0.0 111.046 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.7 91.05 5.83 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.554 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.685 HD13 HG23 ' A' ' 34' ' ' ILE . 1.6 pp -97.12 177.59 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.608 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.2 p -156.67 135.91 3.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.262 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.7 87.48 3.16 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.541 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.75 176.79 6.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.619 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 176.26 5.59 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.117 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.82 -143.45 3.68 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.95 150.31 27.91 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.899 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.76 18.03 37.3 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.342 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.77 108.83 5.2 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.642 0.258 . . . . 0.0 111.008 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.97 25.56 3.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.802 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.487 ' CB ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -120.99 -154.38 0.58 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 32' ' ' LEU . 1.5 tp -136.49 106.73 6.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.614 0.245 . . . . 0.0 110.576 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.84 152.26 20.93 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.93 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.685 HG23 HD13 ' A' ' 21' ' ' ILE . 40.5 mm -91.25 96.84 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 120.874 0.368 . . . . 0.0 110.673 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.418 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 77.3 m-85 -89.04 150.83 22.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.612 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 21' ' ' ILE . 30.7 t -106.85 131.04 57.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.704 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 pttp -116.89 -30.18 5.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.901 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.69 155.13 42.79 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.956 0.408 . . . . 0.0 111.777 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.8 t -138.18 120.86 19.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.171 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.475 ' HB ' ' HA3' ' A' ' 18' ' ' GLY . 32.3 t -64.43 127.89 25.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.811 0.338 . . . . 0.0 111.477 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 103.7 1.64 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.337 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.5 -10.66 4.34 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.419 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.535 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -73.55 -158.14 4.95 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.413 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.611 ' HB3' HD21 ' A' ' 11' ' ' LEU . . . -91.17 -38.79 12.5 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.435 ' N ' HD11 ' A' ' 11' ' ' LEU . . . -71.62 -37.7 70.86 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -66.96 -35.31 79.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.482 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 43' ' ' GLY . 24.1 t -80.75 -42.21 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.607 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -53.79 54.29 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.63 0.252 . . . . 0.0 111.427 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.38 51.81 2.65 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.579 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.768 ' HG3' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -120.57 -51.03 2.18 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.621 0.248 . . . . 0.0 110.626 179.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 pp -109.13 139.03 44.57 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.536 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.0 177.35 5.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.26 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.53 150.8 46.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.796 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.53 40.62 18.2 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.102 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -126.16 177.71 6.23 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.739 0.304 . . . . 0.0 111.306 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.794 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 20.0 tm0? -124.47 149.02 47.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.439 HD22 HD12 ' A' ' 86' ' ' LEU . 29.3 mt -123.76 121.69 36.13 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.706 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.66 -53.21 3.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.785 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.87 157.17 40.04 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.171 0.51 . . . . 0.0 112.338 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.785 ' CG2' HD11 ' A' ' 65' ' ' LEU . 21.8 t -141.17 109.67 2.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.757 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.27 35.89 26.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.13 17.73 60.51 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.457 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.498 ' HD2' HD22 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -124.44 123.04 39.28 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.222 0.511 . . . . 0.0 110.408 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 m -82.63 135.4 35.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.205 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.785 HD11 ' CG2' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -110.31 -3.1 16.38 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.591 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 66' ' ' VAL . 7.7 p -67.58 87.07 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.418 0.627 . . . . 0.0 110.911 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.79 -18.61 2.77 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 113.008 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.496 ' N ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -91.65 -170.99 2.75 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.917 0.359 . . . . 0.0 111.105 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.18 176.99 4.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.368 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -59.38 -31.02 68.84 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.267 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -68.02 -38.77 82.97 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.515 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -67.06 -40.11 87.02 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.457 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.544 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -69.62 -52.93 21.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.518 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.12 -37.84 84.21 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.913 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.464 ' O ' HG22 ' A' ' 78' ' ' THR . 29.4 tp10 -71.24 -32.01 68.25 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.262 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.498 HD22 ' HD2' ' A' ' 63' ' ' ARG . 11.9 mt -78.01 -35.23 50.16 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.435 0.159 . . . . 0.0 111.358 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 12.4 mtt -70.67 -31.72 68.73 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.342 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 75' ' ' GLU . 13.1 t -74.43 -30.6 61.97 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.46 0.17 . . . . 0.0 111.46 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.417 ' HD2' HD23 ' A' ' 76' ' ' LEU . 4.7 ptp180 -89.17 49.18 1.73 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.745 0.307 . . . . 0.0 111.415 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.502 ' HB ' HG22 ' A' ' 84' ' ' VAL . 67.7 p -121.53 171.37 8.85 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.724 0.297 . . . . 0.0 111.351 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.4 p -90.01 -165.7 1.41 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.467 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 80.0 p -59.61 -34.37 72.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.156 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.666 HG22 ' HG2' ' A' ' 12' ' ' LYS . 32.2 t -111.9 139.34 36.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.741 0.305 . . . . 0.0 110.982 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.502 HG22 ' HB ' ' A' ' 80' ' ' THR . 15.5 t -142.73 130.38 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.286 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.456 HG23 HG23 ' A' ' 10' ' ' THR . 0.1 OUTLIER -92.21 116.3 28.83 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.691 HD13 HG22 ' A' ' 60' ' ' VAL . 4.0 mm? -111.37 114.03 26.9 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.113 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.687 ' HG2' HG22 ' A' ' 6' ' ' ILE . 2.1 tt0 -81.22 101.36 9.66 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.5 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.0 p -94.06 147.63 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.811 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.794 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -119.04 126.08 50.86 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.122 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -96.05 131.27 42.63 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.1 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -161.3 -169.9 2.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.976 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 170.42 136.85 2.16 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.519 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.414 -0.803 . . . . 0.0 111.137 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.685 0.279 . . . . 0.0 111.503 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.29 33.93 23.15 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.795 0.331 . . . . 0.0 111.034 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -128.28 152.46 78.0 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.945 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.43 173.45 6.43 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.985 2.457 . . . . 0.0 112.866 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -89.41 89.59 7.94 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.223 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 23.8 mm -85.23 111.03 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.839 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.52 141.56 46.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.14 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 8.0 t -106.63 141.6 37.64 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.834 0.349 . . . . 0.0 111.299 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.9 p -119.5 128.45 75.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.349 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.0 m -82.95 94.5 7.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 mt -93.44 155.39 17.38 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.135 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HD2' HG22 ' A' ' 83' ' ' VAL . 1.0 OUTLIER -117.1 110.51 18.29 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.075 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -57.08 116.78 3.44 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.266 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -86.34 -47.73 9.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.556 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -166.21 42.54 0.06 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.46 -167.69 19.75 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.527 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.1 mmm -133.52 100.83 4.92 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.643 0.258 . . . . 0.0 110.791 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.22 79.98 0.6 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.547 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 mp -145.96 127.25 14.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.62 0.248 . . . . 0.0 110.749 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.32 99.27 11.04 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.882 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pt -96.61 175.4 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.472 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.647 HG13 ' HB2' ' A' ' 35' ' ' TYR . 3.4 p -159.81 148.3 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.598 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.78 124.76 46.88 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.464 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.36 -179.14 7.45 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -114.79 164.82 13.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.792 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.33 -144.17 3.85 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.59 164.03 13.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.811 0.339 . . . . 0.0 111.148 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.44 19.98 49.51 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.455 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.415 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -122.65 -165.8 1.34 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.137 0.494 . . . . 0.0 110.187 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.45 ' C ' ' HG2' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -169.84 20.39 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.36 178.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.767 ' HB2' HG22 ' A' ' 66' ' ' VAL . 6.0 mmmt -156.08 -164.17 1.64 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 32' ' ' LEU . 0.9 OUTLIER -114.01 106.32 14.27 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.838 0.352 . . . . 0.0 110.523 179.175 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.79 -173.05 27.94 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.212 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.635 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 9.2 mm -99.33 152.91 4.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.603 0.239 . . . . 0.0 110.725 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.647 ' HB2' HG13 ' A' ' 22' ' ' VAL . 18.9 m-85 -135.37 164.22 28.24 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.351 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.62 115.78 44.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -101.58 -33.11 10.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.946 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.2 161.13 21.96 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.926 0.393 . . . . 0.0 111.386 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.4 t -135.7 115.72 17.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.683 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.46 136.48 26.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.416 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 145.09 53.39 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.022 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.08 -22.67 39.45 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.959 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.592 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.04 174.62 36.71 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.775 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.94 -37.57 75.91 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.701 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -72.6 -37.76 68.02 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -67.75 -49.05 64.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.502 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 43' ' ' GLY . 46.9 t -63.86 -31.15 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.632 0.253 . . . . 0.0 111.314 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.78 -55.97 16.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.404 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.2 31.69 16.25 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.889 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -111.27 27.38 9.73 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.753 0.311 . . . . 0.0 110.933 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.701 HD21 ' HB1' ' A' ' 45' ' ' ALA . 3.4 pp -172.82 171.91 4.23 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.966 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.64 171.52 16.77 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.468 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.32 136.85 57.54 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.024 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.06 49.27 3.13 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.091 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -130.83 179.18 6.12 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.744 0.307 . . . . 0.0 111.243 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.87 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -118.45 173.14 7.0 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.918 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 86' ' ' LEU . 6.0 mt -151.67 119.23 6.06 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.668 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.35 -64.02 1.19 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.196 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.8 m -126.08 151.5 47.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.569 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.777 HG13 ' HG ' ' A' ' 86' ' ' LEU . 52.6 t -135.78 118.16 21.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.773 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.517 ' HB2' HG13 ' A' ' 84' ' ' VAL . 3.2 t0 58.33 40.31 24.59 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.965 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.24 29.13 68.9 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.834 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.447 ' HD3' HD22 ' A' ' 76' ' ' LEU . 32.9 mtt-85 -123.84 144.25 49.85 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 m -91.16 120.78 32.38 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.788 0.328 . . . . 0.0 111.39 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.669 ' HA ' HD21 ' A' ' 68' ' ' LEU . 4.2 mp -111.54 -5.74 14.5 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.821 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.767 HG22 ' HB2' ' A' ' 31' ' ' LYS . 12.0 p -81.99 71.38 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.857 0.837 . . . . 0.0 110.181 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 155.07 40.23 0.02 OUTLIER Glycine 0 CA--C 1.523 0.571 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.275 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.669 HD21 ' HA ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -158.54 177.79 10.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.741 0.305 . . . . 0.0 111.048 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.55 179.29 5.19 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.268 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -61.6 -35.54 78.15 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.322 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -54.6 -52.5 61.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.72 0.295 . . . . 0.0 110.798 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -62.65 -41.78 99.24 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.812 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.635 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -56.25 -56.21 23.79 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.499 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.38 93.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.022 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.5 ' HA ' HG22 ' A' ' 78' ' ' THR . 7.6 tt0 -66.68 -28.4 68.42 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.24 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.447 HD22 ' HD3' ' A' ' 63' ' ' ARG . 25.3 mt -75.49 -34.39 60.86 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.676 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 mtt -77.99 -39.2 43.12 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.321 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 75' ' ' GLU . 12.7 t -63.34 -32.8 74.31 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.778 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -90.9 57.65 3.58 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.192 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.413 ' HB ' HG22 ' A' ' 84' ' ' VAL . 51.7 p -122.79 178.47 5.02 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.096 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 m -108.43 -167.2 1.2 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.783 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.7 p -57.26 -30.32 64.55 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.478 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.501 HG22 ' HD2' ' A' ' 12' ' ' LYS . 21.9 t -117.44 137.7 50.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 120.652 0.263 . . . . 0.0 111.209 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.517 HG13 ' HB2' ' A' ' 61' ' ' ASP . 19.0 t -143.79 134.65 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.414 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.46 120.37 42.21 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.692 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.777 ' HG ' HG13 ' A' ' 60' ' ' VAL . 3.4 mp -114.67 117.13 29.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.283 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 1.6 mt-10 -81.28 93.04 6.45 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.646 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.572 HG13 ' HE3' ' A' ' 90' ' ' LYS . 10.9 p -87.61 141.22 14.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.541 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.87 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -106.94 139.74 40.85 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.146 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.572 ' HE3' HG13 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -102.81 109.26 20.78 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.731 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -146.61 -173.89 4.33 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.894 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 157.92 139.26 2.67 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.488 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.156 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.368 0.128 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.75 111.28 19.46 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.699 0.285 . . . . 0.0 110.966 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -114.05 94.37 34.07 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.948 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.62 162.44 10.49 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.023 2.482 . . . . 0.0 112.982 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -99.51 93.88 6.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.92 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 88' ' ' VAL . 4.0 mt -90.21 127.31 42.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.052 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.488 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.8 pt -141.67 146.79 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.264 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.496 ' HB ' ' HG2' ' A' ' 87' ' ' GLU . 2.7 t -101.49 147.16 26.7 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.156 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.604 HG11 ' HB3' ' A' ' 50' ' ' ARG . 26.9 m -124.99 128.86 73.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.462 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.547 HG23 ' CG1' ' A' ' 83' ' ' VAL . 88.0 m -87.78 102.5 14.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.487 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.412 HD21 ' HA ' ' A' ' 45' ' ' ALA . 3.4 mp -125.04 167.38 14.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.366 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -126.0 170.82 11.34 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.044 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -69.09 94.01 0.63 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.888 0.375 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.402 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -101.98 81.95 2.18 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.512 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 57.54 36.18 26.6 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.088 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.08 173.4 30.19 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.629 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.6 mmt -87.27 -73.02 0.49 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.559 0.219 . . . . 0.0 110.749 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.83 66.74 1.82 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.651 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.43 ' CD2' HD11 ' A' ' 51' ' ' LEU . 4.9 mp -145.74 117.89 8.35 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.646 0.26 . . . . 0.0 110.658 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.5 m -80.62 96.33 6.82 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.741 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.547 HG22 HG22 ' A' ' 36' ' ' VAL . 2.1 pt -105.11 175.99 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.59 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -156.32 141.24 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.241 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.28 92.82 6.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.639 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.508 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . . . -124.44 178.39 5.42 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.281 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HG3' HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -112.79 179.97 3.82 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.288 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.81 -143.7 3.74 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.676 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.49 161.82 18.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.702 0.286 . . . . 0.0 111.075 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.81 19.92 45.62 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.853 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.68 -163.01 0.9 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.231 0.539 . . . . 0.0 110.173 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -170.29 20.64 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.227 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.888 ' HB2' HG12 ' A' ' 66' ' ' VAL . 5.1 mttp -159.92 -168.81 2.33 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.48 0.312 . . . . 0.0 110.268 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.447 HD12 ' HG3' ' A' ' 25' ' ' LYS . 1.5 tp -105.44 127.44 53.0 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.798 0.332 . . . . 0.0 110.994 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.88 147.55 16.27 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.518 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.505 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.6 mp -81.41 97.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.976 0.417 . . . . 0.0 109.981 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.508 ' CD2' ' HB3' ' A' ' 24' ' ' ALA . 22.7 m-85 -87.86 143.96 26.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.28 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 21' ' ' ILE . 38.9 t -103.52 122.8 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.847 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -92.09 -40.61 10.96 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.885 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 m -165.02 175.82 9.13 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.727 0.298 . . . . 0.0 111.168 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.412 HG13 ' HG ' ' A' ' 19' ' ' LEU . 21.3 t -126.39 145.37 34.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.154 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.9 t -84.49 146.55 6.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.529 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.39 140.97 52.21 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.062 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.19 18.12 80.12 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.506 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -96.38 176.22 32.53 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.234 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 14' ' ' GLN . . . -60.42 -62.18 2.06 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.412 ' HA ' HD21 ' A' ' 11' ' ' LEU . . . -57.64 -33.24 68.08 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.694 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -67.89 -56.81 7.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.109 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 43' ' ' GLY . 44.6 t -66.07 -35.25 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.75 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.13 -48.84 49.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.616 0.246 . . . . 0.0 110.896 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.46 87.59 0.72 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.627 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.604 ' HB3' HG11 ' A' ' 9' ' ' VAL . 8.3 mmt180 -146.27 -67.13 0.28 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.59 0.233 . . . . 0.0 110.857 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.43 HD11 ' CD2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -103.37 152.2 21.86 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.067 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.81 -162.2 1.18 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.181 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.36 144.08 53.54 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.516 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.71 50.58 6.42 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.248 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -130.62 131.95 45.21 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.449 0.166 . . . . 0.0 110.966 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.717 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 53.5 tt0 -92.73 145.85 24.1 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.745 0.307 . . . . 0.0 111.182 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -116.78 121.8 42.61 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.723 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -96.9 -47.16 5.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.209 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.5 m -138.94 152.83 48.04 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.099 0.476 . . . . 0.0 111.542 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.66 HG13 ' HG ' ' A' ' 86' ' ' LEU . 44.0 t -136.03 114.23 15.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.157 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.602 ' HB2' HG13 ' A' ' 84' ' ' VAL . 2.3 t70 62.07 35.93 15.62 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.443 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.38 -18.72 35.75 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.583 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.534 ' HD3' HD22 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -75.72 147.77 39.1 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 117.436 0.618 . . . . 0.0 111.038 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 p -95.83 116.26 28.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.818 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.595 ' HA ' HD21 ' A' ' 68' ' ' LEU . 5.1 mp -101.47 37.59 1.77 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.964 0.412 . . . . 0.0 110.7 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.888 HG12 ' HB2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -110.46 100.72 11.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.16 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.16 4.48 18.33 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.18 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.595 HD21 ' HA ' ' A' ' 65' ' ' LEU . 1.2 pp -113.29 163.32 14.97 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 117.184 0.492 . . . . 0.0 110.867 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 p -85.04 168.5 14.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.871 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -57.08 -28.43 62.6 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.494 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.59 -49.58 76.95 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.75 0.31 . . . . 0.0 110.269 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.401 ' HB3' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -68.47 -38.75 81.34 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.042 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.38 -55.77 27.78 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.434 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.15 94.43 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.136 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -62.75 -37.08 85.19 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.534 HD22 ' HD3' ' A' ' 63' ' ' ARG . 16.2 mt -70.83 -35.0 72.26 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.013 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.46 ' HG2' HG11 ' A' ' 60' ' ' VAL . 4.8 mtt -68.91 -40.99 78.79 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.096 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.5 t -67.53 -36.69 81.49 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.596 0.236 . . . . 0.0 110.614 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -88.59 56.24 3.7 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.888 0.375 . . . . 0.0 111.115 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.435 ' HB ' HG22 ' A' ' 84' ' ' VAL . 31.5 p -112.52 -175.14 2.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.635 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.9 m -102.0 -169.76 1.72 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -34.0 67.08 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.594 0.235 . . . . 0.0 110.968 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.547 ' CG1' HG23 ' A' ' 10' ' ' THR . 23.2 t -119.56 143.94 29.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.0 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.602 HG13 ' HB2' ' A' ' 61' ' ' ASP . 14.3 t -142.76 137.75 27.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.448 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.22 102.5 11.17 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.011 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.686 ' HB3' HD21 ' A' ' 57' ' ' LEU . 7.0 mp -94.56 117.22 29.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.074 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.496 ' HG2' ' HB ' ' A' ' 8' ' ' THR . 3.8 mm-40 -80.42 95.98 6.58 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.632 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 7' ' ' ILE . 35.8 m -86.98 170.39 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.35 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.717 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -138.38 125.95 22.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.094 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -85.18 116.26 23.43 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.674 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -152.58 -167.93 2.9 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.077 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.13 137.03 2.15 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.507 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.953 179.914 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mtm . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -127.06 33.45 4.91 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.653 0.263 . . . . 0.0 110.864 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -115.77 97.24 48.59 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.777 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.0 170.61 2.04 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.172 2.581 . . . . 0.0 113.305 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 89' ' ' ALA . 28.0 tt0 -103.52 96.99 7.1 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.104 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.739 HD13 ' HB2' ' A' ' 89' ' ' ALA . 22.2 mm -79.33 121.87 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.339 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 pt -145.35 146.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.373 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.1 t -121.18 124.77 45.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 110.961 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.6 t -120.89 145.94 26.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.197 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.587 HG22 ' CG2' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -90.91 112.24 24.01 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.677 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.1 152.69 29.27 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.254 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -110.1 158.81 17.91 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.496 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -99.97 133.7 43.96 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.206 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.2 -42.3 3.06 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.135 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -154.13 42.66 0.53 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.838 0.351 . . . . 0.0 110.983 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.44 -156.36 15.8 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.453 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.96 -58.66 2.04 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.492 0.187 . . . . 0.0 110.91 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.78 53.16 39.82 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.746 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.5 mt -142.88 116.71 9.31 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.66 0.266 . . . . 0.0 111.218 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.04 126.58 40.48 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.646 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.848 HG21 ' HE2' ' A' ' 77' ' ' MET . 1.5 pt -115.54 176.01 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.624 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.749 HG13 ' HB2' ' A' ' 35' ' ' TYR . 2.4 p -153.28 137.24 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.451 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.08 101.29 12.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.483 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -134.1 -179.66 5.69 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.411 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -114.04 169.11 9.25 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.19 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -161.06 -143.35 3.65 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.23 157.42 16.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.85 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.72 23.91 46.21 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.52 104.42 7.88 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.108 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.67 11.16 13.58 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.583 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.472 ' HB2' HG12 ' A' ' 66' ' ' VAL . 8.3 mmmm -146.06 -167.3 2.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.835 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.446 ' HA ' HD12 ' A' ' 32' ' ' LEU . 6.1 tp -103.39 119.2 38.43 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.686 0.279 . . . . 0.0 110.593 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.63 177.73 25.87 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.739 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.541 HG21 ' HE1' ' A' ' 77' ' ' MET . 36.6 mm -103.77 150.93 6.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 120.733 0.302 . . . . 0.0 110.825 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.749 ' HB2' HG13 ' A' ' 22' ' ' VAL . 92.7 m-85 -137.92 150.26 46.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.03 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.7 t -80.72 95.39 2.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.628 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -42.19 98.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.965 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.1 t -175.33 166.52 3.36 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.417 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 46' ' ' ASP . 11.2 t -126.77 137.9 56.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.837 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -82.48 119.92 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.374 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -63.56 110.04 1.86 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.838 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.1 -3.2 14.31 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.518 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -79.12 -139.2 1.69 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.433 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.08 -62.2 1.27 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.487 0.184 . . . . 0.0 111.436 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . -63.0 -33.79 76.17 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.411 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.462 ' HB2' HG12 ' A' ' 39' ' ' VAL . 11.1 t70 -60.67 -39.91 90.16 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.223 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 43' ' ' GLY . 42.3 t -67.25 -39.98 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.636 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -59.32 -55.33 36.14 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.6 0.238 . . . . 0.0 111.29 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.62 19.53 37.46 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.312 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -33.65 26.37 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.147 0.474 . . . . 0.0 110.862 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.593 HD22 HG21 ' A' ' 88' ' ' VAL . 2.1 pp -123.99 163.68 20.88 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.17 175.64 9.92 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.276 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.23 145.13 56.63 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.196 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.68 47.04 8.17 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.97 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.26 -176.99 3.41 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.612 0.244 . . . . 0.0 110.844 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.806 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 10.5 tm0? -118.83 153.77 33.97 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.151 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.006 HD11 HD12 ' A' ' 86' ' ' LEU . 8.1 tt -137.77 135.75 36.63 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.809 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.07 -59.03 2.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.793 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.2 p -116.65 158.02 24.45 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.137 0.494 . . . . 0.0 112.097 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.737 HG11 ' HG3' ' A' ' 77' ' ' MET . 23.5 t -140.11 119.36 12.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.53 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t0 60.31 35.13 20.76 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.023 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.43 -5.91 71.09 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.581 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.3 mtt-85 -91.95 148.83 21.91 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 117.484 0.642 . . . . 0.0 111.187 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.5 m -89.12 139.81 30.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.237 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.597 HD13 HG23 ' A' ' 60' ' ' VAL . 5.0 mp -136.39 79.4 1.76 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.962 0.41 . . . . 0.0 111.377 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' A' ' 31' ' ' LYS . 16.6 t -130.45 95.37 2.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.363 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.97 -26.48 4.23 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.891 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 mt -73.13 176.11 6.14 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.836 0.351 . . . . 0.0 111.449 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 m -109.45 -178.25 3.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.039 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -59.04 -35.09 72.71 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.347 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -58.2 -59.04 5.92 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.624 0.249 . . . . 0.0 110.966 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.6 mmt-85 -61.88 -44.72 96.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.93 -54.92 41.63 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.104 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 78' ' ' THR . . . -59.48 -48.31 82.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.092 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -58.76 -38.64 78.89 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.982 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 80' ' ' THR . 7.6 mt -76.07 -35.88 59.23 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.097 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.848 ' HE2' HG21 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -76.43 -35.19 58.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.532 HG23 ' HG3' ' A' ' 79' ' ' ARG . 13.3 t -71.13 -39.06 72.22 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.538 0.208 . . . . 0.0 110.956 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.532 ' HG3' HG23 ' A' ' 78' ' ' THR . 46.4 mtp180 -93.77 59.96 2.89 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.882 0.373 . . . . 0.0 111.016 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 76' ' ' LEU . 31.7 p -117.06 169.41 9.44 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.995 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.99 -169.17 0.45 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.754 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.3 p -79.83 -52.49 7.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.808 0.337 . . . . 0.0 110.377 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.587 ' CG2' HG22 ' A' ' 10' ' ' THR . 7.6 p -89.34 74.49 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.581 0.705 . . . . 0.0 110.795 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.1 t -89.18 148.4 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.972 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.531 HG23 HG23 ' A' ' 10' ' ' THR . 3.1 p -110.61 117.04 32.42 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.661 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.006 HD12 HD11 ' A' ' 57' ' ' LEU . 4.2 mm? -111.73 122.22 47.22 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.296 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -87.65 83.17 7.23 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.035 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.593 HG21 HD22 ' A' ' 51' ' ' LEU . 22.0 t -89.3 145.9 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.536 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.806 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -110.2 117.12 32.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.166 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -83.7 122.65 28.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.54 -159.41 0.92 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.73 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.83 -137.44 1.05 Allowed Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.119 -0.563 . . . . 0.0 112.491 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.119 179.915 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmm . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.644 0.259 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.18 167.1 16.91 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.972 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -99.9 139.85 21.1 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.346 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -76.77 172.64 15.83 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.847 2.364 . . . . 0.0 112.804 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 57.7 tt0 -111.66 96.54 6.15 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.54 HD13 ' HB2' ' A' ' 89' ' ' ALA . 23.2 mm -82.04 126.41 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.196 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 pt -148.49 149.57 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.363 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 14.5 m -113.61 123.95 51.17 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.629 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.555 HG11 ' CG ' ' A' ' 50' ' ' ARG . 20.7 t -122.13 138.28 52.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.375 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.6 HG23 HG23 ' A' ' 85' ' ' THR . 0.2 OUTLIER -110.69 135.5 51.21 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.657 179.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -147.97 176.03 10.5 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.031 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -119.61 144.57 47.05 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.147 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -79.74 146.47 32.35 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.354 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -50.32 4.26 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.365 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -161.39 43.19 0.16 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.999 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.79 -160.54 19.41 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.53 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 90.4 mtp -142.61 101.75 3.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.789 0.328 . . . . 0.0 111.191 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.92 80.63 0.63 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.369 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.539 HD21 ' CB ' ' A' ' 45' ' ' ALA . 1.2 mp -147.17 117.16 7.23 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.647 0.261 . . . . 0.0 110.494 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 p -82.0 131.55 35.25 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.949 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.649 HD13 HG23 ' A' ' 34' ' ' ILE . 1.5 pp -124.37 174.12 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.089 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.49 HG13 ' HB2' ' A' ' 35' ' ' TYR . 7.6 p -157.67 140.84 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.138 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.27 104.01 16.0 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.996 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.573 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -137.28 176.4 8.75 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.819 0.342 . . . . 0.0 111.691 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -101.93 175.1 5.66 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.311 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.33 -142.66 3.47 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.56 151.17 27.14 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.034 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.85 19.35 36.28 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.401 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.83 108.85 5.72 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.769 0.318 . . . . 0.0 111.185 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -95.15 30.8 2.06 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.322 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.447 ' CB ' HG12 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -130.96 -148.2 0.35 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tp -143.14 113.79 7.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.73 0.3 . . . . 0.0 110.753 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.75 152.97 19.16 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.564 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.649 HG23 HD13 ' A' ' 21' ' ' ILE . 31.4 mm -80.63 100.19 4.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.854 0.359 . . . . 0.0 110.444 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.573 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 17.5 m-85 -84.53 156.38 21.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.039 0.447 . . . . 0.0 111.258 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -105.68 112.94 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.763 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.36 -36.78 22.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.129 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -164.85 165.39 20.53 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.831 0.348 . . . . 0.0 111.224 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.9 t -130.39 112.78 23.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.859 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.7 t -60.95 130.49 25.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.092 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.7 149.52 46.48 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.07 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.24 -31.09 8.89 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.545 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -64.31 142.87 46.49 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.521 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.3 -38.57 53.6 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 1.04 ' HB1' HD12 ' A' ' 51' ' ' LEU . . . -52.82 -53.72 44.46 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.683 0.277 . . . . 0.0 111.4 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.84 -44.59 85.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.048 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 43' ' ' GLY . 33.5 t -61.82 -37.3 77.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.469 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.14 -53.32 59.09 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.083 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.88 44.49 1.51 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.159 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.555 ' CG ' HG11 ' A' ' 9' ' ' VAL . 4.5 mmp_? -142.79 31.89 1.43 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.736 0.268 . . . . 0.0 110.983 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.04 HD12 ' HB1' ' A' ' 45' ' ' ALA . 6.5 mt -149.87 168.62 23.23 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.447 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -171.12 151.97 3.34 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.125 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.23 152.18 45.41 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.886 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.11 52.68 26.38 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.782 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.11 171.36 11.97 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.72 0.295 . . . . 0.0 111.187 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.825 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 1.9 tm0? -110.18 154.54 23.21 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.825 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.735 HD21 HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -137.57 119.8 15.68 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.573 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.6 tt -107.79 -55.99 2.29 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.024 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.8 t -103.42 145.69 29.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.05 0.452 . . . . 0.0 112.176 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.739 ' CG2' HD21 ' A' ' 65' ' ' LEU . 21.3 t -140.97 119.81 10.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.763 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' HG12 ' A' ' 60' ' ' VAL . 7.2 m-20 56.65 44.41 23.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.133 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.82 27.39 73.31 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.083 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -130.74 138.07 49.8 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.677 0.275 . . . . 0.0 110.33 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.7 m -92.85 124.61 36.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.991 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.789 ' HB2' HD12 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -130.53 83.18 2.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.266 0.555 . . . . 0.0 111.084 179.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' A' ' 31' ' ' LYS . 15.2 t -110.12 94.94 3.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.803 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.78 36.85 1.02 Allowed Glycine 0 CA--C 1.518 0.223 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.488 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.789 HD12 ' HB2' ' A' ' 65' ' ' LEU . 32.6 mt -116.05 157.55 24.51 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.727 0.299 . . . . 0.0 110.792 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -77.11 160.58 28.92 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.524 ' HG3' HD12 ' A' ' 21' ' ' ILE . 58.4 tt0 -54.36 -35.24 62.56 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.954 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.37 -43.44 81.39 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.459 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -61.12 -53.34 58.23 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.492 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.45 98.79 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.316 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.75 80.77 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.603 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.523 ' O ' HG22 ' A' ' 78' ' ' THR . 1.6 tp10 -65.6 -35.7 81.59 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.248 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.424 HD23 ' HD2' ' A' ' 79' ' ' ARG . 16.2 mt -74.84 -35.87 62.38 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.095 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.9 mtt -69.15 -29.1 67.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.365 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 75' ' ' GLU . 14.7 t -79.7 -30.62 41.07 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 121.297 -0.161 . . . . 0.0 111.24 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.424 ' HD2' HD23 ' A' ' 76' ' ' LEU . 15.5 ptp180 -93.44 40.33 1.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.714 0.292 . . . . 0.0 111.216 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.8 p -93.11 170.08 9.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 111.515 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.6 m -103.57 -165.02 1.12 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.46 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.78 -35.89 71.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.135 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.6 t -93.17 149.66 4.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.799 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 t -134.43 91.69 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.109 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.6 HG23 HG23 ' A' ' 10' ' ' THR . 4.8 m -89.25 88.68 7.61 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.767 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.701 HD22 HD11 ' A' ' 57' ' ' LEU . 9.0 mt -106.36 139.89 40.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.511 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 12.1 tt0 -113.97 105.74 13.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.087 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.676 HG12 HD12 ' A' ' 57' ' ' LEU . 23.8 m -102.53 172.61 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.045 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.825 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -136.17 131.56 34.8 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.526 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 48.8 mmtt -76.3 118.87 19.45 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.802 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -148.01 -159.28 1.01 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.77 -135.66 0.53 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.408 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.364 -0.827 . . . . 0.0 111.203 179.951 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptt? . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.677 0.275 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -115.26 165.69 12.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.757 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 67.29 114.19 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.052 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.422 ' O ' HD12 ' A' ' 6' ' ' ILE . 53.2 Cg_exo -55.7 176.35 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.882 2.388 . . . . 0.0 112.84 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -90.54 86.09 6.31 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.068 0.461 . . . . 0.0 111.242 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 4' ' ' PRO . 3.4 mp -99.66 121.87 50.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.759 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 pp -141.97 137.06 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.315 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.613 ' OG1' HG22 ' A' ' 85' ' ' THR . 3.7 t -99.04 138.89 35.49 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.069 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.55 136.06 46.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.421 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.626 HG23 HG23 ' A' ' 85' ' ' THR . 0.7 OUTLIER -80.15 95.9 6.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.869 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.97 134.31 34.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -90.98 176.7 6.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.059 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.28 130.75 54.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.148 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.02 -45.26 4.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.587 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -161.73 43.21 0.15 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.26 -164.25 14.52 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.794 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 16.3 mtp -119.05 99.99 7.07 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.731 0.301 . . . . 0.0 110.464 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.614 ' HA3' ' CG2' ' A' ' 40' ' ' VAL . . . -90.65 75.72 1.63 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.093 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.463 HD21 HD11 ' A' ' 51' ' ' LEU . 5.0 mp -147.93 108.41 4.13 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.571 0.224 . . . . 0.0 110.871 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -85.62 82.41 8.25 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.055 0.455 . . . . 0.0 110.27 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.849 HD13 HG23 ' A' ' 34' ' ' ILE . 1.2 pp -82.86 175.88 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.049 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' ' 35' ' ' TYR . 7.7 p -153.16 145.75 14.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.415 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -98.55 100.04 11.25 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.83 176.09 9.01 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.805 0.336 . . . . 0.0 111.566 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 178.47 4.55 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.19 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.81 -142.3 3.45 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.0 147.5 32.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.967 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.47 16.91 30.74 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.377 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.55 108.54 5.44 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.733 -0.234 . . . . 0.0 110.852 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -93.34 23.58 4.4 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.862 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.06 -158.51 0.72 Allowed 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 32' ' ' LEU . 0.9 OUTLIER -132.9 106.81 7.92 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.737 0.303 . . . . 0.0 110.943 179.767 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.22 153.38 24.37 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.699 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.849 HG23 HD13 ' A' ' 21' ' ' ILE . 33.5 mm -80.97 90.7 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-O 120.817 0.341 . . . . 0.0 110.523 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.402 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 20.2 m-85 -81.25 161.43 23.94 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.525 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 21' ' ' ILE . 47.6 t -122.93 126.01 73.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.639 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.21 -29.68 6.19 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.1 t -136.65 156.57 48.36 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.032 0.444 . . . . 0.0 111.852 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.02 133.48 26.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.481 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.614 ' CG2' ' HA3' ' A' ' 18' ' ' GLY . 30.0 m -61.07 134.02 26.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.885 0.374 . . . . 0.0 111.366 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.63 93.44 6.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.429 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.26 30.04 4.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.297 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.65 -139.39 10.26 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.688 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.86 -33.56 10.49 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.812 0.306 . . . . 0.0 111.76 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.22 -47.25 11.01 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.374 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -58.58 -38.82 78.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.345 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 t -76.63 -33.73 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.089 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -46.34 90.08 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.978 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.27 29.53 24.82 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.623 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -100.68 -41.63 6.84 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.703 0.287 . . . . 0.0 110.867 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.463 HD11 HD21 ' A' ' 19' ' ' LEU . 4.4 pp -129.44 162.11 28.84 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.781 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.91 -175.14 5.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.25 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.61 135.38 52.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.258 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.0 46.28 3.39 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.347 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -133.36 173.02 11.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.711 0.291 . . . . 0.0 111.296 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 49.1 tt0 -131.11 143.87 50.98 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.883 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.706 ' CD2' HD22 ' A' ' 86' ' ' LEU . 1.9 mp -112.97 122.26 47.09 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.252 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tt -94.34 -58.41 2.22 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.743 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 m -138.99 156.25 47.37 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.955 0.407 . . . . 0.0 111.524 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.704 HG13 ' CD2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -102.9 -167.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.141 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.524 ' H ' HG12 ' A' ' 60' ' ' VAL . 5.1 p-10 -67.22 68.81 0.08 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.09 0.471 . . . . 0.0 110.83 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 60' ' ' VAL . . . 98.99 25.37 9.67 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.559 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.504 ' HD3' HD22 ' A' ' 76' ' ' LEU . 5.0 mtm180 -135.61 147.67 48.73 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.653 0.227 . . . . 0.0 110.633 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.4 m -113.43 110.9 21.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.924 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.668 HD11 HG22 ' A' ' 60' ' ' VAL . 7.1 mt -102.02 68.6 1.13 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.672 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.18 97.55 3.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.34 -32.11 5.0 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.589 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.518 HD21 ' HA ' ' A' ' 65' ' ' LEU . 4.3 pp -68.29 168.72 11.85 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.004 0.431 . . . . 0.0 111.477 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.5 p -91.23 167.15 12.53 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.073 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.437 ' HG3' HD12 ' A' ' 21' ' ' ILE . 30.2 tt0 -55.42 -26.06 39.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.562 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.52 -46.92 71.42 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.804 0.335 . . . . 0.0 110.609 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -49.04 79.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.252 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.49 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -58.38 -51.7 68.7 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.111 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.98 -43.8 82.05 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -34.7 78.94 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.204 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.504 HD22 ' HD3' ' A' ' 63' ' ' ARG . 9.0 mt -74.82 -35.61 62.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.642 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.496 ' CE ' HG21 ' A' ' 34' ' ' ILE . 9.3 mtt -72.67 -38.31 67.66 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.063 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.0 t -68.06 -31.15 70.59 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 121.233 -0.187 . . . . 0.0 111.002 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -89.32 53.18 2.56 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.761 0.315 . . . . 0.0 111.423 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.506 ' HB ' HG22 ' A' ' 84' ' ' VAL . 52.7 p -127.06 166.77 16.97 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.228 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.31 -170.23 3.03 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.381 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 m -54.11 -43.9 70.82 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.253 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.5 t -103.2 135.73 39.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.938 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.506 HG22 ' HB ' ' A' ' 80' ' ' THR . 18.5 t -139.92 121.99 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.537 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.626 HG23 HG23 ' A' ' 10' ' ' THR . 0.2 OUTLIER -92.02 123.89 35.72 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.588 179.391 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.706 HD22 ' CD2' ' A' ' 57' ' ' LEU . 6.3 mt -131.47 134.08 45.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.707 0.289 . . . . 0.0 111.148 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 1.5 mt-10 -81.43 112.11 18.39 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.883 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.0 t -99.72 132.41 45.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.557 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -109.23 142.17 40.45 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.934 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -102.44 122.31 44.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -159.93 -171.38 3.22 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.088 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.78 138.0 2.32 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.462 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.416 -0.802 . . . . 0.0 111.048 179.902 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.469 0.176 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -98.65 172.45 7.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.776 0.322 . . . . 0.0 110.941 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -127.67 116.27 20.99 Favored Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.095 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.61 144.12 53.78 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.624 2.216 . . . . 0.0 112.622 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -116.52 99.35 7.1 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.856 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.485 ' H ' HD12 ' A' ' 6' ' ' ILE . 3.8 mp -80.1 98.05 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.961 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 pt -106.26 157.78 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.324 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.1 m -124.46 128.79 49.53 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.871 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.458 HG11 ' HG3' ' A' ' 50' ' ' ARG . 20.3 t -137.4 151.73 26.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.406 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.93 106.31 18.33 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.717 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.07 154.9 17.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -117.84 137.82 52.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.057 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -72.44 111.44 7.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 110.924 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.53 86.37 2.4 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.599 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 56.61 38.14 29.35 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.134 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.92 -159.55 14.41 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 mmt -136.67 99.59 4.1 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.758 0.313 . . . . 0.0 110.96 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.28 72.34 1.34 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.657 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mp -142.19 128.44 19.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.632 0.253 . . . . 0.0 110.676 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.95 132.29 33.84 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.163 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 pt -133.84 171.08 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.973 0.416 . . . . 0.0 111.933 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.589 HG13 ' HB2' ' A' ' 35' ' ' TYR . 4.5 p -157.24 138.72 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.002 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.87 97.47 9.31 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.74 -179.82 5.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.511 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.25 -179.59 3.99 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.289 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.25 -142.36 3.41 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.97 155.86 17.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.795 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.55 23.6 43.65 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.408 -0.901 . . . . 0.0 110.955 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.26 103.39 7.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.534 -0.333 . . . . 0.0 111.272 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.448 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 10.5 t70 -87.22 9.21 20.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.435 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.931 ' HB2' HG12 ' A' ' 66' ' ' VAL . 4.3 mttt -142.59 -167.46 2.51 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.192 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tp -112.01 132.74 54.61 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.635 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.55 153.16 17.74 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.567 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.572 HD11 ' CB ' ' A' ' 73' ' ' ALA . 47.3 mm -83.5 101.32 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.892 0.377 . . . . 0.0 110.63 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.589 ' HB2' HG13 ' A' ' 22' ' ' VAL . 19.9 m-85 -87.96 136.75 32.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.551 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.81 115.66 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.104 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -73.73 -44.75 55.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.785 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.35 172.22 3.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 111.501 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.8 t -124.77 136.88 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.19 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 t -77.61 142.64 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.407 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -72.11 138.97 48.14 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.814 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.49 -14.2 65.36 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.25 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.64 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -73.93 -168.19 16.81 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.558 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.04 -54.5 6.46 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.831 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . -58.63 -39.96 81.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.299 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -58.99 -44.83 91.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.083 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 43' ' ' GLY . 38.4 t -75.56 -34.2 28.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.096 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.88 -38.99 70.89 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.114 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.19 27.03 71.88 Favored Glycine 0 CA--C 1.521 0.469 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.897 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.458 ' HG3' HG11 ' A' ' 9' ' ' VAL . 7.6 mmt180 -102.51 -34.37 9.15 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.553 0.216 . . . . 0.0 111.015 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.831 HD11 ' HB1' ' A' ' 45' ' ' ALA . 4.3 pp -122.38 175.98 6.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.05 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.96 -171.03 3.49 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.287 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.15 153.55 42.43 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.188 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.31 53.15 14.37 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.085 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.13 160.22 24.18 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.743 0.306 . . . . 0.0 111.135 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.548 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 4.9 tm0? -113.44 109.88 19.4 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.443 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.783 ' HG ' HG12 ' A' ' 88' ' ' VAL . 2.2 mt -85.76 119.31 25.95 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.364 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.64 -61.38 1.47 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.57 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.414 ' H ' ' HG2' ' A' ' 87' ' ' GLU . 2.9 m -120.61 156.99 30.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 111.705 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.666 HG22 ' CD1' ' A' ' 86' ' ' LEU . 38.5 t -135.54 113.87 15.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.559 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t0 64.47 20.69 12.24 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.311 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.36 -23.46 26.75 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.642 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.06 142.71 27.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.494 0.647 . . . . 0.0 111.148 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.76 122.84 36.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.95 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.8 mt -102.79 39.94 1.46 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.931 HG12 ' HB2' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -96.04 97.08 6.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.267 179.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.408 ' CA ' ' HB3' ' A' ' 31' ' ' LYS . . . 119.04 38.19 0.76 Allowed Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.305 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.5 mt -138.5 174.89 10.06 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.704 0.288 . . . . 0.0 110.757 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.6 m -94.8 165.81 12.29 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -55.65 -31.84 62.69 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.968 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.98 -57.72 8.88 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.335 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -53.72 -48.23 69.82 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.664 -0.243 . . . . 0.0 111.621 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.572 ' CB ' HD11 ' A' ' 34' ' ' ILE . . . -65.01 -48.59 73.37 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.714 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.34 90.31 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.025 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -59.73 -26.9 66.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.361 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.3 mt -87.66 -48.27 8.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.593 0.235 . . . . 0.0 111.115 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.656 ' HE3' HD13 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -59.89 -31.36 69.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.076 179.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.442 HG23 ' HG2' ' A' ' 79' ' ' ARG . 15.2 t -74.25 -31.22 62.49 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.629 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.442 ' HG2' HG23 ' A' ' 78' ' ' THR . 12.5 mmt180 -87.1 49.67 1.86 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.734 0.302 . . . . 0.0 111.377 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.412 ' HB ' ' CG2' ' A' ' 84' ' ' VAL . 1.5 p -103.63 169.09 8.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.841 0.353 . . . . 0.0 111.234 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.87 -168.1 1.5 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.57 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 96.9 p -55.38 -36.84 66.82 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.271 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.8 t -122.96 138.33 53.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.621 0.248 . . . . 0.0 111.256 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.412 ' CG2' ' HB ' ' A' ' 80' ' ' THR . 3.6 t -141.37 147.76 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.504 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.4 m -102.7 99.26 9.22 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.856 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.727 HD12 HD22 ' A' ' 57' ' ' LEU . 4.5 mm? -106.55 136.47 46.27 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.259 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 59' ' ' SER . 1.2 pm0 -117.29 101.0 8.06 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.661 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.783 HG12 ' HG ' ' A' ' 57' ' ' LEU . 34.1 m -104.05 166.56 2.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.254 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -122.18 113.57 19.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.769 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -78.57 131.22 36.68 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.912 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.19 -165.8 1.42 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.005 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.36 135.99 2.21 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.558 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.096 179.898 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mtm . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.677 0.275 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -158.62 29.85 0.23 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.655 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -148.85 83.26 6.88 Favored Pre-proline 0 N--CA 1.465 0.307 0 CA-C-O 120.664 0.269 . . . . 0.0 111.1 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' HG2' HD11 ' A' ' 6' ' ' ILE . 56.1 Cg_endo -70.44 169.46 19.73 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.806 2.337 . . . . 0.0 112.952 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -105.86 94.0 4.94 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.123 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.443 HD11 ' HG2' ' A' ' 4' ' ' PRO . 2.3 mp -96.88 122.43 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.867 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 pt -127.17 150.37 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.508 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 m -88.92 120.63 30.5 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.093 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.18 138.81 37.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.113 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.534 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -115.33 107.13 14.83 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.821 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 51' ' ' LEU . 5.1 mt -100.7 164.97 11.62 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.139 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.459 ' HE2' HG22 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -138.62 111.08 7.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.131 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.25 103.76 0.12 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.325 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -53.11 5.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.738 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -149.54 38.81 0.78 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.985 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.34 -171.32 15.86 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.5 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.3 mtp -136.01 80.19 1.81 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.851 0.357 . . . . 0.0 111.027 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.55 80.87 1.76 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.727 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.526 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -153.36 139.09 17.92 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.85 0.357 . . . . 0.0 110.914 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.4 m -100.61 135.59 41.81 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 pp -126.73 178.18 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.798 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.454 ' CG2' ' HB2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -131.96 167.01 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.975 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 70' ' ' GLN . . . -145.41 80.9 1.61 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.546 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.44 -179.34 7.0 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.673 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.86 172.08 14.26 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.755 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -151.16 -143.95 3.82 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.666 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.76 151.52 27.67 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.855 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.56 18.88 39.4 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.086 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.31 112.77 5.61 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.657 -0.271 . . . . 0.0 110.877 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.52 23.9 4.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.96 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.661 ' CB ' HG12 ' A' ' 66' ' ' VAL . 15.6 mmtp -124.21 -149.58 0.43 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 32' ' ' LEU . 1.6 tp -129.5 119.14 23.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.691 0.281 . . . . 0.0 110.788 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.82 164.74 12.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.102 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 28.3 mm -99.55 133.06 43.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.454 ' HB2' ' CG2' ' A' ' 22' ' ' VAL . 54.8 m-85 -117.0 168.6 10.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.666 0.269 . . . . 0.0 111.178 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.22 108.99 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.855 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -73.41 -41.96 62.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.76 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.35 166.04 2.77 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.178 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.1 t -123.45 128.55 74.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 t -81.47 146.36 7.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.414 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.6 tptt -65.73 143.38 57.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.833 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.32 -32.62 6.95 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.598 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.19 150.35 46.7 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.62 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.54 -36.78 56.34 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.73 -46.85 74.13 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.56 0.219 . . . . 0.0 111.143 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.85 -40.35 88.27 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.027 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 37.8 t -74.0 -31.94 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.253 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.71 -55.97 26.86 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.336 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.2 29.3 31.22 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.922 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -99.2 -45.87 5.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.887 0.343 . . . . 0.0 110.731 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -109.37 177.95 4.59 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.914 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.81 177.54 10.89 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.6 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.74 152.43 45.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.271 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.33 49.08 41.27 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.978 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.56 173.71 7.01 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.761 0.315 . . . . 0.0 111.541 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.812 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 5.2 tm0? -115.85 161.29 18.99 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.979 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.685 ' CD2' HG12 ' A' ' 88' ' ' VAL . 0.2 OUTLIER -143.91 129.13 18.77 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.897 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.99 -60.56 1.62 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.461 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.432 ' H ' ' HG3' ' A' ' 87' ' ' GLU . 30.3 m -119.29 152.69 36.27 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 111.445 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.644 HG13 ' HG ' ' A' ' 86' ' ' LEU . 44.0 t -136.01 131.64 49.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.815 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t70 54.92 36.86 27.71 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.779 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.52 28.69 73.05 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.083 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.08 145.49 48.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.922 0.361 . . . . 0.0 110.856 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.9 m -90.94 111.56 23.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.774 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.725 ' CB ' HD21 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -123.58 76.71 1.44 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.156 0.503 . . . . 0.0 110.995 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.661 HG12 ' CB ' ' A' ' 31' ' ' LYS . 4.8 t -121.1 96.25 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.542 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.73 -30.75 2.93 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.743 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.725 HD21 ' CB ' ' A' ' 65' ' ' LEU . 4.0 pp -67.27 168.86 9.72 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.048 0.451 . . . . 0.0 111.86 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 m -91.39 172.3 8.62 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.527 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 10.8 tt0 -54.94 -28.63 52.57 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.054 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -61.81 -48.87 78.66 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-O 120.717 0.294 . . . . 0.0 110.77 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.567 ' HB3' HD22 ' A' ' 68' ' ' LEU . 6.1 mpt_? -63.78 -49.77 71.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.292 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.443 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -59.89 -54.32 47.5 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.511 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.84 94.36 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.882 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 78' ' ' THR . 0.5 OUTLIER -65.52 -35.35 80.61 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 179.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 mt -67.12 -30.06 69.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.148 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.4 mtt -73.81 -39.7 63.9 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.247 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 75' ' ' GLU . 11.6 t -68.93 -30.99 69.56 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.554 0.216 . . . . 0.0 111.194 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -89.79 49.54 1.74 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.84 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.2 p -123.92 172.16 9.14 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.912 0.387 . . . . 0.0 111.381 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.28 -171.42 3.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.637 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 p -51.71 -46.62 64.01 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.534 ' CG1' HG22 ' A' ' 10' ' ' THR . 22.5 t -97.96 137.97 24.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.661 HG12 HD12 ' A' ' 86' ' ' LEU . 3.5 t -128.54 130.93 69.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.92 98.43 8.28 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.271 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.661 HD12 HG12 ' A' ' 84' ' ' VAL . 0.5 OUTLIER -114.03 115.02 26.94 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.737 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 59' ' ' SER . 0.9 OUTLIER -84.88 104.89 15.23 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.978 0.418 . . . . 0.0 110.773 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.685 HG12 ' CD2' ' A' ' 57' ' ' LEU . 32.5 m -92.01 168.31 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.803 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.812 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -127.64 133.52 49.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.659 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -94.56 123.1 37.79 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.319 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -163.12 -167.01 1.37 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.13 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.78 138.17 2.49 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.304 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.346 -179.961 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mtp . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 111.475 0.176 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -90.14 52.9 2.36 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.912 0.387 . . . . 0.0 110.924 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -69.64 146.45 95.91 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.02 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.08 169.67 2.65 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.965 2.443 . . . . 0.0 112.9 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -79.86 84.62 5.61 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.087 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.98 133.79 29.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.303 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.24 138.16 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.392 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.775 HG23 ' HB2' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -104.23 120.02 40.23 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.474 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -118.67 170.72 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.646 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.726 HG23 HG23 ' A' ' 85' ' ' THR . 0.2 OUTLIER -134.17 116.34 15.27 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.857 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.518 HD22 ' NE ' ' A' ' 50' ' ' ARG . 4.3 mp -126.07 165.91 17.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.142 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HG3' HG22 ' A' ' 83' ' ' VAL . 1.3 mptt -107.95 135.67 48.94 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.088 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 125.06 22.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.115 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -102.59 66.1 0.95 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.677 179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 56.99 38.49 29.39 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.3 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.13 -152.81 24.59 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.374 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.694 ' HB3' HD12 ' A' ' 19' ' ' LEU . 1.7 mtt -147.61 -72.99 0.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.709 0.254 . . . . 0.0 111.484 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.17 63.87 2.43 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.604 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 17' ' ' MET . 1.4 mp -143.82 123.8 13.57 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.499 0.19 . . . . 0.0 110.607 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -85.1 125.31 32.67 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.697 0.284 . . . . 0.0 110.989 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 pt -127.88 171.46 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.607 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 35' ' ' TYR . 6.4 p -159.6 138.5 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.302 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -99.2 97.26 8.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.817 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -131.15 -179.76 5.53 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.633 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HG3' HD12 ' A' ' 32' ' ' LEU . 1.1 ttmt -119.72 -179.91 4.04 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.84 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.13 -144.14 3.91 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.789 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.02 163.41 14.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.666 0.269 . . . . 0.0 110.918 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.44 20.93 52.97 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.564 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.94 -164.65 1.26 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.023 0.439 . . . . 0.0 110.092 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.539 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -173.39 21.24 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.254 178.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.539 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -154.35 -168.92 3.08 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.741 0.416 . . . . 0.0 110.221 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.4 HD12 ' HG3' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -113.24 116.94 30.55 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.873 0.368 . . . . 0.0 110.575 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.23 144.62 16.03 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.699 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.426 HD11 HD12 ' A' ' 68' ' ' LEU . 46.5 mm -77.55 99.59 2.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 120.955 0.407 . . . . 0.0 110.606 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.524 ' HB2' HG13 ' A' ' 22' ' ' VAL . 22.4 m-85 -86.89 144.84 26.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.404 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.431 HG11 HD13 ' A' ' 51' ' ' LEU . 18.4 t -93.95 118.73 40.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.985 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -80.21 -42.54 23.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.854 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.8 172.08 4.98 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.437 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.8 t -124.53 132.13 71.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.022 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.73 142.77 14.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.0 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 155.44 39.23 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.344 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.91 16.66 70.68 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.003 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.537 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -99.2 153.55 19.74 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.349 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . . . -54.0 -35.78 62.25 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.1 -32.64 56.76 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.344 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -76.43 -44.32 36.34 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.21 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 43' ' ' GLY . 34.6 t -65.47 -48.42 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.233 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.85 -31.97 61.79 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.33 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.9 54.98 2.91 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.935 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.518 ' NE ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -78.22 -62.94 1.52 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.701 0.286 . . . . 0.0 111.08 -179.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.946 HD23 HG21 ' A' ' 88' ' ' VAL . 1.9 pp -131.07 161.11 32.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.907 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.35 -177.06 3.67 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.08 144.32 57.33 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.412 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.01 44.08 46.87 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.546 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -112.71 179.84 3.86 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.648 0.261 . . . . 0.0 111.143 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.772 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 13.2 tm0? -127.31 158.53 36.97 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.082 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.63 HD22 HD22 ' A' ' 86' ' ' LEU . 6.0 mt -143.81 130.61 20.33 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.55 0.215 . . . . 0.0 111.18 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.71 HD23 HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -120.8 -59.59 1.73 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.787 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.5 m -90.48 139.66 30.48 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.024 0.44 . . . . 0.0 112.152 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.598 HG21 HD12 ' A' ' 65' ' ' LEU . 21.3 t -141.54 110.68 2.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.742 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 56.74 37.13 28.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.119 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.62 28.63 60.95 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.004 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -118.99 148.08 43.38 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.808 0.304 . . . . 0.0 110.68 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.4 91.81 7.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.774 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.659 ' HB3' HD21 ' A' ' 68' ' ' LEU . 24.9 mt -96.61 93.29 6.67 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.995 0.426 . . . . 0.0 110.945 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.71 HG22 HD23 ' A' ' 58' ' ' LEU . 8.2 t -138.86 94.74 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.137 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.9 37.25 0.97 Allowed Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.815 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.659 HD21 ' HB3' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -130.32 157.51 42.35 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.887 0.375 . . . . 0.0 111.057 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 p -74.29 168.13 20.24 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.374 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -58.57 -40.58 83.51 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.9 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -55.04 -40.32 70.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.945 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -66.54 -48.31 70.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.215 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.61 -49.1 67.41 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.235 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.75 -43.63 90.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.803 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HA ' HG22 ' A' ' 78' ' ' THR . 1.5 tp10 -64.98 -37.4 87.53 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.5 mt -73.27 -36.71 66.39 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.235 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.4 mtp -76.37 -34.52 58.91 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.801 -0.182 . . . . 0.0 111.429 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 75' ' ' GLU . 15.1 t -73.37 -39.89 64.78 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 121.216 -0.193 . . . . 0.0 110.851 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.429 ' HG3' HG23 ' A' ' 78' ' ' THR . 73.2 mtp85 -90.68 59.03 4.08 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.0 0.429 . . . . 0.0 110.57 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.418 ' HB ' HG22 ' A' ' 84' ' ' VAL . 43.4 p -114.29 164.29 14.11 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.289 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.1 p -79.4 -165.69 0.83 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.573 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.5 -51.98 67.27 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.538 0.208 . . . . 0.0 110.902 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.675 ' CG1' HG22 ' A' ' 10' ' ' THR . 26.3 t -100.61 138.47 24.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.018 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 80' ' ' THR . 19.4 t -132.82 127.55 55.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.563 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.726 HG23 HG23 ' A' ' 10' ' ' THR . 0.7 OUTLIER -97.59 107.31 19.79 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.472 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.63 HD22 HD22 ' A' ' 57' ' ' LEU . 24.4 mt -116.35 136.91 52.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.96 0.41 . . . . 0.0 111.452 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.775 ' HB2' HG23 ' A' ' 8' ' ' THR . 38.4 tt0 -106.66 97.3 7.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.109 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.946 HG21 HD23 ' A' ' 51' ' ' LEU . 19.7 t -98.8 139.05 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.785 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.772 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -100.84 118.28 36.59 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.677 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.57 123.76 22.16 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.866 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -169.92 -177.89 2.75 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.228 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.85 135.99 1.98 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.507 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.769 -0.634 . . . . 0.0 112.185 179.922 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ptt? . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.523 0.201 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.08 136.45 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.231 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -99.45 107.79 47.09 Favored Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.046 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.83 170.36 1.03 Allowed 'Trans proline' 0 C--N 1.351 0.711 0 C-N-CA 123.072 2.515 . . . . 0.0 112.956 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -75.7 86.14 2.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.006 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.6 mm -91.6 128.43 43.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.83 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 pt -147.84 149.15 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.516 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.656 HG22 HG22 ' A' ' 85' ' ' THR . 1.3 m -118.91 130.96 56.0 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.848 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.755 HG11 ' HG3' ' A' ' 50' ' ' ARG . 13.6 t -125.89 141.09 46.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.409 ' HB ' ' CG1' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -83.74 92.61 7.76 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.632 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.566 HD21 ' HA ' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -84.89 131.64 34.48 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.27 138.86 31.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -68.81 155.33 40.37 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.918 0.39 . . . . 0.0 111.356 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.54 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -144.31 66.6 1.27 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.531 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 57.49 35.95 26.42 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.127 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.58 -172.54 27.1 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.508 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 11.7 mmm -112.31 -73.48 0.67 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.616 0.246 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.82 49.44 7.1 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.836 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.701 ' HG ' HG13 ' A' ' 39' ' ' VAL . 4.5 mp -148.54 110.15 4.47 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.604 0.24 . . . . 0.0 110.744 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 t -80.59 130.47 35.14 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.648 HD13 HG23 ' A' ' 34' ' ' ILE . 2.8 pp -130.15 178.32 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.658 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.2 p -148.52 145.19 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.409 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.14 84.92 2.41 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.329 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.76 179.21 4.21 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.531 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.84 176.97 9.24 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.745 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.33 145.14 13.28 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.16 155.56 40.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.873 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.39 19.87 48.83 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.49 -159.8 0.99 Allowed 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 123.421 0.689 . . . . 0.0 109.737 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -173.78 31.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.923 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.78 -171.57 3.72 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.624 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.62 106.01 15.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.72 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.66 174.81 33.62 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.801 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.648 HG23 HD13 ' A' ' 21' ' ' ILE . 30.7 mm -102.27 111.49 32.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.657 0.265 . . . . 0.0 110.711 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.454 ' CE1' ' HG2' ' A' ' 56' ' ' GLN . 81.7 m-85 -104.35 153.82 20.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.36 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.05 125.45 53.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.128 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.38 -34.81 8.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.337 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 m -164.87 168.32 17.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.763 0.316 . . . . 0.0 111.417 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.701 HG13 ' HG ' ' A' ' 19' ' ' LEU . 26.7 t -135.74 138.44 47.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.991 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.09 133.99 29.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.33 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.65 140.36 49.66 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.074 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.6 -14.46 64.87 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.304 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.55 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -72.22 -161.66 5.53 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.405 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.54 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . . . -90.77 -36.71 14.12 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.591 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -62.16 -51.37 68.13 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.87 -38.99 83.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.447 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 43' ' ' GLY . 41.6 t -73.45 -31.88 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.031 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.7 -44.05 85.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.099 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.8 51.78 14.22 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.681 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.755 ' HG3' HG11 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -121.71 -45.93 2.26 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.611 0.244 . . . . 0.0 111.294 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 pp -135.58 172.51 12.91 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.006 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.9 -160.12 1.09 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.381 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.8 152.96 43.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.574 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.03 48.1 21.67 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.159 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -121.31 170.61 9.44 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.736 0.303 . . . . 0.0 111.422 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.775 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 7.5 tm0? -119.45 135.01 54.94 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.916 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -120.97 129.32 53.38 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.804 0.335 . . . . 0.0 111.014 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.47 -61.4 1.6 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.459 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.3 p -111.45 146.63 36.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.061 0.458 . . . . 0.0 111.867 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.495 HG11 ' HG2' ' A' ' 77' ' ' MET . 21.9 t -132.11 119.19 39.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.479 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t70 59.95 35.26 21.64 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.04 -16.04 56.53 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.678 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -92.1 138.29 31.66 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 117.381 0.59 . . . . 0.0 111.096 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.15 114.44 25.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.825 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.2 mt -100.74 76.89 1.83 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.711 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 t -122.25 91.5 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.034 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.11 32.6 1.98 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.574 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 32.4 mt -123.15 155.67 36.57 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.744 0.307 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.1 m -74.03 158.75 33.74 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -55.06 -35.79 64.9 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.956 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.02 -44.21 97.2 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.919 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.31 -52.89 56.28 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.224 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.28 -52.04 66.37 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.569 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.64 -46.85 86.21 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.018 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' O ' HG22 ' A' ' 78' ' ' THR . 1.8 tp10 -62.54 -36.96 84.26 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.677 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.1 mt -69.39 -34.05 73.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.961 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.495 ' HG2' HG11 ' A' ' 60' ' ' VAL . 2.0 mtt -71.99 -39.53 69.2 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.114 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 75' ' ' GLU . 11.1 t -68.53 -32.35 72.23 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.564 0.221 . . . . 0.0 110.983 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -91.52 48.24 1.45 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.542 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.8 p -109.38 174.3 5.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.764 0.316 . . . . 0.0 111.207 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -84.9 -170.25 3.04 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.67 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -56.14 -37.83 70.02 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.684 0.278 . . . . 0.0 111.094 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 10' ' ' THR . 25.4 t -113.47 139.23 39.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.097 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.1 t -130.37 119.62 46.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.082 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.656 HG22 HG22 ' A' ' 8' ' ' THR . 0.3 OUTLIER -89.91 98.31 11.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.826 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.47 ' HG ' HG13 ' A' ' 60' ' ' VAL . 5.0 mp -103.17 127.15 50.55 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.12 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 4.6 tt0 -91.94 96.29 10.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.543 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.4 p -93.32 147.58 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.874 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.775 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -113.72 135.01 54.41 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.101 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.98 126.93 42.47 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -160.96 -166.77 1.66 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.849 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 174.05 137.18 2.38 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.393 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.119 -0.943 . . . . 0.0 111.179 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.796 0.331 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -144.71 168.05 21.1 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.807 0.337 . . . . 0.0 111.088 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -117.99 116.23 36.18 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.172 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.47 -173.89 1.09 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.793 2.329 . . . . 0.0 112.762 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.56 103.07 9.1 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.991 0.424 . . . . 0.0 111.12 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.825 HG22 ' HG2' ' A' ' 87' ' ' GLU . 1.4 mp -94.49 126.01 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.815 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.5 pt -138.41 143.21 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.403 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.54 HG22 HG22 ' A' ' 85' ' ' THR . 25.3 m -96.4 134.49 39.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.828 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -117.92 127.08 75.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.24 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.687 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -86.07 99.78 11.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.797 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.8 mt -107.79 157.58 18.02 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.965 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HG2' HG22 ' A' ' 83' ' ' VAL . 2.3 mttt -118.93 138.61 52.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.828 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -72.21 114.67 10.58 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.304 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.49 -41.1 7.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.611 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -160.39 44.12 0.2 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.49 -177.6 29.66 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.576 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.0 mtt -120.19 93.57 4.1 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.819 0.342 . . . . 0.0 110.895 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.8 71.38 3.0 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.486 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 45' ' ' ALA . 1.6 mp -146.09 115.56 7.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.571 0.224 . . . . 0.0 110.466 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 m -80.07 129.52 34.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.906 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.526 HD13 HG23 ' A' ' 34' ' ' ILE . 2.9 pp -124.22 176.16 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.017 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.89 151.47 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.617 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' GLY . . . -107.13 115.2 29.76 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.785 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.65 -179.58 8.21 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.896 0.379 . . . . 0.0 111.909 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -94.43 167.11 11.72 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.861 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.05 -141.76 3.45 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.25 147.74 30.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.986 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.63 16.42 37.31 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.267 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.99 107.9 4.34 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.573 0.225 . . . . 0.0 110.951 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -93.37 25.15 3.52 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.946 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.29 -157.77 0.72 Allowed 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -132.68 108.53 9.1 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.808 0.337 . . . . 0.0 110.677 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 23' ' ' ALA . . . -107.31 -178.23 22.58 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.768 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.536 HD11 ' CB ' ' A' ' 73' ' ' ALA . 36.3 mm -97.48 129.04 48.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.617 0.246 . . . . 0.0 110.759 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.525 ' CE2' ' HG3' ' A' ' 56' ' ' GLN . 15.3 m-85 -114.2 166.03 12.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.139 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.21 109.55 28.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.844 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.05 -34.95 22.17 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.201 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.46 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 3.7 t -169.58 170.88 7.89 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.707 0.289 . . . . 0.0 111.518 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.404 HG13 ' HG ' ' A' ' 19' ' ' LEU . 17.0 t -130.7 151.41 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.213 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 t -101.53 139.86 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.147 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -58.74 136.29 57.69 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.043 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.28 -22.48 37.64 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.01 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -62.29 135.08 45.41 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.468 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.22 -36.34 19.83 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.587 ' HB3' HD21 ' A' ' 19' ' ' LEU . . . -60.25 -50.53 73.27 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.762 0.315 . . . . 0.0 111.361 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -70.93 -45.56 64.01 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 43' ' ' GLY . 40.3 t -59.88 -36.42 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.396 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.62 -49.84 29.34 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.657 0.265 . . . . 0.0 110.914 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.04 60.56 1.06 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.809 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -123.37 -50.9 1.87 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.681 0.277 . . . . 0.0 110.936 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 pp -122.57 175.99 6.17 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.945 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.28 -174.89 5.14 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.305 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -69.75 165.81 20.59 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.356 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.59 45.72 88.14 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.34 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.22 172.98 11.94 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.799 0.333 . . . . 0.0 111.423 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.666 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -112.64 173.29 6.44 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.706 179.5 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.837 HD21 HD23 ' A' ' 86' ' ' LEU . 3.1 tp -155.84 133.05 10.77 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.066 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.657 HD12 HG22 ' A' ' 66' ' ' VAL . 3.9 mm? -115.4 -60.52 1.87 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.34 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 5.7 t -97.43 146.15 25.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.189 0.519 . . . . 0.0 112.14 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.698 HG23 HD21 ' A' ' 65' ' ' LEU . 34.4 t -140.41 126.66 21.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.596 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.8 t0 54.99 38.37 30.42 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.05 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.81 -12.92 45.93 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.707 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -90.73 158.78 16.69 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 117.399 0.6 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.57 108.04 16.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.43 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.698 HD21 HG23 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -110.83 96.76 6.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 110.988 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.657 HG22 HD12 ' A' ' 58' ' ' LEU . 17.2 t -125.03 92.61 2.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.814 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 119.16 36.24 0.88 Allowed Glycine 0 CA--C 1.518 0.271 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.313 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.522 HD22 ' HG2' ' A' ' 72' ' ' ARG . 12.4 mt -120.08 174.78 6.27 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.773 0.32 . . . . 0.0 110.728 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -98.23 163.71 12.61 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -57.09 -28.42 62.61 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.454 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -66.2 -49.2 68.11 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.739 0.304 . . . . 0.0 110.695 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.522 ' HG2' HD22 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -65.7 -45.5 82.58 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.365 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.536 ' CB ' HD11 ' A' ' 34' ' ' ILE . . . -64.81 -51.45 62.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.593 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.17 -37.04 78.96 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.749 0.309 . . . . 0.0 110.695 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 78' ' ' THR . 2.0 tp10 -67.9 -37.49 81.79 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.818 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mt -73.47 -40.81 63.85 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.163 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -32.66 74.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.172 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 75' ' ' GLU . 14.4 t -79.63 -33.5 41.33 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.881 -0.145 . . . . 0.0 111.388 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.81 46.04 1.35 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.688 0.28 . . . . 0.0 111.499 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 71.5 p -106.39 168.78 8.92 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.812 0.339 . . . . 0.0 111.026 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -80.62 -167.01 1.21 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.536 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.2 p -59.88 -39.8 86.52 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.674 0.273 . . . . 0.0 110.693 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.687 ' CG1' HG22 ' A' ' 10' ' ' THR . 19.6 t -105.03 142.73 17.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.804 179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.7 t -135.98 143.73 35.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.229 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.682 HG23 HG23 ' A' ' 10' ' ' THR . 0.0 OUTLIER -122.3 118.89 29.57 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.695 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.837 HD23 HD21 ' A' ' 57' ' ' LEU . 4.8 mp -120.2 120.81 37.22 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.415 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.825 ' HG2' HG22 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -81.68 93.19 6.72 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.476 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.544 ' HA ' HD12 ' A' ' 57' ' ' LEU . 9.1 p -88.18 137.31 21.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.641 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.666 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -105.62 126.57 52.29 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.038 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -94.38 101.21 13.14 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.445 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -135.5 -172.9 3.2 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.16 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 157.07 140.83 3.03 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.356 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.634 179.953 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 111.323 0.12 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 mttp 67.08 156.85 0.11 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.949 0.404 . . . . 0.0 111.412 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -77.66 148.79 76.97 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.142 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.12 158.68 53.31 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.851 2.367 . . . . 0.0 112.726 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 41.1 tt0 -100.24 91.23 4.65 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.272 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 6' ' ' ILE . 3.7 mp -84.12 126.72 40.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.657 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 pt -145.86 146.65 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.566 ' OG1' HG22 ' A' ' 85' ' ' THR . 13.2 t -115.42 141.69 47.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.775 0.321 . . . . 0.0 111.107 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.579 HG11 HH11 ' A' ' 50' ' ' ARG . 2.0 m -141.73 148.78 20.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.502 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.691 ' CG2' HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -79.83 128.53 33.55 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.998 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.998 HD21 ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -120.4 121.93 39.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.712 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -101.04 99.13 9.53 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.701 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.3 130.28 43.89 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.176 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -78.95 -59.34 2.82 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.503 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -158.01 37.4 0.25 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.077 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.05 -163.96 28.62 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.359 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.1 mmt -139.4 101.46 4.24 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.674 0.273 . . . . 0.0 111.047 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.7 77.36 0.71 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.729 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.557 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -157.14 137.41 12.81 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 111.058 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -105.45 109.0 20.82 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.776 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 pt -102.91 178.29 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.473 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.461 HG13 ' HB2' ' A' ' 35' ' ' TYR . 2.5 p -155.42 134.42 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.228 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.29 104.24 16.13 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.63 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -143.74 -179.72 6.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.186 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.628 ' HG3' HD12 ' A' ' 32' ' ' LEU . 5.4 mtpt -101.46 179.36 4.38 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.846 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.53 -145.4 4.23 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.83 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.33 163.19 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.652 0.263 . . . . 0.0 110.921 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.49 20.13 44.14 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.555 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.81 -163.11 0.94 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.203 0.525 . . . . 0.0 109.962 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.437 ' C ' ' HG2' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -168.13 18.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.62 178.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HB2' HG12 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -156.97 -170.79 3.41 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.628 HD12 ' HG3' ' A' ' 25' ' ' LYS . 4.9 tp -99.54 123.96 44.29 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.607 0.241 . . . . 0.0 110.864 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.452 ' C ' HD12 ' A' ' 34' ' ' ILE . . . -118.16 175.03 15.54 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.806 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.564 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.6 mp -103.46 154.0 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 O-C-N 122.774 -0.25 . . . . 0.0 110.456 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.461 ' HB2' HG13 ' A' ' 22' ' ' VAL . 68.2 m-85 -136.14 158.46 44.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.249 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.468 HG21 HD13 ' A' ' 51' ' ' LEU . 22.4 t -102.94 108.84 25.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HD2' ' HB ' ' A' ' 22' ' ' VAL . 23.8 mtpt -81.71 -38.92 25.02 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.821 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.0 t -175.23 158.39 2.38 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.094 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.414 ' CG1' ' HB2' ' A' ' 46' ' ' ASP . 10.9 t -128.07 146.13 34.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.901 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.68 140.32 16.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.968 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -68.28 91.08 0.37 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.434 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.63 -32.35 0.48 Allowed Glycine 0 CA--C 1.519 0.342 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.493 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.602 ' O ' HG12 ' A' ' 47' ' ' VAL . . . -59.56 148.15 41.91 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.049 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -55.09 -21.08 11.49 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.998 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -86.94 -33.73 19.58 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.504 0.192 . . . . 0.0 111.442 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.414 ' HB2' ' CG1' ' A' ' 39' ' ' VAL . 0.7 OUTLIER -86.21 -49.13 7.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.264 -179.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 43' ' ' GLY . 8.2 p -62.83 -29.88 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.829 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' OD1' HG13 ' A' ' 47' ' ' VAL . 11.6 m-20 -86.83 -50.04 7.0 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.554 0.216 . . . . 0.0 110.552 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.52 93.14 2.28 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.389 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.579 HH11 HG11 ' A' ' 9' ' ' VAL . 2.9 mmp_? -143.18 -50.62 0.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.442 0.163 . . . . 0.0 111.056 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.704 HD22 HG11 ' A' ' 88' ' ' VAL . 2.4 pp -135.37 138.86 43.75 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.752 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.14 -170.52 1.67 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.304 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.28 153.66 42.0 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 111.121 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.83 37.29 65.91 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.284 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.46 173.88 6.12 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.769 0.318 . . . . 0.0 111.062 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.879 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -122.63 156.6 33.96 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.795 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.443 ' CD2' HG12 ' A' ' 88' ' ' VAL . 7.3 mt -133.95 135.13 43.32 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.152 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.658 HD23 ' CG2' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -120.41 -55.93 2.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.555 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.3 m -115.0 156.06 25.79 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.652 HG13 ' CD2' ' A' ' 86' ' ' LEU . 26.1 t -140.14 139.25 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.138 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.867 ' HB3' HG13 ' A' ' 84' ' ' VAL . 5.6 p-10 43.47 41.75 3.48 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.167 0.587 . . . . 0.0 111.793 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.8 32.55 74.13 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.807 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -132.75 145.37 50.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.932 0.366 . . . . 0.0 110.7 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.8 m -92.55 126.15 37.51 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.641 HD21 HG23 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -136.48 61.43 1.64 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.334 0.588 . . . . 0.0 111.022 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.658 ' CG2' HD23 ' A' ' 58' ' ' LEU . 10.5 t -102.74 98.44 6.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.676 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.6 -26.21 2.67 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.068 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' ' 65' ' ' LEU . 2.0 mt -76.54 174.09 10.75 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.802 0.334 . . . . 0.0 111.083 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.5 t -96.94 -176.57 3.6 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.972 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -60.1 -32.81 71.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 2.0 mp0 -58.54 -58.85 6.73 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.958 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.419 ' HB2' ' HB3' ' A' ' 68' ' ' LEU . 10.7 mmm180 -63.38 -42.78 98.85 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.267 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.08 -48.41 81.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.272 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.21 -44.85 71.24 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.749 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -60.46 -31.88 70.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.05 179.511 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mt -71.17 -36.54 72.03 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.727 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.592 ' HG2' HG11 ' A' ' 60' ' ' VAL . 3.2 mtt -67.62 -46.36 72.74 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.133 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.8 t -64.4 -27.92 69.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 121.213 -0.195 . . . . 0.0 111.043 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.4 mtm-85 -91.19 51.68 1.97 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.407 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.3 p -130.48 -177.29 4.27 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.865 0.364 . . . . 0.0 110.998 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 t -110.58 -165.5 1.0 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.562 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 t -54.73 -49.93 69.6 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.117 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.691 HG13 ' CG2' ' A' ' 10' ' ' THR . 60.2 t -86.95 126.15 40.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.217 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.867 HG13 ' HB3' ' A' ' 61' ' ' ASP . 25.4 t -145.9 110.2 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.231 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.566 HG22 ' OG1' ' A' ' 8' ' ' THR . 0.2 OUTLIER -84.35 120.14 25.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.658 179.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.652 ' CD2' HG13 ' A' ' 60' ' ' VAL . 49.8 mt -110.44 115.15 29.14 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.719 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 2.2 tt0 -87.2 92.16 8.97 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.353 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.704 HG11 HD22 ' A' ' 51' ' ' LEU . 30.8 m -94.39 173.55 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.354 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.879 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -128.88 120.67 26.63 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.076 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 8.9 mmtt -84.59 94.26 8.56 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.6 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -162.89 -177.18 5.34 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 161.58 137.15 2.14 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.577 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.425 -0.797 . . . . 0.0 111.186 179.808 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.1 mmt . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.627 0.251 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.7 125.13 22.55 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 64.66 102.22 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.262 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.63 167.49 2.08 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.091 2.527 . . . . 0.0 113.151 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.89 88.88 7.63 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.469 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.2 mt -93.52 138.75 19.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.57 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 pp -145.35 141.99 22.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.438 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 2.2 m -101.9 114.41 28.48 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.816 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 m -127.97 162.34 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.642 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -97.36 142.36 29.33 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.188 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -114.13 129.3 56.62 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.832 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 82' ' ' SER . 6.8 mmtt -94.63 107.89 19.87 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.72 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -66.7 124.81 23.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.248 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -97.48 -53.57 3.41 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.857 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -154.46 36.3 0.42 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.32 -149.91 17.96 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.273 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.4 mmt -141.9 105.5 4.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.854 0.359 . . . . 0.0 111.055 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.12 36.2 4.2 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.475 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.7 ' HG ' HG13 ' A' ' 39' ' ' VAL . 3.9 mp -111.71 106.97 15.92 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 p -79.67 128.45 33.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.007 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.34 172.58 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.964 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.76 143.19 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.453 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.16 112.83 25.65 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.524 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -154.16 172.24 17.88 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.924 0.392 . . . . 0.0 111.779 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -113.83 161.2 17.86 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.063 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.79 -140.3 3.56 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.2 158.98 16.22 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.863 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.53 25.57 42.74 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.404 -0.903 . . . . 0.0 110.902 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.65 104.19 7.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.396 -0.402 . . . . 0.0 111.088 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -88.08 14.04 9.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.478 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.489 ' CB ' HG12 ' A' ' 66' ' ' VAL . 69.9 mmtt -145.85 -162.01 1.43 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.03 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -108.99 141.76 40.63 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.688 0.28 . . . . 0.0 110.672 179.491 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -123.41 144.49 15.64 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.658 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.506 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 35.8 mm -94.04 108.93 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -96.28 168.71 10.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.9 0.381 . . . . 0.0 111.778 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.35 108.57 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.674 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -40.13 77.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.944 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.28 170.25 4.32 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.887 0.375 . . . . 0.0 111.552 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.7 HG13 ' HG ' ' A' ' 19' ' ' LEU . 37.1 t -134.84 127.67 49.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.597 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.96 137.81 23.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.136 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -65.27 152.92 42.53 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.36 20.34 69.42 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.928 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.39 -147.68 8.59 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.371 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.15 -43.41 6.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.658 0.266 . . . . 0.0 111.443 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.589 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -81.91 -34.03 30.13 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.239 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.74 -39.49 94.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.107 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.09 -35.89 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.847 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -42.06 72.56 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.272 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.03 76.56 1.13 Allowed Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.478 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -133.88 -49.58 0.82 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.535 0.168 . . . . 0.0 111.264 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.705 HD22 HG11 ' A' ' 88' ' ' VAL . 2.4 pp -135.03 148.17 49.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 111.212 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -126.73 -169.47 2.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.161 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.37 145.37 56.16 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.933 0.397 . . . . 0.0 111.931 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.28 30.14 54.97 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.068 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -101.72 176.05 5.35 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.973 0.387 . . . . 0.0 111.655 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.624 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 5.0 tm0? -116.74 169.91 9.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.835 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.816 HD11 HD22 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -155.69 139.09 15.8 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.705 179.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 66' ' ' VAL . 7.3 mt -121.05 -58.49 1.8 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.1 m -121.82 153.85 37.79 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.735 HG13 ' HG ' ' A' ' 86' ' ' LEU . 21.3 t -140.51 122.06 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.847 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 t0 57.67 33.8 23.69 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.207 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.54 -8.49 71.66 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.341 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -84.81 155.24 21.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.133 0.466 . . . . 0.0 111.177 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.9 t -99.29 139.95 34.18 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.036 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 73' ' ' ALA . 4.3 mp -136.02 36.49 2.81 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.984 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.489 HG12 ' CB ' ' A' ' 31' ' ' LYS . 11.6 t -97.85 92.6 2.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.48 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.93 -25.47 4.14 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.644 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.533 HD22 ' HG2' ' A' ' 72' ' ' ARG . 13.8 mt -74.4 -177.32 3.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.866 0.365 . . . . 0.0 111.254 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.7 t -115.82 -171.81 2.04 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.008 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -62.57 -30.3 71.22 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.465 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.75 -50.73 69.89 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.775 0.321 . . . . 0.0 110.817 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.533 ' HG2' HD22 ' A' ' 68' ' ' LEU . 3.6 mpt_? -69.73 -42.49 73.91 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.987 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.534 ' HA ' HD23 ' A' ' 65' ' ' LEU . . . -55.43 -47.71 75.58 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.376 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.99 -69.18 0.29 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.263 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -37.88 -39.93 0.41 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.7 mt -70.73 -40.1 72.97 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.528 0.204 . . . . 0.0 111.384 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.46 ' CG ' HG11 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -85.21 -7.17 59.16 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.14 -29.13 28.89 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 122.376 -0.203 . . . . 0.0 110.97 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -90.85 31.93 1.03 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.432 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 54.0 p -79.89 176.01 10.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.821 0.343 . . . . 0.0 110.811 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.35 -160.68 1.05 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.587 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 19.6 m -56.12 -27.65 54.76 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.34 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.2 t -132.97 142.73 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.945 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.0 p -158.3 127.09 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.341 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.49 106.22 15.91 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.068 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.816 HD22 HD11 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -109.6 115.25 29.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.824 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 36.3 tt0 -88.7 109.15 19.9 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.508 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.705 HG11 HD22 ' A' ' 51' ' ' LEU . 19.0 m -117.02 169.91 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.708 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.624 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -120.33 131.16 54.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.698 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.16 75.14 3.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.812 0.339 . . . . 0.0 110.412 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -124.55 -165.71 1.42 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.994 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.81 142.4 3.85 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.474 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.537 -0.744 . . . . 0.0 111.33 179.73 . . . . . . . . 0 0 . 1 stop_ save_